0001144204-15-054988.txt : 20150924 0001144204-15-054988.hdr.sgml : 20150924 20150915143210 ACCESSION NUMBER: 0001144204-15-054988 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20150228 FILED AS OF DATE: 20150915 DATE AS OF CHANGE: 20150915 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DYNACQ HEALTHCARE INC CENTRAL INDEX KEY: 0000890908 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760375477 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-21574 FILM NUMBER: 151107531 BUSINESS ADDRESS: STREET 1: 4301 VISTA ROAD CITY: PASADENA STATE: TX ZIP: 77504 BUSINESS PHONE: 713-378-2000 MAIL ADDRESS: STREET 1: 4301 VISTA ROAD CITY: PASADENA STATE: TX ZIP: 77504 FORMER COMPANY: FORMER CONFORMED NAME: DYNACQ INTERNATIONAL INC DATE OF NAME CHANGE: 19960126 10-Q 1 v419846_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 28, 2015

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _________________________

Commission File Number: 000-21574

DYNACQ HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

Nevada	76-0375477
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)

4301 Vista Road
Pasadena, Texas	77504
(Address of principal executive offices)	(Zip Code)

(713) 378-2000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ¨ No x

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. (Check One):

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of August 31, 2015, the number of shares outstanding of the registrant's common stock, par value $.001 per share, was 13,460,124.

Table of Contents

		Page

PART I—FINANCIAL INFORMATION		3

Item 1.	Financial Statements.	3

	Consolidated Balance Sheets as of February 28, 2015 and August 31, 2014.	3

	Consolidated Statements of Operations for the three and six months ended February 28, 2015 and 2014.	5

	Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended February 28, 2015 and 2014.	6

	Consolidated Statements of Cash Flows for the six months ended February 28, 2015 and 2014.	7

	Notes to Consolidated Financial Statements.	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	17

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	23

Item 4.	Controls and Procedures.	23

PART II–OTHER INFORMATION		23

Item 1.	Legal Proceedings.	23

Item 1A.	Risk Factors.	24

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	24

Item 3.	Defaults Upon Senior Securities.	24

Item 4.	Mine Safety Disclosures.	24

Item 5.	Other Information.	24

Item 6.	Exhibits.	24

Signatures		25

Index of Exhibits		26

PART I - FINANCIAL INFORMATION

ITEM 1 - FINANCIAL STATEMENTS

Dynacq Healthcare, Inc.

Consolidated Balance Sheets

	February 28, 2015		August 31, 2014
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	14,282,560	$	16,819,504
Accounts receivable, net of allowances of approximately $125,799,000 and $154,132,000		1,611,933		1,986,633
Accounts receivable, other		355,531		380,456
Inventories		262,603		298,662
Interest receivable		104,461		122,041
Prepaid expenses		108,025		262,944
Total current assets		16,725,113		19,870,240
Investments available-for-sale		17,885,213		20,678,130
Property and equipment, net		6,360,673		6,224,136
Income tax receivable		800,920		800,920
Other assets		187,101		187,101
Total assets	$	41,959,020	$	47,760,527

The accompanying notes are an integral part of these consolidated financial statements.

Dynacq Healthcare, Inc.

Consolidated Balance Sheets (continued)

	February 28, 2015			August 31, 2014
	(Unaudited)
Liabilities and equity
Current liabilities:
Accounts payable	$	1,394,843		$	1,015,856
Accrued liabilities		17,464,214			18,512,986
Current portion of notes payable		—			6,734
Current portion of capital lease obligations		29,689			26,513
Total current liabilities		18,888,746			19,562,089
Non-current liabilities:
Long-term portion of capital lease obligations		26,067			41,123
Total liabilities		18,914,813			19,603,212

Commitments and contingencies
Equity:
Dynacq stockholders’ equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding		—			—
Common stock, $.001 par value; 100,000,000 shares authorized, 14,418,626 shares issued and 13,888,010 shares outstanding at February 28, 2015 and August 31, 2014		14,419			14,419
Treasury stock, 530,616 shares at February 28, 2015 and August 31, 2014, at cost		(27,061	)		(27,061	)
Additional paid-in capital		10,578,427			10,479,745
Accumulated other comprehensive income		10,124,848			12,616,346
Retained earnings		2,289,683			5,010,061
Total Dynacq stockholders’ equity		22,980,316			28,093,510
Non-controlling interest		63,891			63,805
Total equity		23,044,207			28,157,315
Total liabilities and equity	$	41,959,020		$	47,760,527

The accompanying notes are an integral part of these consolidated financial statements.

Dynacq Healthcare, Inc.

Consolidated Statements of Operations

(Unaudited)

	Three months ended February 28,						Six months ended February 28,
	2015			2014			2015			2014
Net patient service revenue	$	1,754,888		$	2,231,387		$	4,073,566		$	4,490,634
Costs and expenses:
Compensation and benefits		1,657,603			1,592,448			3,281,313			3,044,215
Medical services and supplies		343,838			304,093			855,225			921,563
Other operating expenses		1,287,181			1,046,262			2,538,186			2,158,740
Depreciation and amortization		86,531			86,535			173,080			194,844
Total costs and expenses		3,375,153			3,029,338			6,847,804			6,319,362
Operating loss		(1,620,265	)		(797,951	)		(2,774,238	)		(1,828,728	)
Other income (expense):
Rent and other income (expense)		(189,450	)		141,564			(168,149	)		417,109
Interest income		193,944			224,292			429,059			426,615
Interest expense		(104,025	)		(85,470	)		(206,965	)		(241,422	)
Total other income (expense), net		(99,531	)		280,386			53,945			602,302
Loss before income taxes		(1,719,796	)		(517,565	)		(2,720,293	)		(1,226,426	)
Provision (benefit) for income taxes		—			—			—			—
Net loss		(1,719,796	)		(517,565	)		(2,720,293	)		(1,226,426	)
Less: Net (income) loss attributable to noncontrolling interest		33			(59	)		(85	)		(33	)
Net loss attributable to Dynacq Healthcare, Inc.	$	(1,719,763	)	$	(517,624	)	$	(2,720,378	)	$	(1,226,459	)
Basic and diluted loss per common share	$	(0.12	)	$	(0.04	)	$	(0.20	)	$	(0.08	)
Basic and diluted average common shares outstanding		13,888,010			14,418,626			13,888,010			14,436,483

The accompanying notes are an integral part of these consolidated financial statements.

Dynacq Healthcare, Inc.

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

	Three months ended February 28,						Six months ended February 28,
	2015			2014			2015			2014
Net loss	$	(1,719,796	)	$	(517,565	)	$	(2,720,293	)	$	(1,226,426	)
Other comprehensive income (loss), net of taxes:
Net change in fair value of available-for-sale securities, net of taxes of $-0-		(820,553	)		750,396			(2,491,498	)		2,571,312
Other comprehensive income (loss)		(820,553	)		750,396			(2,491,498	)		2,571,312
Comprehensive income (loss)		(2,540,349	)		232,831			(5,211,791	)		1,344,886
Less comprehensive (income) loss attributable to noncontrolling interest		33			(59	)		(85	)		(33	)
Comprehensive income (loss) attributable to Dynacq Healthcare, Inc.	$	(2,540,316	)	$	232,772		$	(5,211,876	)	$	1,344,853

The accompanying notes are an integral part of these consolidated financial statements.

Dynacq Healthcare, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

	Six months ended February 28,
	2015			2014
Cash flows from operating activities
Net loss	$	(2,720,293	)	$	(1,226,426	)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization		173,080			194,844
Gain on sale of investments available-for-sale and trading securities		—			(161,864	)
Stock based compensation		98,682			98,682
Gain on sale of assets		(2,750	)		—
Foreign currency exchange (gains) losses		301,419			(70,971	)
Changes in operating assets and liabilities:
Accounts receivable		374,700			(398,685	)
Accounts receivable, other		24,925			(24,931	)
Interest receivable		17,581			(6,477	)
Inventories		36,058			7,123
Prepaid expenses		154,919			71,577
Accounts payable		378,987			71,045
Accrued liabilities		(1,021,710	)		4,148,276
Net cash from operating activities		(2,184,402	)		2,702,193

Cash flows from investing activities
Sales proceeds of investments available-for-sale and trading securities		—			1,233,286
Purchase of equipment		(309,617	)		(106,079	)
Sales proceeds of equipment		2,750			—
Net cash from investing activities		(306,867	)		1,127,207

Cash flows from financing activities
Principal payments on notes payable		(6,734	)		(19,905	)
Purchase of treasury stock		(27,061	)		—
Payments on capital lease		(11,880	)		(101,915	)
Net cash from financing activities		(45,675	)		(121,820	)

Net change in cash and cash equivalents		(2,536,944	)		3,707,580
Cash at beginning of period		16,819,504			13,585,447
Cash at end of period	$	14,282,560		$	17,293,027
Supplemental cash flow disclosures
Cash paid during the period for:
Interest	$	1,534		$	20,130
Income taxes	$	0		$	0
Non cash investing and financing activities:
Unrealized change in fair value of available-for-sale securities	$	(2,491,498	)	$	2,571,312

The accompanying notes are an integral part of these consolidated financial statements.

Dynacq Healthcare, Inc.

Notes to Consolidated Financial Statements

February 28, 2015

(Unaudited)

General

Dynacq Healthcare, Inc., a Nevada corporation (the “Company”), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas. The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings.

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.1 million and $1.0 million for the three months ended February 28, 2015 and 2014, respectively, and approximately $2.0 million and $1.9 million for the six months ended February 28, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and six months ended February 28, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.

Reclassification

Certain previously reported financial information has been reclassified to conform to the current period’s presentation. The impact of such reclassification was not significant to the prior period’s overall presentation.

Cash and Cash Equivalents

The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.

Investments in Available-for-Sale and Trading Securities

The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method.

The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the six months ended February 28, 2014, the Company had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

Notes Payable

In November 2011, the Company borrowed $116,339 as notes payable from a financial institution at an interest rate of 4.5%, which was to be repaid in 36 monthly installments, and was secured by specific equipment purchased at our Pasadena facility. The Company paid down the balance of $6,734 of notes payable during the three months ended November 30, 2014.

Inventories

Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company’s estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowance and the provision for doubtful accounts. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.

Net Loss per Common Share

The following table presents the computation of basic and diluted loss per common share attributable to the Company:

	Three months ended February 28,						Six months ended February 28,
	2015			2014			2015			2014
Basic and diluted loss per common share:
Numerator:
Net loss	$	(1,719,796	)	$	(517,565	)	$	(2,720,293	)	$	(1,226,426	)
Less: Net (income) loss attributable to noncontrolling interest		33			(59	)		(85	)		(33	)
Net loss attributable to Dynacq Healthcare, Inc.	$	(1,719,763	)	$	(517,624	)	$	(2,720,378	)	$	(1,226,459	)
Denominator:
Basic and diluted average common shares outstanding		13,888,010			14,418,626			13,888,010			14,436,483
Basic and diluted loss per common share	$	(0.12	)	$	(0.04	)	$	(0.20	)	$	(0.08	)

Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net loss per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net loss per share amounted to approximately 784,000 shares and 1,069,000 shares for the six months ended February 28, 2015 and 2014, respectively.

Treasury Stock

In September 2013, as part of a settlement agreement with a former employee, the Company received 125,000 shares of common stock of the Company previously issued to him. These shares were accounted for as treasury shares with zero cost, and were retired in the second quarter of fiscal year 2014.

In August 2014 and April 2015, binding settlement agreements were reached with some of the shareholders in a law suit whereby the Company received 530,616, shares and 427,886 shares, respectively, of stock owned by the shareholders. Based on an independent appraisal, the value of these shares repurchased as treasury stock were $27,061 and $145,054, respectively.

Stock Based Compensation

Year 2011 Stock Incentive Plan

The purpose of the Year 2011 Stock Incentive Plan (“2011 Plan”) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and to encourage them to devote their abilities and industry to the success of the Company’s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved 15,000,000 shares of common stock for issuance under the 2011 Plan.

As of February 28, 2015, there remain 250,000 shares to be issued upon exercise of outstanding options, and 14,750,000 shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.

2000 Incentive Plan

The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved 5,000,000 shares of common stock for future issuance under the 2000 Plan. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of February 28, 2015, there remain 534,000 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.

The following table summarizes the stock option activities for the six months ended February 28, 2015 (share amounts in thousands):

	Shares			Weighted Average Option Exercise Price Per Share
Outstanding, August 31, 2014		995		$	2.18
Granted		—			—
Exercised		—			—
Expired or canceled		(211	)		4.27
Outstanding, February 28, 2015		784			1.62

For the six months ended February 28, 2015 and 2014, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of February 28, 2015 and 2014 is $-0-, since the market price is lower than the exercise price.

The following summarizes information related to stock options outstanding as of February 28, 2015, and related weighted average price and life information:

	Options Outstanding				Options Exercisable
Exercise Prices	Number of Shares		Weighted Average Remaining Contractual Life (Years)		Number of Shares
	(Share Amounts In Thousands)
$1.10		250		6.9		188
$1.86		534		6.4		401
Total		784		6.5		589

For the three months ended February 28, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $49,341 in each period. For the six months ended February 28, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $98,682 in each period. The total unrecognized compensation expense for outstanding stock options as of February 28, 2015 was $82,000, and will be recognized, in general, over six months.

Fair Value of Financial Instruments

The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:

Level 1 Quoted prices in active markets for identical assets or liabilities.

Level 2 Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.

Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of February 28, 2015, segregated among the appropriate levels within the fair value hierarchy:

	Quoted prices in active markets for identical		Significant other observable inputs		Significant unobservable
	(Level 1)		(Level 2)		(Level 3)
Assets
Investments available-for-sale	$	—	$	17,885,213	$	—

The Company’s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $7,984,646, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).

Foreign Currency Translation

The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the U.S. Dollar as the functional currency for Sino Bond Inc. Limited, a Hong Kong corporation and wholly owned subsidiary of the Company (“Sino Bond”). The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.

Revenue Recognition

Background

The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.

Revenue Recognition Policy

The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company’s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.

The following table shows gross revenues and allowances for the three and six months ended February 28, 2015 and 2014:

	Three months ended February 28,						Six months ended February 28,
	2015			2014			2015			2014

Gross billed charges	$	8,059,057		$	6,618,079		$	16,317,829		$	13,658,418
Allowances		6,304,169			4,386,692			12,244,263			9,167,784
Net revenue	$	1,754,888		$	2,231,387		$	4,073,566		$	4,490,634
Allowance percentage		78	%		66	%		75	%		67	%

Contractual Allowance

The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.

For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.

Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.

A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.

Through February 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $4.2 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $4.2 million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual’s petitions and ordered the Company to refund approximately $300,000, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court’s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other 47 cases, the Court of Appeals reversed the district court’s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $300,000. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $4,476,097.

During the time that the carriers’ petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of February 28, 2015, the Company has accrued the total potential refund amount of $11.3 million, and an additional amount of $3.7 million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers’ Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.

Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $10,254,990 during fiscal year 2011 and $149,875 during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $779,583 during fiscal year 2011 and $136,542 during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.

Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of “fair and reasonable” charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company’s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 pending cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately 80 cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company’s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining “fair and reasonable” reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties’ closing arguments were filed in June 2015.

Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period’s net patient service revenues.

Provision for Doubtful Accounts

Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.

The Company computes its allowances based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.

Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.

The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.

The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.

The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.

Noncontrolling Interest

The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company’s facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest was 1% at February 28, 2015).

Accumulated Other Comprehensive Income (Loss)

The following table summarizes the changes in accumulated other comprehensive income (loss) by component:

	Three months ended February 28,					Six months ended February 28,
	2015			2014		2015			2014
Available-for-sale securities
Accumulated other comprehensive income balance, beginning of period	$	10,945,401		$	11,203,250	$	12,616,346		$	9,382,334
Other comprehensive income (loss):
Unrealized gains (losses), net of taxes of $-0- for all periods presented		(820,553	)		750,396		(2,491,498	)		2,571,312
Other comprehensive income (loss)		(820,553	)		750,396		(2,491,498	)		2,571,312
Accumulated other comprehensive income balance, end of period	$	10,124,848		$	11,953,646	$	10,124,848		$	11,953,646

There was no reclassification adjustment during the periods presented above.

Contingencies

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $11.3 million, and an additional amount of $3.7 million in interest payable, as accrued liabilities. For a detailed discussion of this, see Revenue Recognition Policy under Notes to Consolidated Financial Statements.

The Company maintains various insurance policies that cover its Pasadena facility including occurrence medical malpractice coverage. In addition, all physicians granted privileges at the Pasadena facility are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property insurance coverage, including flood coverage. The Company does not currently maintain workers’ compensation coverage in Texas. In regard to the Employee Health Insurance Plan, until April 2014, the Company was self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company’s group size. Effective May 1, 2014, the Company has taken coverage for its employees under a fully insured health plan.

We do not carry director and officer liability insurance. As permitted under Nevada law and pursuant to our governing documents and indemnification agreements with certain of our officers and directors, we indemnify our directors and officers against monetary damages, including advancing expenses, to the fullest extent permitted by Nevada law.

Ping S. Chu, James G. Gerace (both former members of our Board of Directors), and Eric G. Carter (former legal counsel) along with eleven other claimants instigated a series of lawsuits making claims against Ella Y.T.C. Chan (in her individual capacity and in her capacity as Independent Executrix of the Estate of Chiu M. Chan, Deceased, our former Chief Executive Officer and director), Eric K. Chan (our current Chief Executive Officer and director), and Dynacq Healthcare, Inc. All claims were settled in mediations and as part of the settlements Dynacq repurchased 530,616 shares of Dynacq common stock in August 2014, and 427,886 shares of Dynacq stock subsequently in April 2015. These buybacks represent all stock held by each of the claimants. Additionally, as part of this settlement, Dynacq settled claims made by Eric G. Carter for payment of attorney fees, and claims by a company controlled by Mr. Carter, for breach of contract. The Company recognized $2,047,652 of expense associated with these settlements during the fiscal year ended August 31, 2014. This amount is reported as other operating expenses in the consolidated statements of operations. A portion of the settlements were attributed to the repurchase of the Company’s common stock.

Recent Accounting Pronouncements

No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.

Industry Segments and Geographic Information

The Industry Segment “U.S. Division” comprises of the Company’s Pasadena facility. The Company at the present time has the U.S. Division and the Corporate Division.

Certain previously reported financial information has been reclassified to conform to the current period’s presentation.

Corporate Division

The Company formed Sino Bond to hold and manage investments in Hong Kong. Sino Bond invests in debt instruments (corporate and municipal) and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. The Company invests in various marketable securities. As of February 28, 2015, the balance of these securities is valued at approximately $17.9 million. During the six months ended February 28, 2014, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

The Corporate Division includes interest and other income related to its investments in securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.

We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.

Summarized financial information concerning the business segments from continuing operations is as follows:

	Three months ended February 28,						Six months ended February 28,
	2015			2014			2015			2014
Revenues from external customers
Net patient service revenues
U.S. Division	$	1,754,888		$	2,231,387		$	4,073,566		$	4,490,634
Corporate		—			—			—			—
Consolidated	$	1,754,888		$	2,231,387		$	4,073,566		$	4,490,634

Income (loss) before taxes
U.S. Division	$	(820,388	)	$	25,532		$	(1,315,776	)	$	(352,426	)
Corporate		(899,408	)		(543,097	)		(1,404,517	)		(874,000	)
Consolidated	$	(1,719,796	)	$	(517,565	)	$	(2,720,293	)	$	(1,226,426	)

	February 28, 2015		August 31, 2014
Total Assets
U.S. Division	$	15,118,700	$	15,967,472
Corporate		26,840,320		31,793,055
Consolidated	$	41,959,020	$	47,760,527

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

This quarterly report on Form 10-Q contains forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or the negative of these terms or other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Such forward-looking statements relate to future events or future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our Company’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including the risks and uncertainties described in “Risk Factors” in our annual report on Form 10-K for the fiscal year ended August 31, 2014. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. You must read the following discussion of the results of our business and our operations and financial condition in conjunction with our consolidated financial statements, including the notes, included in this quarterly report on Form 10-Q and our audited consolidated financial statements, including the notes, included in our Annual Report on Form 10-K for the fiscal year ended August 31, 2014.

Update on Critical Accounting Policies and Estimates

There have been no changes to the critical accounting policies used in our reporting of results of operations and financial position for the three and six months ended February 28, 2015. For a discussion of our critical accounting policies see Management's Discussion and Analysis of Financial Condition and Results of Operations in our Form 10-K for the fiscal year ended August 31, 2014.

Results of Operations

	Three Months Ended February 28, 2015									Three Months Ended February 28, 2014
	U.S. Division			Corporate			Total			U.S. Division			Corporate			Total
Net patient service revenue	$	1,754,888		$	—		$	1,754,888		$	2,231,387		$	—		$	2,231,387
Costs and expenses:
Compensation and benefits		1,085,925			571,678			1,657,603			948,688			643,760			1,592,448
Medical services and supplies		343,838			—			343,838			304,093			—			304,093
Other operating expenses		965,460			321,721			1,287,181			810,209			236,053			1,046,262
Depreciation and amortization		85,855			676			86,531			85,532			1,003			86,535
Total costs and expenses		2,481,078			894,075			3,375,153			2,148,522			880,816			3,029,338
Operating income (loss)		(726,190	)		(894,075	)		(1,620,265	)		82,865			(880,816	)		(797,951	)
Other income (expense):
Rent and other income		1,479			(190,929	)		(189,450	)		21,714			119,850			141,564
Interest income		—			193,944			193,944			—			224,292			224,292
Interest expense		(95,677	)		(8,348	)		(104,025	)		(79,047	)		(6,423	)		(85,470	)
Total other income (expense), net		(94,198	)		(5,333	)		(99,531	)		(57,333	)		337,719			280,386
Income (loss) before income taxes	$	(820,388	)	$	(899,408	)		(1,719,796	)	$	25,532		$	(543,097	)		(517,565	)
Provision (benefit) for income taxes								—									—
Net loss								(1,719,796	)								(517,565	)
Less: Net (income) loss attributable to noncontrolling interest								33									(59	)
Net loss attributable to Dynacq Healthcare, Inc.							$	(1,719,763	)							$	(517,624	)

Operational statistics (Number of medical procedures) for Pasadena facility:
Inpatient:
Bariatric		—									15
Orthopedic		14									5
Other		1									8
Total inpatient procedures		15									28
Outpatient:
Orthopedic		97									77
Other		126									102
Total outpatient procedures		223									179
Total procedures		238									207

	Six Months Ended February 28, 2015									Six Months Ended February 28, 2014
	U.S. Division			Corporate			Total			U.S. Division			Corporate			Total
Net patient service revenue	$	4,073,566		$	—		$	4,073,566		$	4,490,634		$	—		$	4,490,634
Costs and expenses:
Compensation and benefits		2,191,054			1,090,259			3,281,313			1,891,254			1,152,961			3,044,215
Medical services and supplies		855,225			—			855,225			921,563			—			921,563
Other operating expenses		1,986,034			552,152			2,538,186			1,646,632			512,108			2,158,740
Depreciation and amortization		171,678			1,402			173,080			192,839			2,005			194,844
Total costs and expenses		5,203,991			1,643,813			6,847,804			4,652,288			1,667,074			6,319,362
Operating loss		(1,130,425	)		(1,643,813	)		(2,774,238	)		(161,654	)		(1,667,074	)		(1,828,728	)
Other income (expense):
Rent and other income (expense)		4,990			(173,139	)		(168,149	)		31,558			385,551			417,109
Interest income		—			429,059			429,059			—			426,615			426,615
Interest expense		(190,341	)		(16,624	)		(206,965	)		(222,330	)		(19,092	)		(241,422	)
Total other income (expense), net		(185,351	)		239,296			53,945			(190,772	)		793,074			602,302
Loss before income taxes	$	(1,315,776	)	$	(1,404,517	)		(2,720,293	)	$	(352,426	)	$	(874,000	)		(1,226,426	)
Benefit for income taxes								—									—
Net loss								(2,720,293	)								(1,226,426	)
Less: Net income attributable to noncontrolling interest								(85	)								(33	)
Net loss attributable to Dynacq Healthcare, Inc.							$	(2,720,378	)							$	(1,226,459	)

Operational statistics (Number of medical procedures) for Pasadena facility:
Inpatient:
Bariatric		6									35
Orthopedic		32									18
Other		4									13
Total inpatient procedures		42									66
Outpatient:
Orthopedic		166									141
Other		274									241
Total outpatient procedures		440									382
Total procedures		482									448

Three Months Ended February 28, 2015 Compared to the Three Months Ended February 28, 2014

U.S. Division

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $11.3 million, and an additional amount of $3.7 million in interest payable as accrued liabilities. For a detailed discussion of this, see Revenue Recognition discussed in Item 1 - Notes to Consolidated Financial Statements.

Net patient service revenue decreased by $476,499, or 21%, from $2,231,387 to $1,754,888, and total surgical cases increased by 15% from 207 cases for the three months ended February 28, 2014 to 238 cases for the three months ended February 28, 2015. While the number of cases increased by 15%, net patient service revenue decreased by 21%, primarily due to a change in the surgical mix of cases. The gross billed charges increased by 22% from $6,618,079 for the three months ended February 28, 2014 to $8,059,057 for the three months ended February 28, 2015. However, due to an increase in allowances from 66% to 78%, net patient service revenue decreased by 21%. The increase in allowances is due to an increased pressure by insurance carriers towards lower reimbursements, and also due to lower collections in the current period compared to the prior period on old accounts receivable that was fully reserved for.

Total costs and expenses increased by $332,556, or 15%, from $2,148,522 for the three months ended February 28, 2014 to $2,481,078 for the three months ended February 28, 2015. The following discusses the various changes in costs and expenses:

Compensation and benefits increased by $137,237, or 14%, primarily associated with increase in workforce due to higher gross billed charges.

Medical services and supplies expenses increased by $39,745, primarily due to a change in the surgical mix of cases. The number of inpatient orthopedic cases increased from 5 cases for the three months ended February 28, 2014 to 14 cases for the three months ended February 28, 2015, and these require more medical supplies and services

Other operating expenses increased by $155,251, or 19%, primarily associated with higher gross billed charges.

Other expense for the three months ended February 28, 2015 and 2014 of $94,198 and $57,333, respectively, includes interest expense associated with the stop-loss cases discussed above.

Corporate Division

Compensation and benefits for the Corporate Division includes all corporate personnel compensation and benefits. It also includes $49,341 of non-cash compensation expense for each of the three months ended February 28, 2015 and 2014, related to employees’ incentive stock options granted in fiscal years 2007, 2011 and 2012. Apart from the stock option expense discussed above, compensation and benefits decreased by 12% in 2015, compared to 2014, due to a reduction in corporate staff.

Other operating expenses include all corporate general and administrative expenses, including other professional fees such as legal expenses and audit expenses. It increased by $85,668, from $236,053 for the three months ended February 28, 2014 to $321,721 for the three months ended February 28, 2015. The increase in other operating expenses is due to an increase in gross billed charges.

Rent and other income (expense) decreased by $310,779, from $119,850 for the three months ended February 28, 2014 to $(190,929) for the three months ended February 28, 2015. Rent and other income for the three months ended February 28, 2015 includes an amount of $257,864 in foreign currency losses, which was offset by (a) collections of $24,693 on accounts receivable of the Company’s hospitals that were sold in prior years, and were fully reserved for, and (b) miscellaneous other income of $42,242. Rent and other income for the three months ended February 28, 2014 includes (a) an amount of $11,155 in foreign currency gains, and (b) miscellaneous other income of $108,695.

Interest income of $193,944 and $224,292 for the three months ended February 28, 2015 and 2014, respectively, are primarily related to the Company’s investments in bonds.

Investments in securities

Income Taxes

The Company did not recognize a benefit or provision for income taxes for the three months ended February 28, 2015 and 2014, due to the uncertainty of the Company’s ability to recognize the benefit from the carry forward of net operating losses. The Company has recorded a full valuation allowance against its deferred tax assets.

Six Months Ended February 28, 2015 Compared to the Six Months Ended February 28, 2014

U.S. Division

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $11.3 million, and an additional amount of $3.7 million in interest payable as accrued liabilities. For a detailed discussion of this, see Revenue Recognition discussed in Item 1 - Notes to Consolidated Financial Statements.

Net patient service revenue decreased by $417,068, or 9%, from $4,490,634 to $4,073,566, and total surgical cases increased by 8% from 448 cases for the six months ended February 28, 2014 to 482 cases for the six months ended February 28, 2015. While the number of cases increased by 8%, net patient service revenue decreased by 9%, primarily due to a change in the surgical mix of cases. The gross billed charges increased by 19% from $13,658,418 for the six months ended February 28, 2014 to $16,317,829 for the six months ended February 28, 2015. However, due to an increase in allowances from 67% to 75%, net patient service revenue decreased by 9%. The increase in allowances is due to an increased pressure by insurance carriers towards lower reimbursements, and also due to lower collections in the current period compared to the prior period on old accounts receivable that was fully reserved for.

Total costs and expenses increased by $551,703, or 12%, from $4,652,288 for the six months ended February 28, 2014 to $5,203,991 for the six months ended February 28, 2015. The following discusses the various changes in costs and expenses:

Compensation and benefits increased by $299,800, or 16%, primarily associated with increase in workforce due to higher gross billed charges.

Medical services and supplies expenses decreased by $66,338, or 7%, primarily due to a change in the surgical mix of cases. Inpatient cases decreased by 36%, which generally require more medical services and supplies.

Other operating expenses increased by $339,402, or 21%, primarily associated with higher gross billed charges.

Other expense for the six months ended February 28, 2015 and 2014 of $185,351 and $190,772, respectively, includes interest expense associated with the stop-loss cases discussed above.

Corporate Division

Compensation and benefits for the Corporate Division includes all corporate personnel compensation and benefits. It also includes $98,682 of non-cash compensation expense for each of the six months ended February 28, 2015 and 2014, respectively, related to employees’ incentive stock options granted in fiscal years 2007, 2011 and 2012. Apart from the stock option expense discussed above, compensation and benefits decreased by 6% in 2015, compared to 2014, due to a reduction in corporate staff.

Other operating expenses include all corporate general and administrative expenses, including other professional fees such as legal expenses and audit expenses. It increased by $40,044, from $512,108 for the six months ended February 28, 2014 to $552,152 for the six months ended February 28, 2015. The increase in other operating expenses is due to an increase in gross billed charges.

Rent and other income (expense) decreased by $558,690, from $385,551 for the six months ended February 28, 2014 to $(173,139) for the six months ended February 28, 2015. Rent and other income (expense) for the six months ended February 28, 2015 includes an amount of $399,797 in foreign currency losses, which was offset by (a) collections of $163,453 on accounts receivable of the Company’s hospitals that were sold in prior years, and were fully reserved for, and (b) miscellaneous other income of $63,205. Rent and other income for the six months ended February 28, 2014 includes (a) an amount of $84,630 in foreign currency gains, (b) a gain of $161,864 in trading securities, and (b) miscellaneous other income of $139,057.

Interest income of $429,059 and $426,615 for the six months ended February 28, 2015 and 2014, respectively, are primarily related to the Company’s investments in bonds.

Investments in securities

The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. As of February 28, 2015, these securities are valued at approximately $17.9 million. Unrealized gains in these investments of $10.1 million are included in accumulated other comprehensive income in the Consolidated Balance Sheet as at February 28, 2015. During the six months ended February 28, 2014, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had gains of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

Income Taxes

The Company did not recognize a benefit or provision for income taxes for the six months ended February 28, 2015 and 2014, due to the uncertainty of the Company’s ability to recognize the benefit from the carry forward of net operating losses. The Company has recorded a full valuation allowance against its deferred tax assets.

Liquidity and Capital Resources

Our fiscal year 2014 Annual Report on Form 10-K includes a detailed discussion of our liquidity, contractual obligations and commitments. The information presented below updates and should be read in conjunction with the information disclosed in that Form 10-K.

Cash flow from operating activities

Cash flow used in operating activities was $2,184,402 during the six months ended February 28, 2015, primarily due to (a) a net loss of $2,720,293, and (b) a decrease in accounts payable and accrued liabilities of $642,723. Partially offsetting these cash outflows were (a) a decrease in accounts receivable of $374,700, (b) foreign currency losses of $301,419, (c) a decrease in prepaid expenses of $154,919, and (d) depreciation and amortization of $173,080.

Cash flows from investing activities

Cash flow used in investing activities was $306,867, primarily for purchase of equipment.

Cash flows from financing activities

Cash flow used in financing activities was $45,675 for purchase of treasury stock of $27,061 and payments on capital leases and notes payable of $18,614.

We believe we will be able to meet our ongoing liquidity and cash needs for at least the next twelve months based on the amount of available cash and cash equivalents.

Recent Accounting Pronouncements

See notes to the Consolidated Financial Statements - Recent Accounting Pronouncements, which is incorporated herein by reference.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not required.

Item 4. Controls and Procedures.

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation to assess the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report, pursuant to Exchange Act Rule 13a-15(e). Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of February 28, 2015, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting.

There have been no significant changes in our internal control over financial reporting during the most recently completed fiscal quarter or in other factors that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management’s override of the control. The design of any systems of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities’ fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure. Please refer to Revenue Recognition, as well as Business – Government Regulation – Texas Workers’ Compensation Systems in our Form 10-K for the fiscal year ended August 31, 2014, for a detailed description of the MDR process and our accounts receivable. The Company cannot predict whether any litigation or administrative proceeding to which it may become a party will have a material adverse effect on the Company's results of operations, cash flows or financial condition.

Item 1A. Risk Factors.

The Company’s Risk Factors as disclosed in its Form 10-K for the year ended August 31, 2014 have not materially changed.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

None.

Item 6. Exhibits.

EXHIBIT NO.		IDENTIFICATION OF EXHIBIT
Exhibit 31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document.
101.SCH		XBRL Taxonomy Extension Schema Document.
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	DYNACQ HEALTHCARE, INC.

Date: September 15, 2015	By:	/s/ Eric K. Chan
	Eric K. Chan
	Chief Executive Officer
	(duly authorized officer)

Date: September 15, 2015	By:	/s/ Hemant Khemka
	Hemant Khemka
	Chief Financial Officer
	(principal financial and accounting officer)

INDEX OF EXHIBITS

EXHIBIT NO.		IDENTIFICATION OF EXHIBIT

Exhibit 31.1		Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 31.2		Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Exhibit 32.2		Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document.
101.SCH		XBRL Taxonomy Extension Schema Document.
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

EX-31.1 2 v419846_ex31-1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION

I, Eric K. Chan, Chief Executive Officer of Dynacq Healthcare, Inc., certify that:

I have reviewed this quarterly report on Form 10-Q of Dynacq Healthcare, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ Eric K. Chan
Eric K. Chan
Chief Executive Officer
(principal executive officer)

Date: September 15, 2015

EX-31.2 3 v419846_ex31-2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION

I, Hemant Khemka, Chief Financial Officer of Dynacq Healthcare, Inc., certify that:

I have reviewed this quarterly report on Form 10-Q of Dynacq Healthcare, Inc.;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

/s/ Hemant Khemka
Hemant Khemka
Chief Financial Officer
(principal financial and accounting officer)

Date: September 15, 2015

EX-32.1 4 v419846_ex32-1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION OF PERIODIC REPORT

In connection with the Quarterly Report of Dynacq Healthcare, Inc. (the “Company”) on Form 10-Q for the quarterly period ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Eric K. Chan, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Eric K. Chan
Eric K. Chan
Chief Executive Officer

September 15, 2015

EX-32.2 5 v419846_ex32-2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION OF PERIODIC REPORT

In connection with the Quarterly Report of Dynacq Healthcare, Inc. (the “Company”) on Form 10-Q for the quarterly period ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Hemant Khemka, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Hemant Khemka
Hemant Khemka
Chief Financial Officer

September 15, 2015

EX-101.INS 6 dyii-20150228.xml XBRL INSTANCE DOCUMENT 0000890908 2014-02-28 0000890908 2015-02-28 0000890908 2014-08-01 2014-08-31 0000890908 2014-08-31 0000890908 2015-08-31 0000890908 2013-09-01 2014-02-28 0000890908 2013-09-01 2014-08-31 0000890908 2013-09-01 2013-09-30 0000890908 2014-09-01 2015-02-28 0000890908 2014-09-01 2014-11-30 0000890908 2008-11-01 2008-11-13 0000890908 2011-11-01 2011-11-30 0000890908 2008-11-13 0000890908 2011-11-30 0000890908 2013-12-01 2014-02-28 0000890908 2014-12-01 2015-02-28 0000890908 2013-08-31 0000890908 2014-11-30 0000890908 2013-11-30 0000890908 dyii:RangeOneMember 2015-02-28 0000890908 dyii:RangeTwoMember 2015-02-28 0000890908 dyii:RangeOneMember 2014-09-01 2015-02-28 0000890908 dyii:RangeTwoMember 2014-09-01 2015-02-28 0000890908 dyii:Year2011StockIncentivePlanMember 2015-02-28 0000890908 dyii:Year2000StockIncentivePlanMember 2015-02-28 0000890908 dyii:UsDivisionSegmentMember 2014-09-01 2015-02-28 0000890908 us-gaap:IntersegmentEliminationMember 2014-09-01 2015-02-28 0000890908 dyii:UsDivisionSegmentMember 2013-09-01 2014-02-28 0000890908 us-gaap:IntersegmentEliminationMember 2013-09-01 2014-02-28 0000890908 dyii:UsDivisionSegmentMember 2014-12-01 2015-02-28 0000890908 us-gaap:IntersegmentEliminationMember 2014-12-01 2015-02-28 0000890908 dyii:UsDivisionSegmentMember 2013-12-01 2014-02-28 0000890908 us-gaap:IntersegmentEliminationMember 2013-12-01 2014-02-28 0000890908 country:HK 2013-09-01 2014-02-28 0000890908 dyii:UsDivisionSegmentMember 2015-02-28 0000890908 us-gaap:IntersegmentEliminationMember 2015-02-28 0000890908 dyii:UsDivisionSegmentMember 2014-08-31 0000890908 us-gaap:IntersegmentEliminationMember 2014-08-31 0000890908 us-gaap:SubsequentEventMember 2015-04-01 2015-04-30 0000890908 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2015-02-28 0000890908 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2015-02-28 0000890908 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2015-02-28 0000890908 us-gaap:FairValueInputsLevel2Member 2015-02-28 0000890908 dyii:PasadenaFacilityMember 2010-09-01 2011-08-31 0000890908 dyii:PasadenaFacilityMember 2013-06-01 2013-08-31 0000890908 dyii:GarlandFacilityMember 2010-09-01 2011-08-31 0000890908 dyii:GarlandFacilityMember 2013-06-01 2013-08-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10-Q false 2015-02-28 2015 Q2 DYNACQ HEALTHCARE INC 0000890908 --08-31 Smaller Reporting Company DYII 13460124

14282560

16819504

1611933

1986633

262603

298662

104461

122041

108025

262944

16725113

19870240

17885213

20678130

6360673

6224136

187101

41959020

47760527

355531

380456

1394843

1015856

17464214

18512986

6734

29689

26513

18888746

19562089

26067

41123

18914813

19603212

14419

10578427

10479745

10124848

12616346

2289683

5010061

22980316

28093510

63891

63805

23044207

28157315

41959020

47760527

27061

4073566

4490634

3281313

3044215

855225

921563

2538186

2158740

173080

194844

6847804

6319362

-2774238

-1828728

-168149 417109

429059

426615

206965

241422

53945

602302

-2720293

-1226426

-2720293

-1226426

-2720378

-1226459

-0.2

-0.08

13888010

14436483

1754888

2231387

1657603

1592448

343838

304093

1287181

1046262

86531

86535

3375153

3029338

-1620265

-797951

-189450 141564

193944

224292

104025

85470

-99531

280386

-1719796

-517565

-1719796

-517565

-33

-1719763

-517624

-0.12

-0.04

13888010

14418626

-2491498

2571312

-2491498

2571312

-5211791

1344886

-5211876

1344853

-820553

750396

-820553

750396

-2540349

232831

-2540316

232772

161864

98682

-301419

70971

2750

-374700

398685

-36058

-7123

-154919

-71577

-17581

6477

378987

71045

-1021710

4148276

-2184402

2702193

2750

309617

106079

-306867

1127207

-24925

24931

1233286

6734

19905

11880

101915

-45675

-121820

-2536944

3707580

13585447

17293027

1534

20130

-2491498

2571312

-27061

-2720293

-1226426

-1719796

-517565

-33

784000

1069000

995000

211000

784000

2.18

4.27

1.62

784000

250000

534000

P6Y6M

P6Y10M24D

P6Y4M24D

589000

188000

401000

15000000

250000

14750000

5000000

534000

98682

49341

82000

12616346

9382334

-2491498

2571312

10124848

11953646

10945401

11203250

-820553

750396

3700000

11300000

530616

2047652

4073566

4490634

-1315776

-1404517

-352426

-874000

1754888

2231387

-820388

-899408

25532

-543097

161864

125799000

154132000

0.01

5000000

0.001

100000000

14418626

13888010

530616

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Basis of Presentation</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.1</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.0</font> million for the three months ended February 28, 2015 and 2014, respectively, and approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.0</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.9</font> million for the six months ended February 28, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and six months ended February 28, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

1100000 1000000 2000000 1900000

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Reclassification</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Certain previously reported financial information has been reclassified to conform to the current period’s presentation. The impact of such reclassification was not significant to the prior period’s overall presentation.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Investments in Available-for-Sale and Trading Securities</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the six months ended February 28, 2014, the Company had a net gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">161,864</font> in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

116339

0.045 6734 P36M

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Inventories</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <strong>Net Loss per Common Share</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table presents the computation of basic and diluted loss per common share attributable to the Company:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Six months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted loss per common share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Numerator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net loss</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,719,796)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(517,565)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,720,293)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,226,426)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Less: Net (income) loss attributable to noncontrolling interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>33</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(59)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(85)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(33)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net loss attributable to Dynacq Healthcare, Inc.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,719,763)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(517,624)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,720,378)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,226,459)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Denominator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,888,010</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,418,626</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,888,010</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,436,483</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted loss per common share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.12)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.04)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.20)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.08)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>  <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net loss per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net loss per share amounted to approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 784,000</font> shares and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,069,000</font> shares for the six months ended February 28, 2015 and 2014, respectively.</div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The following table presents the computation of basic and diluted loss per common share attributable to the Company:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Six months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted loss per common share:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Numerator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net loss</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,719,796)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(517,565)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,720,293)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,226,426)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Less: Net (income) loss attributable to noncontrolling interest</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>33</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(59)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(85)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(33)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Net loss attributable to Dynacq Healthcare, Inc.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,719,763)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(517,624)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,720,378)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,226,459)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Denominator:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted average common shares outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,888,010</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,418,626</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,888,010</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>14,436,483</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Basic and diluted loss per common share</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.12)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.04)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.20)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>(0.08)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>  <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Industry Segments and Geographic Information</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Industry Segment “U.S. Division” comprises of the Company’s Pasadena facility. The Company at the present time has the U.S. Division and the Corporate Division.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Certain previously reported financial information has been reclassified to conform to the current period’s presentation.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-SIZE: 10pt">Corporate Division</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company formed Sino Bond to hold and manage investments in Hong Kong. Sino Bond invests in debt instruments (corporate and municipal) and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. The Company invests in various marketable securities. As of February 28, 2015, the balance of these securities is valued at approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">17.9</font> million. During the six months ended February 28, 2014, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had a net gain of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">161,864</font> in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.</font></div> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Corporate Division includes interest and other income related to its investments in securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Summarized financial information concerning the business segments from continuing operations is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Six months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="51%"> <div>Revenues from external customers</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>Net patient service revenues</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,754,888</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,231,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,073,566</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,490,634</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,754,888</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,231,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,073,566</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,490,634</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 50px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="51%"> <div>Income (loss) before taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(820,388)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>25,532</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,315,776)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(352,426)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(899,408)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(543,097)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,404,517)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(874,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,719,796)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(517,565)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,720,293)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,226,426)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>  <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both" align="center"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 93%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>February 28, 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>August 31, 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="68%"> <div>Total Assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 20px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>15,118,700</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>15,967,472</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 20px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>26,840,320</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,793,055</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 40px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>41,959,020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>47,760,527</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Summarized financial information concerning the business segments from continuing operations is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Three months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Six months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="51%"> <div>Revenues from external customers</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div>Net patient service revenues</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,754,888</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,231,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,073,566</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,490,634</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,754,888</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,231,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,073,566</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,490,634</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 50px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="51%"> <div>Income (loss) before taxes</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(820,388)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>25,532</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,315,776)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(352,426)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(899,408)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(543,097)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(1,404,517)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(874,000)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 39px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,719,796)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(517,565)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,720,293)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(1,226,426)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>  <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 93%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>February 28, 2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="white-space:nowrap; BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>August 31, 2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="68%"> <div>Total Assets</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 20px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>U.S. Division</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>15,118,700</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>15,967,472</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 20px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>Corporate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>26,840,320</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,793,055</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 40px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="68%"> <div>Consolidated</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>41,959,020</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>47,760,527</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

15118700

26840320

15967472

31793055

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Accumulated Other Comprehensive Income (Loss)</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The following table summarizes the changes in accumulated other comprehensive income (loss) by component:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div> Three months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div> Six months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="51%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400; TEXT-DECORATION: underline" width="51%"> <div>Available-for-sale securities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Accumulated other comprehensive income balance, beginning of period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,945,401</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,203,250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,616,346</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,382,334</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Other comprehensive income (loss):</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Unrealized gains (losses), net of taxes of $-0- for all periods presented</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(820,553)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>750,396</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(2,491,498)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,571,312</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 26px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Other comprehensive income (loss)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(820,553)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>750,396</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>(2,491,498)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,571,312</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="51%"> <div>Accumulated other comprehensive income balance, end of period</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>10,124,848</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>11,953,646</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>10,124,848</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>11,953,646</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>  <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">There was no reclassification adjustment during the periods presented above.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Revenue Recognition</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">Background</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">Revenue Recognition Policy</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company’s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table shows gross revenues and allowances for the three and six months ended February 28, 2015 and 2014:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 97%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="5"> <div>Three months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="5"> <div>Six months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Gross billed charges</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,059,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,618,079</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,317,829</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,658,418</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Allowances</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,304,169</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,386,692</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,244,263</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,167,784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Net revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,754,888</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,231,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,073,566</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,490,634</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Allowance percentage</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>67</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif"> Contractual Allowance</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 90</font>% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 75</font>% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">40,000</font>, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Through February 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 180</font> cases, involving approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11</font> million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 130</font> cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.2</font> million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 47</font> cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.2</font> million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual’s petitions and ordered the Company to refund approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font>, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court’s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other 47 cases, the Court of Appeals reversed the district court’s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font>. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,476,097</font>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During the time that the carriers’ petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of February 28, 2015, the Company has accrued the total potential refund amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11.3</font> million, and an additional amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.7</font> million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers’ Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,254,990</font> during fiscal year 2011 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">149,875</font> during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">779,583</font> during fiscal year 2011 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">136,542</font> during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of “fair and reasonable” charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 179</font> cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company’s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 178</font> pending cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">80</font> cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company’s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining “fair and reasonable” reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties’ closing arguments were filed in June 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period’s net patient service revenues.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Provision for Doubtful Accounts</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company computes its allowance<i>s</i> based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The following table shows gross revenues and allowances for the three and six months ended February 28, 2015 and 2014:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 97%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="5"> <div>Three months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="5"> <div>Six months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Gross billed charges</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,059,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,618,079</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,317,829</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,658,418</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Allowances</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,304,169</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,386,692</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,244,263</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,167,784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Net revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,754,888</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,231,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,073,566</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,490,634</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Allowance percentage</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>67</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 8059057 6618079 16317829 13658418 6304169 4386692 12244263 9167784 0.78 0.66 0.75 0.67

125000

530616

27061

427886

145054

0.01

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Stock Based Compensation </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Year 2011 Stock Incentive Plan</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The purpose of the Year 2011 Stock Incentive Plan (“2011 Plan”) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and to encourage them to devote their abilities and industry to the success of the Company’s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 15,000,000</font> shares of common stock for issuance under the 2011 Plan.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">As of February 28, 2015, there remain <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 250,000</font> shares to be issued upon exercise of outstanding options, and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 14,750,000</font> shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.</div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>2000 Incentive Plan</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,000,000</font> shares of common stock for future issuance under the 2000 Plan. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of February 28, 2015, there remain <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 534,000</font> shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.</div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes the stock option activities for the six months ended February 28, 2015 (share amounts in thousands):</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 90%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Weighted Average<br/> Option Exercise <br/> Price Per Share</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Outstanding, August 31, 2014</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>995</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2.18</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Exercised</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Expired or canceled</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>(211)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.27</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="65%"> <div>Outstanding, February 28, 2015</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.62</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the six months ended February 28, 2015 and 2014, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of February 28, 2015 and 2014 is $-0-, since the market price is lower than the exercise price.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following summarizes information related to stock options outstanding as of February 28, 2015, and related weighted average price and life information: <font style="FONT-SIZE: 10pt">  </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="63%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="23%" colspan="5"> <div>Options Outstanding</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Options Exercisable</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="63%"> <div>Exercise Prices</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Number of <br/> Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Weighted Average<br/> Remaining Contractual<br/> Life (Years)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Number of Shares</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="63%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="35%" colspan="8"> <div>(Share Amounts In Thousands)</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>$1.10</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>250</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>188</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>$1.86</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>534</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6.4</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>401</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="63%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>6.5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>589</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-WEIGHT: normal"><font style="FONT-WEIGHT: normal">For the three months ended February 28, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">49,341</font> in each period. For the six months ended February 28, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">98,682</font> in each period. The total unrecognized compensation expense for outstanding stock options as of February 28, 2015 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">82,000</font>, and will be recognized, in general, over six months. </font></font></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

P30Y

17885213

7984646

0.9 0.75 40000 180 11000000 130 4200000 47

4200000

300000

300000 11300000

3700000

10254990 149875 779583 136542

179

178 80

4476097

800920

14418626

13888010

49341

98682

P6M

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Basis of Presentation</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.1</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.0</font> million for the three months ended February 28, 2015 and 2014, respectively, and approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.0</font> million and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.9</font> million for the six months ended February 28, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and six months ended February 28, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt"></font></b> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"></font></b> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"></font></b> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Reclassification</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Certain previously reported financial information has been reclassified to conform to the current period’s presentation. The impact of such reclassification was not significant to the prior period’s overall presentation.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> </div> </div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"></font></b> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"></font></b> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"></font></b> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Inventories</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> </div> </div> </div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Revenue Recognition</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">Background</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif" align="justify">Revenue Recognition Policy</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company’s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table shows gross revenues and allowances for the three and six months ended February 28, 2015 and 2014:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 97%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="5"> <div>Three months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="24%" colspan="5"> <div>Six months ended February 28,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2015</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Gross billed charges</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,059,057</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,618,079</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>16,317,829</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>13,658,418</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Allowances</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>6,304,169</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,386,692</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>12,244,263</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>9,167,784</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Net revenue</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,754,888</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>2,231,387</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,073,566</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>4,490,634</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="45%"> <div>Allowance percentage</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>78</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>66</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>75</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="2%"> <div>%</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>67</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: italic 10pt Times New Roman, Times, Serif"> Contractual Allowance</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">30</font> days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 90</font>% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 75</font>% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">40,000</font>, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Through February 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 180</font> cases, involving approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11</font> million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 130</font> cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.2</font> million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 47</font> cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.2</font> million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual’s petitions and ordered the Company to refund approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font>, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court’s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other 47 cases, the Court of Appeals reversed the district court’s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">300,000</font>. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4,476,097</font>.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">During the time that the carriers’ petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of February 28, 2015, the Company has accrued the total potential refund amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11.3</font> million, and an additional amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.7</font> million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers’ Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">10,254,990</font> during fiscal year 2011 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">149,875</font> during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">779,583</font> during fiscal year 2011 and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">136,542</font> during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of “fair and reasonable” charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 179</font> cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company’s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 178</font> pending cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">80</font> cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company’s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining “fair and reasonable” reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties’ closing arguments were filed in June 2015.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period’s net patient service revenues.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <i>Provision for Doubtful Accounts</i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company computes its allowance<i>s</i> based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

EX-101.SCH 7 dyii-20150228.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 103 - Statement - Consolidated Balance Sheets [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 105 - Statement - Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:definitionLink link:calculationLink 106 - Statement - Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 107 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - General link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Reclassification link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Cash and Cash Equivalents link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Investments in Available-for-Sale and Trading Securities link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Notes payable link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Inventories link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Use of Estimates link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Net Loss per Common Share link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Treasury Stock link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Stock Based Compensation link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Foreign Currency Translation link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Revenue Recognition link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Noncontrolling Interest link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Accumulated Other Comprehensive Income (Loss) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Contingencies link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - Industry Segments and Geographic Information link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - Net Loss per Common Share (Tables) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - Stock Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:definitionLink link:calculationLink 132 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:definitionLink link:calculationLink 133 - Disclosure - Industry Segments and Geographic Information (Tables) link:presentationLink link:definitionLink link:calculationLink 134 - Disclosure - Basis of Presentation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 135 - Disclosure - Investments in Available-for-Sale and Trading Securities (Details Textual) link:presentationLink link:definitionLink link:calculationLink 136 - Disclosure - Notes Payable (Details Textual) link:presentationLink link:definitionLink link:calculationLink 137 - Disclosure - Net Loss per Common Share (Details) link:presentationLink link:definitionLink link:calculationLink 138 - Disclosure - Net Loss per Common Share (Details Textual) link:presentationLink link:definitionLink link:calculationLink 139 - Disclosure - Treasury Stock (Details Textual) link:presentationLink link:definitionLink link:calculationLink 140 - Disclosure - Stock Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 141 - Disclosure - Stock Based Compensation (Details 1) link:presentationLink link:definitionLink link:calculationLink 142 - Disclosure - Stock Based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 143 - Disclosure - Fair Value of Financial Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 144 - Disclosure - Fair Value of Financial Instruments (Details Textual) link:presentationLink link:definitionLink link:calculationLink 145 - Disclosure - Revenue Recognition (Details) link:presentationLink link:definitionLink link:calculationLink 146 - Disclosure - Revenue Recognition (Details Textual) link:presentationLink link:definitionLink link:calculationLink 147 - Disclosure - Noncontrolling Interest (Details Textual) link:presentationLink link:definitionLink link:calculationLink 148 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:definitionLink link:calculationLink 149 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details Textual) link:presentationLink link:definitionLink link:calculationLink 150 - Disclosure - Contingencies (Details Textuals) link:presentationLink link:definitionLink link:calculationLink 151 - Disclosure - Industry Segments and Geographic Information (Details) link:presentationLink link:definitionLink link:calculationLink 152 - Disclosure - Industry Segments and Geographic Information (Details 1) link:presentationLink link:definitionLink link:calculationLink 153 - Disclosure - Industry Segments and Geographic Information (Details Textual) link:presentationLink link:definitionLink link:calculationLink 154 - Disclosure - Significant Accounting Policies (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 dyii-20150228_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 dyii-20150228_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 dyii-20150228_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information [Abstract] Document Information [Table] Legal Entity [Axis] Legal Entity [Axis] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Reclassification [Abstract] Disclosure of Reclassification Amount [Text Block] Cash And Cash Equivalents [Abstract] Cash and Cash Equivalents Disclosure [Text Block] Investments Debt And Equity Securities [Abstract] Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Text Block] Use Of Estimates [Abstract] Usage Of Estimates [Text Block] Usage of estimates. Equity [Abstract] Treasury Stock [Text Block] Treasury Stock [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Statement Of Financial Position [Abstract] Statement [Table] Statement [Table] Entity [Domain] Entity [Domain] Statement [Line Items] Statement [Line Items] Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash at beginning of period Cash at end of period Accounts Receivable, Net, Current, Total Accounts receivable, net of allowances of approximately $125,799,000 and $154,132,000 Accounts and Other Receivables, Net, Current Accounts receivable, other Inventory, Net, Total Inventories Interest Receivable Current Interest receivable Prepaid Expense, Current, Total Prepaid expenses Available-for-sale Securities, Noncurrent, Total Investments available-for-sale Balance from marketable securities Property, Plant and Equipment, Net, Total Property and equipment, net Net property and equipment Income Taxes Receivable Noncurrent Income tax receivable Other Assets Noncurrent Other assets Assets, Total Total assets Total Assets Liabilities And Stockholders Equity [Abstract] Liabilities and equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable Current Accounts payable Accrued Liabilities Current Accrued liabilities Total accrued liabilities Notes Payable, Current, Total Current portion of notes payable Less: Current portion Capital Lease Obligations Current Current portion of capital lease obligations Liabilities, Current, Total Total current liabilities Liabilities Noncurrent [Abstract] Non-current liabilities: Capital Lease Obligations Noncurrent Long-term portion of capital lease obligations Liabilities, Total Total liabilities Commitments And Contingencies Commitments and contingencies Stockholders Equity Including Portion Attributable To Noncontrolling Interest [Abstract] Equity: Stockholders Equity [Abstract] Dynacq stockholders' equity: Preferred Stock Value Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding Common Stock Value Common stock, $.001 par value; 100,000,000 shares authorized, 14,418,626 shares issued and 13,888,010 shares outstanding at February 28, 2015 and August 31, 2014 Treasury Stock, Value Treasury stock, 530,616 shares at February 28, 2015 and August 31, 2014, at cost Additional Paid In Capital Additional paid-in capital Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated other comprehensive income Retained Earnings Accumulated Deficit Retained earnings Minority Interest Non-controlling interest Balance August 31, 2012 Balance August 31, 2014 Stockholders Equity Including Portion Attributable To Noncontrolling Interest Total equity Balance Balance Liabilities And Stockholders Equity Total liabilities and equity Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Foreign Currency [Abstract] Foreign Currency Disclosure [Text Block] Revenue Recognition [Abstract] Revenue Recognition [Text Block] The entire disclosure pertaining to sales arrangements for goods or services that reduce the amount of revenue recognized for example sales returns, allowances, incentives, rebates, discounts and loyalty programs. Noncontrolling Interest [Abstract] Noncontrolling Interest Disclosure [Text Block] Comprehensive Income Note [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments And Contingencies Disclosure [Text Block] Accounting Changes And Error Corrections [Abstract] New Accounting Pronouncements and Changes in Accounting Principles [Text Block] Segment Reporting [Abstract] Segment Reporting Disclosure [Text Block] Accounting Policies [Abstract] Basis of Accounting, Policy [Policy Text Block] Prior Period Reclassification Adjustment Description Reclassification, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Marketable Securities Policy Marketable Securities, Policy [Policy Text Block] Investment In Real Estates And Notes Payable [Policy Text Block] The entire policy disclosure of investments in real estates and notes payable. Inventory Policy [Text Block] Inventory, Policy [Policy Text Block] Use Of Estimates Use of Estimates, Policy [Policy Text Block] Fair Value Of Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Revenue Recognition, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Allowance For Doubtful Accounts Receivable Current Allowance For Doubtful Accounts Receivable Current (in dollars) Preferred Stock Par Or Stated Value Per Share Preferred stock, par value (in dollars per share) Preferred Stock Shares Authorized Preferred stock, shares authorized Preferred Stock Shares Issued Preferred stock, shares issued Preferred Stock Shares Outstanding Preferred stock, shares outstanding Common Stock Par Or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock Shares Authorized Common stock, shares authorized Common Stock Shares Issued Common stock, shares issued Common Stock, Shares, Outstanding Common Stock, shares outstanding Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule Of Gross Revenues And Contractual Allowance [Table Text Block] Tabular disclosure of gross revenues and contractual allowance. Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Reconciliation of Revenue from Segments to Consolidated [Table Text Block] Reconciliation of Assets from Segment to Consolidated [Table Text Block] Organization Consolidation And Presentation Of Financial Statements [Abstract] Schedule Of Basis Of Presentation [Table] Schedule Of Basis Of Presentation [Table] Schedule Of Basis Of Presentation [Table] Basis Of Presentation [Line Items] Basis Of Presentation [Line Items] Basis Of Presentation [Line Items] Investment Securities [Table] Investment Securities [Table] Statement Geographical [Axis] Geographical [Axis] Segment Geographical [Domain] Segment, Geographical [Domain] H K HONG KONG [Member] Investment Securities [Line Items] Investment Securities [Line Items] Trading Securities Realized Gain Loss Trading Securities Realized Gain Loss Gain (Loss) on the initial public offerings of equity securities Income Statement [Abstract] Health Care Organization Patient Service Revenue Less Provision For Bad Debts Net patient service revenue Net revenue Net patient service revenues Costs And Expenses [Abstract] Costs and expenses: Labor And Related Expense Compensation and benefits Health Care Organization Medical Supplies And Drugs Expense Medical services and supplies Other Cost And Expense Operating Other operating expenses Depreciation And Amortization Depreciation and amortization Depreciation expense Costs And Expenses Total costs and expenses Operating Income Loss Operating loss Nonoperating Income Expense [Abstract] Other income (expense): Rent And Other Income Expense Rent and other income (expense) Rent and other income (expense). Interest Income Expense Net Interest income Interest Expense Interest expense Other Nonoperating Income Expense Total other income (expense), net Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Loss before income taxes Income (loss) before taxes and discontinued operations Income Tax Expense Benefit Provision (benefit) for income taxes Total income tax expense Total income tax expense Profit Loss Net loss Net loss Net loss Net income (loss) Net Income Loss Attributable To Noncontrolling Interest Less: Net (income) loss attributable to noncontrolling interest Less comprehensive (income) loss attributable to noncontrolling interest Income (Loss) Attributable to Noncontrolling Interest Net Income Loss Net loss attributable to Dynacq Healthcare, Inc. Net loss attributable to Dynacq Healthcare, Inc. Earnings Per Share [Abstract] Basic and diluted loss per common share Earnings Per Share Basic And Diluted Basic and diluted loss per common share (in dollars per share) Basic and diluted loss per common share Weighted Average Number Of Share Outstanding Basic And Diluted Basic and diluted average common shares outstanding (in shares) Basic and diluted average common shares outstanding Income Amounts Attributable To Reporting Entity Disclosures [Abstract] Amounts attributable to Dynacq Healthcare, Inc.: Earnings Per Share Basic And Diluted [Table] Earnings Per Share Basic And Diluted [Table] Earnings Per Share Basic And Diluted [Table] Earnings Per Share Basic And Diluted [Line Items] Earnings Per Share Basic And Diluted [Line Items] Earnings Per Share Basic And Diluted [Line Items] Earnings Per Share Basic And Diluted [Abstract] Basic and diluted earnings (loss): Income Loss From Continuing Operations [Abstract] Numerator: Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Loss from continuing operations Net loss Income (Loss) from Continuing Operations Attributable to Noncontrolling Interest Less: Net (income) loss attributable to noncontrolling interest Earnings Per Share Basic And Diluted Other Disclosures [Abstract] Denominator: Income Loss From Operations Before Extraordinary Items Per Basic And Diluted Share [Abstract] Basic and diluted earnings (loss) per common share: Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Option Indexed to Issuers Equity, Type [Axis] Option Indexed to Issuers Equity, Type [Axis] Option Indexed to Issuers Equity, Type [Domain] Option Indexed to Issuers Equity, Type [Domain] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Stock options with exercise prices exceeding current market prices Treasury Stock [Abstract] Schedule Of Treasury Stock [Table] Class of Stock [Axis] Class of Stock [Domain] Subsequent Event Type [Axis] Treasury Stock, Shares, Acquired Treasury Stock, Shares, Acquired Treasury shares acquired (in shares) Treasury Stock, Value, Acquired, Cost Method Treasury Stock, Value, Acquired, Cost Method Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance Shares Outstanding, Beginning balance Shares Outstanding, Ending balance Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Shares, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Shares, Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total Shares, Expired or canceled Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance Weighted Average Option Exercise Price Per Share Outstanding, Beginning balance Weighted Average Option Exercise Price Per Share, Ending balance Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Option Exercise Price Per Share, Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Option Exercise Price Per Share, Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Weighted Average Option Exercise Price Per Share, Expired or canceled Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis] Exercise Price Range [Axis] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Range One [Member] Range One [Member] Range One [Member] Range Two [Member] Range Two [Member] Range Two [Member] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options Options Outstanding, Number of Shares Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term Options Outstanding, Weighted Average Remaining Contractual Life (Years) Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options Options Exercisable, Number of Shares Award Type [Axis] Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Year 2011 Stock Incentive Plan [Member] Year 2000 Stock Incentive Plan [Member] Common Stock, Capital Shares Reserved for Future Issuance Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total Stock-based compensation expense associated with the Company's stock options Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Total Total unrecognized compensation expense for outstanding stock options Employee Service Share Based Compensation Nonvested Stock Options Compensation Cost Not Yet Recognized Period Employee service share based compensation nonvested stock options compensation cost not yet recognized period. Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] EX-101.PRE 11 dyii-20150228_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R39.htm IDEA: XBRL DOCUMENT

Treasury Stock (Details Textual) - USD ($)	1 Months Ended			12 Months Ended
Treasury Stock (Details Textual) - USD ($)	Apr. 30, 2015	Aug. 31, 2014	Sep. 30, 2013	Aug. 31, 2014
Treasury Stock [Line Items]
Treasury Stock, Shares, Acquired		530,616	125,000	530,616
Treasury Stock, Value, Acquired, Cost Method				$ 27,061
Subsequent Event [Member]
Treasury Stock [Line Items]
Treasury Stock, Shares, Acquired	427,886
Treasury Stock, Value, Acquired, Cost Method	$ 145,054

XML 13 R48.htm IDEA: XBRL DOCUMENT

Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)	3 Months Ended		6 Months Ended
	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2015	Feb. 28, 2014
Available-for-sale securities
Accumulated other comprehensive income balance, beginning of period	$ 10,945,401	$ 11,203,250	$ 12,616,346	$ 9,382,334
Other comprehensive income (loss):
Unrealized gains (losses), net of taxes of $-0- for all periods presented	(820,553)	750,396	(2,491,498)	2,571,312
Other comprehensive income (loss)	(820,553)	750,396	(2,491,498)	2,571,312
Accumulated other comprehensive income balance, end of period	$ 10,124,848	$ 11,953,646	$ 10,124,848	$ 11,953,646

EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`%QF.$<71Q9N\@$``+8@```3````6T-O;G1E;G1?5'EP97-= M+GAM;,W:S4[C,!`'\%>IG[_Y"G.=G88X[+J4_+?&(MM3U;'VGD:SRWV@Y%Y6VOO!M#H9-[+M MV!UDG;O5RK34N?;!YBUURJ7I4XY7LSL=THVV.07;#6P*[#]Y7>+L8PI&'TAW ML2=*=JAC>AHH'JN_C[Q4OJ*5?AC2NPH_W[LZT#"MB;WQSZ6N=SE+S+\MJQR- M;ZIPN/%OG1E;AN;']6\[ROD_7LO!3=S:X2KH1W-08'NR,95C;;49CXWJT87- M#^5):%^A-!8Z??_3T*=@9-/AA$B\JP\!TH<$Z4.!]-&`]'$&TL=G MD#Z^@/3Q%:0/OD!I!$54CD(J1S&5HZ#*453E**QR%%QW8OG*\M"_V/Z'D4X$G1H>)%]2-F`Q+M*;V" M^GH`A3&^.R6:E((C-Z."N[_8_`)02P,$%`````@`7&8X1UWP<_ON`0``;"`` M`!H```!X;"]?K M'^G8E$/?Y?8PY,6?T['+J^G^NFI+&58AY$V;3DV^Z8?434]W_7AJRG0Y[L/0 M;%Z;?0I:U\LP7LZI'A\^SEX\;]?5^+R5:O&S&?>IK*O?_?B:VY1*#N>3W$P+ M3(_?AO2=Y?O=[K!)3_WFUREUY8N*\&^!*LP'Z7R04H)L/L@H03X?Y)2@.!\4 M*4'+^:`E)>AV/NB6$G0W'W1'";J?#[JG!$D-9*PY20AKCM8"N!:.UP+`%H[8 M`L@6CMD"T!:.V@+8%H[;`N`6CMP"Z!:.W0+P%H[>"O16CMX*]%;2MS;ZV.;H MK4!OY>BM0&_EZ*U`;^7HK4!OY>BM0&_EZ*U`;^7HK4!OY>AM0&_CZ&U`;^/H M;4!O(^V5H,T2CMX&]#:.W@;T-H[>!O0VCMX&]#:.W@;T-H[>!O0VCMX.]':. MW@[T=H[>#O1VCMX.]';27C?:[.;H[4!OY^CM0&_GZ.U`;^?H[4!OY^CM0&_G MZ!V!WI&C=P1Z1X[>$>@=.7I'H'?DZ!TO],YM,Z;M2QD/W3Y?N^:_X;#H`N]< MWH[I^BGGJ;#A0NLRK93"^7CU%_D\]6](^/1CP>,[4$L#!!0````(`%QF.$=, MIY@S60,``&8-```0````9&]C4')O<',O87!P+GAM;+U737/:,!#]*QI.Z2$Q M"9!I,\0S"?EH9M*$*30]=A1YP9H(R=7*3.BO[UH&"D%V<`[E@BR]MUKM>UI, M7V/[;&A-!M9)0/8Z4QK/:/*\E3J7G441BA1F'(\(HFEU8NR,.WJTT\A,)E+` ME1'Y#+2+3MKMTPA>'>@$DL-L';05]XM=+K),2<&=-#K^)H4U:":.7;\*4/WH M+<`S*/((1&ZE6\3M$K,YY3$CP14,:*]XPA5"B?HWZ3$#,\NX7D3ET[W4+_@C M&YLK[F"3M;U01D^YA80VW8J^GO28KPLZIRJX@Y3K*22;V-W%52V>P&)QTN.3 MHS9]UB58S9>Q@2=23X=<6HS[`2- MMI'1^F3QLFQ;YRYFQM(IP,?)D%OWGTKAS[0J1*_3VCC]*@2[T`F[UH[LR.YT MN16)MUF2]6A@-!HE$S)7PBZYXEH`&^V4.!R%Q7DPCCILQA<%L#*J)E-3 MTPRN_T`H#GR-3I+1*D`/X-B]0=H);*'&S&CF6U80/;;`,;<+4L2(ER#$KY`# MD70K'`$:J\MX0U>6/7&5^TQOI";;2J[H=M!J/@MSC`4YU6R06PM:+-C8+1Y9V%)ARKE*,,O1M0@B3>RRYU6@:"^_^"AWV\VHPM7F5NE4=C!F"S:R`LE)5RE6DMTVOLJO-P"/S67KW/2O-"= MSOY=AQU<@:,.@*QYL^CT:IK%L&P6_^*/Z?TJYRI<@QI!"WYS3N?S'CUC)[F& MQO'LYISN\0\^7] MAKECG*J?VII;V@N[H)[S@6[0VW+!SOOJF[?3:/M?5?P74$L#!!0````(`%QF M.$>PQF7F/P$``&D#```1````9&]C4')O<',O8V]R92YX;6S-DTU/PS`,AO\* MZKU+VVU(1%T/@#@Q"8DA$+>0>%M8\Z'$4]=_3Y9U+0,NO7&K:[^/7\=)R2WE MQL&3,Q8<2O!7!U5K3[E=)%M$2PGQ?`N*^4FHT"&Y-DXQ#*';$,OXCFV`%%EV M310@$PP9.0)3VQ.3JA2<<@<,C>OP@O=XNW=UA`E.H`8%&CW))SE)JA>]TZ;1 M)1GT51D8H8D7>7!R[ZJ:9I) M,XUU8>".SP;A=E%C#R-U&C8C+C9\1),!S)RU*HT?A(N:; M.,+\_N,3.(X'=<)XV7;0-L8)7\7[-43'EQ-6MC&N/:5^1!>OJOH"4$L#!!0` M```(`%QF.$>97)PC$`8``)PG```3````>&PO=&AE;64O=&AE;64Q+GAM;.U: M6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+ ME@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P M&:>O\,`*I4Q>M5II`,,X?+&A`T%116F]?(+3E'S/X%/F7/ MZ3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4( M,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP'`3@4;N>PIWT;+^D00FT MHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ) MQJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[ MW4%<\%CN.8D1_L;%!-9ITAF6-$9RG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\I MM5`:")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3 MUTU"SG"\+`GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0 M'`*D"3&6H8;XM,:L$>`3?;>^",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L M^P>E1M'V5;SOX%^9PU M"AR1&QT"9QNS1B&$:;OP'J\DCIJMPA$K0CYB&38:CFED)O816:I^JAS0^J!XR M"@7QN1X^Y7IX"C>6QKQ0KH)[`?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9 M+2,6D$N!LT$DN/R+RO`JQ`GH9%LE"0AMNZ5/U2I77Y:^Y*+@\ M6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KTL@ M'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E] MF%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L M1K=@N-?Q+!3@9&`MH`>#KU$"\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF M9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6 M"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N M?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU& M\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO M3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVF ML:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9 MMC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%`````@`7&8X1]FP[6Y9`@``;@L` M``T```!X;"]S='EL97,N>&ULS59=:]LP%/TK0AVCA1';Z9JVJVT8A M17"N5/G-\ZITCAFJ1J+$7*_D0C*D]%067E5*C++*!#'JC7U_XC%$.(Q#7K,I M4Q5(1S,__YXFZ(G]N%"P@"BHD4/J&M0*+<,2P\[A'E"22&#!'C-"E@\<&L$71^C'"A;2Y M789AGI'?9Y)%$D&__;T]7=*SV\%LCU"ZN3T-Q&&)E,*23_4$M/9L6>K-<<&Q M$VG]=G@7$BV#\=5:@!UTWD3(#,LN"(&LI51&MHVA13^F0^P=_Y!G>3`^=C[MB'P*A8F?H@6K,O`WNHWCJ;XUZG M'1_$"YJ\2Z"C45G2Y7=*"LZP$^N@J6AGN^B#+?1QB%:L8"XD>='^IA!2#6`) MP0)+1=)UY*]$Y0PWJJU@K\FW*3QTR^^IZ?BGUJO1)?C1QW-P<@L]U"S!7='F]^\KLUPD',C^V:@Z0<(3#,1WS9*5-3E?:^]344:3=G*JTR]O_5.:U M/6NM,6ZTQ0X%24VH(GPE`9F'S(.133LHXA@;__"&:G9K570O[#C?U!+`P04````"`!< M9CA'I".E.Z8$```Q$0``#P```'AL+W=O`"RL?^^AZDI'EE$W5]94D6#P=X M.$=\=8=/QC[<&_/`GE=*NT,[29;>KP]'(U[JUBY&9 MSV4E3DW5K(3VHVP\WAM9H;B71KNE7+ODE>9^A>;65O#:+87P*]7!5ESJY-M7 M=SB72MP)ZPC,^'I]Q5=BDCRKA"GN_%DMO:@G24&WYDGT'MAF?=Q(%6[*<9F, M`NQMJ#>65:86'6RVE.ZOUS\25HLY;Y2?4;!O_4Z2-"NR;*]CA-?NI'AR"`P/ M&*^\?!0S?C])Q@GCC3?G4GEA3[D7%]8T:ZD7Q$K87%KGIV&X[9LKJ>5*_@QQ MTYU;FJ<_C)4_C?9<32MKE&I;A3_:1M2#^^\)Q>AEU7O1\_O;L!*39&],P$?I MY+U4TK],DO9:B3"2T<90VNE_OV*ZG9RW)69'NF9GVA.%7>IN\6AJ0@ST\F7= M=FP/)5W8RSKMI@I!)R2&4;*FN:C9,5=<5X*UPW$`R0"2[01A?]]P`.4`RO\' M-/7T$P;IF)FSZ[6P`"H`5.P$.C&K-8!*`)6[@O8`M`>@O=U`W"T!]`5`7[9! M%T(+RQ4TV(<&^]L-CKF3;3\W5CCJ<].0`VA^L-W\5E2TIYVDS++EUACE&D<& M32-CG!1M+\[^:>0C5V'8".D9&E'T4C]2"NEF2VIV],BEXK1;/I/NGZ=H5XJ> MIA%1KXP7CJWY2VB/#='+-")FB$%[VOZB%SI:F$8T_-.),/%GSDO:F/VV*%X: M,>^*KKX;1^$*&UQ;4::=+KGMQ8W2I1'K9I3!76-?R#A3/6!+M"R-:-8VH,WL M2->P981V6\N/XJ41\\ZYM.R.JZ:=A7.I*3%(KBA3.6^;%:)0PC1BX;FQ0BXT M.VFL%;IZ83/+M5.;(65H9!8Q\E;00E(\9+59:+G9'%W,(BY>&5U1`0@YG:H& M#83J",F)B%ZNC#AX5%'J;E2;!Z[]LEM_YO%K0.XWY*#0>43H01OS#%$H=AX1>]"$/$=4[S,@ M(G:T9+%/I\)3[G<,4:AZ'E%]L'KD):)0]3R6D=OJ<=-5C_=H9N+9-USUIAU5 MSR.J#_@9L(A"U?/=5#\5^3ZB4/4\HGJ_6FR-$%&H>AY1_>-=TT+Q2PY5+R*J M#Z**%%%H>Q&Q?1B%MA=H>Q&Q?7`O%VA[@;87$=N'406B>I^]T<0>20NORXB" M%NAZ$7%]"$0^(`I=+V*NQVOF&PY1Z'H1<7TP6Q7H>H&N%Q'7AU$'B$+7BXCK MO3*\M6NP;I7H>AEQ?3"'ENAZB:Z7T<_F(12Z7J+KY:Z9O4372W2]S%\/M.]G M6#K&2RWJ<,)W;3=T1*["L9]^NB_XH@S?@N'^AZFI[W!>IZ-YH]0)/;O6WPUO M3[4=^>V@_^U?4$L#!!0````(`%QF.$&PO=V]R M:W-H965T&ULC979CILP%(9?!?$`@VV6+")(DXRJ]J+2:"[: M:R=Q`AK`C.V$Z=O7"V&,:Q5N\,+_G\_K<=Y3]LY+0D3PV=0MWX6E$-TVBOBI M)`WF3[0CK?QSH:S!0C;9->(=(_BL34T=(0"RJ,%5&Q:Y[GME14YOHJY:\LH" M?FL:S/[L24W[70C#1\=;=2V%ZHB*/!I]YZHA+:]H&S!RV87/<'N`B9)HQ:^* M]-RJ!VKP1TK?5>/'>1<"-092DY-0(;`L[N1`ZEI%DN2/(>@74QGM^B/Z-SU= M.?PCYN1`Z]_5691RM"`,SN2";[5XH_UW,LPA50%/M.;Z&YQN7-#F80F#!G^: MLFIUV9L_"1QL?@,:#&@TH.R_AG@PQ*/!+%UD1J;G]8(%+G)&^X!W6.TVW$HY M4T%DY$!.ANNF7B[3>R]`'MU5F(EB;Q1(*^"HB&1L+P!-`7MDV9$/<+`5\3P@ M=F80:WNL[\?W[1GI'/TE+_(.7\E/S*Y5RX,C%3+3ZR1_H500.13P)!-#*5_@ ML5&3BU#5E:PS\R:9AJ#=XXD=W_GB+U!+`P04````"`!<9CA'K2!5[&P$``"Z M%```&````'AL+W=O< MX4%4X!BH713M18'%7K372LS$QDJ6*RGQ]NU+'9(=,J.8N8@._H?\>?HXU.;: MM-^[HW/]ZD==G;O[];'O+W=9UCT>75UV7YJ+._M?GIJV+GO_V#YGW:5UY6$, MJJL,A3!979[.Z^UF?/>UW6Z:E[XZG=W7=M6]U'79_K=S57.]7\/Z[<6WT_.Q M'UYDVTWV'G[_CS< MK\7@P57NL1^**/WEU>U=50TE^9K_G0O]6><02._?2O]];*ZW_U!V;M]4_YP. M_=&[%>O5P3V5+U7_K;G^X>8VC`X?FZH;_Z\>7[J^J=]"UJNZ_#%=3^?Q>IU^ ML6(.XP-P#L#W`%"?!L@Y0$8!V>1L;-=O95]N-VUS7767G&Q[&[IK>O6U2;['4H)Y#L)@E.$DZQ#Q3Z79+Y^ED3&)G`,5Y.\>9VO(SB MY1BOIO@\M'B>&C%)\E$""BUJ(SCA/A`:"X46ZK8C%3E2U)%E'4T2/5<$4$C) M&@ITA36&Z!;]Z,B/IGX*UH\F]4BMM0363B"S0NF$\3*1&T/<2'88=H94@P:- MX#LGD`V=@[?=Y)&;G+IA&[W+Z1@(I0S?-X$,42BX[<9&;BQU@ZP;&[BQ@BPY MZL:&75BHA'E<1&X*ZH8=@ET1S.,<-0`_5D4XD7.!2MQV!"(FEJ">%.MIULQU MY=9J7#`5*%&8W(), M$Y*JK!`%\EC\3+?L*`8U4%)+GM2S9AX[FX/@%]MGNF5',:B!DEKRI`:*8.5W MA$(L]5*@S',C--F/EEW%N`9-=D19))00(Q8H8Q7/6*#T!%DHJQ;F8R`4H&T* M]2$&+5#2*IZT$#`T5T8AL&M\'RJMAH'_":YBX`(EKN*)"Y2E"T-/)7YA)\`6 M8MH"Q2T_%CN@&,7"6'8WWXEF7+?F)H(866YJ&%E$B_8"X6LM;/=,N.8G8A99?F MV85!"BAT;A5_7-M'2I47>FX\1%EUX" M-E*,3BJH[X(0@#3H43OX5:G&7FE5DBOOV@&_4H]=^Q[1WWO M&BX'@JH,'G&GML<#:\G@47S>^5_@MH8*4<3/%D_,:'M2_D#(N^Q\/^U\(!UP MAX]&2?]/<3W>O2IC^V@CI,^D\9SF#T@G`/"1P!< M#XCF@&@1$&@S-:^OB*.JI&3RV(CDU89;@5.91&3VQ&28ZJKETJ.W*@5E<)-Y MGI"]1D*%A#:B?B*2!Q*(^E:)<"$1JOA82\#G$H.6T$BF$!@F65$``&QD_40F M,8Q"DW0Z10NGR'0*K4X:R14"-L`J7CLAITF\,(E-D\AJHI%$(0E0/ZO,&N?T M218^B>D36WT2HX[=Q$XX'=*%0VHZ)%:']+\.=L+ID"T<,M,AM3IHI+A??,;FW+3?N[VU_>IG71V[I_6^ M[T^/2=*][&U==@_-R1[=?UZ;MBY[]]B^)=VIM>5N-*JK!`B125T>CNOM9AS[ MTFXWS7M?'8[V2[OJWNNZ;/]);=6GC;]\-`LMTD5[O=H;;'[M`< M5ZU]?5I_IH\%L`$9B;\.]MQYWU=#\,]-\WUX^&/WM"9##+:R+_W@HG0?/VQF MJVKPY&;^>W;Z,>=@Z'^_>/]ME.O"?RX[FS75M\.NW[MHR7JULZ_E>]5_;N M;GP<"S*-_M@JNDE^#'X"))T0F!#`D-Q'/IPD;GXT"`B#2,$S1R?(?$(Q-(:[ M3HH;3FZ&R:)3_8\G.(X*9D0-25"":ZUQKC,YP`895IA7.YSG"@FI,2X M(N"X(9+Q^_IXI(^/3MBD3]RW%Y&]\/.#QIE.B)CR(X62A*'Y"3AA@',TC[G/ M,=#491+-3\`1SH$NT"H8D035%J`&:[Y@K?61,J,IPR?)C7^8^)S57FJ"[81%PC!KFK82;^BB)CRCB*T2KDL[,--4G*H&`1"N3 MA:0RR@C491Z"H!0'/!U%-+EV[P;H!4)_.8NIMP'K):F"V`/XJ4*+G,[,-5K# M!;IJL@"DW.TK:)7SR*'4E*,O6!&`G"I*S`*-\2E,_6-8X\?PS%Q>+&8XRF4! M!\#!X%M5P#F*B!L*0T[*)<<,C<]ARGV%Z#).9^:2='>&X(=#%H):<(56.P\Y M(-+@+U`1@9QR6+)4XV:!^MT"OO.GU#^V/QES:T\..-"$X?[R@!-N5=Q0Z&.2 M@-L*%PB,NP7JMPMX>Y=2&5114;<=H:%G(2E<;XF7)P]!4##LX[C,<'(`Z5;L M`J%QZT#]W@'O=U/J'^(WMIN[2'X?*6X@M]7$C0+U.P6-=PI4+RZ;7EHVO;AL M^O^5+>X;J-\X&+QQH&'G@$LT@40T8WD(X7M:$4)L01<+<:\`?J]@\%YA9I17 M/8E+"TE7/0GX$1B"0_48WD07T>1#]<2"4Q#B7@'\7L$LV)\@[A7`[Q7PM9;. MC)ZB)0\4/1ZS&,/;P7S&Q@9OY%!OQ2_>%O12$'<)X'<)!N\2(.@2F/NM3BB^ M-X4DY^ZG"N!'S&*?1>R32:[C)9]XESFU;=_&:[1N]=*\'_NI^-?1ZU7=9Q@N M@Z+QE#YF%!G/Z6,Q7<1]N-]N3N6;_;-LWP[';O7<]'U3C[=/KTW36Q7!) MW]MR=WVH[&L_?%5#-:;KN.FA;TZ7V\7K%>?V7U!+`P04````"`!<9CA'+/0> MSK\"``#."0``&````'AL+W=O.`GUJDO>]ZW5*IA?XC$J6=T9TAM M$\$X3J.6UEU8%F;NJ2\+?I9-W;&G/A#GMJ7]GQ5K^&49@O`Z\5P?CE)/1&41 M3;Q=W;).U+P+>K9?AH]@L?-\MPUBGP!JVE5J! MJL<;JUC3:"$5^/>H>0NIB?;[5?VK<:NR?Z&"5;SY5>_D424;A\&.[>FYD<_\ M\HV-%K`6W/)&F-]@>Q:2MU=*&+3T?7C6G7E>AB]9/-+\!#@2X$28XO@):"2@ M&R'Y)R$9"#=5&Y-)2V+GE\"<:)Z.X&%@O=:1"D'JES"#,V" M#+-O98Z+Z$WK.)#5`($&0J`/LK8A8$)$*KXW">@FL8(6W1N@LA$$>7/X5&3S M@O_?&P:`[SJ1\YB=W_'@+M\J=,T2O&/`?2C90K1B9 MG_:C,4=/KUA&O'H;&VA6#,\=1M9MU;+^8/H$$6SYN9/#.33-3JW((]2WW6Q^ M!185\,RO5>LR=!HW^;(XT0/[0?M#W8G@A4MUQYKK=<^Y9"KQ^$$5^ZB:JVG0 ML+W4KT2OPM!O#`/)3]?N:6KARK]02P,$%`````@`7&8X1P\FAZS>`0``(@4` M`!@```!X;"]W;W)K/" MD`7$LH/V4"#(H3W3TFA!N*@D9:5_7RZRK!A*W(M)CMY[\V8\9#H(^:8:`(W> M&>5J%S1:=UN,5=$`(^I!=,#-ETI(1K0YRAJK3@(I'8E1'(?A(V:DY4&6NMB+ MS%+1:]IR>)%(]8P1^7V;K0-X"S%$Z]L&7#5"HXD5+O@*=H> M$XMP@%\M#&JV1];[28@W>_A1[H+06@`*A;8*Q"QGR(%2*V02_QDUKRDM<;Z_ MJ#^[:HW[$U&0"_J[+75CS(8!*J$B/=6O8O@.8PEK*U@(JMPO*GJE!;M0`L3( MNU];[M;!?_D6CK1E0CP2XHDPY5DF)",AN1)67Q)6(V'UOQG6(V%]DP'[VEWG M#D23+)5B0*HC=IRBK8%+*V*4D6F78V&$VBY## M'!)-"&P,++J(/[K8QS/Z8H)\CM@DBQ[NBAP_$?G49G+3K,3Q5V.S;EQP7XK' M;!PF7$+D=Q&'NXCC,L(7@F<3P$#6[NXI5(B>:U_3%)VN]U-L)^@FOH^V>;00 M/YCGP-_>JWR6=J2>36+5?H)+296S>RE1`:C.7PP?2T,0_6=*!0:;O=V&;[ M.^P/6G27%VEZ%K-_4$L#!!0````(`%QF.$>?SG&UD@0``"X5```8````>&PO M=V]R:W-H965T&ULC9A-;]LX$(;_BN![:G+XJ<`Q4&M1=`\+ M%#WLGI68B8U*EE=2XNZ_7^K##H<=-;S$EO)R^,Z(>CCFYM*T/[J#SJXNNP^-6=W\O]Y;MJZ[/UE^[+NSJTK]^.@NEH#8WI=E\?3 M:KL9[WUKMYOFM:^.)_>MS;K7NB[;_W:N:BX/*[ZZWOA^?#GTPXWU=K.^C=L? M:W?JCLTI:]WSP^HSOR^$&22CXN^CNW3!]VPP_]@T/X:+/_C[G,/`\/LU^IQ7+ZZ.0LLKK\.7T>3^/G9?J/$?,P>@#,`^`V MX#8//4#,`\3[`#EF.CD;\_JC[,OMIFTN6721F1R9H1]3'F8-1M&URO@0\)03$(0!E13['W2R:LS+2,+K$2'>P!H>TXJ+P!/0SWS63%.!S$'1C@1:&S(7*46*Z<=#_`41D"&)8*$L*2N0 M[$Y+8Q+\Q.SC*O2SL!)5^,PT4^2+7""9X9"PN?"8I#Q$J5A80@B22N9++X9& M?E12?6*8\I"F)ZG=/$0@Q%0FPDTB`!UD?Y-UO16!G0_NNPFIB*@ M3A/HC0,P%KE=:,(C'>,Y3ZE0#$5`4`0:BH"@*)4V=/>!=;[>%A+J)&(D"M1Y M`KE`=@)UE*"$SB6]E)!2&.9[E117,64%HBS=?^T$0JBV/%?Q;^BK*Z04RBHI M$]Y;$=-6(-H"35L10I1+L*`TO:RPTOC?M`Q2;/WR"QS]!$\*$6-2($P"C4F! MZ*<6:()4P+A(60`Q(85"?N@^72@2$L@,+5DV$G-6Z+"V2;G$8!0(C`LM_BRZ M'G'X'E;F=%>-E*",CQC_]ET'QU"U:U_&X[DN>VI>3_UTU'.[>SL"_`S#,59T M?\?OB^D@[SW,=G,N7]Q?9?MR/'798]/W33V>CSTW3>^\0_;)%_W@ROWMHG+/ M_?#5^._M=)PW7?3-^7HZ>3LBW?X/4$L#!!0````(`%QF.$&PO=V]R:W-H965T&ULA5/+;MLP$/P5@A\0RI*< M%H8L($Y1M(<"00[MF996$A&2JY*4E?Y]^9`5VS"0B[B[FIF=Y:.:T;S9`<"1 M=R6UW=/!N7''F&T&4-P^X`C:_^G0*.Y\:GIF1P.\C20E69YECTQQH6E=Q=J+ MJ2N!7]X$*!U15;>:U0H*U`30QT>_JTV1W* M@(B`WP)F>Q&3X/V(^!:2G^V>9L$"2&A<4.!^.<$S2!F$?.._B^9'RT"\C,_J MW^.TWOV16WA&^4>T;O!F,TI:Z/@DW2O./V`981L$&Y0V?DDS68?J3*%$\?>T M"AW7.?UYS!;:?4*^$/*5\#426&H4;7[CCM>5P9G8D8>SV^P\W`01KTR\-QO3 M.'VJGNI-D5?L%(2N,(>$R1-F13"O?K=%?MWBD%_0\\_IQ8W#(M*+Q6'QN4!Y M(U!&@7(1*.^.>(W9WC1A%WNJP/3QZEC2X*1=VKRUNM[.ISR>R0>\KD;>PR]N M>J$M.:+S)QL/M4-TX$UD#UM*!O]^UD1"YT+XQ<E^Y&AHP$``+$#```8````>&PO=V]R:W-H965T&ULA5/+;MLP$/P5@A\0RK(3)X8L($Y1-(<`00[MF996$A&2JY*4E?Y] M^9`5VS#@B[B[FIF=Y:,8T7S:#L"1+R6UW=+.N7[#F*TZ4-S>80_:_VG0*.Y\ M:EIF>P.\CB0E69YE#TQQH6E9Q-J[*0L;50H*U`30PT6_J\V.Q6`1$!OP6,]B0FP?L>\3,DK_669L$"2*A< M4.!^.<`+2!F$?.._D^9WRT`\C8_J/^.TWOV>6WA!^4?4KO-F,TIJ:/@@W0>. MOV`:X3X(5BAM_))JL`[5D4*)XE]I%3JN8_JS?IIHUPGY1,AGPF,6C:=&T>8/ M[GA9&!R)[7DXN\7&PTT0\[,QC=.GZJ%<+!\*=@A"9YA=PN0),R.85[_: M(C]OL8YXNFK"3/55@VGAU M+*EPT"YMWER=;^=S'L_D&UX6/6_AC9M6:$OVZ/S)QD-M$!UX$]G=/26=?S]S M(J%Q(5S[V*0KE1*'_?&!S*^T_`]02P,$%`````@`7&8X1^#.:5FA`0``L0,` M`!D```!X;"]W;W)K&ULC5/;CILP$/T5RQ^P!D+: M*B)(FZVJ]J'2:A_:9P<&L-;V4-N$[=_7%\(F4:3M"YX9SCESQI=J1O-J!P!' MWI34=D\'Y\8=8[890''[@"-H_Z=#H[CSJ>F9'0WP-I*49$66?6**"TWK*M:> M35WAY*30\&R(G93BYN\!),Y[FM-SX47T@PL%5E=LY;5"@;8"-3'0[>ECOCN4 M`1$!OP3,]B(FP?L1\34D/]H]S8(%D-"XH,#]#-9I2TT/%)NA>JKS,JO8*0A=80X)4R3,BF!>_6Z+XKK%H;B@%Q_3-S<.-Y&^61S^1__R M1J",`N4B4-P=\1JSN6G"+O94@>GCU;&DP4F[M'EK=;V=CT4\DW=X78V\AY_< M]$);:H?HP)O('K:4#/[]K(F$SH7PLX]-NE(I<3B>'\CZ2NM_4$L# M!!0````(`%QF.$?H:(+MH0$``+$#```9````>&PO=V]R:W-H965T2VNYH[]RP9*THRMZ*KR+ MKG>AP*J2+;Q&*-!6H"8&VAU]7&WW14!$P&\!DSV+2?!^0/P(R6NSHUFP`!)J M%Q2X7X[P!%(&(=_X[ZSYU3(0S^.3^L\XK7=_X!:>4/X1C>N]V8R2!EH^2O>. MTPO,(VR"8(W2QB^I1^M0G2B4*/Z95J'C.J4_FVRFW2;D,R%?"#\B@:5&T>8S M=[PJ#4[$#CR&7BO=F8QNE3]5BMBJ)DQR!T@=DG3)XP"X)Y]9LM M\LL6^_R,GG]/7U\Y7$?Z>G:X^5Z@N!(HHD`Q"]S?'/$2\W#5A)WMJ0+3Q:MC M28VC=FGSENIR.Q_S>"9?\*H<>`>_N.F$MN2`SI]L/-06T8$WD=UM*.G]^UD2 M":T+X8./3;I2*7$XG![(\DJK_U!+`P04````"`!<9CA'V0A/B:`!``"Q`P`` M&0```'AL+W=OP)$/ M);7=T=ZY8)TXZNZ*GP*KK>A0*K2K;P&J%`6X&:&&AW]&&UW10,@CYQN^SYF?+0#R/3^K/ M<5KO_L`M/*+\*QK7>[,9)0VT?)3N%:>?,(^P"8(U2AN_I!ZM0W6B4*+X1UJ% MCNN4_MQG,^TV(9\)^16!I4;1YA-WO"H-3L0./)S=:NOA)HAX9>*]V9C&Z5/U M6*V*^Y(=@]`%9I\P><(L".;5;[;(+UOL\S-Z_C5]?>5P'>GKV>&/KP6**X$B M"A1)8)/='/$22&D?MTN8MU>5V/N3Q3#[A53GP#GYSTPEM MR0&=/]EXJ"VB`V\BN]M0TOOWLR026A?"[SXVZ4JEQ.%P>B#+*ZW^`U!+`P04 M````"`!<9CA'NOR;-Z(!``"Q`P``&0```'AL+W=OP)$/);7=9[USPXY26_>@N'W``;3_TZ)1W/G4 M=-0.!G@324I2EN??J.)"9U49:Z^F*G%T4FAX-<2.2G'S[P`2IWVVRLZ%-]'U M+A1H5=*%UP@%V@K4Q$"[SQY7NT,1$!'P6\!D+V(2O!\1WT/RL]EG>;``$FH7 M%+A?3O`$4@8AW_COK/G9,A`OX[/Z&PO=V]R:W-H965TZH&32P)I"DH%F:WE+)N$JJ,M3>=%7B M:`57\*:)&:5D^M\.!$[;9)4<"^^\ZZTOT*JD"Z_A$I3AJ(B&=IL\K#:[PB," MX(/#9$YBXKWO$;]\\M)LD]1;``&U]0K,+0=X!"&\D&O\=];\:>F)I_%1_2E, MZ]SOF8%'%)^\L;TSFR:D@9:-PK[C]`SS"&LO6*,PX4OJT5B41TI")/N.*U=A MG>*?O)AIUPG93,@6PGT:C,=&P>8?9EE5:IR(&9@_N]7&P;47<3,A#=/' MZJ'*TY(>O,X99!8^XOFM"3+96@NW!S#*EQ5#;NW5)=+N=#%H[D!UZ5`^O@E>F. M*T/V:-W!AC-M$2TX$^G-.B&]>SY+(J"U/KQSL8XW*B86A^/[6!YI]1]02P,$ M%`````@`7&8X1XZ*&%NB`0``L0,``!D```!X;"]W;W)K&ULA5/+;MLP$/P5@A\02K*=MH8L($X0M(<"00[MF996$A&2JY"4E?Y] M^9`5VS"0B[B[FIF=Y:.N6'+F*U[4-S>X0#:_VG1*.Y\ M:CIF!P.\B20E69%E]TQQH6E5QMJ+J4H\7I M)\PC;()@C=+&+ZE'ZU"=*)0H_I%6H>,ZI3^K8J;=)A0SH5@(W[-H/#6*-I^X MXU5I<")VX.'L\JV'FR#BE8GW9F,:IT_58Y5O?I3L&(0N,/N$*1)F03"O?K-% M<=EB7YS1BZ_IJRN'JTA?I>[WV=<"ZRN!=118SP+YS1$O,=*C!=O#J6 MU#AJES9OJ2ZW\R$>(ON$5^7`._C-32>T)0=T_F3CH;:(#KR)[&Y#2>_?SY)( M:%T(O_G8I"N5$H?#Z8$LK[3Z#U!+`P04````"`!<9CA'\FU9XZ$!``"Q`P`` M&0```'AL+W=OFJ MQ-$*KN!-$S-*R?3_/0B<=LDJ.17>>==;7Z!521=>PR4HPU$1#>TN>5AM]X5' M!,`?#I,YBXGW?D#\\,E+LTM2;P$$U-8K,+<\$:A0E?4H_&HCQ1$B+99URY M"NL4_^393+M-R&9"MA#NTV`\-@HV?S/+JE+C1,S`_-FMM@ZNO8A3)LZ;"6F8 M/E:/U6J3E_3HA2XP^XC)(F9!4*=^LT5VV6*?G=&SG^GYE<,\T//98?&S0'$E M4`2!8A98WQSQ$K.Y:D+/]E2"[L+5,:3&4=FX>4MUN9T/X1#I-[PJ!];!*],= M5X8J9A8'$X/9'FEU1=02P,$ M%`````@`7&8X1^G1<)RC`0``L0,``!D```!X;"]W;W)K&ULA5/+;MLP$/P5@A\0RK(3NX8L($X0M(<"00[MF996$A&2JY"4E?Y] M^9`5VS"0B[B[FIF=Y:,8T;S;#L"13R6UW='.N7[+F*TZ4-S>80_:_VG0*.Y\ M:EIF>P.\CB0E69YE#TQQH6E9Q-JK*0L!-M MYT*!E06;>;50H*U`30PT._JXV.Y7`1$!?P2,]BPFP?L!\3TDO^H=S8(%D%"Y MH,#]&H4;3YS MQ\O"X$ALS\/9+;8>;H*(5R;>FXUIG#Y5C^7B85VP8Q"ZP.P3)D^8&<&\^LT6 M^66+?7Y&S[^G+Z\<+B-].3GR/Q*R_]02P,$%`````@`7&8X1^%7T4&A`0``L0,` M`!D```!X;"]W;W)K&ULC5/;;J,P$/T5BP^H@=!F M%1&DIE75/JQ4]6'WV8$!K-H>:IO0_?OUA=`DBM2^X)GAG#-G?"DGU.^F![#D M4PIEMDEO[;"AU-0]2&9N<`#E_K2H);,NU1TU@P;6!)(4-$_3.RH95TE5AMJK MKDH`*7C4QHY1,_]N!P&F;9,FQ\,:[WOH"K4JZ\!HN01F.BFAHM\E]MMD5 M'A$`?SA,YB0FWOL>\=TG+\TV2;T%$%!;K\#<&PO=V]R:W-H965TLV(:!7,3=U+V`7O0_D^#1G'G M4],RVQO@=20IR?(LVS#%A:9E$6MOIBQP<%)H>#/$#DIQ\^\`$L<]7=!SX5VT MG0L%5A9LYM5"@;8"-3'0[.G38G=8!40$_!8PVHN8!.]'Q(^0_*SW-`L60$+E M@@+WRPF>0O=';N$9Y1]1N\Z;S2BIH>&#=.\X MOL(TPCH(5BAM_))JL`[5F4*)XI]I%3JN8_JSW$RT^X1\(N0SX3&+QE.C:/,' M=[PL#([$]CR&7BO=F8QNE3]50NMNN"G8+0%>:0,'G"S`CFU>^V MR*];'/(+>OX]?7GC&ULA5/+;MLP$/P5@A\02K+2 MI(8L($Y1M(<"00[MF996$A&2JY*4E?Y]^9`5VS"0B[B[FIF=Y:.:T;S9`<"1 M=R6UW='!N7'+F&T&4-S>X0C:_^G0*.Y\:GIF1P.\C20E69%E7YCB0M.ZBK47 M4U!7]X$*!U15;>:U0H*U`30QT._J4;_=E M0$3`;P&S/8M)\'Y`?`O)SW9'LV`!)#0N*'"_'.$9I`Q"OO'?1?.C92">QR?U M[W%:[_[`+3RC_"-:-WBS&24M='R2[A7G'[",T M"AW7.?TI\X5VFU`LA&(E/&;1>&H4;7[CCM>5P9G8D8>SR[<>;H*(5R;>FXUI MG#Y5CW7^\+5BQR!T@=DG3)$P*X)Y]9LMBLL6^^*,7GQ.WUPYW$3Z)G5_S#X7 M**\$RBA0+@+YS1$O,=*C!]O#J6-#AIES9OK:ZW\ZF(9_(!KZN1]_"+ MFUYH2P[H_,G&0^T0'7@3V=T])8-_/VLBH7,A?/"Q25<.>-+.:'^-#V`)=]2*+-->FN'#:6F[D$RG12V9 M=:GNJ!DTL":0I*!9FMY2R;A*JC+47G55XF@%5_"JB1FE9/K?#@1.VV25'`MO MO.NM+]"JI`NOX1*4X:B(AG:;W*\VN\(C`N"=PV1.8N*][Q$_??+2;)/46P`! MM?4*S"T'>``AO)!K_#5K_K3TQ-/XJ/X4IG7N]\S``XH/WMC>F4T3TD#+1F'? M<'J&>82U%ZQ1F/`E]6@LRB,E(9)]QY6KL$[Q3Y[/M.N$;"9D"^$N#<9CHV#S MD5E6E1HG8@;FSVZU<7#M19PR<=Y,2,/TL7JH5G=Y20]>Z`RSBY@L8A8$=>I7 M6V3G+7;9"3W[G9Y?.,P#/9\=%K\+%!<"11`H9H'UU1'/,;<73>C)GDK07;@Z MAM0X*ALW;ZDNM_,^"V?R`Z_*@77PE^F.*T/V:-W)AD-M$2TX$^G-.B&]>S]+ M(J"U/OSC8AVO5$PL#L<'LKS2ZC]02P,$%`````@`7&8X1^'2...C`0``L0,` M`!D```!X;"]W;W)K&ULA5/+;MLP$/P5@A\0RK+2 M.(8L($Y0M(<"00[MF996$A&2JY*4E?Y]^9`5VS"0B[B[FIF=Y:.X0#:_VG1*.Y\:CIF!P.\B20E69YEWYCB0M.JC+57 M4Y4X.BDTO!IB1Z6X^;<'B=..KNBI\":ZWH4"JTJV\!JA0%N!FAAH=_1IM=T7 M`1$!OP5,]BPFP?L!\3TD/YL=S8(%D%"[H,#]QP\[5` M<2501(%B%GB\.>(%YC&[:L+.]E2!Z>+5L:3&4;NT>4MUN9U/>3R33WA5#KR# M7]QT0EMR0.=/-AYJB^C`F\CN[BGI_?M9$@FM"^&#CTVZ4BEQ.)P>R/)*J_]0 M2P,$%`````@`7&8X1^_C?/&C`0``L0,``!D```!X;"]W;W)K&ULA5/;3N,P$/T5RQ^`$S=TV2J-1%DA]@$)\<`^N\DDL?`E:SL- M_#V^I*&M*O$2STS..7/&EW+2YMWV``Y]2*'L%O?.#1M";-V#9/9&#Z#\GU8; MR9Q/34?L8(`UD20%H5FV)I)QA:LRUEY,5>K1":[@Q2`[2LG,YPZ$GK8XQ\?" M*^]Z%PJD*LG":[@$9;E6R$"[Q??Y9E<$1`2\<9CL28R"][W6[R'YVVQQ%BR` M@-H%!>:7`SR`$$'(-_X_:WZW#,33^*C^&*?U[O?,PH,6_WCC>F\VPZB!EHW" MO>KI">81;H-@K86-7U2/UFEYI&`DV4=:N8KKE/X4ZYEVG4!G`ET(=UDTGAI% MFW^88U5I](3LP,+9Y1L/-T'$*R/OS<8T3I^JARK_G9?D$(3.,+N$H0FS((A7 MO]J"GK?8T1,Z_9F^NG"XBO15ZKZ^^UF@N!`HHD`QCTBOCGB.65TT(2=[*L%T M\>I85.M1N;1Y2W6YG?B`0`` ML0,``!D```!X;"]W;W)K&ULA5/+;MLP$/P5@A\0 MRK*X0#:_VG1*.Y\:CIF!P.\B20E69YE]TQQH6E5 MQMJKJ4H!-=[T*!525;>(U0H*U`30RT._JX MVNZ+@(B`WP(F>Q:3X/V`^!Z2G\V.9L$"2*A=4.!^.<(32!F$?.._L^9GRT`\ MCT_JSW%:[_[`+3RA_",:UWNS&24-M'R4[@VG%YA'V`3!&J6-7U*/UJ$Z42A1 M_".M0L=U2G\VQ4R[3&H4;?[@CE>EP8G8@8>S6VT]W`01KTR\ M-QO3.'VJ'JO5]Z)DQR!T@=DG3)XP"X)Y]9LM\LL6^_R,GG]-7U\Y7$?Z>G:X M^5J@N!(HHD`Q"]S?'/$2\W#5A)WMJ0+3Q:MC28VC=FGSENIR.Q_S>":?\*H< M>`>_N.F$MN2`SI]L/-06T8$WD=UM*.G]^UD2":T+X8./3;I2*7$XG![(\DJK M_U!+`P04````"`!<9CA'S*P]Y:`!``"Q`P``&0```'AL+W=OBI\B+9SH<#*@LV\6BC05J`F!IH-?5ZLMZN`B(#?`D9[%I/@?8]X",E;O:%9 ML``2*A<4N%^.L`,I@Y!O_'?2_&H9B.?Q2?TE3NO=[[F%'A[-;K#WR\738\&.0>@"LTV8/&%F!//J M-UODERVV^1D]_YZ^O'*XC/3EY/#I>X'5E<`J"JQ2_RR[.>(EYGI(=K:G"DP; MKXXE%0[:I?? MSYQ(:%P(?_C8I"N5$H?]Z8',K[3\#U!+`P04````"`!<9CA'*Y=W!*$!``"Q M`P``&0```'AL+W=O+'&#UL+^.X+"\4`W="F\RK;SL<#*@JV\6FHP3J(A%IH#?=SL MCWE$),!O":.[B$GT?D)\B\G/^D"S:`$45#XJB+"7 MTC3]5#V7/.,%.T>A*\QQPO"$V:P(%M3OMN#7+8[\@LX_IV]O'&X3?3L[W'XN MD-$Y$D@GP7RNR->8W8W3=C%GFJP;;HZCE0X&#]MWEI=;^&ULC97?CJ,@%,9?A?@`HV#5MK$FT]EL=B\VFR!^_\_T.`0[EP,6[;`A1X(/13NZB1JE^&\>R;@C#\HGWI--_ M3EPPK/10G&/9"X*/-HC1&"5)'C/<=E%5VKE7497\HFC;D57# M+H+1?>*M/3?*3,15&4]QQY:13K:\`X*<=M$SW.YA:B16\;LE@YSU@4G^P/F[ M&?P\[J+$Y$`HJ96QP+JYDA="J7'2Y+\WTT^F"9SW[^[?[7)U^@YK2$SAC6GTGY!?9&*LWM(!!C^&-NVL^TP_LGO8>$` M=`M`4\`ZL8F/()OF-ZQP50H^`-ECLWEPJ^7"F&AGH'.3=FA7/\Y>*Y3D97PU M1HYF/VJ0UPL@:KVQ*+X!)= MS7H9DGF0S#'8!"&.!B;+D-R#Y(X!#$+F&K@JEB&%!RD<"`I"7,T#>[+V(&O' M8!6$S#4PRY8A&P^R<2!9$.)J\F4(3/P;E#@6X?/EB&#^P#6`7VXJ=#CK,&&PO=V]R:W-H965TLMB#J1M&(\RS9,"VEH6:3:BRT+ M'+R2!EXL<8/6PO[;@$Q1U?T5'B5;>=C@94%6WBUU&"<1$,L-#OZL-KN\XA( M@#\21G<6D^C]@/@6DU_UCF;1`BBH?%0083G"(R@5A4+C]UGSLV4DGL4?V5M>^"V8R2&AHQ*/^*XT^81[B/@A4JE[ZD&IQ'?:)0HL7'M$J3 MUG'ZL_DQTVX3^$S@"^%[EHQ/C9+-)^%%65@M%/+O5-L!M%`G*)'AS*4W3 M3]5CR3DOV#$*76#V$X8GS&I!L*!^LP6_;+'G9W3^-7U]Y7"=Z.NI^R;_6B"_ M$LB30#Z/N+XYXB7FN@D[VU,-MDU7QY$*!^.GS5NJR^U\X.E,/N%ET8L6?@O; M2N/(`7TXV72H#:*'8"*[NZ>D"^]G210T/H;?0FRG*S4E'OO3`UE>:?D?4$L# M!!0````(`%QF.$=GPLSVK0$``!8$```9````>&PO=V]R:W-H965T0'*`Y)FBYR+#6=JNUB4M6+[9K8QS8J<%S`T@:Y]H]I;9H0'%[ARUH_Z5"H[CS MI:FI;0WP,I*4I"Q-[ZGB0B=Y%GLO)L^P#'$=DIQ\_<($OM#LDHNC5=1 M-RXT:)[1B5<*!=H*U,1`=4@>5_OC-B`BX+>`WE[M22?>* M_0\81X@)"Y0V_I*BLP[5A9(0Q3^&5>BX]L.7AW2DW2:PD<`6!#H8Q9C?N>-Y M9K`GMN7A[%9[#S=!Q"L3G\W&,DX_=,\Y8]N,GH/0#',<,"QB5A.">O6;%FQN M<617=/8U?;U(N([T]>"^^P^!S4)@$P4VXXCW-T><8W9?FVP7)MN9P,--DSGF MV\*$7AV<`E/'^VE)@9UVPPE-W>D)/+)X\)_P/&MY#;^XJ86VY(3.7Y]XN=3-/Z13H6$RH7MSN_-<&^'PF%[>8737T'^#U!+`P04````"`!<9CA' MCO=]WJ`!``"Q`P``&0```'AL+W=OTVZYT;-I3:N@?%[0T.H/V?%HWBSJ>FHW8PP)M(4I*R M/+^CB@N=566LO9BJQ-%)H>'%$#LJQD09:/DKWBM-OF$>X#8(U2AN_ MI!ZM0W6D9$3QS[0*'=F7AO-J9Q^E0]5&R5E_00A,XPNX1A$5,L".K5K[9@YRUV[(3.?J:O+ARN M(GV5NM_?_2RPOA!81X'U/&)Q=<1SS*5+>K*G"DP7KXXE-8[:IY#, MWN@!E/_3:B.9\ZGIB!T,L":2I"`TRVZ)9%SAJHRU%U.5>G2"*W@QR(Y2,O.U M`Z&G+5[A8^&5=[T+!5*59.$U7(*R7"MDH-WBA]5F5P1$!+QQF.Q)C(+WO=8? M(?G;;'$6+("`V@4%YI<#/((00<@W_C]K_K0,Q-/XJ/XG3NO=[YF%1RW>>>-Z M;S;#J(&6C<*]ZND9YA'60;#6PL8OJD?KM#Q2,)+L,ZU;(.*5D?=F8QJG3]5#1?.\)(<@=(;9 M)0R-F-6"(%[]:@MZWF)'3^CT=WI^X3"/]#QUOR]^%R@N!(HH4,PC%E='/,>L M+YJ0DSV58+IX=2RJ]:AE0/KX!\S'5<6[;7S)QL/M=7: M@3>1W:PQZOW[61(!K0OAG8]-NE(I<7HX/I#EE5;?4$L#!!0````(`%QF.$=N M[<+RHP$``+$#```9````>&PO=V]R:W-H965TTI^_KA9X'5E<`J"JRF$3R3>\+'K>PC]N6J$M.:#S)QL/M4%TX$UD=_>4=/[]S(F$QH5PXV.3KE1* M'/:G!S*_TO(+4$L#!!0````(`%QF.$>\VUC;L`$``!8$```9````>&PO=V]R M:W-H965TDM55QT29&'W+,NLDBGQ(IK6^@0M)?>K[7[C$0'P5\!HSO;$ M>S\@OOK@3[5+4F\!))36*W"W'.$!I/1"KO#_D^9G24\\WT_JCZ%;Y_[`#3R@ M_"1GF9?"ZPO!-9!8!T%UNG5 M%I>8;S2YN2BR60BPJT66F,M.Z-G%*=!-F$]#2APZ&V]HSLY/X)Z%B_^$%WG/ M&WCBNA&=(0>T;GS"Y-2(%IR)],:Y:-TCG0,)M?5;-W5$Q[F-@<5^>H7SKZ#X M`%!+`P04````"`!<9CA':1]GV_0!``!I!0``&0```'AL+W=O<.1[,)#T7;[(&4.B#T5;NO5JI;H>QS&M@1*YX!ZU^ M4W+!B-*AJ+#L!)#"DAC%H>]O,"--ZZ6)S;V(-.$719L67@22%\:(^',`RON] M%WBWQ&M3U4[`[Q09A`;\:Z.5DCXSW,^=O)OA1 M[#W?6``*N3(*1"]7R(!2(Z0+OP^:]Y*&.-W?U)_M:;7[,Y&0 M*J`D%ZI>>?\=AB.LC6#.J;1/E%^DXNQ&\1`C'VYM6KOV[LTF'FC+A'`@A"-A MK+-,B`9"="?\NT(\$.+_K;`>".M9!>S.;CMW)(JDB>`]DATQURG8:;@P(EH9 MZ79)&]H/XK+7-(SC!%^-T`/FX#"AQ6S#)"806X%X$-@\FFQ=+QPF\%TO5\$2 M*'.@[:S?$\1QB@B7$*=9H6^SX^#)16(@*OL+2Y3S2ZM<$\;L."6>0G,19_E# ML,N"A?Q13Q4W!.[R:=*1"GX2436M1&>N]/6W-[_D7(%V[:]T9VL]]\:`0JG, M=FM:[D:!"Q3O;H-MG*[I7U!+`P04````"`!<9CA'<5OX4[4!``#W`P``&0`` M`'AL+W=OEY/2[Z8'L.A#<&D. M26_ML,?8U#T(:A[4`-+]:946U+I0=]@,&F@32()CDJ9;+"B3256&W*NN2C5: MSB2\:F1&(:C^=P2NID.2)7/BC76]]0EEWGWPLSDDJ;<`'&KK%:A;SO`,G'LA5_CO1?.SI">N][/Z]]"M M"P5MR$+ZI'8Y68*0D2]".N3(9U MBG]V,^UK`KD0R$(@T7@L%&R^4$NK4JL)F8'ZN\OV#JZ]B%-&SIL)8>@^9L\5 MR7RHI/\\;[`YL;C)@CD%X%O]P7R&X$\ M"&RB0)'>%RAN!(JU@R*[/B49VXR873RE;?:XS6_JX-7-"-!=&$"#:C5*&Z]@ MR2XS_D3"S7["JW*@'?RBNF/2H).R;C[":+1*67`^T@=GI'>O<`DXM-9OW5@A M'0G6?OD"<&80&_&QCD M8H],[6?./TSP\W)T7%,"4"B442!ZN4(.E!HA;?QWTKQ;&N)R?U-_L=WJZL]$ M0L[IG^:B:EVLZZ`+E*2GZIT/KS"U$!G!@E-IGZCHI>+L1G$0(Y_CVK1V'<8W MD3_1]@G^1/!GPNRS3P@F0K`AX+$RV]-/F&`/DR\QR5T&ZQ)VZ_#7=9S\E4>XZ['&1(]- M@DVS@14()H'XL4"X$0BM0#@)).LJV[&3$9-8C.?%0?#]L4^T\8E6/M]V_\H: M\P63>&,2+P5B=Z^9/%XT$R=!^-@EV;@D*Q=OMY4U9GMZ\.)$,Q"5O>D2%;QO MU7ATY^P\3)[MG<-W>)9VI()?1%1-*]&9*WVO[)4J.5>@BW"?]`>M];B;`PJE M,MM$[\4X`<9`\>XVS^:AFOT'4$L#!!0````(`%QF.$=HT\56I0(``"T)```9 M````>&PO=V]R:W-H965T-EV9_X'(C*(M@XFV;CO2LH;TW MD-W2?P*+=2X1"O"K(6=FO'LR]U=*W^3BQW;IAS(%TI(-EPI8/-Y)1=I6"HG` M?T;-:TA)--\OZM^46Y']*V:DHNWO9LL/(MG0][9DAT\M?Z'G[V2TD$C!#6V9 M^O4V)\9I=Z'X7H<_]+/IU?.LOZ!XI+D)<"3`B3#%<1.BD1!="?^/$(^$^-X( MR4A(K`B!]JXJ5V..RV*@9X\=L3Q.8"'@@Q01RIXH%U-+U1"]^UY"%!7!NQ2: M858:`Q4FA2Y(;4+`A`A$`LXLX#R+%33HS@"5B4B=:=8W1=9?B'R99F05*U+\ M:"Q6?%L@M@1B)1`K@2R?Y]CK4FA(JB`/(`5YFB,7L)H!$Y`F*''AZAD.IC"$ M>>0"KN>1H3`(T6V+B64Q,2SFH=.BAB0*$CESJ4S(0^*L5#W#9$[SZQDFNJ/E MR+*#3#O`:0=]ZIC]/QI-(:MC",9.8\CN6)1F3G?H4\>,4GUI,;4LIK-3G=P6 MR"R!S*@11,[3NLJ,1H`HR[(0.`]'-0/&,<@0="K6]RJN+<4(Q=D=!R&W3.;F M08!.CQJ2Z7:$C\")JBQ4Z#X#&@7""\RIM;:U,LM78`R#C@Q[-8:9MZ&GGNN6 M3[O3I'^"YWK!Z?%R.9EN2.4_4$L#!!0````(`%QF.$&PO=V]R:W-H965T.O.E$I)3;4)98]5+H*4C<88C M0K:8T[8+LM3EWF66BD&SMH-WB=3`.97_3L#$>`S"X)KX:.M&VP3.4CSSRI9# MIUK1(0G5,7@)#WEB$0[PNX51+?;(>C\+\6F#G^4Q(-8","BT5:!FN4`.C%DA M4_COI'DK:8G+_57]U75KW)^I@ERP/VVI&V.6!*B$B@Y,?XCQ#:86-E:P$$RY M7U0,2@M^I02(TR^_MIU;1_]E3R;:.B&:"-%,F.NL$^*)$-\([NBP=^;Z^D$U MS5(I1J1Z:B\[/!BXM")&&9EFE`O=&IB_[U`\B"0.(%D$GB^-]GY-CQFXTWN M$T+(&BQ?PD*R?5[BO!^\N"$.LG:3JU`AAD[[4YBS\^-XB>P-/^1/YM'X&;_) M9&E/:_A%9=UV"IV%-O/C1J<20H,Q2)XV`6K,LYX#!I6VVYW92S_I/M"BO[[; M^<\C^P]02P,$%`````@`7&8X1T-7Z+XR`@``^`8``!D```!X;"]W;W)K&ULE57+CILP%/T5Q`<,8#`D$4$:DE3MHM)H%NW:29R` MQL;4=H;IW]_#BN75];P`0?I%9`:OC$&TR(%E*!_[2:UY":.)QWZM],MLK]'@F\ M8>1W>92%,NN[SA&?T(7(=]9\QVT*4`L>&!'FUSE$+2&\$J*[A*@E1,\28$N`5T)L:FES-Y7;(HFRE+/&$372 MURE8*3C7(DK94>429FD.Q.Y^9B#Q4^]3"XTPN<4`BX'A'&8WPB1!C_&4AUDC M8&PD!R,!,!=D,\+`.N9^WL+";IKE/\Q$6()V'B M49CDL4`R$4C^]W@6$X'%X^/)%X."1B!9+)XHZ'(29_FXH/ER4-`@@CZV"\GJ[IWI'[OL'U!+`P04```` M"`!<9CA'-@;"P1$"``#,!@``&0```'AL+W=O$SKM?.!?%UZZ M4RO40EB5X2VO[GH\\(X.'L/-SO\,MGL`E40K?G9XXHNYIXH_4/JJ@N_USH]4 M#9C@HU`62`X7_(0)44Z2_'LV?6>JQ.7\ZOY5;U>6?T`0Z(,CY1P_?6.9RYH?TWQO1Z]F;$;]#B9/WDTI[D3X)P`;PF% MKMMP=)5?D$!5R>CD\1&ILP-;J6;*0QI[LC2N0[UYLWJI8):7X449K31[HX&S MIKAI0NGOA$`+`K7!QACDT7V#C66PT0;Q;`#650ZF2J-)M*8HDON0V(+$*PAT M0N(%Y(%])!8B62$V3D3R,41J(=(5(G8BT@7B$P3@/B6S*-F*DC@IV8*2+2KY M+R2W(/D*DCHA1I,;30#R^Y3"HA0K2N:D%!\[$Q#971:M(+D3,HL>I_S3RV!% M*=R4N>--R\@0MYY M^KIK*!58>D6![(I6/BVW@.!&J&DFY\Q&PO=V]R:W-H965T")A&># M'YQ[SKUDYP>_$6+8!P$_-[A#_(D.N)=O:LHZ).2270(^ M,(PJ'=21(`0@#3K4]GY9Z+T75A;T*DC;XQ?F\6O7(?;WB`D=#S[T[QNO[:41 M:B,HBV".J]H.][REO<=P??"_P/T1)@JB$;]://+%W%/)GRA]4XL?U<$'*@=, M\%DH"B2'&W[&A"@FJ?QG(OVOJ0*7\SO[-UVN3/^$.'ZFY'=;B49F"WROPC6Z M$O%*Q^]XJD%G>*:$ZZ=WOG)!NWN([W7HW8QMK\?1O,G!%/8X()P"PCD@3'7B M1DBG^14)5!:,CAX?D&H>W$LX4R22V9.Y<;W4U9O=6QGN8!'<%-$*VY]Z) M"GDZZX.YIE1@206>)%4C+\%Y07`MU#23&PO=V]R:W-H965T@+.>&&/SF0MD:, M+]NC1T\M1GM)JBL/^G[LU:ALW#R3>V]MGI$SJ\H&O[4./=X MMXWW\E@PL>'EF=?Q]F6-&UJ2QFGQ8>&^@OD&Q`(B$;]*?*6]>T>8WQ+R(18_ M]@O7%QYPA7=,2"!^N>`5KBJAQ"/_T:+WF(+8O[^I?Y/II+ZFV0E0 M$V!'Z.+8"8$F!'=".$D(-2%\-D*D"9$1P5.YR\JM$4-YUI*K0T](]!.8-R`U04HB)'P=)C"#)0""Q9IST,K9FNWJ(6#]$;.R(T412(Y%TD$CZ6&!F",R^ M^E8`WSR$_(&'F;68&J0Z`T2^_%A+-HTN7&J3S#Y,)4Y/(<5OFP0B"@:UG>L`\&D'XY38R#R$0/=-&_0-F MLHNF@..FS,,(Q,\T4=R/%82CGB9PRI+7^_NO<7N4@Q=U=N3<,%7=;K<;[EZA M&!^,_268KX!E?RV&03ENW.7S[(2.^"=JCV5#G2UA?&B1\\J!$(:Y&PO=V]R:W-H965T[%X[80BH-J:V$[IOOSX0EJ!4J#?88__SS?PR=C$( M^:8:`(T^..O4+FBT[K<8JV,#G*H'T4-G=FHA.=4FE">L>@FT:T M[8*R<&LOLBS$6;.V@Q>)U)ES*O_N@8EA%X3!=>&U/37:+N"RP%->U7+H5"LZ M)*'>!=_"[3XD5N(4OUL8U&R.;/,'(=YL\+/:!<3V``R.VB*H&2[P!(Q9DJG\ M/D+_U[2)\_F5_NSLFO8/5,&38'_:2C>F6Q*@"FIZ9OI5##]@])!:X%$PY;[H M>%9:\&M*@#C]\&/;N7'P.SD9T^XG1&-"-"5$OG%?R+7YG6I:%E(,2/74'EZX M-7)I(8:,3&_*A(1L%D')`M`,N\@N779>9=>DCD)6:^0+BJD-QZS=3!GVYB';0H8U-I.,S.7_JK[0(O^^G)-SV?Y M#U!+`P04````"`!<9CA'X7.ZZ)8!``!^`P``&0```'AL+W=OKW<-*50_MF<3C&!48 M+Y"X^_;EPW'3J%(O9F;XSV]F#-0CVE?7`WCRII5Q&]I[/ZP9<_L>M'`W.(`) M.QU:+7QP[8&YP8)H4Y)6C!?%DFDA#6WJ%'NT38U'KZ2!1TO<46MA_V]!X;BA M)3T'GN2A]S'`FIK->:W48)Q$0RQT&_JC7&^KJ$B"9PFCN[!)['V'^!J=/^V& M%K$%4+#WD2#"-'4%D?B!A'/KEP'N8V00":A-Y?<-'V.GII%>5^S4P1]TFRSAD^: M:M:PP/^R"+\JPA.@F@"K[P&+*\`B`189P(OO`=45H+KL@)>?QS1YS*Q9)!S.MWU^P(``!$(```9````>&PO M=V]R:W-H965TFV`GO\CV51V%T-%'735J$1^U M/LV31&V/HN;J09Y$8Y[L95MS;8;M(5&G5O"=$]55`M.4)C4OF[C(W=Q36^3R MK*NR$4]MI,YUS=M_2U')RR(&\77BN3P_=HLXM26(2FRU=>#F\BY6HJJLD5GXK??\7-(* M_?NK^P^7UE3_PI58R>ION=-'4VP:1SNQY^=*/\O+3]%'(-9P*ROE/J/M66E9 M7R5Q5/./[EHV[GKIGI"K+"R`O0`.`O"]`/4"]"G`WPIP+\#WKD!Z`9FLD'39 M7>?67/,B;^4E4B=N?TY@;O#6FACGR+1+N:'[0KK9]P)!F"?OUFC$+#L&.H8% MD;6/@(%(3`'!*N"XBB7TY,$%5C[!4+"&FR:;+TR^+!--FH6<'O7-NL,`3PRP M,\"]`1X7V72]Z!CFF"PELY2P$+?R.4I!EK)9B%O['*`(L`P&P\*8R8+O[)B9!5_:$8/2X&L[9J;;2^)M>+5H#^ZH4=%6GAO=O:S#['": M/4*[84[FEV"^`H'YM3G]NL/JT[[(3_P@?O/V4#8J>I':;--NA]Y+J84I.GTP MO3V:\WD85&*O[2VS3>^.K&Z@Y>EZ``__`HK_4$L#!!0````(`%QF.$==S=!] M$`,``+@-```9````>&PO=V]R:W-H965TF_J5LWC@];'^R11FX-HN+J31]&:.SO9-5R;8;=/U+$3?#L$ M-76"TS1/&EZU\6(V7'OJ%C-YTG75BJFX=W?!U'+\SQ&\>7"<[4_Z/Y" MLI@EU[AMU8A65;*-.K&;Q]_0_1KG/61`_*K$64W.HW[R+U*^]H,?VWF<]G,0 MM=CH/@4WAS>Q%'7=9S+,?VS2#\X^<'I^R;X>RC73?^%*+&7]N]KJ@YEM&D=; ML>.G6C_+\W=A:Z!]PHVLU?`?;4Y*R^82$D<-?Q^/53L81YJ`^S MAIC\BDE,O=ZBL5,T'A)D-@&[G2!S$F1#`F(3%'"6[5CMB&$C)NU_MWF(PT,` M3^GE(5,>%DA$'2(Z)2*IEVC$T`'F;)'=(";%%!R^1Z`0)F0/T:LJ`OB@BYEH"`)]#,SS4UA5`K1:XS(&`- ME/BI&%BK8#+7'1"0/J5^L@(X:A'`XQH$`NJGN9^GG/"$['/L.@0&XJ?,1_-H M079+$):G98"!8]LHRMM3+_<&%>Q&"@V][K0TH)L8TA9,*\"UA"78DK*TJTK MF;S0'OE>_.3=OFI5]"*U>3<>7HMW4FIA\J5WIKZ#^8RZ#FJQT_TI,^?=^&$Q M#K0\7KZ3KA]KBW]02P,$%`````@`7&8X1SWTV9)]`0``-P,``!D```!X;"]W M;W)K&ULA5/);L(P%/P5RQ^`L[!(*(E4J*KV4`EQ M:,^&O!`+.R^U#:%_7]L)JY!ZR5L\,V^\).M0[TT-8,E)R<;DM+:VG3-FMC4H M;D;80N-6*M2*6U?J'3.M!EX&DI(LB:(I4UPTM,A";Z6+#`]6B@96FIB#4ES_ M+D!BE].8GAMKL:NM;[`B8Q=>*10T1F!#-%0Y?8GGB]0C`N!+0&=NP6^=^PPTL47Z+TM;. M;$1)"14_2+O&[AV&+4R\X!:E"5^R/1B+ZDRA1/%3'T438M>OS.*!]IR0#(3D M0HC'P7@_*-A\Y987F<:.F);[NXOG#JZ]B%,FSIL)9=A]WST6Z33)V-$+W6$6 M/28)F"N".?6G(Y*'$4F@I\.(]'^!]$$@#0+C06#\U.,]9O(PA-T<2LMW\,GU M3C2&;-"Z\PU'6R%:<$K1:$))[5[QI9!069_.7*[[B^T+B^WYF5[^E>(/4$L# M!!0````(`%QF.$?7LUD0>0(``&4(```9````>&PO=V]R:W-H965TO8F3H`6<8F>S_??U M!V$!>3=1+P$/[[V9-[8\R2^B>Y%'SE7PUM2M7(9'I4Z+*)+;(V^8?!`GWNHO M>]$U3.EE=XCDJ>-L9TE-'<$X3J*&56U8Y#;VU!6Y.*NZ:OE3%\AST[#N;\EK M<5F&(+P&?E:'HS*!J,BC@;>K&M[*2K1!Q_?+\!$L-JE!6,"OBE_DZ#TPM3\+ M\6(6WW?+,#8E\)IOE5%@^O'*5[RNC9!._*?7?$]IB./WJ_I7ZU97_\PD7XGZ M=[531UUL'`8[OF?G6OT4EV^\MT",X%;4TOX&V[-4HKE2PJ!A;^Y9M?9Y<5\H M[FE^`NP)<"`,>?P$U!/0.^'S#+@GX'LSD)Y`9ADBY]UV;LT4*_).7`)Y8N8X M@86&=T9$*P>Z7=(N[8:XZ&N!DB2/7HW0!%,Z#+08"GV0]1@"!D2D"_!6`:=5 ME'!$]R98C1$4>6NX*;+Y0.3#,M&L6EL`SP2P%<"]0#HMLG6],MT?*CJ3T>@2;7AWL.-+!EMQ;I4[VT-TF)"/T%S"LW@)%BO@B:_U1'4# M\%V^R$_LP'^P[E"U,G@62E_]]M;?"Z&XKCQ^T/T^ZID_+&J^5^:5FHUP8]`M ME#A=A_KPSZ+X!U!+`P04````"`!<9CA'?3""B>@!``!C!0``&0```'AL+W=O MU$(RHDTH&ZQZ":1R)$9Q'(9?,",=#_+,Y5YDGHF3IAV'%XG4 MB3$B_^Z`BF$;1,$E\=HUK;8)G&=XXE4=`ZXZP9&$>AL\1YM#:A$.\*N#0I7,7R'\0@K*U@*JMP3E2>E!;M0`L3(NU\[[M;!O_D: MCK1E0CP2XHDPU5DF)",AN1+2_Q+2D9!^ML)J)*SN*F!_=M>Y/=$DSZ08D.J) MO4[1QL"E%3'*R+1+N=!]$)\]Y\DZSO#9"MU@=AX3.\PR9#^'1!,"&P.++N); M%[MX1E\L4,P1ZV31PT.1PP(C8/T0%-`H=9VN[;- M]D/`!UKTEY$VS=7\'U!+`P04````"`!<9CA'WBT"S%0"``"\!P``&0```'AL M+W=O&?\4.:72^ZK*6BS]7,IF M$01BG].*B!?6T%K=.3)>$:FF_!2(AE-R,*2J#&`8)D%%BMK/4K/VSK.4G659 MU/2=>^)<583_6=&279<^\&\+'\4IEWHAR-*@XQV*BM:B8+7'Z7'IOX+%%H0: M8A`_"WH5O;&GP^\8^]23[X>E'^H,M*1[J26(NESHFI:E5E+.OUO1NZR;F4'^SZC;;/@+3@GI7"_'O[LY"LNE%\ MKR)?]EK4YGJU=Q!H:>,$V!)@1^A\Q@E12XCNA/@A(6X)\;,$U!+0G9`\)"0M M(7$<`ELL4^H-D21+.;MZHB%Z`X*%@G,MHI0]55]AIN8-VM5+%F&4!AK"W!VK_3(V=U'A0GOFH#^Z5 M!X8Q3M`36V;F&,T&Y<'3`G-'8/Z_>PZ$[ED03K^B50NR58TAGLUG6MIOZENM6M(KU"?8,[Z"BPVMJW<9;*T(2?Z@_!340MOQZ0Z'\W1 M>&1,4A4P?%&[-5>MM)N4]"CU$*LQM\W%3B1K;KVR:]C97U!+`P04````"`!< M9CA'4[Q/2=$"``#@"@``&0```'AL+W=O\Y5\%&5M9R&>Z4.DRB2ZSVO-YX M+G9[93:B619=XC9%Q6M9B#IH^'8:/L+)"F*#6.)WP4^R=Q^8Y%^%>#.+GYMI M"$P.O.1K921R?7GG"UZ61DF?_*<3_3S3!/;OS^K?K5V=_FLN^4*4+\5&[76V M(`PV?)L?2_4L3C]XYX$:P;4HI?T,UD>I1'4."8,J_VBO16VOI_:;^!SF#T!= M`+H$P-L!N`O`GP'D9@#I`LC8$V@70` MC!8.2'4M8NIUZ'"((8!2[\DK]V2$8H+B^Q[C@0 MZW:&KV>(1[1-![&N;]*4`'_?N"`E&*3^7X8+0@*(?E?Y';IG,P+`T&?4^_NN M>+.S@Y,,UN)8J_9A7W8OP]DC,G__@_TYG"R@9W]IACD[+GS*S[)#ON._\F97 MU#)X%4H/'7;>V`JAN,X5F4?*O,+3//HAW`VH42A_,\>1EJ9_\` M4$L#!!0````(`%QF.$?'BB/(^`$``.,%```9````>&PO=V]R:W-H965TV$ M[=_7%Y("HDWV!?O8,^,Y!_OD(Q=OLJ%4>>\=Z^7>;Y0:=@#(8T,[(I_X0'N] M4W/1$:5#<0)R$)14EM0Q@"!,0$?:WB]RN_8BBIR?%6M[^B(\>>XZ(GX_4\;' MO1_XUX77]M0HLP"*'-QX5=O17K:\]P2M]_ZG8%=F!F$!/UHZRMG<,]X/G+^9 MX%NU]Z&Q0!D]*J-`]'"A)67,".F#?TV:?X\TQ/G\JO[%9JO='XBD)6<_VTHU MVBSTO8K6Y,S4*Q^_TBF%V`@>.9/VZQW/4O'N2O&]CKR[L>WM.+J=!$^T;0*: M".A&"*+_$L*)$*X(P#FS>7TFBA2YX*,G!V)^=K#3<&%$M+*GDY$VM.5RJYF!FY*N!-*/%B5;"60/%"6;70"4I!$, M_W%3YL`PP%D(XW5.8/8>!W*BWXDXM;WT#ESIIVU?=PL8 MK9698CT7K@FY0/'AVE)O?;WX`U!+`P04````"`!<9CA'<.&C./H!``!Q!0`` M&0```'AL+W=O4UKB M>']3_^*J->[W5,%6L)_U45?&;!B@(YSHA>EWT7V%OH2%%3P(IMP7'2Y*"WZC M!(C33[_6C5L[_R>+>]H\@?0$,A"&//.$N"?$=T+R5T+2$Y()`?M27"-V5-.R MD*)#JJ7V=D0K`Y=6Q"@C4[URH>NO/[V6<9X7^&J%'C`;CR$.$PT(;-1G4Y#' M%!LRHF?Q7(;M&$+F$+L'Q.*YB7A29^SX<5_G/U213`02)Y#T`LM'DXTOPV,R MWZ@LSQ`NS&0A&F61W'XW-)B8FDQLD22Y7.!="*0_F]3LHE`-F[*,IRK M=9.-FY)&>9I,\N#1C>4@S^[I*W00ET;[JSF<#M/EE;@;?X>714O/\)W*<]TH MM!?:O!OW9$Y":#`^PA?3KLK,OR%@<-)VFYF]]"/!!UJTMP$W3-GR#U!+`P04 M````"`!<9CA'T6E;Y+,P``!QY```%````'AL+W-H87)E9%-T&UL M[7WI;AM)FN#OV:<(&&ZT!*18O"FZJPN0)=G6M&VI)=?4%@KS(TDFQ:Q*9K+R MD,SZU6\Q6&#G9?91^DGVNR(R\B0INW:G>P1TM2DR,HXOOOO*;Y,D59_709C\ M^<4J33>OOODFF:^\M9MTHHT7PB_+*%Z[*?P9WW^3;&+/720KSTO7P3?];G?\ MS=KUPQ&;A+S'WL1/[_W04U>IMT[^O?&!3]N-5_ZQUSWY:V5Y&+V@ M)]X$[GWYUZ4;))5IS!HW7NQ'"*>%NG#3RCA][/_Q+__2>K8W?C)W`_6CY\;J M#7Q9@6YYI*Q;._:O_?(WK M14'U[%=734>- MUFM`N;LTFO_BJ#M"?G6=I4GJACACY>11F$2!OX`-+]1K-W##N0>/`04F0#S? MWUVHHY?';20P;(*EFR0PR:O*SVZR4K`7-<`Y*O12%2T50#%ZQ*TF]-=F$T>??:`V+]BJE[W^R)E,ITZWVZ6%7O9& M0ZRT2I2LO+H^\"A]@EU'L5YG)59AZ`.;4FJ0\Y";V-JZ_4-YGX'I) M=8I/40IX-R^`KFX'28ITE2CWP?4#7.@$V,Q)XM:M"`PV!HQ`$""8-_@D0;`Z M\3Q:>RIU/[>-NZ]:&W^,,\-.: MHVD9HBL@`$"+,$J]QBEKQL_=C8_G"#PW\50T"_Q[XM\[+JME4Q^C\*1F6.7\ M[Z/P_@1P:/T%VVF##?`$7R,.4AZ(/F`%7CBO&7RQ#=WYKRI!!K**@H47)W\D M_$FWE7T#5B\].-Z"ASOJ9:?;`XC'"F@Z\_ZD1DAS1(@LAI6;I2N@H=^\!6!B M!%+13Q*\V2A641N3(J:6+U)%MU;)M<^^G& M19)<>:D/TO[?6^2<%C.@NL3J(LIFZ3(+E&%7MX9;*LU/CN`J%G!&-TXJTU7( MQ>"P_9@"MLV(LGN""K;O^P13P+ZC]R;-0P]4?'KG:6J'UQ^EJ`?M/H>AV(+F MU(I5=RG\PUP5V/4UG)+Y(''Y`R]D`ER:JB M#1B&D(9H&U4E#'@`_,+F"8Z<>:&W]*O2^X.W0!K12_*T2;;9!#6B@U6$B`$! M--ZD[%QXP(#F?KZZNT:Q]QM]T2!L*V>J+&Z6#:*D86O,[-21S'%<@#JP*53S-N5-JJL`#=[\%/$+I':7PUR-^_)B&@61*8W^6I<3]T@BE^3[\72]3>5YDR3O/ M#=+5'(C/`7-MWBD__]I-_#E=T<(/,B1#FFW#@HVX`U+N$Q_;DVU59W,?`/ON MO<)D154"9^:O:[A@(U_/#RI'MR\/;JN-6>0Q%;2U-_%;1M MV<)3,?F)M[ZW\O*5;O&0;:-%_P94IA812&.6-&891VM+6KCSU'^HM5_.%C]G MVO`%^(+L@$OS8<^A9B9XD7AOP4=5R&UXOEA_WZK@4WTGHI?)H=6 MQ<6#^H.:@ MO`4*6H+.L9. MD=UK-PXM`F.?@Y6!L?1#L#+:G[F)@>OX&[+XMD)R8;N/PSYH6K!(*R.M*0M^ MA_:S[K/O(AN:[^O]8S=A"MK.O1^B"8J'V)`?N6FHAWI;ZR!RP2T`+6`ZX*`R M%%6C"A%<-0B"JS85*I(#6C@`>ZJ#4F6][T.XH`"-GJ9XD?HD2]\))Y[&^,PHX*$!$%6(P)7)_$.3YY MGU/U.@`$*T^%,:!7R<:=>W]^L<%GX@?OQ7=*=MDD,AWE@N;YX"Y<8*7Q)F(# M2QWAW?W];_];?.=__]M_@D8#^W$5.B'P;'/^!2X9\")=Q5%V#[<"^)UDL\1? M^"ZZ<1'".-/WH6]D6:(68%0%T8;9Y-H-762C][)/=P[:GL(-PE()T4G"BVPT M>09;Y!H/_@)N9X-6#E\JT-Z]AZMVU"=8\]QL,-];<1^%G4:/(6^(62U^$WIM MN\*SW;B)N_!"UU%P+V[+PF:I+3[V+@(`_B4B90C1F."T\&:IY6TI:`MP\"!C MG@MV>\J.3)M3P_,^G,U'WI7-`.L`4B$?"A#BI&E`K0%00;V*BAG?NZ$8 ME"K76/`O#!06L/9ZJ=XPA<+RED+30A:UV(\GN0-9[2]!,<.(9!VI'4PA>&?N M7/"94=O2OY9FXTF^\148(\`WO1`!NW'1G0,W@)/$"W)F/?KI2B,/H"O\XFW( MB,EW+.B,,I`-1[A4?VVMYUOQ33PYS8G4!$I)&F=S]H2`7@8:S%IA(),=G&#G MSX%Q];H(OUOO'EV3.,?=R?_L$,ABQ*1@Z^!D6[#%4,0)BGD8]R%A1NL4-[", MHI2E88PXBJ>>;0\[)4(Y\)"4=L&X`^R)=A%M`''97\^\@H,LN$_7TEIQ0N`( MN*D0E*HD05K#)5WF\1L;D?+[DV,O`#(P89+-5X59D>!1+@"(`!(!@2%&PB0! M%[II%GM,]6OWYRA&NA7@"1?X8V+<*339"W2SX!CQ++T`]N"MX;3L4B)&!\`+ MT%^DY@'HDX#L"%*+0Z([9[$&J"#QI&B_S+;VFNJ1)M`WBK]HWHZG6:)CB[P] M-F-Q%V!?IWZB1>K:C7_Q"CXF1SVN?(#/(P"Y'!!4O4X/_NNJ/OS7ZTRK7A]] MEGDM-RG_WL(:+OQD#AIYQC=3>?!LC:CW!#90F>DZ([DP(3&_R MC(SGXR_#".O>"?5+6A)I6?:='^6LD=A>%OIL`\ZB<(&NI]@C=TB\X+NR#`;V M0``R_)I%R!2892+UH1N?6#D^C>8R*PB$/&2A>#*8<(H>6*B,>6_=;"3($G\- M5QP73H3R+?:*,X11>#+SV24JDR`!``_/DL+F@&40OD9Q',T(!"30HQG"DBY. M'@=$=]71>U3;5?^8V%/B%3T%<5E:M9I235.`FORS-R<^MO"6;A:D*O:37SK* MLMW(*:,-"^LV^**$/[,VMD=8UGCB8H^'Y@Y\Y8&&/$^+2GU,^E0,_`-X@I]& MP%/\U,8RRB]8@FH3L?8!SRR`=6-Z6M''L*=H[>6&X> ML:?O4AQR^R%>U3OEL/KL%9FNQ5MKYJ71%CHN`U"X,XD^"O+9%-I1%[G3(_$_ M:Y'A81BRDHHP=`KZVLI=H(H)<_$]+5&A&O>:W//9B6J//)@ M/LL;N>&-H*[^$92,]0Q0&<[7*YYOAASF$>``Q^J-G<%@JH:=D1J,U=B9#"IG MU'E@V_W.4C_\X`-9V6?V9X>UAT1;,W#I?D!:_EH';B56ZS`+2XF-D%/$`WI[ MQ'CM4K':'PO..*QJT)>:7IGY9N)+1)O4!+Q@E%!;Q:?%PR]A>Z0QU/U^;?W> M`L;O$URL./A@();W0]R!;63#CVHM:G1M!E);\GWZ">L;9;YNEB0.EX#L_W&B@*Q()U-8-.A>,UX<[5SYEF?6A\5 M*S+1QR;DR=`,-9D[>K:-B8GC+A8ZET?N$[1-6(Y)7U:<\X_ROU$31L`'04//<3SK>%)]"I1LS'@@:. M[E"^(_%4-YAK%RT=4<,!CT?J1'Z1K3IZWW&>#/Y^<4-5V.WRUW*/D2H>(+Z9BF0TJ=[3G<\K2N4*.9'5N0$6TO-@J3X^%,\)\4)0*6_0_U*Z_0# M!ZTKD)U<'@(DDJ8!ZU7N/0@9^L2*&](I\'X%YFP0;3VO:`UPS@.`"*M($"*P MDF1EDX"A(`9<1D!"QU':EU&WH!AJL//YRI,028(TH_'+YCSH%%"!^P@:.^#I M(]"T5W*@+M*O^!=&H4D;CH!O`.7>PP1AT=#4.BY',9"3R&S(LN&L M&B,!%AP(B<7``Z72U6K[`NR&.;EV2+.-0#,"\4#<%19;LW?J`00)_NG'JI@L M#]@*J`QD),[X))O/R6ED'?XN<7Q[E!A_>@I5Z>7$W' M$'*7@Q(ZK=TM8A%!GT65%_CW/BIM>R$07HH>V(Q-&-0N(5,9I(L@Q?8[O5/U5H[W?_X#_W=I%#/]]X8BV*BF M(28$\/FHW^L=JV&G/RDN4K6)0)BK7F?<-UK<3I0*HY(.9!1( MAI5[#Z+N'J,3P!%B/T2=SZ0K536H0F55/6::?2";P>1AH",DOXI+$W]G_Q4[ MIU=>29?JJ&M9UH*6^4X`S@$@_=P-ZU@?C9):N=W\)[G_(S9DS\03Z2E^`_(:<`B^&:IAMZ>X!@!O;-P9J='IU%Q:NL,X M+EV;34YVWJF.D*,G*4)&Y%G)&C:_+]X5!G!?JN'4&0Q[:@J6W6E?G=:6T+Y! M5_6_Z5O/4VFN\CA6RR.Y>M"F1#0]<+!RL,=F";.+F7=V0#T?Y^=^L$4>;A,D MU8Y^*P+OL%:7&Z$=!0>FJ`P&())5'E>CE1.)T5B+YO8>Y_(ZM@,QPS2.AO@8 M*OQQC(P:XSJI[<'#\UG1A@_YA#-@O"`Y$RWF.4)!_D*V)+A,M2&CTS&^-2N1 M6'L>R^6\MCE2V,Z;_")\M/R69/9QA,G[[`LW<-#HYO0!;0_*#ME@TCDK1H5& M+F4[*)@Q:N;8B$89C#R+T+']'!TD6>F3V(YYC7H5 M7W'=EA@6&464"'BBC1HPF#/#+ID)G9#^9&\5%+S8C>>K+6=SP!7^)DY8/P0; M5)R:Z-'F$Y3C6<+<0O3B2HI64AMKQ\?H<_.J^_U28 MHW2*O>;3`#"A?O1>\")_ROD('3,?8[$/UCWVC\%K*`[4]V%4@:-9`0-2'*V8 M89H+6LVX5!CIN21)>BN>>_U8-9&HR*.)YNMO]]/*3_)0P=QD3C'NKZ,%(*%# M_GQQC\QU?KZXD:(@NM<6E`9\ZLU7U)5&SH8496\RJP*ATXBL=MXHWXO]C20W M@/9GTASTI\&Q)*:H]NX0(,M!K7RI>N@Q&#G]WH"_V9&0HNF"G*LAVB8;CR(= M!V>J2)Z)!-$O,^Q.X1HDI4)W5^GTPY=JXDQ/A\YX.&XJB#G7!3&?D!4'M1Z- MRM@6!:,\](NBM6V;9/4B"^=2OV\J>\KF+DJ#QU44>#K&]GWGKJ,NJ#BQ:OT! M9L.*1*&EL91VT+`FLI4['VCO-=P2QQ+>`WZGV#;!M5(=[.Q[2E>`?6&<^3&D MU':3/EXZ`SI(S/3H(.%]LY>5-8_&^J9RHJOAMP08U'"CT&,5Q%3MB9*'K$&QL#=Y@)CHE MTMB\:N;-7>1?87.1.6LGG&*P+8+?)PV/(Y_P9Y1#U>S73_(H,-U@7D\>HRX3 M`!.,M559FR.4*YQ69'GFV=-RE#[T6"TKVSA_M!;U$SM[QH;$S]GB/@^1&R79 MY#_B;CGNBP(,8\*=VDNY83B7J10F=+6J#_*)`H%Z4QB=M ML'L;4WDX3\N_D@\2?LSF>7BE+H[_>T?7G:(!TH)G@#0MK0X2\@ZA(F/T?9,% M`?BGHQESX$X>^LI*"6#$4I)2AK-!*-HYQ>R]4,1S;M_9Q!2+VF=G,NN<"H(/ MZ0^R"2:$KQ_ISF^;2\9BK%-ZJ4Z=[F@*_TW@\]@9]^#OR90RMIP!"O\^_3%P MQJ-3C-BJL[R3%HSH#IW>>*J&SN`4'I[V5:_O](=#IS\>J"G\-''04X$7I.$! MDSF3T1!#ONC:P@V=A^A6F9RJ/R@8 M^`&G"?S?N85O^4/%Q&D*]7*.8SUZ&M.(_$/F,JVKP1_Q^?L:<'::ES.$ M@T3E_B(!_4@C?&$%;70Z*ML@'0RZY..9!ZZ_1C+EL@9&)E%M?2Q$69N*$*#. MQP@4I3@!JBUZ=X"4\"=QK&:I1/[P.UD!ZR@T.S-.\S*C@[Q\%7XT'Z.ONR MW03T$-!/7Q#W8P/),.=0V`\I+3#5O9E*0K`NIK3-V8,"$IUC[1_0'E7D:>V> M?Q&S_.@>02UJ1_NN-.V=G0.&`B:E'S+^B8!!*U;76 M=@`!,%%X0<8D9O7D@QW)&A!PKVVFQBS>SL'#PV^UDX-RM1"_PA1SSA815SBA MZ-*K*F[A$I=70+=4%KA<.^62C_Q/:F5%R]GC^ME?9VNA*+1D*I-H]@\2!I5E M"5^0$17B9*P.8:@*T[ MV"M(@(+!BF&L>'&"OI(MIK`B%!YUXK84E`'Z$RF(.UI$-2R(C`%UH$BR-E#Q M_7!Q2VA`L$F,+^C3Q0_GG!6'MB-M8F-3FX&K)HB.>H,1_G]U0Y8'W>X$G[:$4@=`D&%"KX3PI/,, M#B%%6EUSN19,=E8L^7KGN9Q)31;`]=D[KM%E3DC<+DI\&AEGK*U@9C%@GIIV M408,)7P%2Z>L4+G)+WI[3-9WV08]8W#H+$X9H`^^]\@C\"KE%]S*$O6D),ARL"$E!P1HJUJ$X[YF5Y4;,]TK7,ZH#T@%Z73&0*2?(9\[Q-!H!\F8.I MHUZ+F4$J/<9OBALR$YCS<<$BJEQT@.(I'0N#.>E#9UI:!`]&[R+9"5:+5^4` M(;3@:'"NC%'PU`]!<))^P1G[L=3L48T$(J]C3OW@ M=H2`9$@JCMH$66+R`QUR$Q62=7JG7=7K@1;7Q7"@&D[HGX%$*/6_H'--QDYW M.K&3_T%K\8KN?%]DHZ8TM"\\HC6@"((>A0(%+.?N=@1IT\)2>UD_R39'7KAKX2FPFMZ0X M,?-PP:Q2VDUN87*JFKG.!J,(MI;%IOX>Q2OK#;SAKM,'A7DZQ8#[U#D%=C>9 M3)W1Z0!N=.R,AGUUAS0M^F'.FJ7O!T>%0%@$+M45&"5N3HD:A%BF#8"M[&D% M2Z+^FA9LN03/?H,N(4!#G>N!X<-YFN=Z(.QX!LI2XTT2PYEY.3/C(@.SN_.RKLP/$Q#R`FU1E5,JVR&9C?[LQ2NA M]9(?`V1AC0:#V>7&X+@BO732D).6A4OW(8I9$1/!2>E_!&CD$UP?CY+>%>$$ M?]J/Y0Q(UY11*$Q@:#0BG_;1D_ARM\^WT0-3L@?&&O"?1FHKJA)U(4#!`="/ M-.?GXY)"+@'M;H.L14XE-??:Y,&RUWMJ$9B%B1>0K'47Y#7@F)G)S). M7,S*,@R]^RCU72N7M.9<3V05HFO0`0YA#NY0Q2M]Q2+ M'%-.#J?]&T-L@0XB)#791J$]P3PZ,4V9*(<-/6XIIBS5/%BZ+$:<.H[@\@*Q$XT-)W$NX0F.I$U;P`+P@#[F+[<6RAGWA6LN:N81%P!.!VA@ MV9:<8(2&%5P#]BZ@K&<[;HUQ1\IV;_'`Y.(V434=RRP'8>C9G=F3HK?!M@$M MT@9<3A7F[8($XM[!]%8*KJJW1VW%6$U53()N..-3HW+`EMS$#:2 MF.K]H`O]C390-$$+!Z4A*6`8HF*\W* MK?/@Z<`]^YIKO6E$"<+^Q(.C!2,E*-3X3?5P.W&LO'V][83+%M$%EOMZUSD> MLGH0%8^0E.!FR!UPAL!']=QI'M(?>G10I2LHVYDY)4,YJ0#^ZSQ(AV:U%P_L5**<^X=>S;Y6FP*W8J?@?(!3AOT M7G#O7Z!"%Q4QBP44"8^='@DEAZUIQP5=C`L02MZ3I$9'(YZ4L,$J;(B<+-+E MAX1*0:6.8XP%6K*[9AEV%NJ>6[@HZ%GP)S)RXPN-]'AK)L<8_IR1^4[J6BU,"X5* M!;YT)Q7OJ)4X=-Q*R,CP-,PK#W_.T'4E_N.B_H([EB+XP*B9I9V8G%PQD/$: M='\#VSE+`D7D#^H:U@_`+Q?<'[(&D+F2RYR4V*/@&Y=*L\;Y-??@[@E6`AWM-4-5&1W`;NSI50H M^,(J__I)*<>`*Y*P$MX/N?<5Y[9@+OA1S7=X17GY]F:U3?RY#XP:0^L;.V]] M9:HO-:'%N@<@^[[S7G]:LMHA5W$&P*_'%+$63UZQW5\QC<*W2KRCFA+O@N`F M>Z*AUK13!IF?O[FFI81<*OVL^G&I6M3NGHVHD'HZXQ^1)TUO#SY7P"DF1-@` M\&3E;R1IB[_/LRZY0ITA62R%)0=\S.*^AOORR#(ZX/?)Q?6=R5K.Q]9C$ M\,5DP&J+TW[7&8T&QPI+8@;3,192#Z<]^._T6/6=T:3G#'K]W9O:>Z9#H5IH M=\OP[/6'SNGPE.$Y'0TP@:[EET]+^^*OM/<7C;MN)4![B5]W56G$,HZ&%7/4_YZ8`6=>4YV+41U!"-PAJ;L#(!2^DL&MUA]M:&LF8 MF!(ML/T?_,"[SP5>=>ER'%4?J'9YRY-E-E)(Y$$M.P>)[CV9RPVQL?D%:-79 M;*-H&431HF&=1>1QQH&XI(+\(AH3,O1,*`*E[^Y5*%Y1C4B7NCR-.SE@]8GL M$$OG'+$E39EQJ2'3(^6`!5H!Z*F]^GY1":;$>!8H='*;J=\31=@5[ZD^"*M6 M:@-`H.BDV(54=6)*^5@5X_*_0H&&G)***S9H%J1LE^-*TD4:ZZN-@2&&`)IF M][A3DE`+>76E*9?UUJ'%$ZW2;NJ1I..P;)?KHL1B(2N9N'JF+0TL%O'FCXF[ M`82UEZ)\7KAK[#]=:H4JW<3SUJ?:G`%@\NMF4O&?"@QF6PL`'75#31<[ZGR5 M.>I?772(ONVHMW!7@"-',Q`^ND9^32D&B3[?ZPB1&/ZXT/L_YO9EE^@]>(N] M)&/T*Q_)XP7'_#&0;:3]F![B7JCE'%IU+J><)Q1S1JZ(]JPHP^C?S"@[DE.M M=.J4@.LR"%SU8^=3YQS/A'6H<"5<$^&=30QAL%ZQ#<]0KCN-22OBMF]?B6ET32(!9P1*9'$P# M:2&:=Q[H.]WAQ!F/^@5VB79*!'L./:+IARAXX#7M3()J?V!YR0)%LXQECRVU M\#+0-R)`33FW:%H-Q2347R/;S9U*R#'?" M@X:3?W$FB5#/YB.@2: M\359Z>AO+706CZ,P0KVDML[2&JA?"$(-5.,X0HLBCK5/LL5P!V@VKL?-;?-7 MC10&FJ9H3^IVW'I.,*LDZZW8AZTP)B^5%(<'8QNZ6D@8FB0@2;\01Y=Q[>=] M>0/_%\1HP$/R4%J))KH-+4[H+1CN/.LM/.W7@2JU68%#,)ZC72E MKP<_8KU+N/D6JV._L!OA_MLF#E%^`%VT7*+B<^2.@N!H[OA)Q?]!2DA%HRQI MA*GD(7+(A[RY*]>NFY&%3)+1N:E7TC]U_G\VU:YNIW`^R:G,:W40&:-@8;VE MHER[9:IW.M9CY5<@^NXN"E.XKNVGO+T-SX494J^86WYK//> MS7;3WK9>%\9%9J+9]CD2KB*DE)5*Z_@)ENYSNU/96.6B3)V$\3KEWD*QVJWP M?[$C+^<>6-U@\TL`7$FPGB6HK>>7QK$M???U0+A_C$KEG?Y#X](S4:P`J%]O MD#19\TJGA9S2D8C65LYB5&?9@(4\YBTWI,3G3E4/P2PG,SU.3(H^P'WII\97 M:+]9"D54S6L/3;N/_*4'.M:87\`<`(O,NF->I:'%A3:;3=H:4KJ@E69KDNZJ MDX4X(+&@M^',F"IRO?3O43)RJXMH"+9H M)<1<#0@FX1HWT5IY4V2CA]9]Y&3#'4[X?X7BO$.GO"JXV71R,B%&>:_D@QN< M4@O$_L@9#?K<"W$`_&$RX6:/@U&?&SKF6STZG4Z=(;88Q/#;M# M9]3#SZ<3Z@9S7#[(4_I(5J^OW#Z&>X5(O6_E.D9.KW?J3+I=_F,ZGCC#2=\Z M#2QT.@0P]+LXY60*!QJ-RCL?HGMPZG3[.`WH^)-QUQGU)ZJB4>QXT\V1_E3[ M\DS.>#*/.;I>[B==-W>H1E+_2AY-\<\OSWE^><[SRW/^W[P\Y\MI^9_]U385 M7MKXGI@#8/F=]4:3.TN=_-++>.J;7)Y?=?+\JA/O^54GSZ\Z^2=]U4G.%U&; MN06BD"@!NUB++R#9@WV;]X1\'9;]7_+](!7!5WXAQR'R;H].?H=,5]/$XVM8 M)<^M69Y;LSRW9GENS?+6[,\MV9Y;LWRW)KEN37+ M6[-\MR:Y;DURW-KEN?6+,^M69Y;LSRW9GENS?+< MFN6Y-OQ?ZG-_ZS6\Q//I$#+22L7N'KR_..$GETJ4ZV43= MX$N*^(7?^;O=]8O.?Z*9#@^8,U-%ED_Z"4TBNH(.=1;><3W;\ZWR==U#!']> M_0X!P#U?=O\*WR>)$?DH?D61.QKUM.SQ]\#F>)(CSIPZEC?>ET[>T!E�:P MT!13VF&AHP',;S94GJ*IZ#3?^'A@-C[N#ZV-#R:G]L9QP0LOC,@21R!4`9?G MD>1P*[Y)M#?`"*>#AFEOB(%36'-<_G8`JYT.]KT8W&*WT^L?\X?N4#[TN_H; M.,:^[]G>BZSL=U_;#SN2>G6MWRI\IM^.]C5)C.M7S#O\[#>!6M4\QA&SQ^MD MC^P7SHM/3K\7]=4_QLMSGWA=?+0SYN2_F08$]C52EP>X2[!KBN^>5;?TZJNO M<[76I=JYTK9OZ="W\SIBR?(,C_KZ-(URBBR_BG!9*#)X]8_Z,MXG9)WM1>_Y M/(XNZ$&XO;=>X?B!WX%)8:);4YC`A2Z_$_%3%P-SIH972Z[UOA@7BGW#[`PF M4_%!T1XS+<<7.7)EO\(1@V%Y`09[EQOQ,/&DP0E%'+1'TVID(KU-;)6XYO6E MK_[KO9%QGQ?'[<2PZZ4D(9F2/]TCJ9JW\U5Q:14])L8DEZ4IA)"[/[04X5?` MDC]K_]>3_Q[:VC]YNM87-;G;BYD=-N/OJ+C,\U84^U4=F.)1*V_V]T"QYWYZ M_QWZZ7U)=X]&0D.^'V*0VAB]6B)P>%%/#?IIFB>]C6G)GH9(6E>Q,\BW;S#^[G$_;]7B?MNW!;5R4;MKX;9_U@%]O45 M[4<77@JB)*'39]B;Y41]?W>ACEXBK$'N?<`:`UBQ?KKKTG0_OWZB_X?S]]H)3+VKHJ M"399B[>=NV:OMUH(OL70`*HQU?[6=KU7RRV5'^RI#\S@+I'!5:=]Z*A!EV#0 M:_NQ4I]V@?6UN57:>F(Z*9P.GVD_F![Y>DMERAN:^BS-6V_?`KZ4IQAV1MV* M%GKKF;`\(.7N5=KW969#MS2([_+HP5CDR`'.<+G#EKO+O;=5Z.=.S3I*/-#' M>?BN;AT`EMZ10O5TE3O(^;,6?=@BA]5LI[6P3&V(:50ED8WX<[-A2.VNQAVIG M(3IU.8M]UWCM,)+A#K%D]8&J*RM[SF8)YK%C/\L'X@`-'++9;VU1P+BBAW5R M,7H"HN<;C;;RCV\YWRK'0C%;V4:#2U6=Y9%FRL.UQMT(T9]A(F\[)O*N"K[? MU\:,$AN@_B%'NYN;?C;^Y^8!%8?T/ON[E-3^^LU5G>?L6RYYE'-"/>SLAT[? M"*7#)VJ$YU.FV@GY)TS:>B\[R0F]AB<5"MJ?>KY.[*$^\-!"034.?*?B@M_K MH0K$;TW.LNVA?(\QA*,?/3>N&L5CM<7O59-8KXDL[-XLP^`:(-#$*O6RO:YF MA_VA6KC;AJD^/48[IQKNF&DW.NT6?4S_-7/8K/6UL%89=P!KQ1T*/M8U*JQM ME&]5?MLZ0JVD`"RV$OUKE^!VO7EDJ752TWW]3NS_1OA\C'0+C4(4MCB(9#"H MH^I'+]5>>MQHO2;:A+%?+/ZLFYRWG*PH!N=<8U7LN;##MIJ:L$TWL:9.Q7.G<-M?\.RU7" MCL;FI?.2&&R`O3YFW#VZ_\3"H% M+:2O>N;$9R1.'$!<]@"4!Y*G(W\I#W9(DJJQ<^FB4,_KA5%?+[&O'NSWC8_X M]R&J50JJB^00D,^;*K.ZM=+.S_.TXP8G5)=UOO+W-WGX%O?*>;0_H*9THTNQ M;[FBK/SDM%N/F7;B*TSY?4+$BL1+<1#T@9]E"WK7VKG$NV\:">@#J.;8:."U M-,6YY9)[FAR;9126VW4'9UQR>X,EN*!QYB^^.9>ZJ`HB[7I`TGUV+7P5JA\H MS5PF1(5M_UV4L0,.3=6N,/V_267Q5E3E*Y/3?Q-[NF=1XYL4-9U(H$8$91%F*.XZ>(FJI17K4ZET;>E5WGM?!WI@;/:4"+MVX<(#\S M_4(:E9/\#`8L%;%7H61=5KQS^BLI5\:+,H/W6J/II9=[R)Z&EW:VL/&&9T#G M?I07-UJ,@UXS5'R`AU5N@[M2,B9M'^2'@TLU-4G M]W/5&+9?&%@^<1N.YF\QK'F)8=L)R\I3"_LJ#RT+F7F#C*EGJY?L<:GNYY!4 ME]W$6WUAC3U!*\MJ2?"HX<)-Z14NLMIN&7TNA*@4/:U_44I7(0'U"TY%^:_`!S6KS^;Y)DO2[ M_PM02P$"%`,4````"`!<9CA'%T<6;O(!``"V(```$P``````````````@`$` M````6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(4`Q0````(`%QF.$=(=07NQ0`` M`"L"```+``````````````"``2,"``!?&UL4$L!`A0#%`````@` M7&8X1[#&9>8_`0``:0,``!$``````````````(`!O@@``&1O8U!R;W!S+V-O M&UL4$L!`A0#%`````@`7&8X1YE&POD(Z4[I@0``#$1```/``````````````"``?$2``!X;"]W M;W)K8F]O:RYX;6Q02P$"%`,4````"`!<9CA')>JTV$T"``#S!P``&``````` M````````@`'$%P``>&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`7&8X1ZT@5>QL!```NA0``!@``````````````(`!1QH``'AL+W=OD>``!X;"]W;W)K&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1RST'LZ_`@`` MS@D``!@``````````````(`!028``'AL+W=OLW@$``"(%```8``````````````"``38I M``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1RE::'JA`0``L0,``!@````````````` M`(`!$C```'AL+W=OE^Y&AHP$``+$#```8``````````````"``>DQ``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1]D(3XF@`0``L0,` M`!D``````````````(`!&PO=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1XZ*&%NB`0``L0,``!D````````````` M`(`!^SP``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`A0# M%`````@`7&8X1^%7T4&A`0``L0,``!D``````````````(`!AD(``'AL+W=O M1```>&PO=V]R:W-H965T)6:M2H@$``+$#```9``````````````"``3=& M``!X;"]W;W)K&UL4$L!`A0#%`````@`7&8X1]!8 ML02A`0``L0,``!D``````````````(`!$$@``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1^H[&!>B`0``L0,``!D` M`````````````(`!G$T``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1W"''CLE`@``2P<``!D``````````````(`! M)%,``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%``` M``@`7&8X1X[W?=Z@`0``L0,``!D``````````````(`!/ED``'AL+W=O&PO=V]R:W-H965TY<``!X M;"]W;W)K&UL4$L!`A0#%`````@`7&8X1[S;6-NP M`0``%@0``!D``````````````(`!R%X``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1V'W4G#J`0``8`4``!D````` M`````````(`!QF0``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`A0#%`````@`7&8X1T-7Z+XR`@``^`8``!D``````````````(`!QFL` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@` M7&8X1_9?H;.W`@``(`L``!D``````````````(`!PW(``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1S?WC!][`@`` M$0@``!D``````````````(`!@WD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X1]>S61!Y`@``90@``!D````````` M`````(`!,($``'AL+W=O@!``!C!0``&0``````````````@`'@@P``>&PO=V]R:W-H M965T+0+,5`(``+P'```9 M``````````````"``?^%``!X;"]W;W)K&UL4$L! M`A0#%`````@`7&8X1U.\3TG1`@``X`H``!D``````````````(`!BH@``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`A0#%`````@`7&8X M1]%I6^2S,```<>0``!0``````````````(`!\H\``'AL+W-H87)E9%-T&UL4$L%!@`````^`#X`Y!```-?````````` ` end XML 15 R46.htm IDEA: XBRL DOCUMENT v3.2.0.727

Revenue Recognition (Details Textual)
3 Months Ended 6 Months Ended 12 Months Ended

Nov. 13, 2008

USD ($)

Aug. 31, 2013

USD ($)

Feb. 28, 2015

USD ($)

Aug. 31, 2014

USD ($)

Aug. 31, 2011

USD ($)

Health Care Organization, Receivable and Revenue Disclosures [Line Items]

Accrued Liabilities $ 300,000

Interest Payable, Current $ 3,700,000

Loss Contingency, Pending Claims, Number 179

Number Of Cases Filed Motions 47

Loss Contingency, Receivable, Receipts $ 4,200,000

Receivables Collection Period 30 years

Percentage Of Claims With Positive Rulings 90.00%

Reimbursement Of Usual And Customary Audited Charges Percentage 75.00%

Minimum Billing Requirement For Reimbursement $ 40,000

Number Of Cases Awards Paid By Insurance Carriers 180

Awards Paid By Insurance Carriers Amount $ 11,000,000

Number Of Cases In Which Awards Not Paid By Insurance Carriers 130

Loss Contingency Refund Of Voluntary Award Including Prejudgment Interest $ 4,200,000

Accrued Income Current And Non Current 300,000

Loss Contingency Amount Of Refund In Case Of Additional Motions Granted $ 11,300,000

Loss Contingency Pending Claims Number Negatively Affecting Recovery Of Additional Reimbursement 178

Number Of Cases With Opportunity To Establish Criteria 80

Litigation Settlement, Amount $ 4,476,097

Garland Facility [Member]

Health Care Organization, Receivable and Revenue Disclosures [Line Items]

Additional Loss Contractual Allowance $ 136,542 $ 779,583

Pasadena Facility [Member]

Health Care Organization, Receivable and Revenue Disclosures [Line Items]

Increase In Facility Contractual Allowance $ 149,875 $ 10,254,990

X

- Definition
Carrying value as of the balance sheet date of obligations amount received, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time. It Includes deposits and accrued interest.
+ References
No definition available.
+ Details

Name: dyii_AccruedIncomeCurrentAndNonCurrent

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Represents the amount of Additional loss in the contractual allowance which is classifieds as discontinued operation.
+ References
No definition available.
+ Details

Name: dyii_AdditionalLossContractualAllowance

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Awards paid by insurance carriers amount.
+ References
No definition available.
+ Details

Name: dyii_AwardsPaidByInsuranceCarriersAmount

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Represents the increase amount of facility contractual allowance in discontinued operation.
+ References
No definition available.
+ Details

Name: dyii_IncreaseInFacilityContractualAllowance

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss contingency amount of refund in case of additional motions granted.
+ References
No definition available.
+ Details

Name: dyii_LossContingencyAmountOfRefundInCaseOfAdditionalMotionsGranted

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss contingency pending claims number negatively affecting recovery of additional reimbursement.
+ References
No definition available.
+ Details

Name: dyii_LossContingencyPendingClaimsNumberNegativelyAffectingRecoveryOfAdditionalReimbursement

Namespace Prefix: dyii_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Loss contingency refund of voluntary award including prejudgment interest.
+ References
No definition available.
+ Details

Name: dyii_LossContingencyRefundOfVoluntaryAwardIncludingPrejudgmentInterest

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Minimum billing requirement for reimbursement.
+ References
No definition available.
+ Details

Name: dyii_MinimumBillingRequirementForReimbursement

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of cases awards paid by insurance carriers.
+ References
No definition available.
+ Details

Name: dyii_NumberOfCasesAwardsPaidByInsuranceCarriers

Namespace Prefix: dyii_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of cases filed motions.
+ References
No definition available.
+ Details

Name: dyii_NumberOfCasesFiledMotions

Namespace Prefix: dyii_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of cases in which awards not paid by insurance carriers.
+ References
No definition available.
+ Details

Name: dyii_NumberOfCasesInWhichAwardsNotPaidByInsuranceCarriers

Namespace Prefix: dyii_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of cases with an opportunity to establish criteria.
+ References
No definition available.
+ Details

Name: dyii_NumberOfCasesWithOpportunityToEstablishCriteria

Namespace Prefix: dyii_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Cases with success before State Office of Administrative Hearings.
+ References
No definition available.
+ Details

Name: dyii_PercentageOfClaimsWithPositiveRulings

Namespace Prefix: dyii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the receivables collection period.
+ References
No definition available.
+ Details

Name: dyii_ReceivablesCollectionPeriod

Namespace Prefix: dyii_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Reimbursement of usual and customary audited charges percentage.
+ References
No definition available.
+ Details

Name: dyii_ReimbursementOfUsualAndCustomaryAuditedChargesPercentage

Namespace Prefix: dyii_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15(5))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_AccruedLiabilitiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_HealthCareOrganizationReceivableAndRevenueDisclosuresLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Liabilities

-URI http://asc.fasb.org/extlink&oid=6509677

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

+ Details

Name: us-gaap_InterestPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of judgment or settlement awarded to (against) the entity in respect of litigation.
+ References
No definition available.
+ Details

Name: us-gaap_LitigationSettlementAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of pending claims pertaining to a loss contingency.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

+ Details

Name: us-gaap_LossContingencyPendingClaimsNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of collections of receivables pertaining to a loss contingency.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingencyRelatedReceivableCarryingValueReceipts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dyii_GarlandFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dyii_PasadenaFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 16 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727

Industry Segments and Geographic Information (Tables)
6 Months Ended

Feb. 28, 2015

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated [Table Text Block]

Summarized financial information concerning the business segments from continuing operations is as follows:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Revenues from external customers

Net patient service revenues

U.S. Division

$

1,754,888

$

2,231,387

$

4,073,566

$

4,490,634

Corporate

—

—

—

—

Consolidated

$

1,754,888

$

2,231,387

$

4,073,566

$

4,490,634

Income (loss) before taxes

U.S. Division

$

(820,388)

$

25,532

$

(1,315,776)

$

(352,426)

Corporate

(899,408)

(543,097)

(1,404,517)

(874,000)

Consolidated

$

(1,719,796)

$

(517,565)

$

(2,720,293)

$

(1,226,426)

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

February 28, 2015

August 31, 2014

Total Assets

U.S. Division

$

15,118,700

$

15,967,472

Corporate

26,840,320

31,793,055

Consolidated

$

41,959,020

$

47,760,527

X

- Definition
Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

+ Details

Name: us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Name: us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 18 0001144204-15-054988-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-15-054988-xbrl.zip M4$L#!!0````(`#IE.$<[EICR@[$``-M("0`1`!P`9'EI:2TR,#$U,#(R."YX M;6Q55`D``\\G!%;/)P16=7@+``$$)0X```0Y`0``[%U=<^.VDGW?JOL?M'Z7 M#8#@EVMF;LE?,ZZ,QX[MV9O4UI:+%F&;&XE40,ICY=;^]P5(R0(I$@`I4K8F MRD/BB"!P<+K1#:"!YH=_OHQ'O6="XR`*/^[!?;#7(^$P\H/P\>/>]]NSOK/7 M^^>G?_S'A__L]WN?24BHEQ"_=S_KG7B)=TN]X1_QXOT>W(?[;H_]`=S^#9GT M$8!F[[\A/$3P$.#_Z?U[P/HW&OWU^T<^3% MK`U6SV]'UU][:!_.G[W'*15SD)O^">O M[H`W#A!B^+.RHR#$U>6U[,?T4=6$A@'_/$]:W=1G#_UEY6+A:V#[.%KT96J M?QAI6>BZ[D'Z]+5H')059)7"@]\NOMX,G\C8ZP=AG'CA,(\,F$DB&7;.4[[H%'AS0:D8-EX<7KPV@:)G26)RLFP_W'Z/E@_I#+ MP^@#V#?@ZVM32IFR5;TW?\I?Q/D7?1*4O\,>E!0G+\.G\O+\2:HH^1>"$G$ M2?DKV;.2WH1>,(S+WTD?\5=@_I4X&):_P!Z4%4\FM*(\>U+RPC3N/WK>Y/6= M!R^^3^4Y?U#2]9>11&M^^RJH\C2A$F5A3_?8D.WU/G#U/XQ3Q;XF#[UT.!PF MLPGYN!<'X\F(:VWZVQ,E#Q_W^)#N+\;N_DO,E.R`5919AN,H3,A+TKLAPX09 MG-0JL"8RNS"\38/\X+G"!\^&@^/*BJ8-"6SD$$T*#R%]!D([CY%.FPJB/ MEM7/G^3K%FI9_#0G8=Z>DAES^Y@Q.V,&.'<`IOIR&[&_#;A-NL-8H`GSR62N M/0X;UXMZEL\650G=\7,O&7#9N#]_I1V5VS9"\X-19*;MP;A@9CL'8T?,`'<^ M&`TV&+?-D.<&(YLGN$T&HVCE6AR,.6*W;5"V0FQ'5BY'K'MG@/3OOPVQZ4L& MZ))8+)B";3&61;]U/`B(5PKK%;:0H:$8O[;,'4B<8R,E-B@9,2"XWT M[RTDEMG*=%%9B]CL)6AT2"R$@L;"+226$U2;V.RE3C263T2W3E.7$]&BRK4\ M1=\Z51.FZ`6=:9$9B'Z>*3I$[VB*_DKL3S#A:4!L=Q.>W')[6Z;FPE@V.MV( MV+HI8&Z+IBLKEV-F*W5F?6;XWOM),"9A&N:KN?MNWEU[X2.Y#,D%&=\3.HUY M[.'FR:,D#?0=1^,)J]GC=::_QH-I\A31X"_B?P]]0F^2:/C'Y80_OQIY87PT M.WTA=!C$Y(H&0Y+6/G@)X@W+IFCWR",C*'EM;_[`9T!>)J-@&"19]WO^@LB/ M>_,XS&$G9/!(RF&>^@\'I9"6'!V4]>7=;MB7J=GMCVBG9F^C9J_4_V1J5K[_ MM+-J?S^KMBV;>3NC^&ZT]`V,XGO6TH++_IUXE.]1I,R>AT/>S6?"R17U=?## MH_[M;++EFE;H1JHC*@)^,E=:*GX`_N;BKR;@)Q-_A8_Z'I\$SP%GZR;K1\Y9 M)EXFW6QL4W4JUHX*7G2>1Z-(Y*T+G/3\=!>,@3/WY3J,6 MQ:0$[52K^NS1SDQMA9EZS\>MEKJT,U-;:*;>F6J5APEW9FHKS-0[BXQ6Z-+. M3&VAF7JOJK6;36V?F7JO)V-VLZFM-U/O3+4J)NI??BGHSV<2/5)O\A0,O=%/ MHCNK79I?VCW\\LMNJEVR;[WS7>_4=[U%$&/G?+;#^6Q.-UYOU>T,Q188B@W= M[MW-4K?04'2G&P#/IYLFFV[B^?%B\^YF>A^3/Z><@.>BN<@_VOZ`>&6'*@J\ MZ6J%N0S<9%,%=W=?2YB#G'D!_2]O-"7GX62:Q%_),QE!47E>"QS-7O_\PB3J MT>'3+"W.J5_6$K3,1M?$YZ+)P@?*RH4RI[15%[#V79KIE;G5@I+.*M6 MVC7A2819@G!5.W[&Z9=\6*#=L-@-B\IA@?ZNP\+8#8O=L*@<%L;?=5@T\!8_ MA2+O#&AY<``(29/@W947>TP6WIDW#$8,L:@LY^$P&I/ERM<;\12=-T^$)(/0 M'_A^P->VWN@DB(>CB)N"^&C&_F<2Q=[H,XVFDYA5,9KR5*R\#(,3A%/B7TYX M#E;VZI;O"6R*GW2_J5Q0;[24!$UB&["[O%5624(P8Z?;.]UN%K>SFJ0.ZSHG M6]YN?_8HDXB_4^UWKMJE"8VP6NKJ/_[S4E%Y?.,^(>L1/.Z[UB'[]*KPX56_."9J6U1"OS5 M;],Q5X^(%G56&YI(>+'&D@9/2!BED359DRJJBVVN5KIX*O1<@\/)=(6Z/"1> M0$L^/&7-Z2@=R<6$-3X)#D^BX70\#SKUYCIYS?//5V4;3>&QX9H$_AW<^\3< MP:\?#HHU+7K%?Q^P'_UT(VCD/=9N`NU]>O!&,;P6O6LKGWZ5=4UJY0 MJ=CR:6I?K\EC$"?4"Y-OWK@^U=;>IY/?OPV.?^U].1U\O?UR/+@^[9U_.\YP ME#6Q"N&8(:7>Z#STRN05;S: M[;-@1.@Q>_08T?J==O<^W8R]$:NB=TTF$66^^;'',SYXX4SD(->*".*6>MRS MW\S&]]&HOLD`7/#GYUE3N;I*!!R-QU&8W@G/\E!<3A.^E<7?R;=)R#LE?L1^4:2^![R$R1L2+,B^HQ94D#(0A80\(AMU&R_@A!;WCXG!.FVGQ`V MEI,E5[75QY%+!V!L01%,18/K(*N@R94C0PC@)LBN*)EX@7_ZPK,"U>8+`05? M#D#F$E5I8TT1E?.$H$J=78QK(AK$,4GBVMPH++UE(Q-"<:B+S=3%4,&&PG*[ MC@T0!KH8GKU@Q'7I+*(WS*;?\(AND`0D_A:%P[KT*"RU[3@FRM&CT7I+B"O( ME)MN!"S;@098#_$5C=CZ.IGQ]#A\2X;[SPF?MM>QZ4ANTRW#8E@-<114-[HF MP`HJY4;?0@A#PVH&\#)Y(C33XR9JJ?``C@V!8&=+&VN*J((KA>5O@BA[KDV* M(3?SF$W_7(!6S(AVJ^4=-^2F'-NV!4QD*UN=SZ"8VJ3<+%UBW&"":/=\4YSY@MIDR8T[M+&%$<0Y8.5-KH.M@C.Y78>."?F$ MO@&V;U%"&JN7W*8+=JNDE69`*NB1FW+FDW$M+,?>)$B\T5?BQ>3R?A0\9B&8 MNOQ@N7E'KN6XXN)>UNC:$,N9PZIIO2E.%>M!7&,L8L4,T@/Q(PF$M/E8, M^DL<'(;!Z.->PMS)XFO*^4V%!\+DX:=[OO6V;+'<:H/<;D*QE69`RL5@RNUT M/2#"%G@].DRY*8:8+0>$\5%HI@&,"C)4&^FU8"Q//EQY@7\>SH>U/BD*TPM, MV\&YM4IY@\UQ5;"DF%D#;+LV-NOC&@ZGX^G(2TBV2N!!)DJ>^'&39Y(=,OD: MQ7S% M#9D]C87J3L@#/V:C+P+%ACQRV'Q0\#7JIEL!6\&S?&IO`@B`N&-?'VQJ,YZB MD4]HS+>=DID^DW+'@=A2"!A04(+5MAJA*:?*4LSR'>`:)@1UT%P$8439[XMH M@S8SEMR'6`:;T2R!%)MI`*."$KD/83"`J0]CE:_7HW)7/!8?A8,DH<']-.%+ MNMN(SQ$94!J-1JQ(?0[E+@<9`&,$;)D\F^#;6*\K1*981CC0M`UH=MUK88++ M9K%KV`A+M=HH;JVJ6FX!:07SVNAU;%^DM3<^ZS1K,22V%S[)S3F"UH490 M*FB2>Z3:4+X0;Y0\'7N47-)'+PS^2A>85^S?;`EU0^@S_R@+>2;AE'PE<7Q% MHRSGS%E$CSSFU.Z+.^XZ![CDC@L#VS`MP6^U@'%SWYS'=-$XGF')I@Z[)=$)'*OZC)Y6$:[ M_9JOH`_2$ ML!7C,$AEP2]SC/GT)A--?4(5.WZV`1P!IJ3I]5%*V%0$ZWG8$#="R2F/EYS7 M=Z&V(M3C8-O)'9DL--@04#57CMRY609T#?&@G0K0JQHN-R?JGY.6NZD^LFV, M#&&WIZ31YK@D7,D]5!\ZR+&1'J[L*WDD/;:2CN:L2%,/Y,@]4)\?QL7NAP-Y MLVN!D_`F=R,8VA!H8RL>98H&%+$N< M%M7%UUCC%&LK8+E6"2R%-!NKF&)YA2%&2!M-JGULQ1_EQV]CJN1&WS1<<:M= MWG@K4*MY=!7N`"`#H*98EU;PC$;C+,8W92\M;XD>D8>(SO>U;[T7PF:)"?4B MZ@>A1V?G"1G'.AM%.G=BE#X&`>3F3KAW!O[M>9(HA,KG(60Q$_2&/+$JYOIV M1$+R4(P2Z.B"W'F"8N=66EP/F(1\N>.L#^R*1NS71I,R5^XF5P?,LJW:*"2, MR)WAJCI6HV`^<:FK]3>C=2B3NTA',/JUP735&PGU9?[VU15 M#=NIP-L$2S5K$,@]:J:QX@13"F81H+PB=/'Q[F#(MU2"T30A?H.[F04_*%SC M%X!"!A3L"XY?@:,=V#)6D0YLE,(&3F/<_R+!XQ/[??#,G-A$QWR%&D5 MH&ODTBJT&SO1XD_N(A#"R"V)"ZP5/-$B3G4Q`.#$6')D7NBM4Q4S^(HL6)(JA7 MU,C.@BA:G"F.MG07>%BC/S+RY;ZV,A30RYLQ];KW/I`94)0 MQ$"Y$/*1`6V M1:J<6N+M`+E,+/(92!VQO(F?TY*.:AYB8F!@]SW8]18)D0E=,;LQD&.\"[?? M0-:J0\U$#8Z@0L5 MV8*$M;=.^RUBEG&LF$I8;$6-UP.^V"HA/I<0$T^S:[A0D4+(=2Q'T(;R5M?" M)J%1D5"H$3;FNDGP&&;9*(>S6^JQ@D->>"M0921K MW\JIAY/9:9[VA9R0[+_GX>I77AH0JW!QAHUMD(^"*5&TB%S&L^*(%;1,XC1:]IVFX`7T^5TZYY_=C+TUS(;BE1!?6B;#I0KB`Q01QV2 M2421U`_+Y;%N=PJ?`6@@$,7W&FS'=:0]*"!H"[*,0/$\U4HO M!W8'#,ISECJ^Y.!2`W$H7"J"#L9B2H+U`&ZDNS(1*M,$(N@:7?6653,DQ$_/ MG?&MTLN'"V_X%(2$SL2O*S60HB+E;6YVKXFB7?`2F2A2)+6`W)NEB>]OH\&0 ME:&D)=85>90,X%I0->KEK6FZ>()K>$CC/U2`=_`[EI[U/K(6@5MTP0BKUJ9!C( ML=9%?\W6H)E9O7P0OSO5@.!(Z%6FOH.N*&=^;X/L:A8^<[8H/ M`]5G5)'`"C(5`>60%5#:[X6,>)679_VL8+YF-RJN&P`U>O2"K5QZ9E MFTK?IPEO(YV5B5'NZ?N0+=/$;/7M]K;\N_)7A`:17_1!#02IC!$;5NZ68QTX M'71%)B;%CKH-;%.T&NWW9,#D3NF,B5.5/M\H0%=DXC!,Q\385F$OM-\6Z"J^ M%5[:1JX!T+J@%UN3_,M,#=1;\1UATRBYP,N;:@"C6C61(DT6?[GD!FHYCM=K MB[04K;S=`C MJ_64%2]^M4E+5^3NWZEU+UT-<(.=EFB`*D=7K:'11:^BTP/VJ\_OX0;/PK3P](4K M$?&S=L835F-VK+!X)7LPYGOM]5U"+ME:Q?UBV\%`/#78"M1-]E\F=4O=?P@L MMWL"R@]'#RCE"P.^#7HT6Q:91T`'/SSJ7TY2E1/N=6?WO27[+442;"D)?6/O MD^N:.0I:1]LV'9]9P809X6P#ZS-MM)S-I;(K)Z9%3DH@K[#"5RGG<3PE_@E3 M.^907E:A6*G:R-J6])L+?U`@F1*R3SG8O#J M@3,L]2E`\JP+G`(VH6IU0"A[\1;VHHH>J*2GZ#/>O;T0&BADSU@H[A4-AOK? M@$7%;(25R5;0/G0Z(4K6C]KTQ;6,ESZ%6L/1T*$2U#/&[76H=2X7M7=%)WX# M.FOU:>,NHF6"3@K@@(O5J`_%5V$Y$KR*Z_1%M5D3JM9%IO)]1=-]2 MLZO-%6SA-1E[`=_DX)MAE)$U]4;\O!:J[SP--O&XLGZW+@H4OGU?MICBMS%H M!DQ%"<$%PB<[<;8MSDT;/P.EXL3;(\VVS>[\"=_5KST!,^2??4M=A^-V[SI6 M^_`.J7LC>R7_:AT7$3]IO1/1&]H@>;R*BP@#G9W9SD7$&ANS9GB-\U/K69/7 M)";TF?ALM7XVY8MUOGGNA?*E\-WOQ*/L#YAMM[/2(0\^<9`B_>G"]78V*2-. M)]"5KBY$[FIWHNUM!(%G]2YU"RS)5\DI2WIKL#6ZV!J'N;S/N=R(Z>9FQU3^ M/WM7V]NXK:R_'^#\!R(]>W87<%+);[&3TP+9)+L;-$WV)N[MZ?VRD"4Z5BM+ MKB@E\;^_,T/)DOPFV[%C*6:!+FQ'(H?#AS._X MWZ$M[(!'94^EC_:.F]Z#2ZW,N("PC`&=DSQ](B?;MNG?+;^6"7?*R;1>;]?J M^N[X=3D8.MZ(QR_-QO.-1_('&V,1%7U.S(WD3C0E(Y%9G3%?)5XUD%^6US"+;3F[,:T^G&SD=J-+>A\ MDLZOL":"_CD,Y=9_,,"XH]>^P;_P3F0WWO%'[H;\F@M!F4,$/`%B]Y-A7?#N MD)[,444`XIX\0"&L/N@F>D9,.YYRB@74M>-:HYF:L@V, M;U'V9P2H\>->JO5 M*I?^G\.R#6-PZ;RNI6+9EB1C3M+Y:DVOI6M+E)AE&T;9+FV95U,:6Y9Q>:5R M6E6MUFJ];;W\*C(QKZ1/J]VN:_O"Z.U(TIPB0]5&HU;=2P9O&,DYYE*C7M/: MN[&6.KZ!/OV7U27]_O67"9Y\X=Z#;PS[MFDX,_B1$WDR4;DTE\:IDSO'\9XP M6A#4T847=H->Z$RG\C]?U5F?4VI)KS:.VQ-9=E8A9-.CF.,4SZFZI#?J>JVZ MN5%\\WF/PU\LJD^6`9LNE&LFE MM&!:@HC-T#V/Q4LEU-@TW>N+TM82=W-T35MP2R)//*U&YCRV+G/O9;-DKBQ" MEU!*>KT.&\FTCWQ.M[G4K;7^VTLH([W6:K4T?1$3%\B`&7$5RW.PO8026B*0 M8SV:YK%L"=VS!DVQA7;!A>G;="OFS+4^&<(6MSV0NP+VK617=8#*3PZTLWIX M=!NDS+^=X-2R'YD(1@[_Z>#7L[LO5S],Y83I^[]@#8,P- M?V)WWL!P*_*'"KOGOMUC!_]^"$[91'/GUY=G=R==+^C+E@X_G_UZ=?W'R413 MI_2W^ZO_NY1=G:Y-1D)%%S]]X2Z8GPY^_Y%^H$]`8#&(96`3/K@_'6`4H]T; M'<042E*-P?#T![VIG6Z7_,[E?SN'5S<7ETBT=E1MV.XIV^R8+D:N8?[-I(?6 M!+A7V)5K'E68`;!,Q%R^U.?3YX;P'CJ80'G_!SY38 MF74]W^(^6OXQ])]L*^B?@'I_=\KHF4/'&'EA<-*SG[EU>L!,[CAB:&#=*WH/ MOP\-RXJ^C]OWQY^L\7)+?_23C]@-?DND^NHB>TKH3S\++=S#>K)[MFFX0>3" MH/3FP#>8CY>(_WI1Q;^`-73"6D<@BIBN'VFVNQWM`LW3_\-@0F_@AQ[P,^YI MHH6#N<]$%+#W$S2\K[P7R*?W$:43;4FD8VOXC6``:X*E@9!Y8I<:(<6T>?HK MEW59U9895=G&@E+6,",-%&VV!2Q."\TSUI/E]D#2B=C/+%C?>`0IQKF+HG!H M8$PS$(&-^!9=>G^R@WXL[D'!P%_X$%LSQLL_5D`.#+[G^?`^B&%[D.K/=N'W M@=2H*'6I3=1_MBL"/S1EII'`8Y_A,1C.X?_08V=^8)L@9'4-`7C''_!^!K9Q M?_C?(W9&-$+_SJB"C8V8Y3'7"R*E`)QP''Q/]I,EH.=Y@8NE/)G/HTCN[FBU M42*7'1[P?!X?P0:#J/"&H&J``B!*:G?\-$C5=B:OZB85O`&6A0A&8_TRJJ:.C8`!8!)QQB@X^J%'4=Z(&XAG%O\2[,QQ-3Z8/A>[2 M6P'#>N2`'$&?:2?E_\5I"F/Z*^RI;P-_GH#)S!C"IND93*2`P\S_:Y.B5#_2 M,T*%#6S'B3&XX9ZTV3TA;I!ML.GB,+7PYS[,HPLX89]YUP\16]56A:%*)K)0 M3U=@3G$'B3."JXOF:7MLJLXC?@ML:B]FD["?UV,2+1W!9PM9V)Q&ZP",;1*P ML,;_#%T2?(DT-`"_@$8F+&D=IE!@4+ M`65G+'!L!S?D%FST:%5&DB#N@M;VP!CAB'!-F41UU.^(&S[V@S1ER6T<;7(N MI]7U7-U=UDW\"[;@F5MCY[',O"61*07TRI<&%U7&E9>MTI?$9O6Y+E$+;NDM MJG%+1&D;)FHI:V9!."(25=T:48LXM2#LCSC57I:H&)\7MC`=3\#&X;9WQV,5 M;TJ@4H6;EUB$;641OL`BG)P/9;(5./9;Z\:G(6!!RSV_#=MNDW3P9 M#OX$>M@3=(K[`Y$HG[@?L(M`\\_HQ7LD:RK;VYM4U"L(PN5*D"<-KB]!:YI6 M5`DZAXRN!YOD9<]5D&.TNZ4/*=Z5]%QB0JB5;P!I%W_LPA#DW.C;#WV0:XX- MDV1%/A]IU)#I,T#?`SGTI9V1,E1!L#A@CS!/.E`L:?:S8>B;(`8YBB!T+B`" M>(*`(XF)U"]DWYB&[Y,#(B"?0>P$2!FV0CI8'C&0H_Z6%RG3<\/CHY,K% M:PC0RJ_D/L%.+ND`)I6U`KJ0ZBL*,3T3@F]*>.EO6'AMS0R^RAY]C;/5',+& MX!#SU9#$C&:+)3-94I'SEF1F9NLT<81)1Z!IN?DA\8*2AQ/L.CH!!A2ZEOA( MX@[V<"B>2-XE8HU14DH4J'^''FXRI7<4=W$FCSP[^'8`&)%G`22`#7)S10^3 M7*87+!9*-^NLUL@C).P!0-#/C`A=V3[/MN!Z[F'7EEZCJ!%4(MP5H<@0!UM/ MDOF>[WM=8@'Y[KTN9KPEJ1R]#LK"8!^N\4R=53_&_KDT':04,HYI([-@!"Z8 MY+AY7A,B[/[)3=H/6[QGA$[`?%O\=<22U#_L`83D^-0_-1MRHJ+]OCQXB=-0 M,0\S"M$YPSBE$'JYO0&O,)='KG?YJ/P9-,XSX[T>$),]OVRKV(\9#$C)"`6SL\AEVANX#7VZ]!Y$F3,>4T`$ES^X74]O"&>W2TRDIT'-" MK$HB3S6C-9\6C$=,)OI:[L2A7LF(UTK8S6-^%7;\BE#.4V";>WLIWS"T/1F#(#J&S8`;BCV M(,I!5U)97GIE=.4FL@/K7&2%5!K-2JTT<0DLY!ZT,)2!8S_<& M&.V1\O\"V4$HXU<"VD7%UW&C4`BV22KK1XT,A>_&`1.&B'PN&"Q$SIR-=EQK M3AS/HV*DHV@1@,(@\15I:*"$5('<_H_W>[A1&,HM;>0D(@7NA?XX*!6TN6D[ M(.^RFV0:C^4]27W=-1P*?]JT?FU6CFL3VA6ZR$Z_E6C6&6$;D_JN7F9/U1QU M,56F1,XT/KT@![`^H4$67QN'I0@K,54G).DC<_I*LCH2U=$SGT:7,X].TV@.J,&U?U1G06NPH%&=+O8)%2/1-QVUO8R)"E>D8B[?QTW(W+@380)Z1*V>HG:2WQJCHNZJ]G!J?;B*R=+')[&X(6%L<=X9M2L#+7%L!AT'Y*HF!W2/R/V?^8=O>B^@$A%\*-% M-##^XHS'J)`!TT*$@ZB(JCQ6(<^\%$@4%"(RKG\9W)YW7X-:3E_Q(-,A"MQ' M\9:.T,D&\&=.F!):;2'/UB<]\%%8/X[.CRMP)7'2,H>=R)C,T>5#2>3,-HTX M%9NYI1@CV6JJ^6NK<) M1BQT0$WU0I^.,RP0FJ$0%!1U)JF((Y[E10;+1I\T!BP`,`DL9*F#/A'IV0]% M,J,3(`WF!HF7T8I;K$JFZM@9/I;M%G&*B)?HG,(&AV[@MK@(?,]](#DE4GMC$G;SL5*%-@]#X4<^7IH?4>1DK$P'`S# M8"PYNH:P39*%ENV$J!^<&!FF1`8E?(#MM)L=`M+_^]5%YRL^KKU+IDZR-.K\T^W=Q>7=X:?;3N?V5QSH,R/- M?+=E0.L2(W5CP?Z]5*VJ%>'SZF_6_'?4]QD M6-"7^S'Z.W]('OP](O18@T&17OSIH*&_RTCWG+UOI/'*-,)-#'`" MRS_(VRE,3\!5:!94:^\.<,D`R`''C2E^=-"'GC!%.M.3[^153[[&Q^_)+]56 M12%E+Y!R;S_O)T[J&\%)9"4H!5*F$>Z/6$AOG&:0.)]#>EIJ5*?8A>9IB9"P M-AL44%X.E'J)@**0H$2&$AD[!TII1491-I4..7E>R`K3Y'PSK)BUI?RTG'-O MVH&7#X77'?W`MBQT4FT!"$48WCK+?9NC]^V'?IF&KY5Z]A6X%;@5N,LY/`5N M!6X%;@5N!>ZB&%_?SBXNKFZ^1`?E>BT.$WAUVW260783#C"OIN?OS.1:>GSE ME&U%<"UL4WAM<'R%E$X*G@J>"IZ%'YZ"IX)G@8>GX*G@N7/3H]I6#?VXTF@V M%"@5*(L#RFKEN*I5JNV:@J6"97%@J5>JU6:E7MUO%5Y@LV*[)QK77(@3AL;% M!YDM^*.,,9N\+^IZ+EW#]QS'ID*\,K?4/INBZP:COD%?RFH,6"`7X[42W5=M M[&RMS)*5M9J"NX+[)N%>&&A_:+1WIO\5N!6XMPONUNY<`0K<"MS;!7=M=PZ% M(H"[P);;ZQP(39EJ%R/7,/]F7[GA!'W3\'F%7;GFC$1B^V/>YPJ`&@@`3!V' M_>_>,;7!@-UE_58K\N4-A/+&AU=-Y9!52T,MC:D#M&:UKA:&6AAJ84P?XM6. M6VIIJ*6AEL:,@\0=.A*+L#3V]FK4!7<]RNFM+D?M?'B+UG=:!+W:\'?D2%M_ M_"K^NL##4_!6\%;P5O!6\"[C\!2\%;Q+;WP5["QP.E%@4MLNR1,HF!<&(H#' M;/=AGXWTDOFOBL2![<5N;C?.7:]56JU61=,U!7P%_'T"?KU2UUN59K6I@*^` MOT_`5Q)?`7\O@0\2O]:LU%L[NZY2!.#O[4'G5O8ZE5^M"K8N9ZT+;72BH6A=J712`,[/71553ZT*M"[4NIO3%[N*C M7VE=T*\]SPWB@61(?-\A&F]X5&S^?>6]P#KV[Z?H2KKX$5NC3I8U:W^D*W_) MU_0[\#FF[/SZ\NSN!*:ZGV7D!(VGDQRCJ;FZN;B\`<:`K&M@A?IQN?IA@-7D M98OR!3;18$7^4&'W./1Q1?D_0Q'8O=%!R4A=(!++,0#I%W#C6Z/H#R!'`+,% M.@:&Y"KHCAB,QL8#XN11X]&PG?AV:=J'T/< M-O03](T`^@P=BWFF&?K,[C'!X8,=V-@_T`1OHD/$#7R#&O*`#R),#LP#S_P+ M1@2=\6?NF[8`2CQZ`P:'9-ENBAOX]!'['(W%-!PS=`PB!09OI08BDRRQ#SB@ MC\F(*O1>EZ9H`1LC_L&,03L^-X2<,GQ7COT1R.WU@#7T-(W!&R(=@ED\X/[` M=N&54""?\:T`&PG]4?3L@`=]9/U7[XE#YQ7DFQU@?P9P^##NHS*O1_PYVRN\ MZGHT;">TB&MY',I.]1&[S[3W9`?]\8RPH6^;P`_^;').:((I]@$,;&#X?T%; MT=\)#M%<1G3T0'=(2@CZ8TIF@,T8>*&+U,%\&\.A[SW;`R/@SFBS.N"X5:^` MWLVH@GC"T9NWT<[TBM9LS^TN7I/"?F:RWCVC,OW=*:-G#AUC!(+C MI&<_<^OT@)GY.OD-P] MI[C>$\D60G30U@1((O$+#'37O\JQ#5HH]S3KM>%/A:N!'N3V7TN2RHUM*E MSQM3_.CT?%E+U`RKW]O)\X*4H`12&8H13( MVQ0+J^0NR'!(3TN-ZA2[T.(J$1+69H,"RLN!4B\14!02E,A0(F/G0"FMR"C* MIK)@<>DOB,#=69J<(H1G%V%X6\@/5H"+Z#O-`E:BV5?@5N!6X"[G\!2X%;@5 MN!6X%;B+8GP5^DKD33C@OLI,6H#AO!9^>`J>"IX% M'IZ"IX+GSDV/@F7FC*OT[;/=683AK2.;EKWC6P!GR4HB*:Y\UV[N=:F6(@Q/ MP3(%2ZPZUVCNKE:S`J4"Y10H9<6W:EM5"=WU\!0L,RJ M/MSM>F!J.\N#J^#^-N%>&&A_V&&U505N!>[M@KNU.U>``K<"]W;!7=N=0Z$( MX"ZPY?8Z!T)3IMK%R#7,O]E7;CA!WZ2<<%>N.2.3UOZ8]R4K7K+!@-U"IY?= M:2AO?'C55`Y9M334TI@Z0&M6=Y>K7RT,M3!VSICYAWBUX]VE)5=+0RV-G3-F MP4'B#AV)15@:>WLUZH*[WL!VU>6H`@SO_]F[UMZV<6;]O4#_`V&<15I`277Q M-6D+I$G:S3G=)$B\ISB?`D:F;;Z51:TH)?'^^C.D9%N.G31U?*&<`39;RZ9( MSLSS##G4D%K%>TK*F%^]U+>1E,C^"&^$-\*[K.(AO!'>"&^$-\+;W.#+L&>! MLP<%CE[Y].C[LEYSD%ZR]2N3-+"ZW,W5YKD[GM5L-BW;L1'X"/S7!/RJ576: M5MVM(_`1^*\)^.CQ$?BO$OC@\;VZ56UN;+N*")]BL4]SH M2IG1"0R;74-[9^\Y[JO.I4=>("_F\L+>7"HH\@)Y88!FYO/"M9$7R`ODQH]]CLS_9HT\4'5IAMY;EC[ M06_YFUQ.W3/JL=*VWAEX(^(.B_6[W?,N:SGWLY?-ZS*[`1V*--GO\GO6.?CE M.^+']3CJ,AIWC+(YMJWO;[#[Y$@C_Y^>W;]Z^(>3CN!K6&[`PN621B!.HY9A+'P+? M-)[<0M0)-G!QR;J?*A=VZ]IVKM6;]-K"=J_=IOI`6-2/^&=:\]Q*I]S M\X^4]M?AY;=3@`_8#O[RP#^S)7E@=2O[PB)7RO9D"DVCZHZ^GQQ>[@,/^],H M?U#5P4,XC[O!P^P/H$1HP'OAI\I_4IGP[G!L'YG$(NR-KF9`^P",IV$'[H^' M)->HU&L)WYCHQ33JU1X[Y+9?*:*/OG0.U(A3% M7*K4@"Y)H)8C^(*&PU$9IW$@R065M,-"2KK@"@*>#/=(>U*4T$3?&<5,JF:5 M>R9]*O674PUK(&6-Q,!2FK#Q3WOEM\$VX>F(Q0F%.L"FMURD,AB26#M6UB%= M'M+0YS0@?.((M,%O&`NAG!]0*7F70]E$*)^K2JF/RO1^&L<*)1&X1-&9@ED. M(%T?XF&MLJ3/!L8,%2XT5X;:LC/Z]PVX2^!>&R32[YYT_ M!K2N-0VYSR,:O->7[)\41CLB&7@MGG"FZSA)8Q%EQ0\EIQ9\YP=I)SL5$4J! M8XP@:H*)DNAVPV^UB!Z0&UT.%;&BO_"^+&/UDVCY_T9@\ZH,;M MK^PF3BF,_&[3(FH2:VE7>T,#<-0L']DEFY)#0M5!JA(%$T*C*!;W'#PY`T?_ M7\N,;)S&7FL:B0,>!,K!D^-4B:Y[*OD]&4"!OB0L[$"G'DI4M8J3$P"7A-$D MIJHH*.E1M8/DLR:$P4K5-88*N4I4;'!R[_=IV,L,VZ>@&`@Q$])3PR#4LURM MU!VK6:].*X:',V::4E*7QS(A_X!:$A:K+G4AP@&IAXS&+]8H!^39ZV/7=& MF[L%[3.RLU*UOJ'[H,7LJ%68*P4TR:9)7/-]RIE-C&"1B9N"B9,48<@"/7=G MH?59%52L]%K(8L*$^T\X`"`(N#PK>LG%!\)#*TJ-+733O%H3>&A.` M'N&/.BA2`%VDWGZG4-3)I83F]$1_F,LR*CGJ0,&]0D1]FZ&Z_";?)OC^8"-K M@?-G:E3(8:8G]XK\-U0"!H0*!T27)T3$64I!-Q:#$29$J.;_<`L;H2BA]SFL M0A'NQ@K,VI>!FXU[^2\9&WQ`.7A+FHV"U/=%&FJ410+\.9\$IUD,DH^"H\4) M:%&/(50A5X%1@`\%WD&M-]GXH'].!P,UH$!-$M0$X8E/02]S&M.]B$R?TM,,/Z($6FA5&2_#@];O^I?BX^E\@]QMP' M,O;DN(O\ERRIJ_!]03M3#8SO.#K__OWPX@JZY8,9:239`3G_WY/+K]_/?^P3 M-5#JARC%ARRSS>:IA.,?GK7Z_H+L-I^I:>91IHMK9#$--`H:<+T_*HH:T']P*+49=;3[ M,6,3G621X.1:AX23RU%L./D&@D3$R)9CY(K?(T(VE`AMDAYPJ-@&-_`[!X\5 MO83C%+V$.Z,MM?B)&'CU&*@B!EX]!M`/(`9>KQ]8Y>ZWWTC&'&T$7(YJ&NI6 MW3Z02VF'QQE^K M_=L:*NJC'@GGN.K]6H5=49UJ6S-`(;@?T$L%W+]1S+:S9*9VD$-@+["6!7+;OA M6;7ZQE^U@8%!>LXU9LUGZ<8Y;NV9CHKBK>+'J-FQQ6.KK5$N, M#Z0#T@'I@'1`.B`=D`Y(!Z3#]H66&WNV^Y+38$^S5Y2]4Z\Q>S]Z;YE^81FN M2)@M;DEWS:]WNT:)[8MP1CAOD7T1S@CG+;(OPAGAO$7V+6G(5:K-H48W6K)KGEL[,B&ITS2/7 M[%B>4[,:C3HZ9\/%11@_`6.OYEI5%T%L=])MA4EW?:NL]GT.=+U><=:T>RF'=W9OHU:>*#JDTW\MPH_4-"`623 MR^(]\'G4LZ/O)X>7^V#^_K1B'_3QX*'&_CJ\_'8*BK)YF/T5>SLC^@.1'CB= M1V5;0C^S^Q2^^Q5"`]X+/U5\%B8LKBRSF8S+IV?')V=MK90#\N/TN/VG^KE( MC66!8DIO&8N4N1]Q/O:$P?DOV5I+X?N"/<==;WE_C&\`!GT_O+B"/O@B"&@D M@1SGP)JOW\]_[!.5OZQ=6M%_S+::)_R-?Z@0GP6!C*C/P]ZGBIU=1[33R:]? MN.:4&7H1+[+\Q:1Z<\F92B8)MXR)Q5V?)VQ7@8'MA^(NIM$8-\]<;5Y<(XMI MH%'4`*A`40/Z#Q[&G5''5W83IS0>3M3B-JW"A>W4$`-;CH'#M)?*9*(4SYE& MP"('_FT'`E[U$0SS1H:V2&A`#J5D"1ZZ8+BX*P@RMV&;Y#)#R1*C`\F`9$`R M;%.&@FO.`<'SI@ZXI;A$XAJPX:=4NS&=FN4X30NFUJ4S-2(;D?TTLEOUAE5M MX%[CJX_ZV)\7%/.T7*<3@-ZO\EA-UZU:S:EN>N['I`=($:6(\ M33S':K0\RZXM\LQI:VFROKE&U>P5!-SC@$EPIB7!;3J66^H+WARK56M9]N9F M*<@NI='^%>L-6)A<)IP$9YW+]DM"U/V%:"2UR;;HCC'&M=$X,8$+BY9]U/EPFY=V\ZUR@MJ M"]N]=IOJ`?L1/V$=ZX]QZU\SL$PTMLXDS-*R'B>F9F)/#"HE7UAD2ME M5K+4C-CIA-@]MZ822^=E#8^R009UY+TRA-O1UN"8)A^FSKE=,GZW- MYD3V8\8F.AF`R^C+R34+.ZPSN9R?<(T8V6Z,7/%[1,B&5C]-T@,.%=O@!GYG M6>!W-F+@;AO$P*O>;X,80#^`&$`_\*KWWX_0C)@&1`,B`9D`Q(!B0#D@')8`X9UI=C[7@;S;%N_.)AQ!E+ M2$03SE2:!(MON<](G`>?FP*,B7EK)HI;TA??KW<_:XGMBW!&.&^1?1'.".&\1?;=BF#+\)=#&W$DEHGAN(GBEO_@H/5NYG>L1JUJ-9O-TED:@8W` M?NHP%\OU',MK;FP?)P(;@;T*8%\!&&)L;H&SV;S>Q%*5/.9MO(4E;-P:4LI`G2!&F"-$&: M($V,0`72!&GRBFBROLC5:QFSKC$_HP9(O#XOK`+1`E%A?I@'1`.B`=D`Y(!Z0#TL$8.N!IL`_T=AKZ M8L#(NT!(^9[:.Z#%Q1<)$<4NZ:WZ]VS5*;%^$,\)YB^R+<$8X M;Y%]$;[TED5 M05RRPQW6"VRW9M4\MW1F1E2C:QZY9L?RG)K5:-31.1LN+L+X"1A[-=>JN@CB MD@12Z]ZKN.%3=DP,LS>ZX=OL=:6E;?@V0R-S([)6RZK:FXO(D!'("+,84:MZ MEMUJ(".0$U*A:4#\RHAQGXJSW@9T)9^*8N!"Q MV4@FIA%1ZV?3.=>NO\9&M_K8KU#ON,\&FNKS3UGT^@SY?JC[O6#N2 MQ;R[,].O21,?5&VZD>=&Z1\2"B";7$[=,^JQTKXJ!O:/.RS^5`$!\RYK.?<= MV_[C@.@RNP$=BC39[_)[UCFH$)\%@8RHS\.>OD]=1[33R:_']3CJ,U>NTWUN58AO`-&IG[".]>>XU4^Y[`8*?.OP\MOIP`KL"D9'R^4V9@\0(.5 M?6&1*X4),H6R475'WT\.+_>!L_UI-CRHZF`&YII@IV?')ZIUFP-=?IP>M_]4 M/Q<)G&%BOB.S)]X@_R5;MRE\/Y:VT$#+^V-\`[#Q^^'%%?3*%T%`(PE$.P<& M?OU^_F.?J%QH[1Z+OFBVU3QYL%T%!K8?BKN81F/G&-+*:!1E$#H`)%#>A_^*GBSJCC*[N) M4QH/)VIQFU;A`CP28F#+,7"8]E*93)3B.=,(6.3PP.U`P*L^SF'>R-`6"0U( M-M_!9UIFB[N"@'4;MEPN,RPM,3J0#$@&),,V93NXYAPV/&_J@-N32R2N`9N' M2K6STZE9CM.T8&I=.E,CLA'93R.[56]8U0;N6R['J+ZZ#-=YHSKNE7M27,SY M?I%"#'Y+RV\Y4;=N-:NVY;D;FQX@39`FQM/$BC/PTFJZ/7?E6 MO5%MN$OH\9(UW7BRW_![RX.P[5?]/F-WA[XOTC`!REW$(H2//LO:##M'?1KV MF#P-BV4X<"D*F'Q)$G73U"3JA;M1(33@O?!3Y3^I3'AW./9=-^H#N"!0*9FH MD4SK6KNNF[$3*_K9)0@UG1B^Y]94ZO:2)7U\<"F'`&>"Q)F1Z,1(T921B(@) M=)W%A*9)7\0FE,'!`(=*GDMPP%A(N97X7L>^K,C,1CP9%R'T/"']0,@T9B_Q7*U7YKFF5(AN:M,"'*=, M>0WP0D21)4XH!_M`)51*`;Y!^8D[GO1U"9F(:%>]YXUT&2,=+J,T8<2G4K6A M"@!;(AH.M>,"MQ*<$1TB0XPE[77S7'V/*WVT78W"&."`*9`%C2: M-0P>1LV)P,6MJ`_>7F-N%PA7_X$/9C(A$1TJ;P7=FJ@%HH<;""&4KO?(5Q@) M*$RX0/L!_`::]5.IYJ*JOTF?@WHE:#S?ST94`-(+M63D`MRY/\R2N\F92*#O M8,]B_$&^COW\U1-^OAQX+3WAV@6:#!39X$^26QISD4J`#(PG>NR/E%T5$?6@ M[XM;,"^'.<,%E;3#0DJZ5(6@R1#N\8-4C:1$^'X:QTS=/F`=[H/%80(?Q6JL M@>]T)3!WV".G$VH`*(.`1/VAA.8H=*4'[2O41#'$0P'K*5^0:';/-DUC!K.< M?U(>J]F)&`LTM_F);)..%+4!H88HJ`2&""@4C(DRU*2&&50$7FHXIS:KH(EN M($3GD78Z0JV@"%"J5E823`Q![D3\$^93&@W(&IR,.TZ[\!' M2!9T=[6`(^\K(PC&NMS/'%NOIUI,E.YW)WK("HY==`#.(@#;14IEL?+DI`MN MIM!604IE=I%&1/)_05LGW2[S]53T+SHDCC6GF\K#)_0G*ZA$U:X0RG+Y9>Z4 M`"]I$.06`X'ZF5HB4`9ZH0T)\`.&;Y&1@,8Q<`(8["=J%`)\B2X@#0PW8=X8 M9'OD4!(@(,R)E8_(1QUV2SN4!/0NHV@:RQ1\B.*#BCEZ"B"A8F5'^&D6^:AR M'&X>A`K5&;@UT<'-L*`` M!/2&!+A01KO:(T?]U"+_3=7MW_;(-_!,X!G?J2XK_S0`M`[T^I@
J+4*X; M+HY'L'F?31]/8G"W4,<1C6$:1][EM\.("(.2BB#!2[^'K@AH6..5*8\;YA&] M'U`./4_TD)[PGIZ(4:*FDDRW#6"1J7*7`_I3]5W?,$'I21!0\G][_]_>FS:W M;62-PM^G:OX#KFM2<:H@A9LDRIY)E6S'B9]K1WXL9_+>3RF0:)(]!@$CF M_/KW+-U``URTD29(]0>O8IAGJ?S*&B5(*;+Y\=/KB@3=/2FX1$QTF.@6+C4',(F10`;@>S_F@63OX%%[%T'P(]OYG$P_$L+3^!. M(-??Q4-@/*"F:"#=@%H-H,PR5):UMD$\A$D>MCZ#0S,[Y0>9L>C!4P%,:CC! M?7J;M`:\DV[+/VV?5DT"-8%=T*'KZ4&E`"Z$LGKX!=?/Z;E:RN(.>ITSO]\_ M77R37U'Y0('6Q;H+OF]TB1/2=)3P!OE\$`R_*-PIC$!NJ"C2KT]$1&Q+!,.) M`5*!KP#HPFB*YGX5F%)9T/2+1>F3T*@8Z5-(DBIC1?DC-<#Z--TC-'N@Y4#2KJE[*AM)_X>V- M6GT=O]4[\T]/.M6#AG5HN;',?%955`SS%.F>9`O8>T#/#EG8G-7% M$L7!D:5RD&>B4'5+.C(O+5,M;71W`K(!=B"`58,%R!GL<_.\_LYNI>XR4'.3(#O`**` MN$ZF`GU1CW",=UI/QS$.6`A:)'ZZ&(*%E$?$JB^)KU<@ZS%HO>?OP<+G.FGE MNWO*F/:>LVY2L:CH$\BR1Z#[)#>D*'"9K7PZ#5+0:!3+=K[40@X56*BC;9`* MZDB-.N@<^@&5*?P9;.$X>[&O@-\^YG!XU'N*S7I(.;1EQZ;&DHVL,"Q>WB1LL*Z^^H?MF6=OCM\TD:!X).UZY@=;(`#S"`4B%* MJ(!!D4U4^9G,IO+C\J)G#E6>!*ICRC?MEZF8QG-Q03',ARB'#;+:(I2VJL[M,_;RX#F1$ MWOY1DAZI`'U&8IBG?'MQ?US9*'AN!<=^EA2[\_8.NY;H]K??Z-JA#KD=[#[EZ.QAD M;XAI=V\C_UZFW>5M\>Z+(>Y/R+IOPO:^=M^-=W?-WA^-/AZQW_Y*SM=]L[;Q[_-*R]SND# M^_ONZ.+M*?L`&M']>B]<8+M0!W;J)-NY#>CHXTG2QR-5B9W2S(XM2$)(7LLTS9N?7:!)II2(AHL[+_!/4.F.0#G'_W M2+%!EOK(:/I5<&F0IV^3K+3=\MN=GM_O]1VU.&IQU')KWN'Y2=<_=9E8CEH< MM3C9XJC%48N3+?>D%OIV*ZUW[FPOEZVTO(5W0M=%YQMUMDL%]"S+4@`S&'[T\%VUX#,8?N3P7;7@*PYIIUK0-8$?K?[ M8W6N*^>ZQR#<@.W6@_7`_57E02WJY; M:N?%YQV&'R:&-]H9ZQJ0.9P_:*Z^^P+P#LNUB=FT#.OIXDO2QS\UB7`,R1S%.HC38_G04\B0I9)]ERLZMUR;0 M3$-"1)N5_><:D-V58[BV%Z[MQ=@UB7'4XJC%-8EQU.*HQ;:D#&\-EH![+]Z5[UR&Y4]>96GU,1J#R=7V7PXV-Z5G6:VK-JQ3(&210^ MN-F3!II'4%M`I@TL^C`Z,FUW`^]B^'&6B>E`I!Y@9-?W`N7-@I1BUP-/B2R+ M!#6T"\:IX+]N9#:!WT;`*>$M,9U%R5P(GQIT(0$%\1Q;XPD@H7"S3*O=.?%! M5E1XEZ6A"0];5,YXE0 MPHQR@^W]@N$PR:E1'\7K*R\SR&J>0@C\5Z0)3*DR@%D<\INIR&0*[\F8)E<" MF$#H_94#0`%4L*215,,@\N8B('CW%IL`[@?B'`+F7^1C^(*.@4[P8I;*"#^> M^-Y`QBASEA*`,F<=H!QA9%#H3M4H1T@R`=XH4NY4YT7!C:=R":2#[2,'\V]` M*B?=%E8_J9"*;_`7=[O1V7J=,[_?/UU&F#YL4,T$B+AK$!\)[W:<=J0W>=VHLLUJ+J>M4I#*Y.P M?@4$@H7]$L@8U;;+^*HH,G^12@4_O:&VK!_IGN-S\+6JI+4[=U#2NL^\/);\ MQN]7;YYYH1A*,!D4@N.G5KFI+2QW=Q#I6A#IU2#2>TH0N9,B?_(D(;(.1TX; M`)%P+N6+3^):Q+GX!)K9&!8DD_@Q%MO9$[+8-.0\"W3;T/U6K%QFL*1A,]75 MK2SY53#\,D[!#EF\CV_JDO?>*/A@K>I\SLH M>`,Q#'+00#'G>Q8`)T*E3Z37"5`*Q08'JIU8L:M5>9X5PJCS*R8I.9 M2*F=/"C"G\J7]2K^RUJM'AW&!'4V%!'P2;`[R9B%CV!L3F7,/>FU41),T:3% M3V9!8/\.A#TLF"K``6-4*.$],FNR"D"*27'[^>`_\"2.8D/B/WDX9AL)56`! MH)T&&0+]9B*'$UXMF,"Y0NU$*+DQEG`WXP^EW!P[R,AM#N#G3,<#RQ6)!BP MCJ1"O$`1A&Z(%(D(/)$(:.8BE"B!ZF@128LF='S:AUO^"4%=CT,VWZG??92%81,7L$(J!;#Q@JJEO$PRD.8$%]')2H%_2B'11:/ M$C?`7V=I@DW>`?%P0WA-E8WRR'C<8$3@)T&:8HQ:D*WCI\`>#K=WM89X-4J0 M#I"6V0VC)LF-\L9$C@7"$EH4I$5(A@2382-X^E')KQ[W]_:HK;=GNGE[G;Y/ M;DMZ#"V6Q0*@^W,,6UDV7\":#I/5G>`V_GCWYO.O^$+KNV)A_+05#,QG5S?S MOKX(\BPIAC@_^ZZXWWY]^?[]Q<#!3XJ5W^>^?/[U]?_G'"P_Y((QX MJXMMY7KVMUNY?>?=.SG$;N6[S5]H!`CLEK&=GMTR]F0!'I^1RY5`8397?B9^ M5WXTC*_\!CC@(6!*QV'*;9ARM4X*'@(.[#*SI7'`<,+A<$C>]:5_5.SCTY$- MKB^]TQ(/+.K88U,EQE=94"2"+WA)$C'0CW@V`^F-%D3MK?- M1LP-+;%W+P;5]ULGY_#O;/]/^*(>NJ?M@%9S\[W_R0=HAXRHK9/ M_6[[S.]W'*8V?7M/'5.[_NE)W^^U=U:8:ZM'N5^FR7;O@RZ*2.Q='?4WJBIU MQ^VY_E8-*2"^0:@L51J[K9[?/MV9*&Z6=]%A_9/`^I[?[8.Y=-[\KFX.ZQW6 M;TR;[?B=7L_OG'8=VCNT?S)H?P[JS9E_UG](7-_!''I#;+CM7B]A?KA.KVV\ MO7ZPA;1WV25J[PII[[0[5-L_.^GY_?X!.+>VJ`XX8G'$,L96:IUN&\Q&=PWL MB,41RZW^E=99US\Y;7XW6TKN&+_U'2.6!L/8U6"\ M,T-U+VX;F]_QR5YADR#4(&?=P\&VA%F>-;]%VD-4BN\V[U]G0]G:QIA+FIVL$T],JNG.%^%/%M M=F%\6LQKJTAY888[>.^^"#XVQLBQWCW6NE]>2GY@FL-A>>RR\+I51AU_Q/?' M2_)+JY7>*],51>ZQ$'[P!>MURQCKT7-Q^LH,IFF?[^4SK%F_22;0K36X#(.Y M\H(1=I"D+<>A:>K!)>7]HEAX4?D??J#VG*$N*ZX2LSO8.*A,9)3AA5'+>F-!F;)AKZH:*G1IZ.J[U&$+N%Q`YM@)=R.LA39,4S M^%^.Y*^7>3$$ENJ]QH??Q4XZ36JRF_*G" M<+"7U!3`/!IQ9\]C[_FB8J M(PD69Q%V.TEFF984Q:S>!^HSD]9G0)$`/)<>'@&O2%+U$OC;#7"I%%")F?`T M^"JG^53+;)0N"X.89C!#$>:IL(0-R!$\1&!3@'E#;LWNY4HO?1$"<6UL0`)K MY]A"UEN"6:A$2-=N95<;N)HD>80ML[$9&/55+MN-V:+//ECJ'!1J;(8G91H> MH1"=@RB=(_+!:(RO?^74@QN%+'(FP3BI^R;!A*CQH4*21/F"_/_PYE.%&@E% M08D$'D4\`]0#'!@G`84*?Y[9S+!`;\.OCKVW**'_)XBY1GVK=8;O_P8B6/=< M-^RH;`.%C=$`KU4^Q*FQ/9)D?9:V(S-N=6[KHN,@#0UQJRR9'46H^`X#17H< M=[(>"%@7PP*X(D#@A-4,WH1UHLZQD:U8N^\JA9_9UKG:8FIVSR9INW5+55:XJ'62@<1 MX@-RB)I]GF;4DI1:4^6S"?<8)>U-8E$A&+V4N@SF($,\`A%"`H<1KG8`6N_B M9T!!9.P=BC0+\$ACD+!DT@RQY15((>XD#Y,4^-'NLLAB[$.D!T3!Q>*QT9@5 M?D=:(D(?^SPS($KMTS3\*P0W/+O1$]+>TX43RA59<+"U(3"!A#H@!GDHL](L MX[7&MC(")ZCP.)@\BEU,L6<[BH@D!N&%QAWN(Q)HF6RTY7:OY;=:59SSO0'H M4&1.80\G!C)*VM:N$9CDH]T1?6 M"P>R;+DWQ+H)D0"&(>.]5@J12>![P$4U\N$ZCP;S(UKO0F/*]7K9T\%+:[&H-\'-]1H M4RS2?J'>`<,!V91*Y/11,F20:\6KV(-4Q0Z=+K2C#5P`*F;Y,Q4:-4CO0#1;+PPTQ\!VDH2:H8BE[G"8D@Y0U3<`!P;897@],A;C,E8N M65ZE7V2Q"E#503L#F0Q4'U%C153#,N:4&A<-*=9(E&?*8R,NP3+%1N#E>XS# MY-4(Q4S$6MT'Q6,.\B`>9Y.YT=^.O3^PB5[A<1G!@B>H-)KGP&"38UZ74?72 MX!I@\QJUT;GWQJ@*M%=5N(48$/I+FW9?Z9;`Q*)@G-J"B@&*_<$DI/,.$]I` M=9>^I?!1#TX/'95`W9&E+X_@%-6M8+4LK!(@H2/_G3F_TR0?3ZPV5JWVB;]$ M-V2!`\H%G#;HYQ':/9)Q*+A!T:A/OJ`][?1!35"Q0D`TC@+%]V91KEBS!3/& M)P\D"HROIC/J1O7"=K_FT=8XS;H22>'*Y!M5X]KMZMQ3['_+[(?U\V/O7JZDWMUW%&B!QL%UZ#)P58K>S$BQ>P$#XHVS;JL7LL62:UWW%E*:[[N M$,T.;6%ZQ%O\Q\@JUKTW8#LL-VE6F.\$0<)[LRZ+!?07!V)%(R[P=U]!< MQ/&J8QD`Z./AC3/;X#-,E/T0[:5P(!BK9(7-`+2!7C&S-GY-554^T);08R-" MR^&FC4N:RT(:LO-P:6A7*FY8K5]7?#O*P!DCIL[-K(RNA1\"G@+3!P$NAKGM M1%D-B.-2L%_&WO_DL?!.J",O%J`DL9.2H>J`B7`9+^H(QPR^,P$%<^;%*];A4>R',C$`!3`J3 M+A43=MF57M2%G3';L7J?(W>P3(,".7A\'IT8%M#*9MEZ[VP)5R^77F-ZA5&D M95KY$UX)82?49E"P`8[7, MA2%N/TGEF$RXWAFC"[\Z!MF)$+:74#$$RWD+MBBJ4NJ;2*9N:YDS;[U4PI79 M^Z)]+S)F`P++O[Y`?`4W6L3O"K0**!=SF$GY0#6E+),'"W,:;4"KHQKR!3.G M04H264)]2%XD3XK?6"WJG1G]^%%['54W6MJM]E;K*DV5.>V*9=BVV@9XQC?& M>Z9?FMU07K'J0EIJWQ#(%ZGPVFP.`H:V6US>GK06/`L`YV&NR`4]2-!5#+2S M68;H]\Y._=9Y58`XW\6.-O`F3XV_$H-V2X(SEI,=55%*`F,>510V;0'X%/]0 M.,X6_&.L9W$L66`L79C;1^T4?K>[@6M72O5R516$F!54,$O`$,AD20^E3VW# MKHCC[@H#B3A$;$OL+:VA>WRVTA]2L*99,,.[-=NG#*2R8T<%/\N[1Z61R193"B M6R3+X%5;L7@+(&+DGXBM*R3CCIC7'%CU4*\WE3U?6GO&FX$@H]@>,T+=D82O M3,$L'*RR..MV.8>*%')?FH7K2_TB0K;N#+*4##3KD9N8T,DEVD/=H/31\08; MY0OYGK%"*UHW`2>@Z"CB(MH/5V!]Z8"[0SPJG8*^5*[@HK:FJ\KS-/@B"E9: M4UF]Y]KCJ#"D3',45O+A&86(G15NXPH4?JC"'KC"+"DO167A\:S`IMTVP+$U M,$EW#;:I"8B!1R4KM[`T*K)RTCDUZ/A)M4@AB#OLR4[TQ:Q]H34&>/&NDMDL M2;,\QG@\#`CB(!$.]T:ZP9P-5`4H3/E+B;D7IP MTARP5RI9&.VHPY>,9AQD)7D5'%?#KLHBB:R&P0Q),B0#DD,B684-8+M9QL&E M2%0CV"J"AB@-\!9^CD9'="D!$R#%`3S+`*5HSO%41O&M*X86L\0`!GX=4=!$ M2\"91]FD$!81XF+)U1:")FV5AR+,9@$S"DY$*PF.$;BAJ(328NO21#DPT;R ML4L[3`CP20TMWU%TH75I9BA5ATN94`*=FK#J_DT?QY@$KAT)UCYQFNS.-%EA MR*94."62F5+)4`:VB:S$79+D%'0V<=` M@4B),7A51Q-O7!EM^9V3GG]^7L\V8:6^9O>UB>%L=@&]<[]?"QDSLY/C@E?P M%VB&&=U<(6^[R,?H=>T6DN;YHN:\`K#;T:?/SL[]DWYW5S#LGOHGO:&%T+]3Q@CQ6U4!0:WX$AQ@:48PX-"SDL$$?'`%? MKF4]%;%''/A*DAK7`V:KDH/(1-QH_;G0A@-V3(L(T;2\D9GH%`)]_[(DNT%9 M*B29!Z08Y7P16$0:F)U6XO%86R=K!6G/>-Q8;[FX>EU/U+&<]Z6%J4,R81<< ME'VM MI..#`Q.P.:J\5AK4%I-85,LEK8.9*_S1X=/9;"""[J)7#V"Q0B<6[F?7!`A@ M.-<$]B_BL5:8@9L"B64Y2S!I^[HB,!!H&QAOCD0%/'J M9!!$Z/2@^W19&@"M<[,3_7`E8!T38`&R^%T^H_O1]8&"@$]:P'3XQK:U,F10 M&X5@?=1#()FJ*-9Q?8QO-2S1WG@M;-\L>FF\GJ%]#4)Z4 MTD>D0_8P+J_40BI,P2\CUDTFK1G6UPXI/9;A7AO&WWX5?RMLYQC3X17:\Y@/ M]I#H4-N5H7%(9R+H,V!(E9EY9?H$ZAN5+#Z=72-3RY]<\5QH?L[1;PDB#W." MM)X:(#BS<#UKHQ1#F[\5$?XTFO6R(.N7U@/ZE"%2DU>$N7+V,#B+]7(PG$AQ M;:7UD?N`5=4DJK\X$*4<`$J(,&!4APG`EI@#T^9))&B'&/R,<+L&JF5^P;'F ML,:(TG2TUU:?#RIG$LZ8Y&?-2@]J1X*T7\VL]#T%HI?2OM'X1UY>DV1E:-\2 M=6"1B9-H(#9N'*[PH8="\$9@AH=:.\=:G:*8H\BEK26#%F%^5K)FEB1?]&$= M>U^W8W=()48MBY@!F97P'RQ@1N]_)C04*-$P@%7M+AJFD6&`> MLSCBJGS`,USI%EL]WO:B^U;$A%HB%306$@0FN$7#9@J#FDH"?)(&93X$=(70 M*0567/JHM,*"WJ["8T/3D$Q#):)K9,TRZ"]#,7U'G6FE=+4S?,+.RS"YB4T( M+J?=%AFY(ILD81(EXWG%^4^2X,ZJ654/+?R\LYS@""RB=KUKAV2LDEP(&@:K6;>Z M1HPI#*,U4/H)D^%TU@?K5I3/R=9*NW4'D:+SV$P1!]0'QN3F`O8FJN%608@R MCTF_](]K/%^24X!N])I[FM,,9)KQA0;^/,,Z-]5K=(R0T6Y_D+-(*"BEEP"A MZM^Q@:%O["O>J%9_T86$DZWP]:_)D_@( MN"/H.C%LRIA)%-$.X+&`!>"Y1K#/+0Y; MV%!!P8\XAB4#E12XGE4,)N/L=$QNT0J6^#H4,^:C;,B"R9H,@>TY%M:TTGN! M7121^)O%ZKY!"3[TI9DE&*,0+]_Q\8'EMUYQUX=^_0KC#@WC-G+8?TB5OVZK MR<7X]A0']YZ(+I:JO2;4B*L@FA]4M9J97=2H8C=?Z#H?@R`BC%83+(:!5B[& M"05CUH791:Y66B"4V6'PBKU'!6E@X";J\!;9:&7>%&.9+QTS%&)*]SL6PCK4 MVR'_+LY/L9I`MD1@]91!!L5\V,9#K8XL(AA=0Y+CI,A-LR:QQZ448/+7@QXD MEO)ZTHNT[:?=QX9UDSN$/.=J4N&Z^G'0XLB)C4RROGRS;'082M3Z.#88[W@5 MU_UDK80O7I/J%K0`JH>&D)5%X!L'&!^\#&8Z1YKG(2K(9(2FX(3UND#IL`N. M0ZF(0ZIN!&@EPYR<;,5>N&J9"9%PM+1#6AHE0\H'D&45VP$6'T1WA33LF@,> MC,<@%;8.;=D*6*SSJX=^UV2&ET1\LQ-@29X4/I5Z>%4?XFATK%Z$*D+=&ZN# MEFO%[]22H`,R#!073-&V`(5&ZM!ZL*>[TALLU67]_4,S9P`ZM6 M75G=]Y5ZDRO'KU0/H%#_""^Z=0W:7(>RKYW6)(&@M@E,4X(J$A9W>L75)"+6 M8NU.RYO!CI,RQ,":*\@!K"GG+BVV>#"]0+!Q!2L7="GVKV>M9X8RJ67$BW:K M]=U+CYXYBH(Y:!TO1O*K"%\^\X8BBM0L&,*)TWOX>89`X\_%^&GQ5U@X#>T_ MT_)/TV#BGS^&?^DYZZ&`*H\ M$I>C7U!_T:^IBSBTFAX4/0\^XRS%0)Q/\S7[)$;_>O:Q=?YGJ_TG7IE^3EJ= M/SM]_/ODF2?#?SU["^/(\,]NI__LIQH7>S#C\9[M&5/<8UX^2A`#R'''\3B3 MY$85&B^CC'97%-:%\4KHX@+H/"R<#SJT>"']TMQS]5[L*;"VMFQN4\,74KII M4+$3W,8?[]Y\_A5?:'U7+(R?MEJ?ZEBJ&MU]?0$,+RF&.#_[KFC_\_KR_?N+ MCU>P$I3FP4R)E][EOW_^]/;]Y1\O/'284=WU6]C9RO4\J%6K@0&#J0&=@98U M:[UWIZA&[W"+K;"LOL>-`\&9W2:M!W0%1`!H#IA\L@"/S\CE2J`PFRL_$[\K M/QK&5WX#'/`0,&6+#<\/!5.NUDG!0\"!7?;Q;APPG'`X'))?UA/16N)*CM!N MVQRALP`NU'SW"!/N`X:G*1NVB"B]/4(4APF.93B6L7-$.0B6X91*IU3NX08? MROB>_/Z7=!'?2P!L5;0U88,.PQV&.PQW&.XP?'\WZ##<87CSS"YL*O!H4`R' M0FS/Z/IE20SS`X[]V^YT*L,P$M^0K!MVD$NV]X\'["J5X\F*;7V\>//FW6^_ M''WBR4],6,FWW^H2!M7W6R?G\.]L_T]RT_*W8=M[XHAZZI^V`5EU,;6]/DF' MJ(>,J.U3O]L^\_L=AZE-W]Y3Q]2N?WK2]WOM_D$>Y7Z9)MN]#RIB]G=FD-QY M?]_$(+G?-7###OC;`V!['&Z#4%FJ-'9;/;]]NC-1W"SOHL/Z)X'U/;_;!W/I MO..PWF']D\'Z=L?O]'I^Y[3KT-ZA_9-!^W-0;\[\L_Y#XOH.YM`;8L-M]WKI M-RH&1>FUC;?7=VG$=8'`L60;SK_[(][@;?I=?5/WA$N#W%>;O'IO^VX?DSMZDH1[%]%$&63UT$J+M-Q$,O_4M>1C]RTX8J+ MQNO1::97,HJH(W"E`':[US;UUK;WUJGOKMM;N[?2TW6^=G3=O;W=0X+*G5C`R7HJZ71ZO" MY;Q]>G;6[^T+5#Z6[>^\E>[WW-N?=:MY[[`[39N^T]5T?C()B]^"!C[-8S?X>U M4X3*D$5$B8+%/*)33:_=U$XU*Y8Q2*+P+EU+:"F_)3$UA`B/6@_JOF>I;L"E^P1[0"MC6%S9YE,W]3)-^=IG+Y4W M`E,^HJ98/V!#OJ%(J4.;R@=*AC*@UW5O8].Q3&)WH%F29F7[9T`[BBF@SJ.5 M;J(*VV'&5<24&C&/ZQAK?BC'ETO&ES$V=N<^I]RI,!6CHF<@O#_37<[-<,H, MH]],4B_""C]Z7Y&<2AP7^ZT!X-5$SJBIF_D^DH'NFSLD"#!$LU0.\LQN5;?L MA/7Y%QN[`6BTO\,#6>B2],,^=B6[![>N,_C/J0C@@?E5!C]>30"1U<40P)52 M$_%5$NO\SVZ+_JXQ=MO85328+;/>_?86=?F35JM5KGG-`C:SUOZ?W?8RZ=J] M?:TGW=9I^_3Q:_UW$.7"//DZ4=D'D4V2ARQZO?78.8/UKECNBC4\',8]O=P3 M6&Y/X\/)GU?`LH#<@"'\#.H&3#(=B#17.';MI\_SF;CX*E5MAR>W'TNO<];O M?[-CV=(^UYMV[=Y)ZZ3WN*.LSISLOJ+XS.N-7@<+=3V"VMM@F0*7.G]:[X'<"E>(B8_F41%%ZT`O46`!! M']N*\Z355`-GG]LT[J`59SZ=@O+]7\&]Y!6B"K5,QA[RC"O2ZL9YAQZW MGRO?%R"R)CAOW;-[9_5>?7%6?;M?_'#G;I]X67YPO3Y/7>>-@VFYLQH$M_34 M8?7='?:3..P_!$9`V?IC*H?6 M3V!9E!$MYXV:C4D=69S643+A(9E&_C>13X&7<7KMDD#>])Y4TW8GLD0:DI; MA`/-$SP_WUFLD'>0*_L$$+QSO`=U=K>(X0T1Y-NU_GY)@QC5PT., M)M\])VM65F]#$R/NQ93TID_:[DR?&D4ZE-UGE&V(--VN66P<)SN3I\X&/CAY MNMV6&KMG3LT]TP.G2(>R^XRR#9&GV[5.?_XZH["X)/6&&&H;.4NU^;72&]@/ M9PVK:XR9\+S3;O_0>.S>3R'<+.(]!*.V=]QI?@F*PQ>_W_"6=R'2KO':URXE M<3.*R3;A*K@Q%7MV>IFVPWXG3;!6FK"]`Y+M6VZS>GRZLTYL34#6PZDSM;D, MC7OG?'".6)Y-$HSN#W^/`3#6-!^C(%:OYL9A3C&%GS`QY3$Y(8U->G M#!&/'HGD2-BSOB`HC@`)#1AKX%F6F8&/[_%I/)D\$V;(+M%DDRZ#,]N:[!YB MHLG93IV8C0-!IVOG'IPLN@^82Y=@L?P)#@4.`@5N2S]90`&M$&*^J11X&$. MQ";?^SQ(*"RF&I$IL+?I:4^3/]S'4W8?]O%;CC4_2J`EH^4I:7N7TOA@@#F4 M>B1*W2DA\I.8!C)&-:5XRBKJ9S_Y'JS&\J'G_T\$J7K(+:YC7@>':>N8U]XQ MK,9H0(T&AC-[]WZ#W1.;JON+83JK#E?Q[W;?%4W8O::W MP;24Y9I>_P`:NKI$E"8EHC0ZW/^DN[/P58?O#M^_.;Z?'CM\=_C^=/"]UVHW M'M\/7VO=KG_RU7Z MS;_7<'F6F\RS?'169#T/L^P_>3FR9_K$"6_8NDXM=/E2CTFR[#0UR5(!1%]X M_>,3&7OM]G%+QAL=_I&-BY>EV]')>W0RGGUX>]\1>/\W`"O-\0\,Z,4\TK;' MA_4NQK`L;+J+M$J[RPN.L(?[W/>#VJ.E8JKS+$]GB1*F(_-Z[/*>FP[6G=9+ M>HIPSGS7?OD#MJBFI.A4Q&,8,*[TKQ[,=<=L2H^.L2NT'AW>D9GRQ'06)7.! MRTY&(Y`U*?R%+:CS*`NP>1[F18.R]RW"O MV%Z:VOY1_^]L`E\9B`Z$%PPG4EQC8^ZY!S)-<%XXKOA^^ZRU`:=MP$.55N$` M3E`>L&EV$H^/8)U3"[S8K7`"*BNH:M\+D=2A/4?^6,PF\%^I$Z@1_T9?@)" MD2'`A=JU7P<1C%[\5EDAM@%5.G,>CD\.,S//L??9@LTDP*;D2J0(=B3%A7QY MHXY^7R.8[_WO%9+*]PLZ*--U^\0'U1K_$6-RQ&Z`R3Z13VQMM%D$L% M(,7EYZA6$2@+JEGL.;X?3&/O&?3%JK(,<#PI=K''3)O-HD[G9#7>`#<`3H&8 M`@B;SP!_A%:V<9EV/8F"GI`*-HO:/?]LS1)O)G(XP7JG]DH7,=H+1L!VO#&0 M-*P6^`AP+Q(&/(I^$1=O2J?6:&"?,*M8&BE;'32ZG2;6K`WLT5(M"?:]\I9@ MD_?\&7V+?S_[06M1@ML0F]HS2%D),C&60$<#,N.TY"3]9!K,D83'W&*'%!%8 M"Q83N9M&@E+>/+A:/4'!5]-.ZC(ZW)*,OK^('N59GHKEDEK#FQ=??/3"!-U8 M20;[@-,)/'+H>*AQR9BUFS#(A&\.2>N&<;)">S*,U9P*P@VT(=2$X(!T*\/. M.4FI]K&W`_%UTNUM6GP!--`16"V>I%'U1D;1"DEC3F1_Y<8JVWYCAU4Y)=?@ MO,'2KQF%IUR#\V_>1&#_\U-=SVO7X-P=MFMPW@S4.KQ@2=?@?"]S$5V#<]?@ M_&F4K'<-SEV#\X,5Y-NU_ER#\T9L[X#J!VPW$VOWW2V;>Z8'3I$.9?<991LB M35V#\WV6ITU0"QMO`^P94;8@\W:YUZAJ+7-3C?-3&[6@:;!5"#K)*G5BMG/V5[L]A!0U'Y7KCJ M&IRO++RQJ/:D`LT0PMLTDMMS@?^)ZOVV3;!)RDDXP'J=B M'&38-SM+9:SDT+L.HKS(;[]WM^YB'9CM_8^CUI$/B\=$(1QM&J1?1*9;=L/O M47)#J2H!I[T7F3#T@$OX/?#TFOWK%5]/G7+L<3]R=ERS^,V[7US7O">0Q^&: MQ3L4<,WB7;/X30D%URS^$/B#:Q;_K0#F4,HUBW?,:R\PS36+=\WBG=F[;QMT MS>(;2>H-NW9US>(;NCV71.&:Q3M:7H;3/%QS>(W MY^(YF%#ZI]9,V#6+=_C^E/#=-8MW^/Z4\-TUBV^"UNJ:Q;L$.)<`YQ+@'+TX M>ME'>G'-XAV].'IQS>(WW"Q^*PFL9KW?,BOK,8W%FY-$^*A=+#M.@U6,Q@=P M5/?8Y%V>,SF_V205XNY9OW8/PZ'5BMX37_%OX05*)=A.&!,C9399V;VYFG1Y M$RCO'YLDR]ZYW^VUJR%P"<]_W3?F<]`#!1-D,# MWLOC5`R3<2S_NVI;U-+22HVM]0AFMQ9C)\6?X7%,NT_T_)/(P#_^6.NCL9!,'OQ1JIAE*@\%9>CU]9) M?^)TYM>)RA2%([Y"'/\8S*>\7B M@1N@&@)X/$6=BE%Q/+(\'BPO(>"M*?%[E@K`-'4%BBP-B%=:%0!\[X;J9@37 M@8R0.(^]BX'"KK(SL%"DFL``^FV:F3M^!K$U*18!Y8;"(&I$!MN`+05C0;_E M"EY)!MC%E[B0'BL,L@!+'01IBHUN@XQZ`9N5$_,N=WOL?2@''(A(BFNA6Q6C M,!O"('.JCD!1RM2_-U`3W4(<_A!_Y1(&0O@`;QX.N?\H,&8A>5'X)'R?8A_9 M2`8#&7%STV`V2Y.OM*3*C M.3^";"O!1L'9C1#%P<^"-)-#.>,6S0RVJ0B0.1)0L1,Q]0Q6^7#BVX@&^POT M*%K)L-^CC:B)V4DHN+VQC7JPDWRJI;+N+KVX)(8%X`IN"8%'QVF!H=@SK))5 MQ*,(L""RESJ1(%G3X62.(R0I'*%I7BOC&6@*.#[!4N^@T^\<'-KO4]'7#;^]\\069&-$5M@ZG]L&$ES)!DB%0V!&;( M/,C&&6PLWOS=?D,)==0Z7B:A^/_\TP8.KN-=EFQ?DQ*+":I\]%?M5(=1CJ8. M'*\^=Y^8$9)7]5$\;B6G(*V,P-&E;4J^O8`C+RMCU##F3N,99",6%E"-J4Q/ M\K(4@+3-\AE+[G&A;&22PR1-$U#&64+/5PC'[9>!VC86'!Q"=[W?XV0!I8O# M5OELEJ3Z4`%Q,C[U.#''JKNFSPF]RM=@-CD"1$1QFI"XJNIYI#9+P+!U2P[\)IENCA56;DLR5/+`%G!-K7"%.KJ9)HZ9+S&!05, MD4T*V[Z9)4J25@O8:-,&?('*?5'9Z!T^G1H-JT%P2Q$& MMI!*J+"F7'Z65K8VZZSXLJGNH57;\A%0CZUWC9[L<.E)X-)5J>I953W0NK%Q MIE0!;2Q#7="AR9-#$PLO;.-@7S&A*='6C0/&8>H:N\VEV(=Z4+U[\(7GY"LI M@?:@SED.+PX>+SH.+QQ>+,&+[A/'BX-(TKK-07%!_L(''/3!1`4W87N/)NUO M5PRED=M?W0%Y'T[?(;=#;H?<^[D]A]P.N0]9^]RNR^I=?"U4QN&R1=CKT2A) MCU3P(*_EP52(:,+V'F);_6.S/*O114ST49ZTFW^4#E.?-*:VS_Q^_\3OM+N- M/TJ'J4\:4QU/K2M_3R)3_:E&C7Y>$7XI+<6XB,/O4)0RAA6+=":P,Y`7BD%6 M23I[/DS2&46T4ZCG-(\ILR<":L2V$)1WQME`&%;YYT?3<,_^\W_-/>Z<59/-I3YB9F^*ZJF&E1>:23AFPNS=;X=YZ3P"82"A5 MSTG!S"U\`9.:*)=IV6B55`8;^)AAEXKJ"'$2'PTDYSKK089)K$2L'DR`>$P(@>#@'VPH1'W'..F5NE1LH1EV, M#-^?Q.2UF<3UM..KX42$>20N1\5K?,MQ$8?ORYCH#SHD^C+^9`*77V'<\F>< M_C%IRKVFIBE_HRCX/67#+L3>A=B[$/OF7>:[$/O##&-9#0(78N]PR878.S1I M)II$+L1^&[>5C0/&8>H:+F36A=@[O'`A]@XOFH`7+L2^$4%.+L1^;R_>7:"F M"]1TR.V0VR&W0VZ'W`ZY]U#[="'V!\?;7#BH"P=UF/JD,-6%V#=E>PY3'4_= M7(C]_@3);C3NU035AG,I7WPJ^G.HUTD4"6IL\9$Z13T@/O;DV4\?NZW_]\\? M;QN['MA[8=37MTEZ!ML+;3:9R"(00[O&&C=A@&M MOWD4@P>$',>O87DX:1F<_YCP^?.FAL]O/E)^@']H('H&BMYG;!X447H'L?I! MP?2;'8A]L`E:HSPFJ11$WM`/ZJ>&4=S-)(FK3A+_\?GQU[+W!0.Z4 M6QJ91S&C)Q38QH'"\VO/XDC9BCDQP>=*QHGW*HE#[UT\//;>RZG,L)]AX/V* M8?[_%_]C4L`HB0#['\*Z(ECR#7:#4OE`R5!BND!M#\]-=D*G];*8IOBN_?(' MWH<8C4!(US2\V)_E+;;66B=Z7[FSG$E5\:VC-]" MI%?Y]&EKK3PY.^_W3GNGY4:7+KNB98+2AZ$-P1B[3T:!G*H_9#;Y2.DPU^)3 M'L'KZOX"Y;1M+70&D+57V@;)=WRN5=$[+:"F&,OI($\58>7EZ'>5!Q%HVZ\! M]X&_I/.+/$3R?#T)TK%0Y?B+Q]5N_]GNPNI;_=KJ.VM6W\'5GYT4FO3#%E/9 MT0<9RVD^?24CW.TG[->G58LDK4Q0W0(LGPZBU?^Y5P/Z7?S'1`XG/,9O2;8Y MD)_>`O+N4I#?<3V5#;U/%/`C:@Z)7!AFS./P>_=]K=&B/F"$SD7L<^H4AGZZ5PM[:'NTU?Y4O\"JMEE:=?+UOL74!_UK[3HN\V_3HZ M9M9U.6)R>1L3B=E.8$5413*]&#KP" MSBV`<__/+OW=_O-CH()0Q($9R%97&1D*:^!5$.&P5Q,A$#5*`%K%`EZA9CU+ M5!#]DB;Y3!6L$I^A(P$D*RV*177WK+?>Y]3JG/3.S\U)WPT0CX?=J89=UX)= MMWFP6Z.-(.QZY_U"B7T`Y,I%&P)[$,;]$J0`B[`Q0%OO$CX[.S_I=PV3O!4" MCP/8TTM5Z+MKR ME]07%MF'?H?B;)??GJQ: MWH).]57)%[&,_O4L`TWPF??CHB:$S.9S\%6H4AM_B#+=7^^@Z+=:YYV*0K1V MWLO'8.^_VVI:AN.7U[Q9>%3:Y"E[K[TO/^Z?]SK>'%PF3GZ>S*)D+ M\P:-^ZH^+E`X!OZ*D!#VI7T$9H9W`<65LZG.N,O[9VMK=^ZW7B]K6KU]KNQJW_:"5Z_! M<,AWM5K:E5>C9?DX55Z23H)KP<4C9ZF8!2F7H\-!TI"L/*S^YH&&!D857A## M+V)&)>,*2L)REC#N+-+U)24Z@>34FD_&(PP`+"^;<4R\NN6JI$/V*V>)]Q8> M@^T<_2\]=I%F@1C M^MFG==IWX3B@#`4N*@9E3"F\A\5&@3DE\?!B0B'266,UDU,720BH`8+-#X M?W3T3LD-`[Y\7SX&E_&\R,=`T5ZW38OI'9L(%T!N6$T>9:IVXKC:NVP*"`%Y MIV$X$LX8JQV@9OA!JFDE3=!VBC[:9JHPI4\Q=>_QAT'J\- MW$K3V5^BUC='_W$8VO!%^#U-D)L\6V-"30_U-25FO,QV;NY34H MS8$D._!:)KD"#:"H4+[Y24`7DJ]L;\BX'%)(+37O M08>-\MY5NUY=5,K5 M8"HB\26=2>*5T-Q3PCXDSK2N>]F]FY2YEF#UEF#&!6FO@UAOQ?>^6-_)4P61 MK!I"Y8/_B"$IVJ$8!7F4>:E47XZ]W^-4P*'_%\8>@_&@O,5&07Q09:NC8#C, MISD%QGO418&N4E(Q`4#@`4B*1?&]6.C;!7Z4OP:^_E5G%U8S)E.Z'4I!TH'T MDED"TD]F-I9YN((1L-2$[U+@G1#T11E3'J&U7CH"O/.DM<$G;*`V151,Y^;6 M!+!.T1!DHZ#)(E.:!`$#71P2OX.?5:)1D'%? M8K@&]N_*!R#;\09+I)2Q",>-&E,VMXC1X$.9M$MA$-[/.H'V;O2>:4E8CLOW M.73W96EEEO*U9%QZVN("HRC'6%B^N-4T;S/&8^]-GA:8>MO]0\^O7/I-@A#O M*6$L)H\--YELG[;]_FFO>A'$>U!59FCM8213E8$("("-I=R,30WA).FV8W$+ M"E4:?0&-?&CQ%.@0)MJ9,1'XN.$GUD-`[2!E?DNN*7#:Z[8(7MU]UH]7J[J+ MT9#7@'Q)NH$HG<;V6]R!<[CI3OF#N5TXF(T["983].Y-.`:X]-3(/PDKF@./"';(TZHU#Y?`R&6UC8HC+0W*7 MQ.YJL_3W6!:%H8IX7V5%X*(].PV^"$\41$0!CTKETYD.32:?(;F=F.U2;IM: M:.%]>[PUC6R':%,8L@Z\129NWVM7`W`K[M-RK;J6V()[28?EXNY2DQQ1QCER MVH6J&*VS-+F6H=[^TC$#D_I:A-#JT%QEMF^29,M'B]%H>&6B+<,D'V2C/#+G M"3"X$L*SZHM]TANP\ERL2F/>0,`$--0H3\E7%X))GBM%H007O`H3L>6$")2++*$VFL+A$V:>?J_)$:TB:K0SRW&>3O"I"%BHXFG)?EZ.W9N/O M2D_]@Z^I3I^0W$$8>IQE!EA4@-&SX+BGG/P@1)'E_J]((OM"2I9,-RROF+33 MT_CWK/`HY)"47V`N7(`I#13=1.24R%W>)=',2M]+6).B,<#7$`$5:?9MJ95C M(L:*.R'@^>C9O19H8Z#_L61NN#_+U?NA'!`8J@26JZ4=\7-=KDC+.[)13.1' M_=[?+Q@YBAN=0FS$'9;G\:*RHI!][U]9SMOR("26P!R1S<.W*N*KU-YE#+W7 ML5S&/ZM72$N_*:/M<2$44$>MXV42 MBO_//VW@X#K>9-_-OFVPLX M\K(R1@UC[C2>0;8B+@,OQ'B2EZ4`I&V6SUAR#W,Q[Q,PL?V;\6UCP<$A=!>, M]&0!I8O#1N1WK#4J8&0DNJ MTK8=%J'Q+#^G20B"S">#$]4.H=6A$5JD[(5-HF1L;GD-#61B.(GE7[E1L5`J MVXO,%X'@PCAVM8$-.M&K^3!D;Y!:0[HK'38H6`;*";6J%*=3Q M2%4GU#)W4>&GJ-HW,ZI;C;ID)8`.O["2PP=4`X(34!=21T&8B'&*5;AP.=/$ MZ..HX`.]H(*O]3[TWBV&AQ6ZY59TO`UC"B]M^[C-K8W>4Q^EZA9P_7^\>_/Y M5WS<;MRD$:GF2*D]7G0(?7WY_OW%QRN8=(@M!68*9.WEOW_^]/;]Y1\O/'33 MP6BW>I\,X6##)VLE#VJ3V8B.];>U:7]4A[/&[7`3+=PT/KVZ_/SY\L/2IK/- M!@'``$D`D#S&6OEU>+"%5$*%->7RLXS+OUEGI?B!]$<:2*NVY2.@'EOO&CW9 MX=*3P*6K4M4K04/6C8TSI0IH8QGJ@@Y-GAR:6'AA&P?[B@E-:I6?+S\N7>)J"-W"%SC/IP1:^P>'%PXO%O&BX_#"X<42O.@^<;QX MO-JPD;[6PZ$0VW-0<#/G!QSTM]W;?G:7O_?1/9BT-[S[-5WH&[G]U0WI]^'T M'7([Y';(O9_;<\CMD/N0M<_MNJSLVCR+=49V=?QWWO-^\K:MVE;_V"S/^GCQ MYLV[WWXY^L23GYC+]V^_U=6,ZJ3=_*-TF/JD,;5]YO?[)WZGW6W\43I,?=*8 MZGAJ7?DK\^^\A7>VDK7?T%"Z@XP:O6.Q0Q/&CU'*&%8LTIF@=-5[5T'4-0QU MI;"?\S29B:"(J?C5;1.O//^SW_M'=:03;?U65#C%V`H1UZG:M4)L9;7'18ZS-_G&=\HHKJA7^N:SFP;>#"78@E<-F2N^M+/E5,/PR M3I,\#O=FR8>D(WVOBBHE:8GPWHPK2DA5R8X:B&&`&5,QI3AG$I-9=!F38A3* MJ>8"7',J*YS$.N=%4EXZ%P.!CPFW30,Q?^Q]*E\N"J50SGE1)`55AE!$H(:D MV%]Q937?,DW>*KXR$/:P7-`F%K76;R5`BDEQ^V7!51L2_\G#<5E-IDCM+VKJ MXVJY%`HJ*%@FQ:61?3/Z7,+!/594W!GLG.&0_@T$$Y@"'`/L_XC-$[D!!68O M9ZJLVF=H4=54KDG$ MNCA!67W%%AJIMA7MYD^FS!;!AS)S]2*(X>\I&N\]'6Y/:UZ:4CM);I0W)G(L M$);0HB"M![9*U?U?]R%?==4Q;#%IU42,KD];-0OCIV_+8IU]?1'D65(,<7ZV MK4S6A?4<1GY)[\3EEQQ*O'@%!'8\<*=G!X2?+,#C,W*Y$BC,YLK/Q._*CX;Q M68D%??\0,*7C,.4V3+E:)P4/`0=<\J$3#@=)\O<)W+Q/4C)JOGN$"0^-7WTZ MLF&+B-+;(T1QF.!8AF,9.T>4@V`93JET2N4>;K`IJ4Y[M_]-YSHU#L,W(=J: ML$&'X0[#'88[#'<8OK\;=!CN,+QY9E<#*@+=9G25`4E8I7X2I.,E70^?4")^ M$[:W_UF#&]SJ$@;5]ULGY_#O;/]/^*(>NJ?M@%9S\[W_R0=HAXR MHK9/_2Y6#>@X3&WZ]IXZIG;]TY.^WVOW#_(H]\LTV>Y]T$41B;VKHVY"<8B' M7@,W[("_/0#VM28*B.)6SV^?[DP4-\N[Z+#^26!]S^_VP5PZ[SBL=UC_9+"^ MW?$[O9[?.6U^I3:']@[M-X7VYZ#>G/EG_8?$]1W,H3?$AMON]1+FA^OTVL;; MZ[LTXKI`X)B)C_/O_H@W>)M^5]_4/>'2(/?5)J_>V_[92<_O]P_`N;5%=<`1 MBR,6^!MTYVX;S$9W#>R(Q1'+K?Z5UEG7/SD]=<3BB,41RVW$TCMO^:?=G=FG M[H[Q6]\Q8FDPC%T-QJX1S-TJHXX_XOOC)?FEU4KOE>F*(O=8"#_X@O6Z98SUZ+DX?66&5`R%O!:A[^4S MK%F_22;0;578@!<&<^4%HTQP17`1AZ:I!Y>4]XMBX47E?_@!OIMBKQ`J*ZX2 MLSOJ2Z8KX9L-85WK-4-@)Q#)X(X"E5F%R(^]BTKWC[+)2)*G5+V_+(?/_4U& MP-.]S^)KH+R;)/TB4O4]'8*(%;+ M@U36/1%!E$V&N-SX-T'G'@)@D:H8,"G`P213V24@\7"#UR\NHS5I@WO)7 M=6O!+F\W@,K8M&4L8L$]W@B>MZV-85J^70.HGKD@-]>%8$<;>`LTJ,\J2"4U M`.36$8`O>%!R.HL$8G71V>>VDS>H2&B:WSX77ST48_VJR&"MT)XO^02 M&Y/$@KH>8B/(9]2,D:DZ4$D<4&E\ZBY)#1.+UD.Q9@TXTPB&&A=#244=/X+9 M#%0!?/_8N\J0S`".'X(4WFECGX16W[=8Q6W,`9^W=U1LX[($%*[Z70'%M\%0 M1C*;5S>JO.FV'03)5B<1=CM))EE6E(4LWH?J,],6I\!10+P7'IX M!+PB2=5+X&\WP*520"5FPM/@JYSF4RVS4;HL#&*:P0Q%F*?"$C8@1_`0L9=E M$`V1O1?-,)="(*Z-#4A@[3Q!SKH$LU")D*[=RJXV<#5)\@@4"VH&%HRQPTG1 M;LP6??;!4N>@4&,S/"G3\`B%Z!Q$Z1R1#T9C?/TKERD\AT(6.9-@G-1]DV!" MU/A0(4FB?$'^?WCSJ4*-A*+8Z35CG@'J`0Z,DX!"A3_/;&98H+?A5\?>6Y30 M_Q/$7*.^U3K#]W\#$3P=P)LE.RK;0(77%[_:D/&U"DQ"*E&2W@35C%Z$]:*.L5&MV#NOJL7?F=9Y6F+J M-D^H$Z%,J6ZITA(/M58ZB!`?D$/4[/,T@X>&W)HJGTV2B("&VIO$HD(P>BEU M&4 M*[+@8&M#8`()=4`,\E!FI5G&:XUM901.4.%Q,'D4NYC"$"3GDQB$%QIWN(]( MH&6RT2[2O9;?:E5QSO<&H$.1.84]G!CR-^*Z]KX+G@P(R%'HQ/`"]P*H*O70MQ0UJ'"D=6EB:5Z!M'\&> M8"ZSB_H3R]?/G@I:7(U!OP]NJ-&F6*3]0KT#A@.R*97(Z:-DR"`O^W;S'J0J M=NATH1UMX`)0,>->G('Z8J0X&R=7.6S$)5BF8-N*\CW&8?)JA&(F8JWN@^(Q!WD0C[/)W.AOQ]X?V$2O M\+B,8,$35!K-V-4!=JK*MQ"#`C]I4V[KW1+ M8&)1,$YM0<4`Q?Y@$M)YAPEMH+I+WU+XJ`>GAXY*H.[(TI='<(KJ5K!:%E8) MD-"1_\Z!XGNS*%>LV8(9XY,'$@7&5],9=:-Z8;M?\VAKG&9=B:1P9?*- MJG'M=G7N*?:_9?;#^OFQ]RYFF($=%,.>FUJ0I38-0\]#B;+0] M2/U?F0R-A]Z\B2^9$T*7;E;*:Q+Q2T^-ID,/<*JO/-B,\)X7+K`Y/?/#L7>9 MIX556HQ,J@LP>JV<@J8E8I``K,D8M.&Q:"KD"PL8IN5"L5(M_F-D%>O>&[`=EILT*TRPZIU@ M"#A/]F71X+Z"8.Q(I&7>CFMH+N)XU;$,`/3Q\,:9;?`9)LI^B/92.!",5;+" M9@#:0*^861N_IJHJ'VA+Z+$1H>5PT\8ES64A#=EYN#2T*Q4WK-:O*[X=9>", M$5/G9E9&U\(/`4^!Z8,`%\/<=J*L!L1Q*=@O8^]_\EAXI]3DN.O?!L(JTRR: MFB\SKA:TW(F(C!.E1EPW`3G6]2P^-EPG3X3E8M0$%C)R5#U0$2Z#)7W!F.$7 M1N`@KOQ8I7I*";OL2B_JPLZ8[5B]SY$[6*9!@1P\/H]. M#`MH9;-LO7>VA*N72Z\QO<(HTC*M_#D2Z1=$T`J/0T>0T'J0P7+&"XVK>I_L M:H/ME:[9=J]*)N:.WQ[-M&\?ICF)/V9@,#;&G\`ROPD_)8T%&T1GQ%R7H(?N M&JX?@:\KPFM!K*3Z#$H6@+%:YL(0MY^D*N'*['W1OA<9LP&!Y5]?(+Z"&RWB=P5:!92+.&TV!P%#VRTN M;T]:"YX%@/,P5^2"'B3H*@;:V2Q#]'MGIW[KO"I`G.]B1QMXDZ?&7XE!NR7! M&V85?$<7>%@40<(K8E]I;6T#T^6^D/*5C3+)AC ME`0!U8`KDL$`XUHD>V:ETN)3*)O7%=9$(6@&P?!+C9'::A=NO,)/R54;)AS* M4WILZ:3QW9IM3NY?K817%'!5Z-0UZ8`VF8Q5)H*P\C:,.UVMM=,="6L^BY;\ M73TXY243&K@I_EU:O2R.R#(8T2V29?"JK5B\!1`Q\D_$UA62<4?,:PZL>JC7 MF\J>+ZT]X\U`D%%LCQFA[DC"5Z9@%@Y669QUNYQ#10JY+\W"]:5^$2%;=P99 M2@::] ME4Y!7RI7<%%;TU7E>1I\$04KK:FLWG/M<5084J8Y"BOY$Q"Q,X*MW$%"C]4 M80]<89:4EZ*R\'A68--N&^#8&IBDNP;;U`3$P*.2E5M8&A59.>F<&G3\I%JD M$,0=]F0G^F+6OM`:`[QX5\ELEJ19'F,\'@8$<9`(AWLCW>#+C[LF7T%A5;E3 M,C)5`(5Y#^!J("G"9TKC([J4@`F0X@">98!2 M-.=X*J/XUA5#BUEB``._CBAHHB7@S*-L4GA`K*/$Q1,J+81,6RN.Q1A,`N:4 M'`A6$QPC<4/1B:3%UR0(\F$C^=BE'28$^*2&EN\HNM"Z-#.4JL.E3"B!3DU8 M=?^FCV-,`M>.!&N?.$UV9YJL,&13*IP2R4RI9"@#VT168CE-5JWBPAQ,QK'\ M+^'5$.-/17%/MSR[)<@HZ.QCH$"DQ!B\JJ.)-ZZ,MOS.2<\_/Z]GF[!27[/[ MVL1P-KN`WKG?KX6,F=G)<<$K^`LTPXQNKI"W7>1C]+IV"TGS?%%S7@'8[>C3 M9V?G_DF_NRL8=D_]DU[GD3#4./=+D$8ZKIM0SB3A(*,>1D`)L,>*6B@* MC>_'A$,,C2A&'!H6RGHK8(PY$4F-ZP&S5F])%W""OPN\RC?47+, MV0K_9Q[3)35G?^BP<*)D`KR^5M+QP8$)V!Q57BL-:HM)+*KEDM;!S!7^Z/#I M;#8007?1JP>P6*$3"_>S:P($,)QK`OL7\5@KS,!-@<2RG"68M'U=$1@(M`V, M-T>B`AX]SH.QJ%MH&O`@"Q=A;S(((G1ZT'VZ+`V`UKG9B7ZX$K".";``6?PN MG]']Z/I`0<`G+6`Z?&/;6ADRJ(U"L#[J(9!,513KN#[&MQJ6:&^\%K9O%KTT M7L_0O@9FY9ZB!!E8&<82#RA/2NDCTB%[&)=7:B$5IN"7$>LFD]8,ZVN'E![+ M<*\-XV^_BK\5MG.,Z?`*[7G,!WM(=*CMRM`XI#,1]!DPI,K,O#)]`O6-2A:? MSJZ1J>5/KG@N-#_GZ+<$D8M5&*HQB5,PEG3/*S9J4'M2-!VJ]F M5OJ>`M%+:=]H_",OKTFR,K1OB3JPR,1)-!`;-PY7^-!#(7@C,,-#K9UCK4Y1 MS%'DTM:208LP/RM9,TN2+_JPCKTK$_Q_!_1?Y+UV[&[IA*A%,7,`LS*^@V6, MB-WOY,8"!1HFD(J])<-44BPPCUD<<54^X!FN=(NM'F][T7TK8D(MD0H:"PD" M$]RB83.%04TE`3Y)@S(?`KI"Z)0"*RY]5%IA06]7X;&A:4BFH1+1-;)F&?27 MH9B^H\ZT4KK:&3YAYV68W,0F!)?3;HN,7)%-DC")DO&\XOPG27!GU:RJAQ9^ MWEE.<`064;O>M4,R5DDNA`QE'&G8`)1T`HT=06PS9&N&RC4#VX.%6D'(7ZIX MZ-A=%U-I(@&LY!M2&2O.Q>%^KL&MXF&EY90)B/`;G%/A7S:/D_]25)/UHX12FV&9 MN153PF$.4@>^.<]@$SV#U:Q;72/&%(;1&BC]A,EP.NN#=2O*YV1KI=VZ@TC1 M>6RFB`/J`V-RD7_K'-9XOR2E`-WK-/6+!>PU&D2(UIH6:_3D'D$W/12!*%/R($YN#9/4\ITIZH^ ME7/%4CHUQ<94AG%5#.Y3)^RN!<)P%1+_^HC:HS*1MF^2?)!A1OZ%/DY:NG35 MVIJP@>(*46<**I3L>-\'+',&.L*0S%DT&;-,3&=T/Z_)M0A;"8'=DV:IJ4W9 M4:+#Y*BX;0THT"3,N7S6DA=KO,DWSDR*E`+F8L@8%-Y(4-4>ON]E6PZXZ4B` M9J83#A15;(B"FX7"5Z3SQ$E\!-P1=)T8-CF4Z3"?H@&(YD_"=0!$I.W.HN@* M#V7,)(IH!_!8P`+P7"/8YQ:'+6RHH.!'',.2@4H*7,\J!I-Q=CHFMV@%2WP= MBAGS439DP61-AL#V'`MK6NF]P"Z*2/S-8G7?H`0?^M+,$HQ1B)?O^/C`\ENO MN.M#OWZ%<8>&<1LY[#^DRE^WU>1B?'N*@WM/1!=+U5X3:L15$,T/JEK-S"YJ M5+&;+W2=CT$0$4:K"1;#0"L7XX2",>O"[")7*RT0RNPP>,7>HX(T,'`3=7B+ M;+0R;XJQS)>.&0HQI?L="V$=ZNV0?Q?GIUA-(%LBL'K*((-B/FSCH59'%A&, MKB')<5+DIEF3V.-2"C#YZT$/$DMY/>E%VO;3[F/#NLD=0IYS-:EP7?TX:''D MQ$8F65^^638Z#"5J?1P;C'>\BNM^LE;"%Z])=0M:`-5#0\C*(O"-`XP/7@8S MG2/-\Q`59#)"4W#">EV@=-@%QZ%4Q"%5-P*TDF%.3K9B+URUS(1(.%K:(2V- MDB'E`\BRBNT`BP^BNT(:=LT!#\9CD`I;A[9L!2S6^=5#OVLRPTLBOMD)L"1/ M"I]*/;RJ#W$T.E8O0A6A[HW50*8TQ4JQ, M;$=E_XXX=D@<5@D:X\+#(R6%=B`X])FN.9CE(_&($5X\$$OGN'L.^UB*V@$& M0A-#K%\B7%EWC:Q?FUO7144*WI7Q?RA,61?'K;HN<<4REBAYHB)J8MG-"3ZH MZ^18.G?E8I2,:VV+HYO1^@'#U5F_K^)O+6:#U3?2R339<_(_ASK#N$5!8,Y_ MJ=9UA;W>$-EFJZ]OZAD;N(%5JZZL[OM*OJ!U"H?X07W;H&;:Y#V==. M:Y)`4-L$IBE!%0F+.[WB:A(1:[%VI^7-8,=)&6)@S17D`-:4N9F9T::;QHMUK?O?3HF:,HF(,N]F(DOXKPY3-O**)( MS8(AT`&]AY]GB$K\N1@_+?X*BY79?Z;EGZ;MQC]_S-71.`AF+SZQ'_P3:U"( M%1_)?_49&-*K*!E^^>GO?_O[WSSOG^8%`(LVV6`='],D3O!FAP0?OUE[G[., MOF:?Q.A?SSZVSO]LM?_$B^3/2:OS9Z>/?Y\\\V0(N`2R5(9_=L_[SWZJG=2# MV;'W;).B8L-B#18UP#\^43%IKP2K5X4KG=W`N[*:XB$^1'8LUS_88\9T7SYC^%0XE_+%NQB$*)FR[^)/(HA^)IBHBSC\ M+8'_?^0,W<=SJO,]XU2#)`KO?(M'H/(TK/:4>\[RK)KFUJ_HX$&^:8.'< M#6?:G_K=;BUHFZ,8T5A@A&!C.K#XCBRCL"EVU$J)3_6MQ&8K(1W7*F;;*3ILD&3X'),[&/TB7HR,CK,""^_)B!(\@:-_# M!^\K?94FN/E)ELU>_/CCS-[X M$)[]1(/_N#`Z?/_/'W$H^0+_2ZOX_P%02P,$%`````@`.F4X1\M@K1E&"@`` M$I8``!4`'`!D>6EI+3(P,34P,C(X7V-A;"YX;6Q55`D``\\G!%;/)P16=7@+ M``$$)0X```0Y`0``[5U?;]LX$G\_X+Z#UOOL.$YW[YJ@N863--T`26/$[N&` MPZ&@I;'-JTQZ22F)]W#??4G92BQ+%"G_J4?.OC2)RZ%FYCA M]PA"4L[.&^VCXX8'S.^VC]M&IIWXY/FWV8-H\.6[_[/V[W3X[:9\=__0?[W^=N_][ M'WM]K^D]/3T=!6J&*)GAR.<3K]G4SPDI^S8@$CS%&)/GC7$43<]:+3W^>2#" M(RY&K9/CXW>M=&!C/O+L6=+,Z*=WZ=AVZU]WMSU_#!/2I$Q&A/FO5'J:(KKV MZ>EI*_E?-532,YG0WW*?1(FJK'QYQA'ZKV8ZK*D_:K9/FN_:1\\R:"@=>-X' MP4-X@*&7,'`6S:9PWI!T,@TUX\EG8P'#\T8PHS11\_')R7M-_^,ED>,."_2/ MC[_%])&$P"+9\/2,7QYN,HP',T;\W[3R6_J_6R;:EF)J0[9NV*.:BPL*CKQD M"+;`0%\`D;&8]2+N?W-C885D"TQ<3P5>F&CGOA_>3W5,5ZBM882F M>7;([D;ZKCSI+@514?8ZY$^;LOXZS4YBP!5$A(:.3):0;R4B1""[9$8&>JQ; M'%BF>&'!)Z&OO4[Q=ZL>F&$%GB-@`00I,WJ>-8-R\BI7CPNYGWE$J),(+K+B M+IZ09`I#(@=)NA#+YHB0:4NKH05A)--/$L4TC]N+K.''Q<=?.U(FKX/YS"$9 M0)@\[^OJ@%07WYF]1V4,&HQK+GHJN^B!'PME)R!UQ(Z%4#9=QKP3^9)H2T!W M1%9*(OST2>K7',K9C&TQHB7CR229K4F5`Z;T0\$GQ5I>/)"O(T8L%4=\JI]& MPH;'10!"9>@J07\".AI'ZO=]P=@57`7[:-95UAZIA%$GBU,=CSY#&7SE9.AA M*V>_&*X3#'#-7VA]\@Q21690>;VR/2>'LU*B!\TJ03%N[S#@EJ2$<_&]B9'["@,RCWHW M)`6E,0^5BJ1.UZ)9B;G82?=C]DM\N7&/PL1=@5BU^HP5T-0-+I,@RR4^ M.U:%HVN%4J$$B!>4EV1*(Q+>`I%P/PCI:-XC8(?*1E@KU&S"(%Z+&EAWJD@X MT.*"L2)^]G(%BAB93W-OF!_&NLFSRT6B[R@2=!!'.JKTN:E]RHCSMAZ`RQ@J M+1"VI0+$9G1'&1>)8%:#R`]%`.UVW6#5`/(B(\YS*^U`6/8<#A/.(J$1^V97 MS07J332/6+;J9^%HE)"6[$+F)4#L<)=\,N',"9S\T%HADVW&!`&=,]8E-+AABRR\;"_&1%$KG(Q2(%XF.AYE^`S1_;!/ MGLOWTZK-5"]LJTJ'N/+YH)O[&00?B6`JI9)+LEW!D/JT;(G@0EPK9%T$0ETE M-9SFV4.Y5%G_\BD<\W9N=MS>NN&'-+)PNCP(@547*KB@X?V%9\2I]:L@UTI. M9=`19;%RP%<3OH`A%[#4"O[Q.1)$R4`9$;,;I2E9>N^E>] M(WL@'JD/BQ./MR"E\IA'JN]!N.;B@JAW_J#T)-Y69D=@2"7NL&H`6Q$9L<%< MQ>/)V&\ZKM/5".+U!$2\';O8$9'1J_`O M,:DLQRHEJQ&@Y8(@[O*Y@JD`G\XURX+.1!?@YN98@ELI58U@*Y4#\9YM8FXJ MA^?9][X]LMH($6"WC_6-12L[";SY:U+T)U\?(+FC(&')AJJ-``&:;I::`F(3 M"'$*E-I8AF/;63P32>V`LXN$.'E)F;:'S]S(V@-E<2T274+_@]@(8#$MK M5$8*!("Y;M`6<(]YJ9ZI3&S8EKK&7`B`=:K-K"&:.^K[+CZ:KN/;0R6R@!6' M%H92JKTUH)E8VG(S^-:?A,`G'H:1%]PYZMVC1J M?2?4-VGM0K&8*1/`?']E)_AO+*/%G8B;V$RU1R"PJRK^4\58JBD"<8#Y,Z]? M(X;J?>3UA1?F=4%0'BB5ZT9YN(+YS[)_,\S5_23:%PNYA] MD:"8>RDL=?R(/LX/,1?LDI>[X4838_#)-`#D)#^#L$G0IG%7=W(#Q9U-_$QES%Z8R+@ M0KV0`IU1JG32YMXF@H/%V"0PXE:,U/3NV1654RZ3\W_WP_F-C.T2<&V$!PNR M37#[N;G]N;!:S"L>V/SZ'W_6%T39J*]93:7ZPL0B*)5@7VV:@[6$:FJP'\'; M:X4ZL^2X8?F;PH_4B-+=0=T*3K4.6;!N0+%-]8;,Q::*8ALY16LC2]^W6LD@"KZG]4V@OR2W M:4<(*=;9*]PKP;U*^H807Q7=`'H;*>@KMS&OE2_DODKS#<">D]V`.XJ]P4+V M5VYUKHI\COQM@9\3WX`_BG-8!KU<4T:8OX-:G_/$"&QFA[4^9S4@+BL\J+?; M;%&:SWYOLM$HS"0(X-Z.*^0O>3*);*\*[B\;R%_\U_&5"P@(ND0D?]]!-.9E M>XWN4QPL]NXJJ(F;WW(VZH.8&&XW=_1\ZRP':Q"5M("YI&A0CU[CREVT"#E/ MC,!T=I@V.*L!\^NU]5]3HHQ7/11 M@9=/@DMY09,#`T7B;3@?`I_<(NR9NT365\I.7MJ;FX(.28+X44S"3ACR)_WM MN$D=4R:;W>5NL,N'_6E$536VZ8&?#RW-ZD"M7A+5_P%02P,$%`````@`.F4X M1XTK2ZUG,0``&2P#`!4`'`!D>6EI+3(P,34P,C(X7V1E9BYX;6Q55`D``\\G M!%;/)P16=7@+``$$)0X```0Y`0``[7U;<^,XLN;[1NQ_\-8\5Y=E6[YT3.^$ M?*MVC*ODL-TS.[&QP:!%2.(T1:I!TF7UB?/?-T'J+N)"$"!2]KS4Q2;`_/(# M@41F(O'7O[U-HH-70M,PB7_YU/GI\-,!B0=)$,:C7S[]]GS[^?S3P=_^]__\ M'W_]7Y\_'WPE,:%^1H*#E]G!M9_YS]0?_)XNVA]T?NK\='$`_SB\^/Q$II^/ M#CO=@__;Z?Q\U/GY\.3_'?Q7[]M_']P\/1]\/OCQX\=/`?20%3W\-$@F!Y\_ ML_=$8?S[BY^2`Q`L3G_Y-,ZRZ<]?OK#GWUYH]%-"1U^.#@^/ORP>_%0^^?-; M&FX\_>-X\6SGR__Y=O\T&).)_SF,T\R/!ZM6K)NJ=IV+BXLOQ6_AT33\.2W: MWR<#/RM4)97K@/L$^]_GQ6.?V8\^=XX^'W=^>DN#I5SP3)`M7[/>0?=+^29FR,I7=Q[Q6Z]U\B M`H,L]2,"PPYF(#97/9%!3L,L)*D.E,8O,3R8GD"=I!"G/^Q/V90+RM48\KQ^ M#(C[G63W29H^$'J53"9)_#2&<3I7BYJ@XAXLBUAK>"AU9$#@9TK\-*>SIRP9 M_*XCJ+`#`P(6_<)W3P)0Q)3$Z?I7KR:BI`O;0G8,2-FQ+V8MUM5Z,B#RK1_2 M?_A13OK#VS"&)2KTHSNPIVAA`Z2UQH%J7ZV)74OE-;NTN#PPRBD9`^OA*[D# MRWU"V%S5;*W@=FH`R"-Y)7$.C0?)*`YUQ[R\%Q,+2`+0XPPZ@,=&=W%&P-;) MM%80I9X,B-P;@$&>1XS0/AB-E,-DK4^U;I^MPZA%A6;79C[A#-B'[?6.!:G^ MO0IZ,&)M!SG,8K,G,BJF`K!]OY)D1/WI.!RL[>UJC9_:G;8/1-$LJ-]K^U!J M;GST^FY_06NXI:[_!IL0_71\&R4_FJ[2JVY,V*,A+*1#P!YG,$4F>3'3/,![ M=^<:1;.T3H'\G^O=+EV(89Q] M"<+)E_DS7_PH^B2%Q'%F+GR1S(O9+9`6O345"?[-/L\D_AR0H9]'F4$!*_HV M*&XR\4(F+X2:E'2SWZ9BCD$B.LA?R.>E"@P*6]E[4Y'C M).L9_986'2X%@Q$;EI/3/72W\2*8#4@]XXWQ%W1VJ.;@L/06G0]'V6UYO,A M32;J"IR_.%&3/T]!EF3*?L96H80&A/[R"6S>@2^AM#%7 MOX^2E`2_?,IH3MHA[YZ,_*@MS5=X7DUR<;[QK'>V;P1P8503<=8N M$;=A.O"C?Q&?WL)/9`;TUM/>^;Z240&DFHYS%W240T6=D+7GO8O]IF0+2C4I M%VU:0H]D%*89]>/LNS_AS555CWJ=PWWC@@N#LV4[;).(*X!"6;0\(&]_)S,A M$UO/@H6WGU14X>!PT6F'BZN45C?(MV%$Z!5( M-$JH^//8>-+KV/0I6?PX=E%P6&AIY[Q(]IQ-7I*(H_^-9[S.R;YI?E=^CLY; MVB_/I\DRNY*ELQ4IEFD_SUBV/A-5O$X(&GJ=O=M<*X+B4#:'"U"_;(8+;`01 M^`GVVA&$H9^^%+K.T\\CWY^R@=/]0J(L7?RD"*VNC:#YC[UE<%P42>`_['4; MSC`&).<%$ZH?]+HV;=/*.()$?9N#62#U1XD>=&V:K$JQ`P$)\K!!EVNI(@T: M=*T:I%HA`Z9#B>NZR[4]D88+ND=X@P5*^K8<*-!?"GII"LMG[X5MW0>98"G8 M?-#K.C1"M1:%"OFM1!&:4C'?,"HSLO6\UW5H?PIT+2*E"H*5@(,^-RSYL1<' M[*^;/_+PU8^*_-7LRJ=T!A9R<3I#P)52>Z_K,%`DIZ2:0G5D5D(7#3ZW,DLT M?20#`F*#D?*=9'/B3RHY$Q]#W#.04<+?^F-=U&$C496@'@)T821,BRL-BJZ$C M_Z*X;;Q3A\$L?8I$:.S$4?3Y>J!DZH?!S1L[B:O`5>7SWJG#2).W488-%>@'80V`FN-.!B46[C-J%/8*NNBFRP0[-RBA2:>Z<(]L;J M6S!51'9"-DUFOF1*:#9[B/SR5`'L/J;,&R`V(43-O--]VCQ+D8@C-BYL"W;X M\=E_(^N;#97/3M+2.T6S<5;@304,ASIG_H]B.U$B5"*L\GGO%,WV6($F/@0. M.>X\&8604L/".T6S85)V#18R<_3MS`-Q'_HO852LD3#M%B'S<1*!4"F;@K.9 M@N]6M0OOU&%JII:?O18R#K/.W!!KPJO[X?F-O#,$^]]:A$@YK4+(B=@Z\V$L MW&#S`^SJ+L'-!MX9@EVQ1/5B/V`%'@Y7SOP7("K-2;`+4TQ7=1L/@]-6ES$! M)`YISAP:Z^4AY'15/.V=(7!N:!'%`\.AR)F?X\J?AID?W1,_)?V7*!R5Q3CE M;(D;>F<(?!M:Q"G@XG#HS,-1:U*LFCH0>#.TN.)@X?#CS)^Q)N9JAUC/8-QM MYYTA\&68M1DY(#ET.LSQJ)PAE/P=TK;>&8+-MYR36G/G%CH.G\[<(FMHU3Y& M[PS!9MOLIU=`XA#CS'_"CAJ$V:("X$:52=$GQF_EG;^/?;8,(H=(9^Z279!W M\2#*@Z+R'BWTGV4T?,DS9BX_)]5U:1563+,O\LYQ;>QUAXL%K7"RPIVY'A@.0^Y. MV@1!6`KSX(?!73S?5(G\W-4M/*L%`FU2)0+$H]?PNC/WD,R)UB`#S[MX'TY")9P< M7CLH:OMLWI2SAX5^.N[,6=U*/YWCUJ\,D"F0-[GMROU1BOUTCFWZ;)I4^REH MV"2,"V"OZOUTCJWZ7O3N"#@6E'5;EWNO2OZ`Q'AK_BBJ'&_5GRA*?K`5]C:A MUTG^D@WS:+<.A$(F;IU^0",HG!]UEA<-@,BJ"FV&EL"6ZM-"!4'A*G\@M*CV MJ!QHXW4`V%%X2NJ06P<9LGI$FZ*7!3M[>39.:/CGRN:6LKG=$+"B\*GHLUB- M"%GIH2J1[](TK\U**RP4KM@2T"/P,S;G;@82L MP-!:$%]C#51H#:A1Y!;5(5(9%K8J13O%JI76/D$K@(DB=TB3O6HXV&H5[0@L M7?,X+0`>BFR51FRM0\%6L:AF:7R59@`41=I*(\YV\&`K;[21#%7*K)H'5C[M M=2_V;B+DPA"7+&HGK''IIV':'X+-E`*>XN#,UHWJM2(:NW>]LY]X%6\1!2ND M;;S.F<8RP1'N:3`F01Z1_K#BE=S[C-5:>AVK54VJ+S=6T]Z6?[`.G@\3P;!: MWD3MKN,ZO"B$-/AE3;"&-.P6*=$+:>S&LZOEWJ^0QMDAXI"&FLHMA#0XJ\95 M0J<)!3N@/QR&`W*5I)4UKKC/>IW.B.0PH:D?D5X<+.[Z6I:1M&#MK&18O49J[@@;`1D:KJD:X@G-'&X#$,OFIHEO MW2@HJV+D2G#@L6H,)-1\)KW$X_['WZ]\KR%K]$J3&D#P@_BPVF=@6'EG6QXX5]DC\B$4& MO@(>=@A+Z!64M/4Z+NMMZ-DG-<$)TSW:SX=>3A*PF>C#HE[6W]G'7.@C=V5[ M=7.ACZQ>Z5LW%[I0H,0@6Y,;C\UMUY-XU'%N28MHD#L."P![Y3@\ZKBU@;E: ME'BQ"KGWRG$($N,P6ANH'&TN]*]@`&3C*Y^2/AWY^_)!2$?21%E8*YS`*FJAL`-@09FF+- M5[,EPH,L([IZOOA&`K8+?\JGTZ@\OWI-\U$J9U*G.]`+@@1.'9[UT2++LIY7 MC4FSE0+FNUUAVIFH&>!$D,^DPZH<%;(4ZVLRI600%H,/9.Y-6'&!5];0+:`O MKX;(0?15-/B2)6&2MS36:&4VN7V++X5U(S`W5)OX%A7![:; M;I=`YM_&)8F!):6;NC=;`#P$;A@=MCE0L-U<^T`3D$VR15P]!"#V;F>X+3VV M:V?!-EM-$`WKG-;N"U2R?QM&/9#8KK#=@*'**4!!L+5LP%<)`-O-M(OJY(OR M%0J^&%X3`(A@"UF/(3$6;'?4;DO+3DL-6)PJC/),6!="TM([0EJ+I09UE9"P MW5#[3Q*.QB!=[Q4,X!'YGC.-](<%@+5:">K$ZG4(RMD[Z[()4FP7X9:K0F]2 ME$7<7,@?R93%ON+1/!\L3%E&:4Z54F<:]0NJ0A`]U-ER-`(LOE6WG=1U,!28 MB?!07`'#*JBP03T_!VKD`*ADLKR7G055;>\==37VWGI""T^(JK0%8=T<%JVG MS8HXA3JZ#Y/.WG6>SEZ3F2U:>9CV*\.]BS##O:N0;MW=NPSW+N8,=S65H\UP MEWS$&GMD3@^@!8=;YL9KD19:9`GJ\A"%LMVMTHEW=(H@>EN+,-W0SB9D9+GN M](;`)=C6R%+5 M![+\?\U(RBF"_&,SS%8`0Y;D+UEJB]2:>DX^S1Y!.P@BV`8LCT;XL9TC0!,0 M.$40#6_$K-FHP2D_\=I9W-QB^.\,@15I?VHH<6([%[&Y$FZGQNWFPP&X+5RJ MD7O#;X*OQ&%*AC'OA16MB`]MN(\J:547-727'IAZ`5-<^$I69:5NWMC>C@2E M-3B9YF7UU_YPFV)1K,KT*V#"<%=]:5EBNR$::?4FHR\"E=F,(@NK/YFEO7JV ML*$M/$&Z)F`Y*2YK65R9_0POEY1\56D.RK*Y<:U7L\K",*@> M<.J:059`5B:XM"BI6@>`W>J^5KFTK#I1>D2OPT56'F26J`&.<%F8 M!LE":T(^Y2\I^2,'D#>OK`RTW%W`:0$HG7L(FDV((ES(,N-_:>4B%H7M!*QC0#C-ZZF[RE`$A2^#:D/>FG3+H)*T^S?K.XDXN!YOD* MFP+U*/7C46'P7\Y6CSSX,_:CW@^?"@]KFNO<.[IPMHE;6<]2'"D/B'K4N^$[ M0%$V5T_Q=4>&:):%NHVH"(_[SO)1U`N;R72:46HC#&YY;7G8]^O(ZH758PYZ M1U8O=B^ZKI1[OXZL7ASAV"%YKN2E!&H-.U7.@R1]J&<<%[%V@60^41 MNXNI':5A\PDV1/D5'LS2N_B!T#`)OE+QL28+;P.M(C@6"X58G$2D[X;-([@;!?N*4U1B<@\R@9MBJUSUN MK(`%1N<#NY8@0`:"T\3(Q[:&1K$=1[=N4.GI#R/,SC0YO.(Z/1;!.TRD/< MA4+V*L1]?&BU3(M6B+O0HB3>6LB]5R%ND!AOB%M1Y7L6XM;^Z&4G3,R_#;1K MTXN)?"ZUKMB]"(5KFCWR\QGFWP86EE4?I?J)'%LCQO@`%:L26WC\/0Q0',OM M^QJI%HX[<8H=%"_NQX1[<*GB*9`0K7O9P"2Q9:#Q\!N+1(N8>?Z1*#"S?`HD M0^O[M,C,%OZ]"*UJJF-1/G]'!+?AU#'_ M#7,#.%H;=B4`]:/-']N[M8&G7O0Q68WS4 M>C4]TS3KQ4QKJ@A/>+1!9=,"D[P8U<9S`-]Y33Y+G%8/G`KTR.KVZ8-?88L# MMBI^]R>ZGLYFKP.]XJ@=6,&VZ0Q)F1:051Q\)Z,+ER/=^3"S$`7G>%K_17P* M/^V41^GB`<@7OA(FD=CW*FL'*/;A)*OV-%#ACE53B;$XL9#0PT,]0OGM0/I] M.$]JGE"92K#%58U5,ST^LNFSPV=*"O6`[YNR("2M. MX,?"`T.U^P)UHG4GF_(':2H%98"PP5FE-6>W];I(.^_RCH_1IKH8\SO:4=I^ MA-H48&[<6)SV7OTP8ECA\RN.1]L8CI)7@H+1IODX'Y5*NL-V`W$O^'>>9H7M M_IST@B`L)7OPP^`N7I_]=P+ICV`YA&F8D2=8%,(!*<]O/I)!,BI'1%$76.0[ MM_QJ4+A5RQK#8&U'A^(;C1WJVW@DJ?A\5$`7#U++R../3G*.VGOSKQ<]D`+@UPEIY M+ZAO'QS%6F.O105RQA^R\T=:]:3NXHR&<1H.9*NYM7=ZG0[>#"[G1J>B]C@C M]+3-!*U;/Z2%3/WA;1C[\2#TH[LXS6A>V"\.[V-82M9+4Y*QRB3WH?\21L7] MJ=^*JRY(T`>3:9!35ND2'H`Y@R[^"Z2$Z;U"MI;1]WC')\Y<<":`R!*WC+T# MYFB;L11AXI8%QJLG$,/:PI/#9;G$Q3&:8]F&&=PRAGC8]ZN:Q8G;4\E<+>XJ M>U?N_:IF<8+D>&T#E:.M9K'\TB]GRW_^&A(*:AG/[LDKB21)`VH=@`[0W$9C M=7+340NRBA%+>>>Z*"SB71#2>'6M?D`3;B_`T2%.0KTZ;F2I0\Y&`(YYWN%0 M0'O%ZU+HNW@*^_L"?4=ZT:N@%:!%$!'1^%8E3/.0(DM`JI+W2(O/HR5*!*$# MJWQN($66B%0E[[$6G\=+E`C<\5;YW$"*+6-H;?%9PWY+BQRY`<^O4*,UP+:9 MQXW:)!?K!%O23M5'L!1;RPC;:@VPK=8LT3&^Q12IFUN54+%EOK3",%KCVB+5 M,GO:7=Y(Y&TMF*M6PI_W68LD@$ M0.B]I$55%E$^FJRM=]Q%<'-/:R$E17U@2WY83[Q\\B/RQ)`7RA%QSVT$(!$D M8BMRP2%2`FY_D@,E+:S!$XE7M&S6CKP^0(=&TZ M95SMV;N[QZYYV/Z-CY8CT$5RLY'#H;!7.0(-8\JGF)Q< MZM^J1DSYE.N^W">ID_,O2[%4'%2[#WO'9^Z* M^BRDD=8!WG@01+:YJ1<7\^4HL'IP5\G]83PO9VBR):IH4'"?G'$W]5C=)V=N MLQ*X6I3MY<^X&S:L[I,S)-D!#52.UGWR0)-AF!7K*7])6#T$6#`<,:ZU,&Q+ MC\Q;T<_&A')LG.\DZP^?_;?R##W\G((U2*Y)^;="J+YYY][Q.8)M3CW&3:%& MYM40P>*'KE>5;Q;0-<=+G5>`_A!LK$R-@_JCK+ZND+E+5%37<-X!W`@.6;@; M(YMZ0.9>J9!Y(2_\+\J9'^$AH05964;#ESQCP_TY^9[$;%<%%$1EC0U"B=`Q M8_A-H$T$1SWJK5=65(#L#`@`6IL>FPV9VGV!1A"<%ZDW*#1!8CLJ(AC;>I," MP,10XM_4!U["$9_J:,?_^DA>29R3M2MF#S3KV.ITS=Y?I+*\9F$OXE.1T0-)J2.K7OBGW!D/6 MIA-`Z!,VPAO'@:RKB0_C9;ZPZ0G0O&JC)E<*KN@+[LX?JROZPFKBO9XK^F+W M-OA*N??+%7W10>R*5E,Y6E?T(XE8Z/?!I]GLF?IQ"GMK5K+Q%E*9H[3X,F'!<%%27!CF9ZP"1.:<-D(9C:FV#/;19 M=+FYO?0C=FW-TYB0#"SK5=W\->/Z<@;_F2:I'WVE23Y-EQXK]@Q8OB%, M9T$?)L-B[DHE\W<[`@`'>!(FS,[];2H0F<^Z%@JEBV0U>V3;3!Q7$; MT>S3WMJIRL":JWO$H>7!3_V`Q+X:+]5/,UD1!">,$R-$BZU>46\PH(!P+8?^ M*J>4W0-1Y,T/RO\(YF2U#KR30P3?H$5_>!TU8"M@M(B)/O@SIH4K*>?5#0"< MU2Q?YQR+8&,K6<3BX%?%_#5BU9D>2'&+RU7DAY-4>N^HO+%WTD&0Z&B1:U45 MF*M3Q%EI%_<_7ODI26_#B`3?DF(IXBVVW`8@,()D'PNU5NH!7.@-%P-G(^[)44(&(4D<)A*KZX M3]`$U'"*($'4UM9J`E.NO! M)A"FBJNQ3TI,DYW^P"DT9"@3EEFW1J:X!#H\:CBJ5 MC_0N_N2OZ=!T4FL.#(BYF.F3[?IW/+J'XX(\2=+Z' M6JTA0X"@_+:U"5X1/X=!#9^8VC=>KBTL=8<-N;N834O]X2K8/7?8?87Y*"-< M)TBC3AER!&>M6_JVM73#&17F'%^+H\%W\2)"RD1FAX/9YC"*DA]L/>+1K]:: M87G'%GDM)7`(-><96PVHQ?A3)5/>DF%XS[:XJ@(X))ISB,D#7M_)R&>>NFC6 M&PZ9!Y;M\P?)*Z&S]4E%R6UBYVU,5^_8G+>J-,[1(G.NMHW-"//\]J?3A&8Y MT#-[3FY2=EP[3,=7-`0S,_25MGGR;@`=AI(\K>SPE+7!X=K9I1[W0,>HT,@3 MR;+RY"?7BR-OQ%"^3_->&3N'X:,VC\A7%UYP?TS^6Q@G\#W,%A+=*YR`Y[;Q M3G3V2W:`R$ZO5S[OG72G1X'B7$`21HSGXK3S<<%-@. M;S/II/J-[^NOL_8D+3<3A= M)09=SC:W%>4C-8Q>Y3Y!4P@\R$9,Y)J8A2>5V]D[]@:#?)(7V;JBJJ#SS62] M723'/\5>D<3E+1JB=XJVBWH=>2?'YJ(KJF_G;1;K=P+BV]R.5.X@FRBZPHVF M@??#[#6/;>YXE(P_78H4-J#'_#`XTFW1L4U;7',#>KQSB5*UW/NU`3T^PF'J M-5`YV@WH73Q,Z*3P8%_.KF"9'R4L1'5-7K)Y]7=9[3+%'D`+-C=,+)&_L=0Y=)C^:V[/5AHRL]IJB=\/0-446WL;4BN"TL3+_G.%C33'(*K'Q MT*D@NR0PF1,;UZH9?#M3N\.3T^9GMO9TANT*%![RWV*0/F(K_:])Q/(>OP(C M3)_]>$T)-$Q9[:Z<7?5T8V>OSJ.# MK)O6M+&TW$E8;$)8W;'HY#5D4A3DJ67LV_^OQ-:6*N2;7&-7KR3 M4^='S75G+FVXR))F!?*OI%>Z/Z]F3]Z958>9^B:[-H.U!P(?/K+45:>#`V8E-PZF5^5\*#UEV*$=>Z0=V;U] M0/>2W5TV:I&X#@Y9TJ4U&G'-PK;XM'''K*%(5/Z2DC]RD/KF%?YXAO?)XE#5 M+0"FS>3`5B97(31L>7D5PDH_1VX;YOJR6IE6/08EXD"9M@U4V!+8S#.':Q8U M3J%T^G065=R26UI^I_)YAA%!VJKL,U)B;@,1MGMDJ^^\5;T<6J&U=V;W%*U: MTIU6G*,V2NN7Q:Y*/.OQ5K\3`(8@9U(_3*4!%MM5LL\L!S.GLR)#X6GL`XC> MH+A_K>H.#8563%L.3ZT8^2;E\,Q=\&JO"/;-VQ0L"%$"I*`5X#S9UV]3'9[X MWM=VDB#NXB!/,QAL97@Z!:Q?23*B_G0<#M9.PVN5*S-D=96B/1)6'KXHQ[V4 MZEXAM5BEN7=RYFY_,!B3((](?RB0]')!D"RK6*,W[\3J7EZ87*Q.#L<>U87[ M8=(WK/I.:V4+:W.U&_6N1+E?61UV;UW5R^HXW2G+62WW?F5UG)[A<)@T4#G: MK(ZE%_PR3V&^3M.E':%XO*&J'2!VGG-F>-*J@1M9"L=<0+G+ASL6@37>U4, M]`I?DQ`"NB2$C-"YO7X3A9,P+B9IJ;=>V`Z0(KB72TI6#2S(<@ZJKQQ[@#\! MPA.AK^&`S.\BE'[`"?2)[PT#OH#4$=<.:;IB-*0);:L/J M8-,M**WTU^7L=@`P]@J,:5D)H'SNV7\CZJMW0:\J.=\4UH7[H?QHEJ] MR-N^0^),[6R!'JAOP[3:`U'G-#<.3E2)FG,[\=5E5]U^[;0`ACNI&$@Z$.RP> M+)S.?G/$X9@Y[3%HN5K<8DT;)'D,>RU&Y/'B/XS#XS4.YS_V?OU[!5FK7X+4 M5@]6U=H-\SZ+32:VA4<6".#?(:=41T.EN=<]Q)-*+&CP3'U6PG\E M[^.\MO^BJ+^`7FE;0(PG/J?-K2),<32@M6L-TB0*`W;_PW)%2/M#SC40#SX; MEV.2L4G*B?]J64A/Q5NU\S`HWGVT3>IVVG@01+9I\HD]2AP%2NSR-;D_BFNH M>VC3D*BWVZJ@0>[U*0#LE=>G>^BV*B%7BQ(71"'W7GE]0&(<>Y<&*D?K]=G_ M>ZRZ'0SV>*VERIH:<-Q456W2^>GX-DI^N"G+U-1NO3-MNZ]B,2M2VVSKR M%*8UN3^,W=;!XR6OH$'!;NMP7=Y8[;:.6QL&_\[2HQIH^)X\$C)5!&!%0P=HU MXXFYK]?&Z[SN$0)/N-E18T]/R*ZGNB:PL1R$Y04Q<=";L#A"63Q%,(P$K0`E M@J,P]OBK'B]2A2`+?G[SZ>\D8]:[5G1,I3G@1E#GI>V!H*X99,'2HB#[I0_8 MF;,)S&39'%#=`+!9W3/A9%VD"VPGJ59^PNLPG29IP4U_6!Y4Z`@(%S<$L`@2 M5-HF7D4GV$Y;W2:4A*.XO$UC,'NF/HS7`1-O@6;E6Q8,ASK=@"(0;`';'ASU M-83MJ!8HAEW:0:Y)^?>:*J[\:9CYD<*>0[T34,*[VW_618_M;K!=^7N#(K,/ MS)H!"5\ED0:5YE[W&$'!V+I$J=+-PXOO6C&YY+"U*>*1JV]!=I:S0:]>%T-A MTO:&A5`-YNXILS5:%N4K`0:K!A*0.-"=(L1=P>>#((IO:URH8,=VW5D5"G:- M8D)AD:S)_+(=0$7@5K1'\Q90;'>?[8K\0,G4#P/Y!6BRI@#X'4_L55C%-Z)A M('>Q',VO6M1:T>=M`3("%Y#M=7L#+(=?EQ?=[XI-!V3)W@,_O7O[F#\8P[ND,-IPW\)/I M1'SN5:T#`(\@^&N8]AK(.;0[<^[M#MG:O*OU`/`=WE/>UO!]-M&/OQP)"%*.@,E((@(FC$0I2BY%#O MS`/X2*;S%:\__)YD1,$WQ&OB=;MX]X-28JII%F/ED.G,X_?,'!LYG3UER>#W M?_A13N9&3/#@T^+_WT@V3D0)'ZI=>)V.W7,S+MBN"9Y#OS.'X/I@O4_B$=NK MS!UD]\SCU7^)PI%TR:_1"WP%"+;V]KYX)?B<(UC8O(45ZC!C"RIV#,K"NUG4 M'"LF-,(9/LZ\A0P0;'C87VS3\PI;(18(*8Z5;[O0!8.E3C>@"`3;R7KV7WU\ M'**=^0:K$?1@1%,Z@X%:K'>U&=YJ#]`16`DFJ*T$QN'4F>/O*9].RR/P?K2H MK[!6+4QA]Z;8`\!'L+.O65>@#C0.LQJ^/('T;!X<0EZEJ MB_NXF9!@IHGS(+8>!E`.MS5-R:E&PZ'(F=]I,36PZJ+PSY7[-`XJS.?K,&45 M7')*%):PIEV#PA!$,^O;+,TQ4H?*Y&61.&`J:3![4<" M^F*R)E[G\$+##Z`L&Z^`F.AQ[_34II%9649,44\5QJ00!)Z:8M@NWSX]H73A6BIDY(`9'D3/S#*&M?;9* MR'N&5TFFOMV'`9O-_9[5^8Z'!EF-LDTQKV!$CA(ZKYVC<"NWK#%@MGI.07DZ MY-&A0AX?&+)R9BV0B6L*M<&JY=N)L%S[=GIF,_[3CBE9#0I9L2^SUX.=GEOU MKM'>95G MR1I22O),X)*Y4\*ON<)\88R8CY M2I,TG;\B95GU25QD'^5^U(NBY()#E[AC@")?I8I`L"VD\G+7S M5["&LO&53TF?COQX'@-_@#\!R!.AK^&`S">/8B*Y#"/H=,0U`W3[@[G'X6DU MDZMI,PT82PIJSG<5_J(:=EILY6\3>ND'U^2ELCJ=O9>!GAR>H7,T4NJJ!UDZ M4@VD]R1-B]/Z;-(5CS&#O<.DZ_H\6?-!95P?QM*>[$Q&#V`+LT.L(^YNSM@+ M0!\.#YPAFG2V52),L6K'.[)>]*G)@2%3%WF^9'=Q"CO:C9.!@NF+T\([/W%F MFV^*Q'.8")X&X6W&'2I=(DKZK)XQN0C>@X-C$YS$L['[,"C">>J]E"<56E=@ MD'DK-L5D7FGI?IC7!/#A"/;P5*]"U#8<9(X+PW3A@YSO"JJN^+Q>%/O@4%"4`:I+FNU`=K>/J\+L12NK&^G\G%M-0&A M,10';O(M52.JOT7]ZQ?VGA<_)84R_C]02P,$%`````@`.F4X1_GB),G`4``` MG84$`!4`'`!D>6EI+3(P,34P,C(X7VQA8BYX;6Q55`D``\\G!%;/)P16=7@+ M``$$)0X```0Y`0``[7U;<^0VLN;[1NQ_P'HF3M@1I79?/+.V9^:K%RR\03L)T%26;OWSQT_W[LV^_0/_Q[__]O_WY M?YR=H1]P@K.@P"OT<$!O@R*XSX+P4U[2HU@ARC(A@2?Z7+QZ+8O?]UU]#^^>'+'Z19INO7[]\^>;KLN$7K.7WSWETU/KS MF[+MJZ__]X?KN_`1;X.S*,F+(`EK*F#31_?JN^^^^YK^E33-H^]S2G^=AD%! MATHI%Q*V@'^=EI=,DS@-K5]R>^*("M&R-ZDMRG]?5H$\2"Y MFY0V)?Z(AXUS36=U?(G3Q,/&MT$YM<1%5UKC0>V,9@S_OB8R'$F'GPNYL M5(]E"AY,9")S'J&$J1TG9S_=??'O)1DB=(@1H@8E^KFD_:\_L_Y;2IUGQY\@ MR,)20O*C0BO>XNLP)1/RKC@[4G"=I5OC,>>BI,8#T_Q8.JCB.E%]^@GTI3^R[=[3[#%TRU',CXGV4AT'\=QQD[\EO M1/&&L+435'1E%N*"-470%M'&?B!#,.I]V)`.N1UT,'CJX^.HO4.$',NMP@AW M(=ZAI&?TQ3@1#OU<2&$QZ"W>1+"43HJ/P58TL?0WM8H/@;1M:/"U0-T.04.W MH)`-=!,/ZE&>%PJ7!(M9$%\E*_S\5WR08J'3U@$8NO(*T,`;(MH2D:8^X$$P MVEU`2(=Z+D1<[K/L:`J31Y[BYE9Q(9&Z#0W>]"C,\",&50U]$R%ZXSZOVW@? MQ3B[))UNTDSN-%HM';B,MJP"AT&;H;*=#]ZB=Y"[OD(RPG.!X#X+(.7@[K!] M2#N#SW5HM;'ZX=ORM3\Y_SMB#=Q^Z]ZQ;'YER4#.'!NDVVV:W!5I^.GN,2#? M:+DO(!T#I)$'"E)"%U!-1"$&I$"5;($:(&I0^^`B=;]037FA_H!%GMK_H:"IN%Z^*__\9:$-G&:[S.\7'=DVZ;[I+C'S\4%D>!3#Y@& M<;$&L6$Z=G9#*FJ4KE$'AHP!^AE8(,K#(1Y'?-42I:,_J3WL7@;YXWFR@O^] M^V4?/04QB=5SB>_3);2.4*4FG>45:4DS4^@/#1HOW*+9!VHCS^3KN`9;;24Z M;M*`AR<0[->O%XU!'QH;SM,O#VG\.?50JOR6]@![E3SAO-A2J?`#S?(BPG2I@)P110=]=C M35_228+UBAEDESZA%2.;$LL0Y]QD%; M'X':LZE$\4GZ4*GU/9P"2]?AB\E\@);*\7:QY9W#5'T7#7B-<%R"?=*? M>?-I,"([51T+$`_MY:(IM6GBP"#._EJ,<"SD"09BD^%Y46=MH_%J6I@(*H/M M1@97'W_O;B9UW\=VX#FO MHP1?D1_[;OS*&KOSH$V))7X)FB':S@]7.I783GQJ!R5"ORJ`B#UDLWP!C7"T MW=`ZHCN2=JJ=T`;*2-(.D#6E=0_:?@"T`2O[^K;!RN]E:F.VT]X1=+MR]V-B M@%W`+`-./<2E:7&>7098=HF3SMR#>RY9P MFO2>9)IW]=+.,E^@H$`E-:+D"T1+[;JUF=&*AO`#KDEG4F?7J:8\DTH%>L"; M*$G@,Z5KQ/J=5:FZO/5L*F'RH13*N+_8(/`:FE=O9"[#XM0?AG#M++_%(2:B M/<3X(RZXKY9%`%(R^X&`7(M./,";H[K]`A&**D+PPM,-52IK*)7@`NPHB./T M,[Q#D--_[799^DS39^(#^OVKUW]8_,_OOEN\?/F2.LC?O_K#-XM7;U[#+]R; MG@Y`.Q&'-CKM&QKQ!,OB$6>U;+F1Q2GHG9F>2B\A7`%RE+)AC?FQ.?IAAX,U M;!ID"AS\L2HM-(K,RP"*#M+7B2@2AV@16Y_&:"G52=&+LG. MUFEVEA/"QLUF$OQ4M%[$0`.5;-[J#CH*.SU-&Z;011##9@("LT3;^FYZ7I&[ M=Q`F9M99X!C;F,W9,MWAK#C($M`] M@XK$PAI)0($H27/Q6!.Y73\.U*<(GCU;1VJ!K+N: M-$"8/9.A^Y(L\4#+4`3MK9N'2.XVB-B&.<_,\L,2S$0//$G3D@*E#78-E-A. MVI*M%'D#1VE9?:L]GH6I<[,;33V+[W82)-2^+@F\B#16`TGB8%X MDG)](UX1@;/LI7O4RQ$C2L>1P<4JVK,] M7G7-4`YX$8T+S`OE[T$.M$7-8,,/Y!NKT'#[3A=F!J+SM9JN`I8-6&X$/3:L M8P'VS/AC6F#]&:NWM773[9>YZ1@G52#I[ M#=?@.Z9!@C=0$V8:':YQGG^/6IJXMUH)YMOVJ@2\S1MMNP@\*PYRO'R(HPVM MX:,QZZH('=QA4VC2O2U$"1"E0`T2'V9AK#KWH72 MQYS+30NCS0HO-BDT-R<\V'PW".["[J:$>^3K1W7^A',-2>J3*[.=N3XZE[CO MU4.V#5P3^+>]K:4,:7368Q%^;=.)X26Q#A6VG$=36DD$&K2^Q%32$WIQ6.5' MIL$0G:[39'-&N&]/.[Q2YR@8@M#)%*0WX;B=7E3QE$]AE#!^\C5NTI@2G$T` MZ78;L61]*-J0)D64;'`2RF$KI;+O]*4Z=-Q]W9J]?MML[]3/#U:#UGE1JV'5 MH:MQU7'ENJ"R6;"QG7!PE83Q'E[(NV'SZGE19-'#GEX(N4]AVB%RDX$BHFS* MJX=:59JG[HNM+JQXIH]D%C3#U8 M,.4,#`W;5_.4/5IR2(+P%Y0W:/[M=V^^^Q-/Q?/2 M!LWMR;5MW!!>F*SK6"J@JGIA;VL7%^=[9.ZY<\Y:\9>::#O'E^6-Q*;(7Z#? MOWCY"NV"##T!Q9_0'Z"N%BVVE/:1;]BE<+E*0)1E&>0T9#FJ%T M7^0%"6:),W9O+A*H]5RXE^/,[GHN3;2LH]O4R*;5]\N_OCZC^5?N7G`&N_5F\6WWWZ[>/FJ(FU8#-21?(\? MLGV0'=#K;Q<($$+)SO>;/8EYW[RBO_O&O6F)0-JW(A0CU-%+ARJSZFOL]H5# M$5*/WP9+/[ZJ#$;7#FC)WS#-/;BZ+0:8]!%$MZ54 M5ROZ'%$0WP31ZBKA._$2RQ!2V,]Z%21BM6B)HBJX2Q!L[37D=(C_4!#J+ MDO(8R#WJ%0CJ)(WJP,=JYO=^NZ=/Q]&+LO"D7(8?<9)'3YC=$[]..T\@EUIH50R6S3 MU#FB3#RPPV%([DGJ'@YC>W9[BXL@2O#J79!!$?F\(?9;O(["2+;-ID-LW3JU M-&J#LR1")15JPI73N;2_<5IA3N7>NO3QUC8H4[#9LZ$/44(6K+"]SK;,)1;3 M;6K=/GJD;>.F;%*=$+E$OH:\-#>N<;`5S2NVP>L>&L*7]?2.UV.O73_B,5AR M#W941`;9=BER:SRU@_79#]2].#L;.#*S'J"[S`2;;818$IFL=(9-1SJ;FMR) MN7:W;O0[O:2'>9,=/$B/[2WL(G'M:E+ORA/UH%2C+)$GZ;:Z&G5R<$^J$I'( MS,S09L^`W@=11O?_WT9Y&*?YGD!!(T](3F;=DST^&`&O0>8&PIAZZ$`,:1(D\!5GGX^B@3/!E+,(L MS7"T2=A]T5`GTU%(81]:0MD[H&(M4=G4+X\E_P0=&.F,OS,`U=C6<++'MSA,-PD]I-9P9#(B!V=($@VZIRRT M,6JT]LJCJ3]']ZA%[UOH0&IUB"(*E)>O7W]+80*_Z>E"YJ'4)-8@HB&]%D"4 M7FBT!JLTW,/],7H'>!I-[A\Q(APCXD97M4>%-S."B+Y!7J0(GC4BB]TL(X28 MW:A]B\C-&P18J&<+5[(P/6,:D^A6O M*`O\'&QW\-(0[2'#Q3Y+X*GZZGWC!201@'Q/\'.&'X("?@!1Z^=FX_00Q,4! M'B[99,$V?^'.0G4MH;1/,S.P62]NX$4_[R[N&=\I&WJESFYILR'7Q_R\#M8^ MLC.+<+6HG9_(Z\6X(N1Y&^H:?#K50:U'P6Y/7A?4!]1!HYK4Q144E38]-SRZ MF8M`Y!G\=#]4S[4+@Z_D1:V*VCPTYF!#/C[5L^C5TZC"Q9&W]&C*'O1Q#4I( MJ+ZL9S#6]*9&C/P$LL+3:B+9-\<[X`L/`K-SI\S+\1/1+A]A_0NROLNR-+M, M,[*:I=6X-'RR&1M73T/H:BEX*QAP&>UN);' MGVLQ;[(T(3^&N+([)O=5TFP3$2O^?HIT=/9D)@<.A8S?/$&!+W%M`!ELM&I82,DL9^%*Y:^DU?+ MFJ*JK5=.7/49.EF%6M_`'8S,(F0M:N?@THN%NSCS-OXU^&@J_'D9Z=ZD<01A MN%%<0!Z/R;V$/4A=!'N7+=4NP`_NOCH/396`= M:MJ:=;/W"2$KQ^OOKG/J>[$V]Q'F;1KN_,_:B\D=8+9+_P8V%IR"&]:/^%*-)[^"I M!SV]NL\]Y(]LHP%^:)#Z#5NCS]A])<'X&UI,<`BR3YA>4KO#X3ZC5VV8:+*\ M!@F1_70&F0:=4@-58U2WYM!S.Q6,5\-O$U(#K9.%H8FR$6FA5\D39G/%57*+ M@_A=7D`.'['6YJ.+:G<]AIG=5-*A&K<16/.!JFS`"7%6]'#EZ.%3?4".UETK M"76J,6BDI^Z8@HTL5;*(BJI^Z(9Z!H.$^2#!''CTEJKKO-!1IG"4,3J!'=B; M_T#8A/`V6/:+2:S/?1+I^PR6-JUFB?FM47/J&Z*%WY.="E7MJ4X/4O:LXJ<< M+]?$;J,M6*[$%MH-K5M`1](V8GZ"9^76J&KB%NI:XJ8-3].VNB6@<3! MG>KE^GV4!$D8!?%5DA<9#1C4BQY->G=WK!5Z2>Y:$_NH2%&#UHN%T03ZI0+] M_#8N(\`*[YOKH]7EC4W]Z$N#UH/[F^I(IN>6GM]PU/YHZNN=GD0YD@P?TZ-` M;5X>%Y>4OU?9J]3?H)% M^*7RG6E#/O:S*@SU["1:E/2(,$`EAQ+E.:IY\.H.W''`XLTPZG\^38] MD+JR02I*?EZ]&*9M>UU"QS;7HXG*UA@)JFG\L2\C;;A==9Y_\\V01&"3&Y`< M:6X-YXH^IF=H-"61%P93::!I+*R];X:BH<6QD402-5P;R#&H=(RC#U%N#6-9 M/R1I:!U'E%Z8R+$NFG:R5+T]Z\Y8=/4YMAB/'],50D['=H1X<_+([H`UD1:U MRZ=X#=8*1Z_S>KL4&J7;R2R"#%`I>6C7M^5/0S2#M8^4RJ5M::P3CFS*JR7/ M(#W\7>QH0$MB*+XL/C`D8'9$H[\6#IDBR/$*ZOWA)*<)ZU3:Y8X5Y@F+Z"DJ#O?T`2F=<@L3,+=?C6&*$>D4:^!, M(>^+LCU[`+ZHR7C!9S/.>X%*[NCG>_;\GD_9"],!IU/R86+4>&1,K1#QIV1% M5E.U.C<$,_G%X=TSSL(HQS=9%.);*.HSB;%-T+E_QCC%B`XTUO9*#.VA\R,C M1K3_!7HXH%($1&5`5(C3-.S)0&QL^!,CV(5CJ))@S_,AN4\S3C++KI.QR4Q+.Z$WX)KO,);]H!3N$_*> M$*M(XK?I3@@SL95.CK$1UV9KJ7[(TCSG";YEH52HZ;,/XBK'2FE0$_"T>XEV MI/Y"0UFN$66(2HY5W5W.$]7I>[HF,7HDM*[43CPBI,$^#K+6?=H-'9NL'!MP M(&%C;*J'65Q?I9W"/(YNU$YG&RYFX?.0`(A\SH+XI^(19ST5[J^)5@/FW8&< M'"+*%/6^D?`E,/[*\ZET%%;$D^<$0+%Y.PJ&CQM$*5-*[-C6&MW+6=/@PIUYL'BX(?!XX]!GZ=PT#+17&P9?F37MXB3-PA02*J,8 MA@=[)K',-D$2_4JEK06#6GC)ZH:@L(S>&W>!:9()*V:NKJ,[$7_KQC+5N+0M MI\D7'3&F"[8FZ^.[]35WKZKY3HJ?MC'-`)Y)MBYX\=>F"-2UJ3QIYF#70V59@KT-/;,:8?L]'5Q' M";XBOJ:OQI$&C5U[5\C?7\R[`Q8@093&G8F?BB9:5FU)&6N&K&,F1R:L;R.3 ME.JLJX%*YVL)@:N2FUW))64U&_5I/9BZ9E;"09E+`8P$I2RE&+*XJUY&QC]@ M>$Y^]QB%07S^',EJ]$EH[.^$2^3O!#YE6]1L3!9.I+F3J6N($MJB6]UO5Z&H MLY.N!R'K+U,UQ7F;;H-(]@B&A,;5*U2]\HO>GCJ&$FONU@[,E5B8:&'5)%2` M$KR5I4*3J4GD.'RQ29^^IK5HL@-8Q)OR'V`,;QK&P'_]CQ__VH/ZYA^MP?M( MHC8$?D1_=9,7+Y=J^?$']%?XS\\?\/8!9P[!V/V@)>I$7W/B@%JY'%80N0^L M92LO05SJR3+2EC9.0VWY0M(`7?9"C?LL@#LCM410TQXR8G\@SAZR!B0AAP:M M]=!#1Y]./A:C:0*MI$)`AH#.[:6G4U-+*\(:HA05G"?[I`DJ'C&*H.PJ";=V M^X%?]G#K):^Z;KTQ`BE&UBM(X9QZ0_Y+)\OL M"6Y?L-2=:YSG-UGZ%.6DQ?LTNPA6;_%#(9NF)N%N'9C3C$EG/4"Y(F"+CL[Y M.6/$.5=99,`;5.>8;G(R[0CH]$SD>"9V3/I6Q:!+$[9>=5 M3C.XL?XM/8@")G1Y;><^N;^S66\AIY=_WCW#33VM5]#%)`[J+`BE[U8E($UI M.E796!E.V/&KQCK`/17,&W_OWJY4".H64M"!CST+(-\GS8@\MYCF\W.Q)/@7 M$5A'OU#R-FYH0XI]WK2T`9>XUY:^>8N8@O\!)W@=B:(AF]B78Z>-?!W@N%X" M?,`K.'JXV^]V<42OA+W-]IM<;17#V'D2Y"NUUH[J.2=4LJ)61YGY8',3:5\J MR8,\-B7EG-R]58Y!MEYH9P)KBVG[["I:7M2SZW*'LZ"0U\Z2D]E/LI=KTAC:EF:VHBS?9NK6.$(C#C!/,KHC6KCE`#RV("F_:M81=M M\]8V"G>[&0:[&![L7FCM6KC<%=40^![XH+"S4>$>X2)LJ/8GG$5SY519UQ.0 M!7%]K>W';KTR=Z*<*K[A)WQS'HOKX-I4[%@HK]603`R03B2F0H?%1U+3)#V6 MAAN:QLZS!JW]9U`U].D'88[_J\\V*'6AESG M<58SO(U(GKR%G("$%9,YZJG'&E0$=I,F99)W*T0D;)7.H'*,?&>7!XTU@+@F M[06[RWS/"=5P7?!,:0U'69Z:IF`S.XN`#N?%D3`?L3P]2T3B(#]+*'TW08LU M;<]AI+7;C84A.C`C<#];J=#3S2S3@8Y]]*N/C#HMG6%=["DK>,PT2WW'!$WP M!HX$=7&M(:\W.TL"/(A@[,,9BC#N4YVB2`C=G*/(-.F/WR5K$Z=+=%-MV$94 M?WRS0(EHAK)^IJ+$6N^IBB;0;&>DP\8"E#6#,K)1LB?"\9V'-,DO\#K->'', M^^`9Y^^>R1HJS591$F0'>B6':$4+\*9Q3/5B'D$Z@\S8JZ/,^+G&4)!=#]TA MZ`_5':*Z1\2Z+#T![10=]8 M^C*FMX7X8-!1H*M-*+_-)("R_)4$[CVQ!>_5?R'$@NNR/0<04?E<=,'R])3^ MNX?"D>_MDUV`<=*T6N_RQCY8NHX&]>62+WDJY5>(0,V&US+PVSJ:L""OEEN^ MZADM_:Y1D>J'?;2"ZO@.]+#O&84VW>_5%`9MSR,1I)/>%4>GS48.GKQO2-AC MJ.2/SH]'I3+"I1_Q>:@MY^=21*T#-9<"KH@)PHUM+:>E%#1JQGCN'537Q-L^ M263?%L^\<5&'>^=%D44/^X*^#9$:+WD'\+)_)CY`WSZH-9>H33;H/K6UWC3; MGYU"<;@A^#TG?&B^$P MFY:F&(GCYW;.6VH;F8'5I(NA/J^3A#'.X3GR\KH>W+5W5GM>EY&GCJB]WN#M M(0G"7Q"[O1,&&5Z`2H*\!KL!EAV=G)FZEAF[,M%W099`H:(;G-'W:#5R#L4D MU@U7(GT;1&53=`./&D-C3Q(+#72`,N`AWS>.]W!KF9K%CFA$<+1-$Y0#!_?X M5Z&J;0IZD')G%73@X4XC&W8#X^A0.K>1KBX:IL*01V_N,C*W4:2Y3IJF`R$U M6I'H*26C!#GA!@K>,N#^:$&-]]\TF2# MT#7?@(]&TWISE#;&`MP6^[537^5R#-R[LW$.H.WEIK!^VR?=YUNHHMW:D[C% M.[@'FVS>)454'-Y6+X[KE-8:R=?1J?GP<1#L=7&&G3W?BB=B3%&#JR?KFZE' MI!P*S?*DQC&B%M:BE!,^GR4'JW=NUN:^@Q9,3E_]?%T==.Z M[>5,/6N7P$R,[>@^F+FES><2KE4/8.C3>^4:KB4/2>AA[-J#9R-_`TI.X2PL MZ.F+U^C8HXGG$!BC-QNU`TXSA!Q\V[@U.^OH@>C0U(MWU84BG];I`S7]2*;<#%#F@''AKTP)$;:/Q5;XAWYRJOW*V(A=KHR#/AO?+MX[Q.^9^>+S3\[GCPB@-]A[Z8ZU1 MD><(K\7^=U3Z\/#1,:UR,LL@S9)8[Y<[TC>I`4&@H3UYLRU""V:8G<,.YNC; MMHE$]T';**Q&C'_'KM,-PUNKAV%4.T*R-TRR$0M5H: MZ69Y3]Z3X\ABBK%2+O&Z56+Z"L.`.^DZ$DLYZ8-N[,\YB,I=W$[BJ@=>:"8[ ME,<@$QNA/:]U%S[BU3[&R_4Y"8OH9XZ>;WFP>^VP[LSF-T^8C%"#45;+"SWAUGU[E^9X`]-TO>[+=GS]' M\EW-JZ-/]G>,4U,+[`.I/1L<.6=? M2](^I^_"NAU/.#J=^PY31>G7;O-+?1@JWZQQ;U<0NI\^D1MQ8N<]PD.^S`_ULDJ,1 M66.[=U%$$G>JZ/)VB"%2=;A@[4Z"=,2/+B!H#/>(+U]O21WU([VV**>QBP.% M_++-WS8T7.]%:G^/(WCH?PR+IQW$;6&X@709!WF^7#/HRK<%)33VSR`D\G=> M8X8F$$67#L:/C3#E)^CL3>N-O\5WNQMR*+>W^AK;?[N[3V(57KS9NA&/=^PEK:]:YN*(YO_6Q#O<2G199H7'W#QF&H;OY#!Z!;7>9:1CT87 M(/G%H6YS$QS@=^>?@TQ82VF&/ARFO8T?']FF1Y7$3Z:6)G_4[`!='(X:\DX0 M[<6O9+<91ROEHW7VH!BMA\-10X/1'5X/YU5=1S.Q"9U`IZ&94CEC>JW MK"KN'(Y'W-?I^"')>$UN=PO$>ULTBW0O>`7O!;K`FRA)6-WN&"X=S76_"6=1 MNKHK@JR8S8&9CFM^/"3U4#Q8&(IWB?)ZN:N!>,>*ETM'X22:[];S2 MZ;CR'TC#(K]*;BA4?\CD[X3-TMO)N?/^,9O3H;,>490@UB?\QO'KL18'L1P` MT8;Z*7DHB;U-[:.4QF8S(R,-/]%\^M7;?0;5@EB00+\N_2.7^1W/TI-M@`]A MYB"'8X#&<[J0LI^&%W&[GS[="#6T\\%##,9Z-R=F'-!/)PIYGV9K'!6TP$>R M>O>\BZKR8DSG&6,2C;Y/+D+1&<\YG4VC?UI8HB%!,XBYAP=7W1;VX8VO'I.,?&6K/U)%7I]V_@RH*=/3BY!"?G*/7' MUMI^7><)OE(21$7YK6_D&7Z&SFCQ.\O'@]:X]/0OLQ$X\T#^IC*C>NQTQUTPVI13^S6:3CO&0&4V>;2+=L53,:XXW(YR.O+GO/9W] MT.G=@K'CGW[HC'CO^`.-BCO6>^;OX,$^^FE[=,O?9XB#_U?Q!S*A M[_'G;A$[[CG?%X]I%OV*5S\E*YPUCF]O"#S)C'BDRRT,V-@+1V,[]NX6TNB1 M''0UB2=.UMTBVB^OH,"]!^T:K@VTW`CM_A3N+,TWMI*+3(N>P=T+!G1(*CQTS[0M44SA*YX7*[8RAL?+N M0\M)3$\O8)S0[D["874545:UO9K;O9D;$-6(8MT@+]S-HX,5+/9%VE MX1ZV7"C89A?76M'2?L`>E2F5H76LJ=Q_3C5,I='*@:DT9>S_GJ2%)Z;BA:SZ MIC*%N'9-I0/8KJD(T'JBT?3UX`(IXSL\[9CZ>D@AE=%A];7/]57F&LF9HFOE M6)YLA-VQZEF#;(%)GZA'9$4+ENM&TC$_@K/E(F42G+;/E(ZM/=,O*[_`^4M# ME#*YP,>D`!L#SO_25R.G.JGRX/47R]8^J^O4-77+OO1A(O6Z:K6R%&XQ[,^0 M/U^F"7T^91_$]SC;OE;Y6A\D=..+?=#5V5M*@A+@)Y/7#G7GZS M7G>O.:[7T1JC+_^.@\R'XN?^C+%XQO!!O-]0=,[_`FD8CJ+S/@E^&]%Y[]BZ MBO)?4.;>=Q4/&XNIY0=2X1U>(G*\#\QV`[-)]F;'>>3)6C1VU(#77% M,PX-XR`]TJD209_>YX-,`\'I[LSIXF_$,3P>A6OHT48ZD""@X9%=1<40Z\FQKNX'.CKH-?LZH^'S\N4P^,CH7,!'JH<` M/B]?G@!\U!^H!SZZ7\?BPZWI=DN"89#J,MA%11"SP/@6YSA[PJOW:?9^#U?, MH+(F7.>31`4#>-E_]G6`OIU782F/\HDRSJ9K._WM'3EW\Q\8#QLE"IN;GWX=[,9@/=U%>(%8@[`3,M M-V3X?LY3$,6@#?$_M%#1'-:J[/)TC%8]>C/8;GN'$E7]TDF3]GS"-JR)R,E, MV0B.%OSLR%;=XF*%-6=(N@5*JKP?A>2&^M5 M[XAWS\NPH(8`,Y4V-SO%<3#`-'KFHQ8V72E^AI\Q"O(\#2,HS(X^1\4C*AXQ M'=X@.?S;[]Y\]Z<O%6#M^=#WVUW<7K`I7#]4\3' M-'G".9SVPVR04UMJ_AW>D_Z8%G_'!5?K5^F#,3/V:=UKSCE^G4OJO*_*T8F= M8M4CBXCRQ7$D1=\X)SVB`RY0W:<7;M+FB%(ZM$^RJE&_FX2@,6UDA'GF%&Z67NY9II/+O!U?S_R M=?.^N:5U7='EV.9\;',ZMCT18E*-[9&S.VX4PM@F?!YI.%'VOL(+Q\HIB$L#C_@(-\G^'5DD2[X3Z#M]%( M`Z)E5OZ3#$&4JPKH3=B']4!PRO%I6RWP1I0Y8MQIBD:#/RH[0,L$55W05LU. M$.W%A^IWED:+<8:6#[#Y19-!C+1S;3FOS2VG%W!N+>?-(,MY MXY7EO#&VG#?>6HY8EZ;E_)2DM=7HJ>3:7-Z8FTLORISL;#1BRO<9_F6/D_"@ MOZTAIG:YIR'12;ZAT2!$%:5?>QD&NIEKXV@C0X5!R2Z&'@#=;F%4@@W:N.A0 M>[%=T=5);Y.B"41/-R9,5%L,TLWU#H0`D#K[#E(T.MXIK$X2]`,_*;D7AM:C ME>YV8'T*Y55(.%2Y]M:?KGJNK4V$2ZUM/BDH3^M,_EJC%O/$_9SDV?RUI%[P MU.?SUW[46[8W;(MRW`+1N*6)[/A>=]Q.[22_8YQSG.8++-/B/1XJ>Z7*VR@/ MXQ0D/W_(:3$YB6O2H+5_DT9#G\Y5&(;_AB>IRT:!K"@>>[NT2,=^39P-(;=8GV`(BCHZFZYODK"=`OUNR`E.\./.,FC)\Q_ MJXY)C#G9O\UOK&OW9BGG`$]UL]9T.7/$I?R#*GZQ>NE^V&?NW*4?\XWM@9J> M>/?(=9WF^4=,A+\/GMF]`O+[C*P7\%O,_J^!\RF86X?^)"/2*9-+$PMZL0]\ M$6$,=D)8EY?32^:HY#Y_D*^UYI]Q>,*CX8G8\'Q)8NG\JP5*R`BE:U0$SSC_ MWKV7F,YNVHYC:J/QPY>(0\#ZXGRIW4"/8M:%5W[%<'1,O4M=W(;P1W?'*R-4 M=]%P0W-=>\3KB!4U^&$?K?J*^=D9,5`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`Y?[+(.7/^A5@9#]0^*9=!G8SR[6U:R3:VH7H3'&"1>*G$G(C`P>PED+R;] M;E`M$*=#C-"?=^OT/U@;>*9?:\3C`>5[5Y=!CO/W48Q7'U(Z4?>`245@MUR_ M3/).DA1[)&VY1K0UHLT1;^^R+OX`)=(U"JD2:ZK$EK5W78!>B:.CRO&:('+F M7/EJ_!:'.**%H"Z#+#N0/])[+LJQ\6'8SA=X05I.OX< MI4G1T[8+#>A8W*B'U&C5:5?=QOZV?$.^SK8V3>MVOU,W3D:K&^[MK]W99^__ MU);QJ*P/==3*#2:%!9'X%_?GD*4[HKU?W6T!H[93O-8H1B2A<3X/7TNJW?3, MQ==^U/DQT4(X*2MU<3DS=W"EFIT%H')G&:%I`K50 MEFO9%1#1PFP($[L[CICGV[N2L\T?OUWD`O2&:IZ M0W5W"\0Z1*S'YF/;48+*3A>H[A;.[9KU\'S(K?T7&E#KE\/GM//>&^7S&[F% MQ8]L5VPH(S\70;*=)\-(V?'>VF]7[4F7138U]VY])-R5G,*HK680[[=[>LP_ M9`MG&!L7V<0F6O;D%)?D,BA_>4VO@CM?YX_YMCVYQP,_K'<8UCF?,F?E*Y9E MSMD0SUXXY[$?>R"PG3MHD7`_)1D.8HA\?TQC2*;]@42W(/$R:=0ZRZ(<+J[L MX;T(5IAR6$VQ4;UY4X)LW)@95"RK.T*\)P1=L6!GF1Q5>&3=(=9?66%VOKHH MFE7Q__\0SE3Z<=H!G*A6IGNW/J.;TZU6-YF/&[>KL(WH?@4M25YFXI*.58>H MN\8+]!]B@<&8%8%[4W[_`&OCSY.%!W%VKK-K)5^!_U M:V\:<'-8>]-$9UGM3=X458Q0@Q.Z.%0-/+CT-['VJ4+[!81O6NJ[J;UI#'MQ M[$EIP=Y)>.UX-TOFEDM8KG/A1T\"N&P(@U MTT_YV^@IRLG4P?D+[^3*F]M=!XFE;G_LGW)4-JVC`];:W=ZP@?AWM?@SBZVU M)#,:^%4I>C1IL0`G00&YMWNA1)\@GE-$WDNYC0HS/KX/DX_Y^9$% MH2P%04[FPC[@`66ZR]"E: MX=7%X:<<\G)Z#$$#=D.860?C((W[TI8I,DLV<.`)C$C<+_"1"O#:*JZ@7?`JX[H4\+-R\3DCY[Y%LT[-PX&LDA15@TDW`B! MUXSAM_!S2!V5R$5][]Y'S6FOG?N"LQNKQ?J40?8)TZ>JZXLMM_SN2WGI1>*W M],CM5YW4TZI3VK4B:]XI*PGK2V=3^X;OF%8)WL`=5)5O&*@J[8NX-W02PG3J9QFBUN#Y]##)\$1`_`??1<)+WGM@V MUTT"`OMK4I'DG=4H-$2T)6HV=3O5ZHM?I.$G]$#%#Y7B6UU"2['363QK`,<> M[NN;E>RI19KTO%RS:RRO)/A7$5JW`Z4FO1Z95U8@CKE!!?Z9T2U(#%L$L=L9 M9YAFC;DFH"W=&XH>V-H&8X(TBQ<#TPQ'FX1=!PB;+XF7\M:WF"5F9,;&_M5` M,RT[=P,9.2KI48-!HXA`S<.MH4VD;5AJBY]Y18`O-X2>N)F8ELIS;XA#P-NY M_C@8N5;?&RF.$, M/-GQ':7I);7#'$IS-'90V`UE6&K%]8N^'NRFF,.VY['M09AU:9KG89CNR7*X M?N3.R"C[R#TPQUZMM`RQI&P\=^AV>ARH7*5'IM##K8F)X:&J%X#(2V^67)[RN81GJLD\XDK)!6XW1#LO;RR7#U!Z3' MGA6#N2FVUYM^JF`,4 M;ZCX>#P;#U";:^CWS*P'7K7=FB#7K;$^X:2@=?,-+;-!YX49-O70M+F*Q#_K MDFNC$-RU"74@I6,O`CRY-(Z;#.^":/7N&8Y.S&:N-JD')M+11LM*.!7B9+Y9 MBE*I4G[,6GAI,?TX4QN-#&0^+`-Y&:-!B[V*U@/+Z>ICMJDBK0-GZ_![B%J5 M!CM_*MEI@DU_:=6+-!^3R5FETCT\Z;I9F:;@;=MI$.0:]$P@P._[W$>_K*/,OPA"!^C!&>'\V3U MCOQFM\724N:Z#.P;IJYF'6534;O>'AFM(!'J$93NQ22S7 MQ:J=&6&Q8V<#@.AR`C0V-%T.'DR!VD`L)X=U-0<22-;&%LQI;&8;2L.5[,Z# M/MF<&2[5DYM75B<(D-]'29"$$RTBIQ&YKO0] M@46D!K(U%Y':L+9GS;=XQ^?XY?IC6F"-$QI MBEG$::##3181^.R"&%6ZI`E*J"[>G*^H$-6V%3TXV;.(>SCH/S;_`H M)H]]5S=!1O_]`1>/J>R:E#X+ZQ9CH%T;?24IHK0+1%LORN7<:D',*6._1(R' MV^!RA*;-M5Q1:IT#'[>N8I*/!Q=Z5NLHGYJ!GFW6EC>Z*`O4X.'/A&VN[$UCY@ZY M@C&0N;?$`4B53>9&,+5GCQ"8PZ.MY'^PEGXB*VQ(X:!/,K=3/"0&:<;&ND4: M:MF[8*,/]L(/#0[E*^F=="67B0TCE3U^#)TF-,`F&?T!U_S<&^@0Z+8M=#AN M+9:WV>]V,2W9&<1ER5[SW8LMH(A7# M,=FP.)J`17/\?K8C62U"C M=3G`AR%:N'X.2LM&CAZ%,C`0%^^G1[+=J>-F#E]$C_HV*AJ/4D>.=Y`T)74_ M)?5]>/$K[.VO;O6>1[K%]\$S;/)&*Q)W2V':;>SB)D=7XIZK&U!$F+9B$P]I MYQJZ^G(7T,H'$(O`T7,10XH,NWL)$,#!X^KDQSI)-%GUG/6]K<)8C17,>-9. M]AQ&CD9OR$"7.9QI,]^:K-%[#\YKSMZ4Z)YA:#ZF?*^BD9%-1J3O:-V#(E%3 M64K?=L9T9F+QR8`R59?$C9#D4]<89L6_KA+BUNJ2=#^F,:3P:A39'LO8_C,` M8T>B<^6P9$C7?#0!KE&@FS&%I!O8]JOY(LYXOL+=AD7]IQZ6AJKU9N?SU!/Y)KCS.<@R[#F*BR"/\N7ZAB"LW,\CL=%=M$FB=10&2<$OL1-A;](X M"HGX]_BYN"`B?9*XB7%LK3N)D:/0-@+*#F;,)D,:?C=8HIHG*IFBGX$MHGP] M>$YO"G"TS60Z9%B,QFD!/%8<6OKRUG$[^[%R2\Y.Z,N?`>`M/)A_5!)3`7D- M\L*;TO^]>.@$CF(P."Z=D^WQZKJN$2W?9-4@]Z.`3ECI2[#E*`F29,2E&;]] MPVWSH6@BPF,:KW"60SI5<9`E)?4T=O`H=(_$O:]7\4:(M7(91&C)S"*)MX$%QPZ4O>W&XBD%AJ M0=6YULH+&CM<=.F,_%&2B=:PVPPUR\H:]Z2K\^=('EAV&SL((WLD[JN%RQHA M:(5^AG8>K,W%P]T-I.1C[0HBET&!-VD6_4HW`3[@[0/.M"'33^P80@*-Q)`B M;N=MN@VBQ#M`R3Z.'&#J+V,S4_PA)S,[D>S=$Q>/C;)01*CFQ.T$U+U0SDP=8*Z^ MM?AR#.*/@L_Q+\G*?IEM@H1/-3?DO\1/W.'L*0HQEXA*=Q'% MA.FF+R`=R<^N_8[0NPUBQ@H!+]1DAC@WQ-F5V.9(+SDZM.()!X'I]$`:L*R7 M;#/;YJ_6C8GIOV$WS=M?M\=_[XY_[X9_[Z;:BR`H^LK%V,M_,A736/>=OQ5 MG_>D3_SD=+'_/LTN@M5;_-!;N77.SKSU=$8C-MH-]L[N_%$MUB%-*R1=(MKG M:3C*46-8S_(GXCNG0(R^8PT;B`DJQ$`RR*I$S)H@YH$@9@5]GI#K-7=60_WR M4$_ESFG?8()R@MF-<,4X80PJ[YRC5"NZFUM1&\Y7!Q%C M'6X]4"?N8+N.94JG*O(J(QRIU@;!=93@JP)OA6&M*1>[+M%8Q_ZEJ-9&$K!! ME(_+S;3?EL9:7FZTRE2/"/Y(G-6.9<"6.?*0YLB<1XZB)(SW*WJA``6H@+VS M%^C^D;2OVX`[W,.E@R(M"Z"`"]RE&6U/2.NZ+T&>IZ2'@K3^'!%?NJ+;Z&A+ MSV9R$G82&5AO:0).%FV#Y(#H?67"'4I*,!D<.\YACN3(.X[Q(K8OPM\1--)* M,-?0$^1)J\[4)52.KL:+=!#<-:^:H[*]1^?MRF_2?Q%=XX/80];[*"'^YSIZ M@JLI!?D"$3SX3C.5/P3_3+/+F/B*C\%6?4QJS,DZ`LUU;:.2<3BC+%#-`Y5Y M])0-HGP0,/+HM'7@AVY#>-17=NXPE2!6T/GB-(4`E;A-;Y"H]6TT7:=;E,'^ MDE&1#A&!=5P))6\#"AJ:%,BP"23Y\+<1I#/VKJ"C'6; M4?$-Y`!R?@<1Q+E*"(KI.E64BB1M[00Y79F%^30IJ^Y]5D!U;XJEFMB#!!J- M+]&'(>EG<(4?Q5*RK[%C]`@6CBV8>+-<%`^W'",N%X?'DFBM`L4DCN$B7=>U M0+/P;?&F^A!R"+E?CAW+(]O:5U(XAI%L-[?C>I3;U.XP)-P5-?H`%A/WH
J87^E<8Q[-/2,9R?=7C28SJM6]3RN/DW5*FW&OE2M MTA$PZI5C;*9IUNU:MSHU%6K&A4S_:]:96@[##_B)(^>,#MU@KJM$@56_]RS MR\YDZERN[X-GF17.T9M]LYUES'J*T MD#.9VTBO,[D(]M[.71%DA=)-6!_*E`YE>#24$1O*AR"&?*<%>L";*$D@X"7C MQ+29=:C>)!MX6Z7\1 M42,PL]*[]2G"SIBVS7?2:>*!B@'3Q,*;J-+EL/9ZPB]C&%8/'@RQ:,1M5VC= M@MV[1N'[!LNDH646Y>1/[,T[IE^E[@"'.$&?WKC!*<9O@/,3/5_"_@Y/C#=] M(>N^?!63"=!TBWZZPCF&MC%N&$M9VX/PY`F;#%!'T6#'WY_]O*,WM\-XIC' MA3GB5SNP!R'B[!:MZQTG-F>+*?.D^VB3L$+>X>$^"Y(\9HG\M5L_@,9I`@D< MZA!P,$?[*?2#=>^DTC-.J&2%&KR.P[`#JOAY$X=-/PYA.0Y%8QR"BIE[QS$2 M]IV+!%-@WGT@U*<&'!+21RSZE9IMQ3BC+-X$3G..]X"`JM^+,8%H20^A5ZNB M*&]\FC]#?IHKS=E=@6YD9!SD*V6-"4E7^X+HE4"J^:KI"!K MXSP*_P:OLLIR8^?KTWZF[8SCU\G;!49G#\`)-7M#C>Y@D=ILQ[M$M,\%XKV2 M'^I^%ZCJ&=&NW=O@[*CL9!C;@>2(0(7(M8UHB,1K@Y"N2$RE$[!HD=H-7/2T M:1M`3575Y*GH;)3B45=6.TV]M$H,.5'-6O!I8%Y'0:BQ;3E[84+YBHF@O>N7 M)81OE71>E?B9-?4@AI0.O>(Q";?/DEQ'1;2A?N`.%T5,Y[YWSS`CRB(Z*95U M`,EUZ%8^*UNCNOD"<0+W6-+X(FU$:7\.BX]Y[W/B#_.\DXA&G>>Z^9,4(,+WW[V]K.[+NE;<;E_%FB+5#M*';^-)0$0)'D)#U_4?92AIQ8LJB(S` MZL>TP#E9G4*F%[\S>W&`!SAW-$`MR-(4D^]7W)+^11@VXV$7VX;Z=:Y2`CGB M]*B\!7UQ0!4+=`[7YAD3!%Q<&L0DVNZXMCG7]N%`WY-EV@8%BDIM`9.NK6@( M?H^L:SAX1UC=+=ZQ#2$R%\D%$-F<"0>[%F>D6W=_OR2&]\C4UN?2V*92E$1D MB=+P7-N9.6*/K&PH7">:V:KNV1&QSD36(7$W;W6EET]357N>]NK+C*2K1VD' M6:4'2T5U;0,:B!).+5(XV5M3OPLRN!F7$RGHX83.TEE"8WV%+)._#::R+5@! M.^#R;+&K_!CM-:WFE["X7UR]F]D6#1;:(7W3*-X7>$6+!>J`;3!'^WO.@W67 ME8SL@G9!-VY"NH7#.?+JD<@K-(_$0F>+>PH@C`@?[B%Y;)\=[@K"57E>*FIM M-V@0RMQ&7-D0T98^':K)A_UH>M49\U%KM!!'3P"N_#*-8TQS$.7QHY3$]BI, M)GUW-5*U1G7S><-']37+Q)\ZB(GO#M/I8]G:U);->4=35J(ZFF@[T41HF` M%)6TB!.[M(ZAVET&.3$)^@!4O@]#./#BUQ+H.POE&04)JIRGQ?I-L@.Y_M51,*P M2_;@N/JAT.'\;,^@@_7N^O0&*S!&RHQE-Y7L$.>'.,/Y'_W4G+QF&@5BF'LZ M"K"N":M1"/@H\/?K/7KHSK=PQT]D7EJDEJ]D:FG3N9JI,B#$2%W:T2C- MQ`:#`DKJVFX,4'A\"]44@E/-1U?)?SY&X2/K_V-:C)F9M'DYG*/T]57-5E<) MHJS*:8LP.X6I:_0`5)-8E*#/=`#X;):0`3B1&*Y;1#D1]@NE.FH[P<= M;O%ZGZR6Z[^E,?$0L$@$0:[HZ^IPHSW#_]RO-@"0,F=-9,@3,+9KU5.,1.<2 M!^'9N%QV0(PKV'S%EYD[JCBC!NLJZ].EM<\V,&%C8#(V,,07/%4#0]T`5#?A M`[-K#$R9(.K:"TQF/T()-O#^R90-X453($KA1]37CU%'`.K":T7 M)5%JTE.:!&C*HD:$=U4)73EOYU&OP.T@DGD``;U!%?!44#30^$@D%?M1ODC MQ@5:L=L,*'V(^;6M,BCF)X9XM8"]TR*(:"7T(F67'@BKH$"0"@6%)?8$:3!] MHX3\#)DF\`=BTR#="@IJ@A>`VCFP3]OH:H&@1&150QNE3R14**(M?H&N"NXM M2-H%9$PL9[K)GRT+EFOF;JX2"$B6Z_/5*H(O M$L0?4OIE?B"12(&%"0HCF3J=](U'0#GA,XXPX?.IGT3YP!5^4_-%G#'BG#V: M[J<9DN94SWT(\2Q\TB?.`18`$N@'I(M'Y(-X^S:EB>Q%=DD/\90[&5C_HB# MN'@D,PA>9IL@B7ZE6*J3+HBCNL5/.-GC^B5P:2F0J1A;S\T$]%".]I\&'JQ[Y^E@S@E15CK/3X]63IH\.+>&^:*Q(]#D=O2N MJ&^O<(^#>N>%Y2EP/B(\_B'(R!=:O0_"*(Z*@[!2C:RQW7!6)'$;:[P=*ALJ M:M38"3QG$MY:A"B%RU'DIX&5,=FI01ZLFN@M(^C[<&@9`E;!JMF4)26<8!K>S)# M\9%]#8'PF)W]:F>AW(C0M34=2LM[^SJZ=#;WZ[VF:MO.*_,:I%7+M&J+:J@+ M#P6`"4&#?OMBY_!1CL(XR/-H'>%5#@<%?AJ=/I2/-]H-<3S=3OL-IC5YV<4* M=O[_$6_HW9'X<+Y>PZTER"4-X=3CT-P%U,J;GJLWIWOSTXV9=U7>9^)Y M*G5OJ.H.E?VU]O.]2>*V.XC-;?X='\20#6+"!C&I!S&H!C$K!_'X!,"K)/%Y M+5AV,#"+^4Z5[@>WPI:[79H5^X1$+/H4C`-,W\`-@Z)L&ALBO_O&6NY*K9)UF6RJ([(!736+/L:NE[YS*\.:HT=Z3 MPU;=;U'Y**T/031@&I'??R+_)O\B/\"K+53%_P=02P,$%`````@`.F4X1Z-9 M7+3Y.@``0N0#`!4`'`!D>6EI+3(P,34P,C(X7W!R92YX;6Q55`D``\\G!%;/ M)P16=7@+``$$)0X```0Y`0``[7U9<^,XMN;[1,Q_R*G[G)6697FIZ)H;7K,< M[4PY;%??Z9B88-`2)+.+)E4@Z;1J8O[[')!:*`DK"0J'=+_D8A,@ON\<@,#9 M\+?_?'\-/[T1F@1Q].M/O9\/?OI$HE$\#J+IKS_]_G3S^?2G3__Y/__[?_O; M__C\^=-7$A'JIV3\Z7G^ZT\81'\\^PGY!`.+DE]_>DG3V2]?OK#GWY]I^'-,IU\.#P[Z7Y8/_E0\^\=KVSL[,O^6_AT23X)2"33_D` M?DGG,_+K3TGP.@O9P/.?O5`R^?6G\3P(OL``:PZQ4*-0;S2K MARV\^,)/@F0XN:`--$;D*BMA6'=1F\D29DZ)K?1^9L?A/YS2$`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`@A'W].XWXD>D>F?E@P)`)!;CWE]7JG`ZQ:TGQN=^5$6?@?`'U$0N(HY;P@2*W\#D3S2Y9 M$^_(M?3,YID*"U^@1RT0Z!-TJQ`@>\3#N#!NB$`LM.7X^4(:(!;2.0Q_S"#< MA/Y4(*6-9SSGJZ*YF'8`\.5TC%A.2]#WA`8Q[+S&5[#/5\RJC6>]D_;)30B$ M+[^3%LCO)DC@^/M/XM,;^(GJP[;UM'?:7AERH/"E>-H:*19JJ2_'TO/>6=LE MN06&+\LSQ+(L-LT/9!JP0VN4?O=?10LJ[U&O=]`^$0J!",[?!^CE=PGX*7/X MCAQKW?8/D%*P0ADB=^^ MMK%P3/WG.@63)YZGOSYB&#;Z0,$V6/\E];R556_S8 MV_6#2MQNZD:P4SD:U)LHU;%<9`GH$HL]248TR'7A/!IS8M29C_1 M`!HSUDK_WN#XS-G]WK.9N05G&S#.,DH&4YVAO?*]$%G`AKTXAVZM<@IY<"?/:8( MVSQ7!!5_''Q0^2/1^%+*&WJ'-0/*;"-::Y?.;-/NPSMT:K`Q$`9_TID!;?.4 M,R]9Y6`VE@9Y19[SV$*02CI?CTIC9NIWXATZ.X-NB&,QS&\^_8.D3"P[`P85 M)33U@V@AIO,D(::3NJE7>HO!XURU.;E8Z.2G(.5@P.N[]KV! M,[/%]J!TUGQA&X8$A6%"035_Q5?!:O.\V2PX[&*^Y&D=-0'0FM_%D@06%I`KP1^APGY,Z)!5Q8Y]K!G%BY^4JNO_LX"10> M)Y/FWI$S!]1J>*),:_Z#W@"%UU:;7/XLXF"R-'M20C?F#LY$ZP$*2PE'"EN[ M9<'0+>57[UM6UX9)U@.GYW,1^;LBVAFTI?1J6_*QL$C>27*MQ0][.+;;RGFF M0&`IN=J].`M'A$Z(YL:#W@#%'E$@';XH.0@LI5]C$>,B141;FEO/>P.G9B.) MG&0"Y8&PE*Z]N^_'$J5QGE[ZE,[A\)]7LC0//]EL[PU0>&;%`C4)RN!ALY3_ MC4$A%K&1";L;!"##Y^L[21>J@[GF5S#7F MQ$C\TO9`&@K_5U5%T`!G*>T<@TJL_'V`4"K>QS'&(L MB@^OE58]FX5MO&,4MBAS`=R_?#4YTCU_>,0J3B/%'=P>#K3SV-$[]T*TCN7>,PH*B?]C6Q60K11[#M_F>QC-"T_E]Z$?+0.$9LS?)MURR9MYQ MNXPL2BRV$N7=K]Y%Z?$G_YV4CY0Z$U[1TCM&9%[1D+D.'('8C6UL[L6>'QD+ M;K2$S7W>.T9D0M$0L1B$0+#&MC+W@BW@*;=AWC&B0[&VV3L?M4!6QA8N]SNN MN\!_#L)ELDP>RO,2AP`GT8[#TNW".W9:2[&2[\H(FT`KC(U<[F=P";:^;TO< MR,-17\%(F$I]X&$41(.TTCZV-.XN#D]FT.(H&D6V@; M`Y`T@]'N$"07-;^-A\.1457:$E`"@;?06%;.%%6+FO.T=X+"<%9)R"(X`O&V M,%#LTI\%;%=)_(0,G\-@FLM%8U++&WHG*.QFE82N@4P@_Q9&EADMY+S%#H6= MK)*"6/GF+^_>I: M*8(V7^2=8C/Z5%6U!G@1I"09&PDQ:FW-I@0Z$D+38SW MR_'FB%69$YRGO5,4%B>%P$2!''PX`O&VT*!8NM-!F16S]:AWBL*J5$FP7"P" MJ;;0CKA1WD$EU]V'O>.#]HI6!$<@77TKX5DAW8A,65T)MWZ?\3@H@-S[P?@V M6AR:95X??@O/[4WIM00M@R00=@L#[,Y'H^PU"YG*Y?%'L'(!A!<2)<$;*8+. M6*VL[R0=3I[\=[GCSZ0GS^W5[/54HP)4@EKHJL7%%)L$H MD&WQU8V]4Q1A>Y440Q.=0!=::%[<9.>=HC`F5Y*U`(U`MBVT,GX+HICF M1]SBV"J1[/:CWBD*(_+>CNM<_`)-^+"FQL9-C-X9"BNV0R-19=8$Q7/,#8_. M5RV58;=&M+)WUA73M192@4Z8&QFW=&)_A1IS8!=^0L9LAP[;UF66&!FY*`_<]+JQ"CU[1RC.'Q8$ MRY_[-NAI\5MX9\X^ MCELC,KM-1=W8.T/QB9/Q+IA'>M#:/)D>R!N),O)`1O$T"EQ-HMU1:,PC<2/O MK$(%<>&UNMMO4=[*(FGB]0Y0&`T4W&U.!SU0;9X%`@N2@YE0.6Q.8=;I'3B[ MKF7;6FGV>=%H#>!0!.7HB$#/H"L$V>9)ING&;---+[T#9[?"/)M1]PZFB"32W>@F2:-^0&ZG#B>8>J":T\V@(X", MPIE904["N6D,O\TSE=7+BM)%P0;F&Z-Q!/\<$6?VOO58+E]\X)[)X9K2&+[` M0.4HSTC3N3'`H!NOUW-V*^QW\D/$/E/`8NRW4?F9`-1Q%NK9#6UT#_2@2#`P M%RE_CMOCI,TS_S8:9\#5_)%,E]"_DGA*_=E+,+J-)C%]=6:F7(SI@=L,#+,OL49K=F\FAIDI)U\0H*$+K\V33'@;XGW.ZPM)@Q&` M;"D-W[DD,P_@'VV[9:^Q#3X:WWT46K"=D-@"86I MN(X&\#%9NJP1I^1ODR0SEGK1R.L=H0@?J2_Q,AY+ES3BE/8P2Y/4CUB6C*'( M2RV!)Q2Y(/7EO@/*TG6,[H5?*L)1X9NOT1KX0N$T,%,";6"V;G1$I0D&WWI) M*R`(EPW-5/)\0-VYU7$'JO(;+V@!Q."RLE63=!E,=^YVW(&I]VV7-0.*<+B; MZLE[!Y&MBR`QG."72YCSM#*3EWVZ#=):C,`K)V6[D]7HGKB;,A9\$R7"R-;AY\:>.GUZO`X"(P@"F M$@)_>IE@M.^O=W$V#F(*._X@'C^04>@G23X-83@%4E&-,B!2@_+ M9ET!B2CL9-44I1I:2[Y.#-_?2S]Y85%D\!>+"'_S0Q9H!!Q0VM6K2Y6&Q MY![%(%-%>1SE5UVK/;"&PLI630,,(%KRI&)0C-UZ`_KKO+(ML(4BO*Z:0FC" ML^19=?J1ER06F1J53+L"$E&$WE73D6IH;?E@W13Q("FK'W"?5Q9@_@EFL\[C M5MW4%%@4Y5YZN76J"PB:L*P=9X4&'DR-3QFPAS!<>,J"+.4C'.J MM=*PJO7(6$"Q:BO$Q)^0]4"W.6.+7Q;5W<3$6ARU-SAP/\?7I3C+"'(1#F=% M/O`H#=Z"=%YANE?M'*A!8:"S(6#5ZE"/HRYXBI1<;`43_0ZK$2T1=!_Z47(Q MOWXG=!0DY)X&(_+`,M"M*&OMEX.@4%@<'2JS)0XM^;@PE@5V]W5LHCAP;^"N M8,!*%U%< MJ*H%P!H9;=X`MBNM]@85PHP$WL"UVGRE<)!?O'59-8J]+O/#56ZA M@924!P. M>:)2?1YK`&[S_-0ME.5N@EHMEW7L[&X,]LF`HT48Y'0.)XOOP`TH[Y+[I[A< M44G/NU:U4Z`"A2=>+BJ1TZT>ZBY89K8Y*#;U)0KJ*Y-NET`JBB.2#54RP]QF MJ\-. MG"8_".G?E=+NL!&4C!,LLQP-O)-4@U.V`;Q.3[IU)I@>-@3%X@2RO(PI[/#@ M^S"<3((1R;UC(AGRGF5U>YV&DVE*@",V"1S[>03[-$(LTR=89?(WV(0RY9W$ M-/%#`IN$)^JS?/9U4HW[G6IIR%?D.67%VG.CTWJ,&MM1_4Y`(RKX[92I/NL7 M2;>:P@8P+!1'/U,B.5-+@;$+-H/5IGIMX?-#P:92V09H<1H!J",T@%-SE>2(/%*=S)NO^\C],S/V2F!<_ M]G[[.T>>ZU\"1!3G?X4,-@6W/?QVY,RNEQ_EL4+:"#"[/[@;K:JZF+J0Y[JS M#V6YOBQL[BLHJ=N3_Z:@N2OLYKP&DN!W6-N2RFCV_TYA&UW MC2[]XS?P3OL5[FFV!V$=;ZFZTH3SM'>*HQ2OC%K^K!&"Z<)Q8Q.F[A<;26<2Q:6#$`KT93JDQ8/440$<1*225C.CPOX7"[2%$<(HL M;R@7([Z8,_OE+%^2TN5-]`]^*K30FO3!'`8H[`(&$JT*TM)YPZ[`'\ALD<(U MG,@QB<2MWP/C`47%15-A&T.T5(FGN;F]0E14D-29REM-6`8ZFI-.U9G+QV2I M7(X3]V4Y0G`=N#2<#&>$YJ]P$C==Q*ROQJ/ECN2V\`X=7C)<\:;30QQ7!TL9 M57BG2D`^5.C:80]%91&>'+96-M'@/TBDVF'/;12-B/Y=*>T.&T&DFN4%4N>H MSKEUX!!'X7;U;%-A0!"O9D>BOQ$_3%\N@;9RW/0]_)E[9>@;*\%09+SI"%2KVS'5J:(CU?%VYM+41>)[DJZI M6]@PI+>JR9H!0RC<0%4T0HW+4EU?#$6>KPB,>10L\_+.7UD2;3$'I,X_82M@ M"(7?J(KDE;!L5>?%(/EM@@SV?T`&"CM;O7U?@<+:%:AQZH=NE_'E(K4N6R); MO7>?!D)PV>"TQ"H$8NW:4^>2_1Y'\2;*A0YKG-V4;8$L7''^6E+7A&7K%M0& M\AD?F&<@*JH.;2`0>W\%#0`J"FN>IDRX7E\I-%OWG;K?:B]C%39`?B=R]QR_ M"5"#PAY72>IZX`1R-S:Z8=AN+9&J3^!;3WJ'?11&-BMRWL`D$*^^K>VL$&]$ MILR\X_X,+:1(=8H6-@2B4%C?#+=D&I@$PCR#UXO:>9K2X#G+KQE^BHT_%\9]`9EM M-`M4@RG0&7TC(**=Z`8%NAH!-*`P(=20=@%!(,D6&OULWEYWV$=A*C"3KAR- M0-`MC.53W$9G(.^MEMXACF3+>F+G@A)(?\_U0>S(_[](,'T!9.O MSX0N;FX:9FF2^M%X<3&+GEI4ZQ"(;>%>O@Y6@1*UU+S(OH/GKZR,SM;&9U49 M>Q$/;72K5*U^@684L0!5CH>U(`LTJW84X1[+G?"N\EW4/6G[7;Z'52Y#$WCQ M=*Z2%3GT=-K"8%&$6LC)Y+CT],%]K#0GMQ"TE-N$Y!,E<@-HG'IU.O,-C%)$91N*NZCS=!-V9+"DU<'@BS)@-X9X=_4"P M]1PQS;P0I((B3L14CZIJ8W6.+.5]M62YD]!2[!'K+83*[H%S%";H?>FE+B-U M<\?:[V_$<7F@';W@0+.4(C8FDZ"X*,MO@KF)WIJI9:MJA!=;:7]E4C?\PT*G@CZ_M,KM^9H8&,B^/!ZRQ;WEF\#499J=+J MBX`R%)$5"?CI_@V23(84W&MX1.\7'&?ADYS M8`S%V;L)/>!KG#XKR#S9S>F1\@8/O0Z`-12'<7T)5].0,EH$KG0[.E)SVLD\ M\[9?`/1'G2.:(%1JHW_)@4O\L'=XVK,6N;5>##?>)8UYE;6!P3EU M%JIHXX1DJ>%TX4J_5?S\9>@GR7!2<*-Y@_AV&Z#%:9Z)IMP$9UO"$X7KOA[S)X3\F<&C%R_P1\:Q@1!"Z#$J?V@W@26 M8>K$17^[`)6S6-B&W=*$8B%F\BV,WPCSZ^H+NG@>^,`1QZJ2 MF):<-S"AO`=P8\&2&5$D3S-&W/O_3!=A-2"WM_G9F90;`/-#;G(^^C,+J#3$ M0-(*J'2?-"85&W]F*B%9JJ"/(19W`^L__#`C2ZBL[/0WDKYPKWXT:0Z_'H=@\#/W/O\EU$KF](ZI]2/IL5UGA?S]3,+#.<_?"I,[+;^#N_P M#,7FS(:X5?$`5JA"%@K0<#KY&8K`0\LBW-HUBG`C<]8WEG9^YM8J+J)_5TJ[ MP^Z,KURIUR*UUO&2U^\#!-;J/[',]7*L](;.!M(!4< ML96HE5E(7&?*"N1F@#R*<'R549:G7LRPW`B6_W)!Q?4[H:,@D9H&S3L#-E&$ M93:LAA5YZ5`)@+HS\2:F$Q*D>1YA?C->L"JP4)#9X/*I?#=("T5")N[%5)/& M#E4<:/MV%TOH\ZH\59^]_)[=T^#D=1(O9\1@.QP!)&T M1>759-HJ_M":@Y_06L0]4C0U'^R-PNL?H'#K.)X3M@FU5:RB%7M[%7E+?IQ/ M"Z.!@"!Q^+1PSXP*G-HJV]&*R5'WU.1H2U5K7"!F%-7V<&^T+%!LJ[Y(%V92 M>XXA_0,A'\&>:D.)']B#OP\5\]<_P.$5 MV8-,!A5H,[?*C3C^V_S:OWT-L7K>@:M8U6\YD0Z5Y+&33YD,=1D28^\QY"C`A M-C%;$-?6%UG$`()P.YE4GW[$&E)=/068$%L_&Y3J%@.6PMLZ]A6ZJYR'4?>% M(!4<,<%MW'`I>;640]XQ;5_>\%"RYB[LN_M2?_$(0&XX#!@-:N4>YH&*X,:2 MZ1U-C6=+O.WRM>7G>"#LDPN_9M=!,>MFYH=/A+X>JJ:.^Q&"Y!$'ES8^M;`( MP%9T'IJY9WO-6OR&[1LLV/JQ0 M=/@CUGKI'Z*P8-@0=S5GL"%572BN7&!25V/=>`[@XXAELBM/OM)PD'>AT')U MQM:$1&/V&?[NOU;ULM1['0@#1>T&CH;8#KM6D>"V1+3`C/Y/XE/X::_(E(Y& M`"9X(VSX#@H)H>B-L!9!31:P[T0$5* M!\M+UR@9WS_$89?:QW9%RH';BM082\P?(ZE<)I.:MJ#+F+I0R[I^KD(3>1]K MJ]:QV]J(^UU7+-%ER6/J]I*:XBID]@6^]&=!ZH>%N?(!Q$_?R/@FIC<92_%B MY8&*6YN%:FC<%P@)L:787"'XZE:1%DMNQW:N>INYN6Q"-UY@9N==7K^/.+C- MEG8V1)LMSUT[U7?INUFX?M[\(&0$P4S/ZS`TH<6*5X)4<'S@<2JS%GNV/&YN MK>3C?V5)FF^@GN+S\3@HX-S[P?@V*G^?=F(`'F"+'B1!2A[ALQ6,2)'C_4!& M\33*>\FOI)`9WAM^-4@)QPFH41W?#XM=*G%Q_3H+XSE9PN:+YWL"%E4CW\EZ@OAV^CDJ:NT<*;16+:.?>>K>\QFV4TB!*@I%J`]+8.[U>#W/, MF_/MM29_`L6NX^O97RS;C1_0',QP7K4:V#D?2 MB563-8.%Z,35RK$:UWF2D)25GKH+_.<@A"TL2;[E5^21\1!VNZ.,LF+F\``L MN73Y7U#.(%%%HEE[!Q"%PF&G%B9_RELFXF/5%^FC^"98%N'6MD>$^Z.4$CER MFAXOI']72KO#[DPID96&7\Q7__PM(!0X?)G?D3<2*J(M]#H`UE`X!!J=T%4H MZ4RYCA72!8OYSFT7OC)(PZ@?X!"%:=Y$X@J=T8>-H!Z&9=6YC69PS,GYZ@F# M`C5:`3\HK-D5A*K0#A%6!%4TFM.%PTJZ<+CB!X71MU%=V,#:F=H;/*3]2KK0 M7_&#PHS:J"YL8.U,98K2%[9$V@W-8Q]'HJ.E06O@"T48^;YWJ'(^+$52(=(? M'MY*F]*MUL`7BHHBVJ+5WX=RD=J*4L*I&LEJ?NE_;R3-@3)I[0`C=MY\VR)RM$![WZEMPPG%A:'BQE&V]_@!%A=,& M-$`00*;'"(X8&4L*5`KH?/1#\LA8RXF5:8ZP$1"$PA"L*4F!&BC@V8HR<5E? MYC*.DC@,QGX>;0-_YA_[HA8')2\D2H(W.';"\^2.77'OP#F_&M9P4@P$YC5G M>!HKG6%/7O_DR%GPSW*HRHHP&P_"D%&8/BHQ+0BIX0#\6$[R$Q06"YX<-#S= M)T+S0O<\W2=.30-"^E6>[A/A.;^%GNZ5FNJY^<[]DD$ZO:F@0\X;*5U5U?"D#6W.Q;BP6VU#^']>P;R0`<]-L,H`W"`PBUG(G&%SNC#[G0&8,VLKV,4OIL*0E5H MAPAK9_PU+0VX/D81UKC?KYL]YCJ3L_A$?6;U7?NM6$4RB19RGP=.4/@!&Q`T M7Z,D+-BO%+\_X]8#K-)11DIE0AV6LMH=C(892]S(.^E5B($5U&U&KBZW/0_#^`?SS`H-4)7[`C`HK`TJNK<.IO7@=N'BPI4]_3+TDV0X MR>M"JNX'$K7Q3@[=QFG6DR=_:56@[<(EAF5DRM/E[L-`!(HCI$)2`A>1``[* MJP"U-%JV=Z_0"\R-[DSJROA1W@CX&_'#].42Z!O2J1\%?^4RN8<_@<]%'>`% MSASS19#[OH6*4;4_H,CI`E!9JASEJ,^.,K M\IS:4"7]EP''3@/0'>F9*4&6+%D8(MP-6+HC27)/X[<@@2?D&FJQ=]@L.+5; M65))ZXS8LD?5",)K9AF\)Y1=%NM/A>=G:R\`)IU:L1`M=]ND-%26"X%ERV&D M5EDRZ^QUIFO1^+Z$OA1IMDYLU\DHLM&_US\]=68L69U"%N)[C#/0RX2OW,K\ M`#R*##R+DA087:IR\[%"O,Y0^&@K"TLCF.M,Z)GM7C#7F=N=I(A^53#7 MF7"[U\)@K@<2L@C^>Y^F\R?J1PDL5``JN9B7?Z,PD.MW`NRA<%1:FL)5">A, M"%<9GM*2OOLPL($BK]!4?FHM*./K3-15D5&RVME<^"$[JSR^$)+"1FA]/V8I MZOUB#O^9Q8D?PL$JFR6K-+?9X#(C_-_]5Z)B'@^3`E<^Q%?%H1Y[R?^F$2^GC3Y3S-\*+Y$UL4IQ6LI MH=UIB`G_&_U`1B1X8Q]J6"H7'_72.BF+9+#3,6,8Q8[;\M[&"BNV*M0[5;SS MT8C"="S%W5YFE$FDB+4=%?^1*)A>!][1`8H/C17!\W7*A`A;>?5.56=9(^+> MGS/J+I6JPF\`C*!(W&M0-63`;96"=ZH*K)S(9?YIG[*;'NY)?I'T9>@'K\GW M3)%FI6[L'?506/(;5!%=$FR5?K>[>RU&.)Q<^@E);H*0C+_%^>9.M($5-@"4 M*(ZM#8A:![BMRNZ85H.%G7/-';!*Y_#+//4G__%,&H=4J3_@L^L[CAJ\"/3, MV,AL=QE9#QUPA2')K>I%@3[10B)I`MP=HSB\-+66J+$+Q&QL6+5LZUA%*\$Z MF'_A_BM(7^[C!';-;^0A"V5!V%J-&?Q.?T9,6!`H@;$)T_9<#UZ?,YHL+FOX M/6'Q;-'X,DO2^-6G\_-L',!J=OGBTRE)U&&%5?MC)'7U0V&#&('V.#:7?@NB MX#5[7607/)`_LV!QVUQ,-P"+U$6[`T8#"J-J4_IARH1`(?9E;]4Y@9S_\.DX MN?>#\<7\-@(BF,N)[88"0O6.)-(>&!%=-5E4HT(0@K8O4ZA`)Z0C/W]ER2$B M9=!HRJ"CR.ML2@OT.1"(?U_F3)TEX3;ZKY=@]%)@^AZG=18'S;X8.2C"D?>R M3)B1(M"8?5D]!1JS9-%X./E''(*NLZT2`[>NO$W)O[+QE'T:)16F[73, MA-!5$ZA5A@2*Y=@^NO`-%;$P&VXAL==$KR&#C:(R5&-?(4T&!()WG(*^I=;% M5Y,YL9EZWT9LY1Q.UD%0"UOP5U@R4R*T>=7JE-&%(J9Z3RM))78$RN38/+J\ MI.0V6L;!\'(!15JCUYH1T.FSC1$-`CUP;#]=*^]2UW5U0-V2`>_VJ4:7`H'L M'9M-U7[B[^R2C>"-A//SR83Y!)A19Q2_$3HOKWM:5K)FWL8([O3!J%':!'KI MV""[<19DOHCA;!;3-(M@@7V*KQ-VRTR0O%S2`+;K@:]USE9W`Y3@N$-Q+T=L M;3X$*M*ND-@[F`/3G,9'DJ9A/@6$1CMU(T9-5P]*VN@%>:AU[+3[JPG!OZ'* M?5T(_K@T"C[(&WI'/6>5'+X%40Q+RGPY)E6M!N[S``#%5UZ'9OY\DL#Z4(44 MC@Y1?&0EXMCZ=(HP?)!2"4>.BVZ)Z-^5TNZPNU,JP8?=OZH2PO(9P(["**<] MQ00(NE.I@.%2WA!2>@KPHP@VW!*(1&KE<5NJ.>#TP+"MNW<:Z7'"-D`+BJ@? MXPFI0-293/MMG,,?$8SI)9BM(]@NYIM;O^(1`VW0[A.X16$T5PA?3V,,45M* MD'=RI#P?C;+7+`^;E]WF[O!6C>L_,[:%4A\F-Q\$T9Q9L^TQ5N((6$^&$QE- MTFLSC#KQCOHH3AP\4CE6N@K8/M;YL>^^"'`%&6D<*OOBR`/LHC0^5/;=5ML5 MT:\Z5/:%QY(6'BIOHTE,7W/.+^:7\-V:QLQCQ"I++RZW4A7?T^P!>'-ZG+$S M9RN![LP9-J?LZ<6/G@CP2'TZOWV=^0'-[X`!&$'*R"/)HLKR7RS*ZMJG$G%99KJJQ=X)L4&1T&:D27QL;Y@A!_<":&TG9R;U:1\", M^UMZZF]!:F#OS,'__`W.8HRAFY@^^B%97^JH<4I2-_9Z!V[C(^L(F;_>:(.V M=)3'<#.*YLE>0LWX7UFQN'XGZ7#RY+_+U,K^VYA(4!B4M;5'H'R-46.ICM\L M3YA_3'V:NM^M<=C18>:"P*:$`#5%]O\RQO6*%'_K7#[1_-N9V)QNX>ROK/MC MS5*10PQ+LXBTWR,`'K+M[F]QR`(FO\*6EHEB&)7XHT'"2DEF[`+H@KD5D174 MN_8[F7A0E`_8GRJ:305;#-NJMHAY!EC-:T=M3UF+!5'1/S)H''4''_S'DTYO/5V.FPL;$P>;;'_U3KK-@TA[9* MBN[.":QQ.@YS02J'ZQQ5"-?9Z_Y-E0)BTHUW-$"QX>()H=;6J(3.4H"/TXC: MU:T]EZ$/!_;)8QJ/_E#$%PC;`"TH\N_,1)H@"*BJ)H*[<<*OZ+)4E"1RT/$NB('8-T\*C@)[0O&.CIV::JK.ULI0N[`UEX!>0]:Z?=JP)^\$AV'/6.K&RB-& MWX54^JU+N^_8FY@$5:E%PE;>R9';KT?-940)S5)X/4:I*Q<):3OO!,?U*4H) M&@F^C,U^`KP#2W_VG)`_,T!X_09_/,'[5'9^?@N@Q&DX9-V)+H7E]N;XQB2M MG.#"-EZO=XBB6K!4;-J2W@#5A6OEMS`JZQEQGV=\H`@!54E,2\X;F!Q?X6YL M5I-Y9'2;,N@H%Z_C^=#L+PA.+\\OH/`].>'P!EI/S47YO(^_. M&(U6C&+,VW:]%4`-L!O7JW.J?%^_STB4R.+S)*V`G*/VK@3Z`!NX]'Q_WNO; M:)PE*2@WF2Y=DE])/*7^["48E8J2.*Q5MQC:`V%7%(#T-'S7HB;>T=;]W?N$ M,7HAXRPDP\GVZ#9JORQ^J8J+K=`;@$>14BH7CN"T517NQW*!X[")5A:6AF=< M;!GMGF?<[6W00OI5GG'QSG\N^64L5*-O!4DA"*?J:ZR-DY1ZVW!Y]42%OJC#WX!$5"E%PX%NW!)Q\N)>JDO6:F$[U,J9,/E"GEMF*B MD'Z5/5AW!^.X.UY#4%KV8'&MO"[9@T]QF(EV MJ3>Q!Y\*#3[_M@>O.,)DI!$+V@!-=^S!RQ5K<7J'4\,H!4UG]486A.E^D.4] M`&\XK!\-?9IUT'?&,+Q`QL&L^]T6-@6F<`17F0A6^E%70+5DLD6C%,VZEDZ[ M=!`WAV[+-.I>6XHT?8D^%`\`;!R1'MHBXHNXC*:IS">TUFV'!7^MVKC/>A_8 MQGV&Z;0F$(Y%&_>9\%S751OW&8Y36E5A:=BXSX0GM^[9N,_<9HR*Z%?9N,^$ MQZ0VV[C7'T<_U#U.;[4 M#">""P3N<_)?2,H^Q$YL92N7QV1QL24K]+![W:6&"T.!B'Z%<2L?=O>, M6UIGI)V'@0T@QJ&4FMS&4T M7;CE]39Z(\6%\1K7.>P^#$0XW>Q4G:HB)%VXV&D3VR7H^S2FBVH.&DD4JL9` M%`H+A4B$.@(7X^K"Q4QV(SZ.3YS:&&M_C/F`NG`5D]UHCF,D"5)RN9E&B" M\I.KUP%0=H3";FP@WVH*LH'75AJ24Q7Y%M-TZD_)7>Q'R3!BD237"=O'7)%D M1(,<'4,^G-S3>$:HT"%-#L8C^72GM#OO?477+.",2L@]&7K,=]B07\]\3,KZ- M.%6!-#[NYIT!FS@RSP1RYFM%59S(DD>K:PT@GP2I(F-H_1"@1Q&H555N?"W8 MQM>9.HOGXW]EA4L\>8H?R"B.1D%(@+QU-M!3;&_5:.)UWN`0A?'"KL8UQY0E M1RB&?.DK`F,>!86DH_'Y*TL#+.(Y)$HH:04,H7"`-R=]OK8I*;'DA<6@--]\ M^@=)V6ZP4G*L3G/@#(6I8-]JI,]-70?Q6:%/$1S3TL6SS@Y*[/[X"Q]X8ZD3 M)$I4ZP^_`?""(H]SWSHC8Z.Y^W?VKR;KG)FK()G%21%WD#8$H M%.?L?:N-#BNU_ MH+"+?.&QA8W@B`1O"I>;3G-OT$=QMXZID'55182XMF,;]2JSBQH.HGE&\GH. MJBIUU^C5&^"XP'5_2B4E0J!K^O9KU+JVO.43*&"7Z8Q)-*ZZ/,F[@HF+(IZS M*:W202]0)7UC.7)5>@/^8PH;`T.]6;4#FE`8L)M3DBVH`HW0-T&CUHA[2F9^ M,+Y^9\8,L\5DLRF0U>E/$@^M0#7T#7V*:/A'ZNB[`H0@FT^@`:$-Q M:JHJ<&&@F39V@^=\]&<64/+-!]8C0N?GT9@EC<[8KV4JH]4! MT(8B+,.RRAA@%ZA,*TW(NU/%6&OT>@#J4"2.-+W22,`+],8XG!GQCII#HYT= MM6;'0#0*;[M=+;/!B4#YS*.ML>ZH;X+(CT:6=M22SH!.%+YV*SMJ)4Z!VK3P MII\',EM\XX>3[W%*-.R'HB;>8(#YW*X4*E]%Y&@%BM!*F_(3,WUE=/Z8QJ,_ M_N&'&5EL^L;W/LW__XVD+[$L!$RW"Z_78?RA,.,VM-EH$"'*"]>W1B!8@?2KM[)XU.P:B M,1_M*VJ:#4X$RM=">S2C@ETJ!7^QX^D;'%J9@S"_:F+;.211-)-N@$(41W^S M';,Y0H&2F%N?D2K).:0!^,3C%8(_>I]XU(8A59<1X[S]K+9+,QY\L-E(:72!:(Z!:[T>@#R M4%CVS/3"")Q`,_9:[D)0-"_?0/G!N+B8ZI_$IS_,UA>, MX:`DCY7;>A@(<5_ZLH9H^7@$`FYEE8;E@L8N:(=_KAU&T9AS_+T*DE$8)QG5 MN1.Z;M=`-HK($_-]7GW4`A5KI3GT_,T/0N8F@&G'/.#KFA67+^Q&@]L(9I;P M[DN)@M7K&(A&$?9O1V'XRFB#(4%=/@M1OH)ROW_[PK`\^PG)9?/_`5!+`P04 M````"``Z93A'98Y5_V@.```SHP``$0`<`&1Y:6DM,C`Q-3`R,C@N>'-D550) M``//)P16SR<$5G5X"P`!!"4.```$.0$``.U=W6_C-A)_/Z#_`\]/>P^.XV33 M-L&F13XV>P9V-T&2[0>*HJ`EVN95HER22N([W/]^0TJR)8ND/NS=JCB])++( M&<[,CQP.1Y3XYON7,$!/A`L:L?/!^.!P@`CS(I^R^?G@T^/-\-L!^OZ[K_[V MYN_#(7I'&.%8$A]-5^@:2_S(L?>[R.C1^&!\<(K@XO!T^$"6PZ/#\0GZ93P^ M.QJ?';[^%?WGXL-_T=N'1S1$S\_/!SYPD)K#@1>%:#A4[0AO04*,).9S(C_B MD(@E]LCY8"'E\FPTTG0KAKT_%,U(M7!X=`1"DH"$A,F;B(?79(;C0)X/_HAQ M0&>4^`,$:C)QYJ\HK6:EZQ:J/1\?1'P.50['HY\^O'_0,F9,`\I^+]1^F?(@ MJW\\4L53+$A6797Z`^,\4^JH3)F0F'D;(4I"IRJ. M3T]/1[HTJQJ+X1SCY;KR#(NIKIH6:,,-#\?#XW%&XD4QDWQ5U%$0[V`>/8W2 M0D5VO$46[Q*"`@@2>'Y&498(9EQ%4S:+T)]Q0_?M,"?P(Y$A=?+J?V!R#5NPZ M\F+E7RZ8_Y9)*E<38,A#W$8'&)&GK\$5BCA MA7+,WHRV.7SUMVWVL2#^+?M.7P-\`KAI6N4S4OJTBIMVTTA32@\'7AQ8&TW) M1@4D0#KD12=/!^4,D() MIQZ9ALC<87#IW2Q42@AR& M86:IY\;NM0N[#4<4S="&9X]:,]2NHA!,L"!,T"X+T`7.%P&W-P0__U7J#O/?2.70&+Q4T0/5>-[G4U-ZC? M-``56"+-L\?,C%F244E'8O;#;?]OU0J!"B^(1,P)RK(R06]BLXDOL:#0O>]R MZB;F-A6X37^Z;7K-0O7T/),>"#,0]\0+L!!T!EY\@T+IKA."\>$V!-OTO?4M MLP/XX@OFJW]O_XCI$PZ4ETZG!'.9&XGQ-A+:VV/F)Q4M#>WV=R?!+F=O162AA#^IQ;?NNP)$\98;@&^V`D3,B-Q@RG_`00R3P`UEF'D4!Q,F)->/-M,YHJJ2&Z/2K1L:5.(`2- MR3WQHGDB\B$FX!MKYA$D"BLML068XLTW_XA9G,@KZ#3 M0X>'V6"]7B_>:I_=C@K7N>,3@TB.Y^*RBCAN6TIH^ MX88V[%"17X^4+9GEQQ#`KA[(7-OI@OGO2#3G>+F@7FD?8NW:;O1*F8",+\H8 MZRSPAG6_1;'&,A4"7_VDJC"HHH`J1Y7]3U>MM:JZ,2PE$W),"\,P98=>95?] M5-4DW_:H4O'"D75+*[C1*J4U@2PWU,.V6 M(\KC5:^J$[CCUH4Y.%M2./&MY0*:;)`Z.%MOFOQFDA,`_%(7F2<;1FMKN8&L90Z,>YH M1*]2IBCEVL.VKRU=)E!W9>*&O)26:;O=J^\5;3:`F0!WE+NQ+&_7T)O#4E8] M0#NMZE/C.9;U60TW2*4LC&-=GW+L@6H!5'%(U:CHAJU).J8?9RTV1YE@&I01+K71U[S3W`6-A/#8C<8-: M2K@T`;4?HXT?1A2&I;W8#9IA)XOA<40_\EJ"4QALE;7<4)4R(BZH^O'4:LNK M.855HZ8;NG*>Q+P=MH=OST\`"SZR(8T;TE(.I>$SP-ZE[A/@PH!M1^J&NY2# M:0=W/ZZ;[)M(*Y(TIT8/M_1`N,^<;Y;>B=2.^X\Z;?I;=PV9]8]ZV`8$; MX5*6J'+C_O\QJ.J/^L#^/9DA_>7Z,_51\/.!H.%2?7`GN;?@9'8^4`<`#+,O M_?\&2A^\A$%61;7@^(:^[A3;=DH;SEBDWT%W?UD?F$1+PM4>FE$F_`"-]J@8 M(-)4L2*(W50KP-.F:@$)";JK$0R`IAIMC9G]ZI6,M_SW\N%7_GOZ^A:H%7&) MF/%T#MO!$\G!'N^CY#-]#A+U:YC1#=6MX?AH>#P^>!'^QOI-A-CHV$R(C*Z% M$.9C/6HVGQ&H=D_JMN@\E\/2L&[42#@B@139G>&&52/]'6=DN`0RD*77PPV+ M5H*8SAZI(TF>+ONQLRRF\TQJ"9,G7/\:;MBT$J=T]$D=4=9$^FK7;E(^%J6. M#!NJY'*X8=!*BNVS5NK(D-&HBYW;WSZ&I98`&9&^:B%"^4@7/=DP,E?)NWJ> M*^"\0*76@;9IMH5)_/90W^K)Z5%Q>TO/7='+;MD%E4^%;Z- MV1U%;')9U<#S/(%*/EP&^KN'B2;)D5]G,KMOTF:&`_'9U+'*9^UCI?=5.Z:3 M4T*+5ILW?";LGN``#*+Q97[^S1.=3%IU3=^6LELLH4YN].,`.@6T*41J3,5- M/>52RL0XN`B"Z%DM/O4[BETSR&XJ5-K%\$;A8_+AZB_LG'QYM@!*[L53,K&9 MP"ZM15$#P7O*=`/BS_>_;NDJ1_?FW;S.0>80LH%:'8*J0CSK_**#'[T7(MG\ M`,L!PL065F$$ZQ?,5WMR+4G=:7+NW?G`X\2GLLF48Q7:HN9;S!D@HEZ_TF]( MJ7[M`8MK&L2P,.Q<[ZPG;SME.]1GZTMJ4;7P>E9WPE:+6)5S78&NI2U-(0\%W5+]# MD4X+D>W*AU2F2_K1))ZJRUYQ2+-JB2?Z)UJ3F-7VB`OBDN^DZ,]E9);-U72P6=YCZU['JE6JJO(EX M=Z+V"O%LG;6TLZYSX]`JXEZ2DMW3MYW\%F/\D^!`+JX@4KGEQKJD(Y.X1K' MN1U2K):05@7Y,@(!8)J:0:]7J]HNNSRSN+;U=NY1J'X<0?S+E3J!>:EM);-X M^![X[>J4K-%[[?5W(V&M#U*6>!4F"SPWPRX'!DVTJ`']FEV'H\9NB0 M^[')9=^P1.B3_L[Q510$Q--S;W>@<+V/ M"['XGQ?WU!33"AP-IS$7^M[M[)-0P0%,.+&0L.SGJXL81CGQKQ:8SXG87[RW MLVMM+[C%$A\HHV$P+NB.MRB*,+C75X)FV@0YUT]L4SYKY0B8O+U82! M.U!"083-*>'=RV]72&N+;EU4%Z$*+KN6 MVV($E1G?1->K>S*+F7\[^R$*P'3*C2C&$^8%L:\/A2/_BOUYLD4O.Q2SL]Y@ M#[K9EX0@GY\\7"BDG*_VECK_7%:I(7N]OI(,K]M98M<)4_WQ=K;)S*>/VMY! M1]3OE736(COJ9LJ4/G@+^OM?R'=ZPA?SV?=$:9\?;).2";2C^H--E@I!*N+ MV4PMC%3@Z$5/A*_RH]X1`K<)`W:._S^78G6");7`NEVJ=Z1B!AWQ,5([]:`L``00E#@``!#D!``!02P$"'@,4````"``Z93A'RV"M&48*```2 ME@``%0`8```````!````I('.L0``9'EI:2TR,#$U,#(R.%]C86PN>&UL550% M``//)P16=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`.F4X1XTK2ZUG,0`` M&2P#`!4`&````````0```*2!8[P``&1Y:6DM,C`Q-3`R,CA?9&5F+GAM;%54 M!0`#SR<$5G5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`#IE.$?YXB3)P%`` M`)V%!``5`!@```````$```"D@1GN``!D>6EI+3(P,34P,C(X7VQA8BYX;6Q5 M5`4``\\G!%9U>`L``00E#@``!#D!``!02P$"'@,4````"``Z93A'HUE&UL M550%``//)P16=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`.F4X1V6.5?]H M#@``,Z,``!$`&````````0```*2!<'H!`&1Y:6DM,C`Q-3`R,C@N>'-D550% K``//)P16=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``".)`0`````` ` end XML 19 R25.htm IDEA: XBRL DOCUMENT v3.2.0.727

Recent Accounting Pronouncements
6 Months Ended

Feb. 28, 2015

Accounting Changes And Error Corrections [Abstract]

New Accounting Pronouncements and Changes in Accounting Principles [Text Block]

Recent Accounting Pronouncements

No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Direct Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6510796

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Indirect Effects of a Change in Accounting Principle

-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.10-01.(b)(6))

-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Accounting Change

-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 250

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56949863&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Retrospective Application

-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 270

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305

+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 20 R50.htm IDEA: XBRL DOCUMENT v3.2.0.727

Contingencies (Details Textuals) - USD ($)
1 Months Ended 12 Months Ended

Apr. 30, 2015

Aug. 31, 2014

Sep. 30, 2013

Aug. 31, 2014

Feb. 28, 2015

Commitment And Contingencies [Line Items]

Interest Payable $ 11,300,000

Additional Interest Payable Current And Noncurrent $ 3,700,000

Treasury Stock, Shares, Acquired 530,616 125,000 530,616

Litigation Settlement, Expense $ 2,047,652

Subsequent Event [Member]

Commitment And Contingencies [Line Items]

Treasury Stock, Shares, Acquired 427,886

X

- Definition
Represent additional interest payable.
+ References
No definition available.
+ Details

Name: dyii_AdditionalInterestPayableCurrentAndNoncurrent

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Commitment And Contingencies [Line Items]
+ References
No definition available.
+ Details

Name: dyii_CommitmentAndContingenciesLineItems

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of interest payable on debt, including, but not limited to, trade payables.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.15(5))

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.15(a))

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_InterestPayableCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.
+ References
No definition available.
+ Details

Name: us-gaap_LitigationSettlementExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 21 R42.htm IDEA: XBRL DOCUMENT v3.2.0.727

Stock Based Compensation (Details Textual) - USD ($)
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Stock-based compensation expense associated with the Company's stock options $ 49,341 $ 49,341 $ 98,682 $ 98,682

Total unrecognized compensation expense for outstanding stock options $ 82,000 82,000

Employee Service Share Based Compensation Nonvested Stock Options Compensation Cost Not Yet Recognized Period 6 months

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 0 $ 0 $ 0 $ 0

Year 2011 Stock Incentive Plan [Member]

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Common Stock, Capital Shares Reserved for Future Issuance 15,000,000 15,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 250,000 250,000

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 14,750,000 14,750,000

Year 2000 Stock Incentive Plan [Member]

Share Based Compensation Arrangement By Share Based Payment Award [Line Items]

Common Stock, Capital Shares Reserved for Future Issuance 5,000,000 5,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 534,000 534,000

X

- Definition
Employee service share based compensation nonvested stock options compensation cost not yet recognized period.
+ References
No definition available.
+ Details

Name: dyii_EmployeeServiceShareBasedCompensationNonvestedStockOptionsCompensationCostNotYetRecognizedPeriod

Namespace Prefix: dyii_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415241&loc=d3e4534-113899

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11149-113907

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11178-113907

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Aggregate number of common shares reserved for future issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AwardTypeAxis=dyii_Year2011StockIncentivePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=dyii_Year2000StockIncentivePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 22 R37.htm IDEA: XBRL DOCUMENT v3.2.0.727

Net Loss per Common Share (Details) - USD ($)
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Numerator:

Net loss $ (1,719,796) $ (517,565) $ (2,720,293) $ (1,226,426)

Less: Net (income) loss attributable to noncontrolling interest 33 (59) (85) (33)

Net loss attributable to Dynacq Healthcare, Inc. $ (1,719,763) $ (517,624) $ (2,720,378) $ (1,226,459)

Denominator:

Basic and diluted average common shares outstanding 13,888,010 14,418,626 13,888,010 14,436,483

Basic and diluted loss per common share $ (0.12) $ (0.04) $ (0.2) $ (0.08)

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations attributable to the noncontrolling interest. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568447-111683

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 23 R52.htm IDEA: XBRL DOCUMENT v3.2.0.727

Industry Segments and Geographic Information (Details 1) - USD ($)

Feb. 28, 2015

Aug. 31, 2014

Segment Reporting Information [Line Items]

Total Assets $ 41,959,020 $ 47,760,527

US Division [Member]

Segment Reporting Information [Line Items]

Total Assets 15,118,700 15,967,472

Corporate [Member]

Segment Reporting Information [Line Items]

Total Assets $ 26,840,320 $ 31,793,055

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=dyii_UsDivisionSegmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_IntersegmentEliminationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 24 R47.htm IDEA: XBRL DOCUMENT v3.2.0.727

Noncontrolling Interest (Details Textual)

Feb. 28, 2015

Noncontrolling Interest [Line Items]

Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 1.00%

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_MinorityInterestLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.
+ References
No definition available.
+ Details

Name: us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

XML 25 R9.htm IDEA: XBRL DOCUMENT v3.2.0.727

Basis of Presentation
6 Months Ended

Feb. 28, 2015

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Presentation and Significant Accounting Policies [Text Block]

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.1 million and $1.0 million for the three months ended February 28, 2015 and 2014, respectively, and approximately $2.0 million and $1.9 million for the six months ended February 28, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and six months ended February 28, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.

X

- Definition
The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R43.htm IDEA: XBRL DOCUMENT v3.2.0.727

Fair Value of Financial Instruments (Details) - Fair Value, Measurements, Recurring [Member]

Feb. 28, 2015

USD ($)

Quoted Prices in Active Markets for Identical Level 1 [Member]

Assets

Investments available-for-sale $ 0

Significant Other Observable Inputs Level 2 [Member]

Assets

Investments available-for-sale 17,885,213

Significant Unobservable Level 3 [Member]

Assets

Investments available-for-sale $ 0

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 25

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=51813488&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 5

-Subparagraph (aa)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49167202&loc=d3e26610-111562

+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 27 R29.htm IDEA: XBRL DOCUMENT v3.2.0.727

Stock Based Compensation (Tables)
6 Months Ended

Feb. 28, 2015

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following table summarizes the stock option activities for the six months ended February 28, 2015 (share amounts in thousands):

Shares

Weighted Average
Option Exercise
Price Per Share

Outstanding, August 31, 2014

995

$

2.18

Granted

—

—

Exercised

—

—

Expired or canceled

(211)

4.27

Outstanding, February 28, 2015

784

1.62

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

The following summarizes information related to stock options outstanding as of February 28, 2015, and related weighted average price and life information:

Options Outstanding

Options Exercisable

Exercise Prices

Number of
Shares

Weighted Average
Remaining Contractual
Life (Years)

Number of Shares

(Share Amounts In Thousands)

$1.10

250

6.9

188

$1.86

534

6.4

401

Total

784

6.5

589

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R28.htm IDEA: XBRL DOCUMENT v3.2.0.727

Net Loss per Common Share (Tables)
6 Months Ended

Feb. 28, 2015

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The following table presents the computation of basic and diluted loss per common share attributable to the Company:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Basic and diluted loss per common share:

Numerator:

Net loss

$

(1,719,796)

$

(517,565)

$

(2,720,293)

$

(1,226,426)

Less: Net (income) loss attributable to noncontrolling interest

33

(59)

(85)

(33)

Net loss attributable to Dynacq Healthcare, Inc.

$

(1,719,763)

$

(517,624)

$

(2,720,378)

$

(1,226,459)

Denominator:

Basic and diluted average common shares outstanding

13,888,010

14,418,626

13,888,010

14,436,483

Basic and diluted loss per common share

$

(0.12)

$

(0.04)

$

(0.20)

$

(0.08)

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 29 R44.htm IDEA: XBRL DOCUMENT v3.2.0.727

Fair Value of Financial Instruments (Details Textual)

Feb. 28, 2015

USD ($)

Significant Other Observable Inputs Level 2 [Member]

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Trading Securities, Cost $ 7,984,646

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cost of investments in debt and equity securities and other forms of securities that provide ownership interests classified as trading.
+ References
No definition available.
+ Details

Name: us-gaap_TradingSecuritiesCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 R30.htm IDEA: XBRL DOCUMENT v3.2.0.727

Fair Value of Financial Instruments (Tables)
6 Months Ended

Feb. 28, 2015

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of February 28, 2015, segregated among the appropriate levels within the fair value hierarchy:

Quoted prices in active
markets for identical

Significant other
observable inputs

Significant
unobservable

(Level 1)

(Level 2)

(Level 3)

Assets

Investments available-for-sale

$

—

$

17,885,213

$

—

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258

+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R31.htm IDEA: XBRL DOCUMENT v3.2.0.727

Revenue Recognition (Tables)
6 Months Ended

Feb. 28, 2015

Revenue Recognition [Abstract]

Schedule Of Gross Revenues And Contractual Allowance [Table Text Block]

The following table shows gross revenues and allowances for the three and six months ended February 28, 2015 and 2014:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Gross billed charges

$

8,059,057

$

6,618,079

$

16,317,829

$

13,658,418

Allowances

6,304,169

4,386,692

12,244,263

9,167,784

Net revenue

$

1,754,888

$

2,231,387

$

4,073,566

$

4,490,634

Allowance percentage

78

%

66

%

75

%

67

%

X

- Definition
Tabular disclosure of gross revenues and contractual allowance.
+ References
No definition available.
+ Details

Name: dyii_ScheduleOfGrossRevenuesAndContractualAllowanceTableTextBlock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenueRecognitionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727

General
6 Months Ended

Feb. 28, 2015

Accounting Policies [Abstract]

Business Description and Basis of Presentation [Text Block]

General

Dynacq Healthcare, Inc., a Nevada corporation (the “Company”), is a holding company that through its subsidiaries in the United States develops and manages general acute care hospitals that principally provide specialized surgeries. The Company through its United States subsidiaries owns and operates one general acute care hospital in Pasadena, Texas. The Company through its subsidiary in Hong Kong invests in debt and equity securities, including short-term investments in initial public offerings and pre-initial public offerings.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R32.htm IDEA: XBRL DOCUMENT v3.2.0.727

Accumulated Other Comprehensive Income (Loss) (Tables)
6 Months Ended

Feb. 28, 2015

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

The following table summarizes the changes in accumulated other comprehensive income (loss) by component:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Available-for-sale securities

Accumulated other comprehensive income balance, beginning of period

$

10,945,401

$

11,203,250

$

12,616,346

$

9,382,334

Other comprehensive income (loss):

Unrealized gains (losses), net of taxes of $-0- for all periods presented

(820,553)

750,396

(2,491,498)

2,571,312

Other comprehensive income (loss)

(820,553)

750,396

(2,491,498)

2,571,312

Accumulated other comprehensive income balance, end of period

$

10,124,848

$

11,953,646

$

10,124,848

$

11,953,646

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of accumulated other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

+ Details

Name: us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 34 R40.htm IDEA: XBRL DOCUMENT v3.2.0.727

Stock Based Compensation (Details) - 6 months ended Feb. 28, 2015 - $ / shares
shares in Thousands

Total

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares Outstanding, Beginning balance 995

Shares, Granted 0

Shares, Exercised 0

Shares, Expired or canceled (211)

Shares Outstanding, Ending balance 784

Weighted Average Option Exercise Price Per Share Outstanding, Beginning balance $ 2.18

Weighted Average Option Exercise Price Per Share, Granted 0

Weighted Average Option Exercise Price Per Share, Exercised 0

Weighted Average Option Exercise Price Per Share, Expired or canceled 4.27

Weighted Average Option Exercise Price Per Share, Ending balance $ 1.62

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price of options that were either forfeited or expired.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 35 R53.htm IDEA: XBRL DOCUMENT v3.2.0.727

Industry Segments and Geographic Information (Details Textual) - USD ($)
6 Months Ended

Feb. 28, 2014

Feb. 28, 2015

Aug. 31, 2014

Segment Reporting Information [Line Items]

Balance from marketable securities $ 17,885,213 $ 20,678,130

HONG KONG [Member]

Segment Reporting Information [Line Items]

Gain (Loss) on the initial public offerings of equity securities $ 161,864

X

- Definition
Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Such securities are reported at fair value; unrealized gains (losses) related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain (loss) of an Available-for-sale security that is designated as being hedged in a fair value hedge is recognized in earnings during the period of the hedge, as are other than temporary declines in fair value below the cost basis for investments in equity securities and debt securities that an entity intends to sell or it is more likely than not that it will be required to sell before the recovery of its amortized cost basis. Other than temporary declines in fair value below the cost basis for debt securities categorized as Available-for-sale that an entity does not intend to sell and for which it is not more likely than not that the entity will be required to sell before the recovery of its amortized cost basis are bifurcated into credit losses and losses related to all other factors. Other than temporary declines in fair value below cost basis related to credit losses are recognized in earnings, and losses related to all other factors are recognized in other comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Available-for-Sale Securities

-URI http://asc.fasb.org/extlink&oid=6505594

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49167202&loc=d3e26626-111562

+ Details

Name: us-gaap_AvailableForSaleSecuritiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) realized from securities classified as trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(c))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Trading Securities

-URI http://asc.fasb.org/extlink&oid=6526789

+ Details

Name: us-gaap_TradingSecuritiesRealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_HK

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 36 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727

Consolidated Balance Sheets - USD ($)

Feb. 28, 2015

Aug. 31, 2014

Current assets:

Cash and cash equivalents $ 14,282,560 $ 16,819,504

Accounts receivable, net of allowances of approximately $125,799,000 and $154,132,000 1,611,933 1,986,633

Accounts receivable, other 355,531 380,456

Inventories 262,603 298,662

Interest receivable 104,461 122,041

Prepaid expenses 108,025 262,944

Total current assets 16,725,113 19,870,240

Investments available-for-sale 17,885,213 20,678,130

Property and equipment, net 6,360,673 6,224,136

Income tax receivable 800,920 800,920

Other assets 187,101 187,101

Total assets 41,959,020 47,760,527

Current liabilities:

Accounts payable 1,394,843 1,015,856

Accrued liabilities 17,464,214 18,512,986

Current portion of notes payable 0 6,734

Current portion of capital lease obligations 29,689 26,513

Total current liabilities 18,888,746 19,562,089

Non-current liabilities:

Long-term portion of capital lease obligations 26,067 41,123

Total liabilities $ 18,914,813 $ 19,603,212

Commitments and contingencies

Dynacq stockholders' equity:

Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding $ 0 $ 0

Common stock, $.001 par value; 100,000,000 shares authorized, 14,418,626 shares issued and 13,888,010 shares outstanding at February 28, 2015 and August 31, 2014 14,419 14,419

Treasury stock, 530,616 shares at February 28, 2015 and August 31, 2014, at cost (27,061) (27,061)

Additional paid-in capital 10,578,427 10,479,745

Accumulated other comprehensive income 10,124,848 12,616,346

Retained earnings 2,289,683 5,010,061

Total Dynacq stockholders' equity 22,980,316 28,093,510

Non-controlling interest 63,891 63,805

Total equity 23,044,207 28,157,315

Total liabilities and equity $ 41,959,020 $ 47,760,527

X

- Definition
Amount due from customers, clients, or other third-parties, or arising from transactions not separately disclosed, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.
+ References
No definition available.
+ Details

Name: us-gaap_AccountsAndOtherReceivablesNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Investments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer. Such securities are reported at fair value; unrealized gains (losses) related to Available-for-sale Securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income), unless the Available-for-sale security is designated as a hedge or is determined to have had an other than temporary decline in fair value below its amortized cost basis. All or a portion of the unrealized holding gain (loss) of an Available-for-sale security that is designated as being hedged in a fair value hedge is recognized in earnings during the period of the hedge, as are other than temporary declines in fair value below the cost basis for investments in equity securities and debt securities that an entity intends to sell or it is more likely than not that it will be required to sell before the recovery of its amortized cost basis. Other than temporary declines in fair value below the cost basis for debt securities categorized as Available-for-sale that an entity does not intend to sell and for which it is not more likely than not that the entity will be required to sell before the recovery of its amortized cost basis are bifurcated into credit losses and losses related to all other factors. Other than temporary declines in fair value below cost basis related to credit losses are recognized in earnings, and losses related to all other factors are recognized in other comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Available-for-Sale Securities

-URI http://asc.fasb.org/extlink&oid=6505594

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=49167202&loc=d3e26626-111562

+ Details

Name: us-gaap_AvailableForSaleSecuritiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of capital lease obligation due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_CapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 840

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.(a),19)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.17)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 5

-Subparagraph c

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_IncomeTaxesReceivableNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_InterestReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655945&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesNoncurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 27

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 7

+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_NotesPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51662447&loc=d3e5879-108316

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Assets

-URI http://asc.fasb.org/extlink&oid=6509628

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4I

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568447-111683

+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 37 R45.htm IDEA: XBRL DOCUMENT v3.2.0.727

Revenue Recognition (Details) - USD ($)
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Gross Revenues And Contractual Allowances [Line Items]

Gross billed charges $ 8,059,057 $ 6,618,079 $ 16,317,829 $ 13,658,418

Allowances 6,304,169 4,386,692 12,244,263 9,167,784

Net revenue $ 1,754,888 $ 2,231,387 $ 4,073,566 $ 4,490,634

Allowance percentage 78.00% 66.00% 75.00% 67.00%

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dyii_GrossRevenuesAndContractualAllowancesLineItems

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Health care organization patient service revenue contractual allowance and discount for bad debts.
+ References
No definition available.
+ Details

Name: dyii_HealthCareOrganizationPatientServiceRevenueContractualAllowanceAndDiscountForBadDebts

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Health care organization patient service revenue contractual allowance percentage.
+ References
No definition available.
+ Details

Name: dyii_HealthCareOrganizationPatientServiceRevenueContractualAllowancePercentage

Namespace Prefix: dyii_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Health care organization patient service revenue gross billings.
+ References
No definition available.
+ Details

Name: dyii_HealthCareOrganizationPatientServiceRevenueGrossBillings

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 38 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727

Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] - USD ($)
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Net change in fair value of available-for-sale securities, net of taxes $ 0 $ 0 $ 0 $ 0

X

- Definition
Amount of tax expense (benefit) before reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (e,f)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 39 R35.htm IDEA: XBRL DOCUMENT v3.2.0.727

Investments in Available-for-Sale and Trading Securities (Details Textual)
6 Months Ended

Feb. 28, 2014

USD ($)

HONG KONG [Member]

Investment Securities [Line Items]

Trading Securities Realized Gain Loss $ 161,864

X

- Definition
Investment Securities [Line Items]
+ References
No definition available.
+ Details

Name: dyii_InvestmentSecuritiesLineItems

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of gain (loss) realized from securities classified as trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(c))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Trading Securities

-URI http://asc.fasb.org/extlink&oid=6526789

+ Details

Name: us-gaap_TradingSecuritiesRealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_HK

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 40 R22.htm IDEA: XBRL DOCUMENT v3.2.0.727

Noncontrolling Interest
6 Months Ended

Feb. 28, 2015

Noncontrolling Interest [Abstract]

Noncontrolling Interest Disclosure [Text Block]

Noncontrolling Interest

The equity of minority investors (minority investors are generally physician groups and other healthcare providers that perform surgeries at the Company’s facilities) in certain subsidiaries of the Company is reported on the consolidated balance sheets as noncontrolling interest. Noncontrolling interest reported in the consolidated income statements reflect the respective interests in the income or loss of the limited partnerships or limited liability companies attributable to the minority investors (equity interest was 1% at February 28, 2015).

X

- Definition
The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

+ Details

Name: us-gaap_MinorityInterestDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 41 R36.htm IDEA: XBRL DOCUMENT v3.2.0.727

Notes Payable (Details Textual) - USD ($)
1 Months Ended 3 Months Ended

Nov. 30, 2011

Nov. 30, 2014

Debt Instrument [Line Items]

Secured Debt $ 116,339

Notes Payable Secured By Equipment At Interest Rate 4.50%

Repayments Of Notes Payable Secured By Equipment $ 6,734

Notes Payable Repayment Period 36 months

X

- Definition
Notes payable repayment period.
+ References
No definition available.
+ Details

Name: dyii_NotesPayableRepaymentPeriod

Namespace Prefix: dyii_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Notes payable secured by equipment at interest rate.
+ References
No definition available.
+ Details

Name: dyii_NotesPayableSecuredByEquipmentAtInterestRate

Namespace Prefix: dyii_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Repayments of notes payable secured by equipment.
+ References
No definition available.
+ Details

Name: dyii_RepaymentsOfNotesPayableSecuredByEquipment

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.16)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.16)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19, 20, 22

-Article 5

+ Details

Name: us-gaap_SecuredDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 42 R24.htm IDEA: XBRL DOCUMENT v3.2.0.727

Contingencies
6 Months Ended

Feb. 28, 2015

Commitments And Contingencies Disclosure [Abstract]

Commitments And Contingencies Disclosure [Text Block]

Contingencies

Due to the uncertainties associated with the stop-loss fee dispute cases, the Company has accrued an amount of $11.3 million, and an additional amount of $3.7 million in interest payable, as accrued liabilities. For a detailed discussion of this, see Revenue Recognition Policy under Notes to Consolidated Financial Statements.

The Company maintains various insurance policies that cover its Pasadena facility including occurrence medical malpractice coverage. In addition, all physicians granted privileges at the Pasadena facility are required to maintain medical malpractice insurance coverage. The Company also maintains general liability and property insurance coverage, including flood coverage. The Company does not currently maintain workers’ compensation coverage in Texas. In regard to the Employee Health Insurance Plan, until April 2014, the Company was self-insured with specific and aggregate re-insurance with stop-loss levels appropriate for the Company’s group size. Effective May 1, 2014, the Company has taken coverage for its employees under a fully insured health plan.

We do not carry director and officer liability insurance. As permitted under Nevada law and pursuant to our governing documents and indemnification agreements with certain of our officers and directors, we indemnify our directors and officers against monetary damages, including advancing expenses, to the fullest extent permitted by Nevada law.

Ping S. Chu, James G. Gerace (both former members of our Board of Directors), and Eric G. Carter (former legal counsel) along with eleven other claimants instigated a series of lawsuits making claims against Ella Y.T.C. Chan (in her individual capacity and in her capacity as Independent Executrix of the Estate of Chiu M. Chan, Deceased, our former Chief Executive Officer and director), Eric K. Chan (our current Chief Executive Officer and director), and Dynacq Healthcare, Inc. All claims were settled in mediations and as part of the settlements Dynacq repurchased 530,616 shares of Dynacq common stock in August 2014, and 427,886 shares of Dynacq stock subsequently in April 2015. These buybacks represent all stock held by each of the claimants. Additionally, as part of this settlement, Dynacq settled claims made by Eric G. Carter for payment of attorney fees, and claims by a company controlled by Mr. Carter, for breach of contract. The Company recognized $2,047,652 of expense associated with these settlements during the fiscal year ended August 31, 2014. This amount is reported as other operating expenses in the consolidated statements of operations. A portion of the settlements were attributed to the repurchase of the Company’s common stock.

The Company is routinely involved in litigation and administrative proceedings that are incidental to its business. Specifically, all judicial review of unsatisfactory determinations of reimbursement amounts due us for our Texas facilities’ fees must be made in the district courts of Travis County, Texas in what can often be a lengthy procedure.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 44 R7.htm IDEA: XBRL DOCUMENT v3.2.0.727

Consolidated Statements of Cash Flows - USD ($)
6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Cash flows from operating activities

Net loss $ (2,720,293) $ (1,226,426)

Adjustments to reconcile net loss to net cash from operating activities:

Depreciation and amortization 173,080 194,844

Gain on sale of investments available-for-sale and trading securities 0 (161,864)

Stock based compensation 98,682 98,682

Gain on sale of assets (2,750) 0

Foreign currency exchange (gains) losses 301,419 (70,971)

Changes in operating assets and liabilities:

Accounts receivable 374,700 (398,685)

Accounts receivable, other 24,925 (24,931)

Interest receivable 17,581 (6,477)

Inventories 36,058 7,123

Prepaid expenses 154,919 71,577

Accounts payable 378,987 71,045

Accrued liabilities (1,021,710) 4,148,276

Net cash from operating activities (2,184,402) 2,702,193

Cash flows from investing activities

Sales proceeds of investments available-for-sale and trading securities 0 1,233,286

Purchase of equipment (309,617) (106,079)

Sales proceeds of equipment 2,750 0

Net cash from investing activities (306,867) 1,127,207

Cash flows from financing activities

Principal payments on notes payable (6,734) (19,905)

Purchase of treasury stock (27,061) 0

Payments on capital lease (11,880) (101,915)

Net cash from financing activities (45,675) (121,820)

Net change in cash and cash equivalents (2,536,944) 3,707,580

Cash at beginning of period 16,819,504 13,585,447

Cash at end of period 14,282,560 17,293,027

Cash paid during the period for:

Interest 1,534 20,130

Income taxes 0 0

Non cash investing and financing activities:

Unrealized change in fair value of available-for-sale securities $ (2,491,498) $ 2,571,312

X

- Definition
Cash paid during year for.
+ References
No definition available.
+ Details

Name: dyii_CashPaidDuringYearForAbstract

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This item represents the pretax change in net unrealized holding gain (loss) on available-for-sale securities that has been included in accumulated other comprehensive income, a separate component of shareholders' equity, during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30690-110894

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30700-110894

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895

+ Details

Name: us-gaap_ForeignCurrencyTransactionGainLossUnrealized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51824106&loc=d3e2443-110228

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the total amount of receivables from all parties and other operating assets not separately disclosed in the statement of cash flows.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount due to the entity in the form of unpaid interest and dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInterestAndDividendsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the total realized gain (loss) included in earnings for the period as a result of selling marketable securities categorized as trading, available-for-sale, or held-to-maturity. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(c))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 10

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27405-111563

+ Details

Name: us-gaap_MarketableSecuritiesRealizedGainLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow for acquisition of machinery and equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

+ Details

Name: us-gaap_PaymentsToAcquireMachineryAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from sale of machinery and equipment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

+ Details

Name: us-gaap_ProceedsFromSaleOfMachineryAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

+ Details

Name: us-gaap_ProceedsFromSaleOfShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfLongTermCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for a borrowing supported by a written promise to pay an obligation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_RepaymentsOfNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_TreasuryStockValueAcquiredParValueMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 45 R3.htm IDEA: XBRL DOCUMENT v3.2.0.727

Consolidated Balance Sheets [Parenthetical] - USD ($)

Feb. 28, 2015

Aug. 31, 2014

Allowance For Doubtful Accounts Receivable Current (in dollars) $ 125,799,000 $ 154,132,000

Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01

Preferred stock, shares authorized 5,000,000 5,000,000

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, par value (in dollars per share) $ 0.001 $ 0.001

Common stock, shares authorized 100,000,000 100,000,000

Common stock, shares issued 14,418,626 14,418,626

Common Stock, shares outstanding 13,888,010 13,888,010

Treasury Stock, Shares 530,616 530,616

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e5074-111524

+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 46 R17.htm IDEA: XBRL DOCUMENT v3.2.0.727

Treasury Stock
6 Months Ended

Feb. 28, 2015

Equity [Abstract]

Treasury Stock [Text Block]

Treasury Stock

In September 2013, as part of a settlement agreement with a former employee, the Company received 125,000 shares of common stock of the Company previously issued to him. These shares were accounted for as treasury shares with zero cost, and were retired in the second quarter of fiscal year 2014.

In August 2014 and April 2015, binding settlement agreements were reached with some of the shareholders in a law suit whereby the Company received 530,616, shares and 427,886 shares, respectively, of stock owned by the shareholders. Based on an independent appraisal, the value of these shares repurchased as treasury stock were $27,061 and $145,054, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.
+ References
No definition available.
+ Details

Name: us-gaap_TreasuryStockTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R1.htm IDEA: XBRL DOCUMENT v3.2.0.727

Document And Entity Information - shares
6 Months Ended

Feb. 28, 2015

Aug. 31, 2015

Document Information [Line Items]

Document Type 10-Q

Amendment Flag false

Document Period End Date Feb. 28, 2015

Document Fiscal Year Focus 2015

Document Fiscal Period Focus Q2

Entity Registrant Name DYNACQ HEALTHCARE INC

Entity Central Index Key 0000890908

Current Fiscal Year End Date --08-31

Entity Filer Category Smaller Reporting Company

Trading Symbol DYII

Entity Common Stock, Shares Outstanding 13,460,124

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 48 R18.htm IDEA: XBRL DOCUMENT v3.2.0.727

Stock Based Compensation
6 Months Ended

Feb. 28, 2015

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Stock Based Compensation

Year 2011 Stock Incentive Plan

The purpose of the Year 2011 Stock Incentive Plan (“2011 Plan”) is to strengthen the Company by providing an incentive to its employees, officers, consultants and directors and to encourage them to devote their abilities and industry to the success of the Company’s business enterprise. It is intended that this purpose be achieved by extending to employees, officers, consultants and directors of the Company and its subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights, performance awards and restricted stock. The Company has reserved 15,000,000 shares of common stock for issuance under the 2011 Plan.

As of February 28, 2015, there remain 250,000 shares to be issued upon exercise of outstanding options, and 14,750,000 shares which can be issued under the 2011 Plan after giving effect to shares issued and canceled.

2000 Incentive Plan

The Company's 2000 Incentive Plan ("2000 Plan") provides for options and other stock-based awards that may be granted to eligible employees, officers, consultants and non-employee directors of the Company or its subsidiaries. The Company had reserved 5,000,000 shares of common stock for future issuance under the 2000 Plan. The 2000 Plan does not have a fixed termination date, provided that no incentive stock option can be granted subsequent to August 29, 2011. As of February 28, 2015, there remain 534,000 shares to be issued upon exercise of outstanding options, and no new stock options awards will be issued under the 2000 Plan.

The following table summarizes the stock option activities for the six months ended February 28, 2015 (share amounts in thousands):

Shares

Weighted Average
Option Exercise
Price Per Share

Outstanding, August 31, 2014

995

$

2.18

Granted

—

—

Exercised

—

—

Expired or canceled

(211)

4.27

Outstanding, February 28, 2015

784

1.62

For the six months ended February 28, 2015 and 2014, there were no stock options exercised. The aggregate intrinsic value of the stock options outstanding as of February 28, 2015 and 2014 is $-0-, since the market price is lower than the exercise price.

The following summarizes information related to stock options outstanding as of February 28, 2015, and related weighted average price and life information:

Options Outstanding

Options Exercisable

Exercise Prices

Number of
Shares

Weighted Average
Remaining Contractual
Life (Years)

Number of Shares

(Share Amounts In Thousands)

$1.10

250

6.9

188

$1.86

534

6.4

401

Total

784

6.5

589

For the three months ended February 28, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $49,341 in each period. For the six months ended February 28, 2015 and 2014, stock-based compensation expense associated with the Company’s stock options was $98,682 in each period. The total unrecognized compensation expense for outstanding stock options as of February 28, 2015 was $82,000, and will be recognized, in general, over six months.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 49 R4.htm IDEA: XBRL DOCUMENT v3.2.0.727

Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Net patient service revenue $ 1,754,888 $ 2,231,387 $ 4,073,566 $ 4,490,634

Costs and expenses:

Compensation and benefits 1,657,603 1,592,448 3,281,313 3,044,215

Medical services and supplies 343,838 304,093 855,225 921,563

Other operating expenses 1,287,181 1,046,262 2,538,186 2,158,740

Depreciation and amortization 86,531 86,535 173,080 194,844

Total costs and expenses 3,375,153 3,029,338 6,847,804 6,319,362

Operating loss (1,620,265) (797,951) (2,774,238) (1,828,728)

Other income (expense):

Rent and other income (expense) (189,450) 141,564 (168,149) 417,109

Interest income 193,944 224,292 429,059 426,615

Interest expense (104,025) (85,470) (206,965) (241,422)

Total other income (expense), net (99,531) 280,386 53,945 602,302

Loss before income taxes (1,719,796) (517,565) (2,720,293) (1,226,426)

Provision (benefit) for income taxes 0 0 0 0

Net loss (1,719,796) (517,565) (2,720,293) (1,226,426)

Less: Net (income) loss attributable to noncontrolling interest 33 (59) (85) (33)

Net loss attributable to Dynacq Healthcare, Inc. $ (1,719,763) $ (517,624) $ (2,720,378) $ (1,226,459)

Basic and diluted loss per common share

Basic and diluted loss per common share (in dollars per share) $ (0.12) $ (0.04) $ (0.2) $ (0.08)

Basic and diluted average common shares outstanding (in shares) 13,888,010 14,418,626 13,888,010 14,436,483

X

- Definition
Rent and other income (expense).
+ References
No definition available.
+ Details

Name: dyii_RentAndOtherIncomeExpense

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total costs of sales and operating expenses for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CostsAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of medical supplies consumed, for example, but not limited to, bandages, syringes and drugs, for patient care.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_HealthCareOrganizationMedicalSuppliesAndDrugsExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 940

-SubTopic 20

-Section 25

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51673353&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 5

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.9)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of operating interest income (expense).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.10)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_LaborAndRelatedExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.3)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherCostAndExpenseOperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 50 R12.htm IDEA: XBRL DOCUMENT v3.2.0.727

Investments in Available-for-Sale and Trading Securities
6 Months Ended

Feb. 28, 2015

Investments Debt And Equity Securities [Abstract]

Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]

Investments in Available-for-Sale and Trading Securities

The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method.

The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the six months ended February 28, 2014, the Company had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for investments in certain debt and equity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-Glossary Debt Security

-URI http://asc.fasb.org/extlink&oid=6509901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-Glossary Equity Security

-URI http://asc.fasb.org/extlink&oid=6511694

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27405-111563

+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R11.htm IDEA: XBRL DOCUMENT v3.2.0.727

Cash and Cash Equivalents
6 Months Ended

Feb. 28, 2015

Cash And Cash Equivalents [Abstract]

Cash and Cash Equivalents Disclosure [Text Block]

Cash and Cash Equivalents

The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.

X

- References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 6.H.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13728-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section H

-Subsection 3

+ Details

Name: us-gaap_CashAndCashEquivalentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727

Accumulated Other Comprehensive Income (Loss)
6 Months Ended

Feb. 28, 2015

Equity [Abstract]

Comprehensive Income Note [Text Block]

Accumulated Other Comprehensive Income (Loss)

The following table summarizes the changes in accumulated other comprehensive income (loss) by component:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Available-for-sale securities

Accumulated other comprehensive income balance, beginning of period

$

10,945,401

$

11,203,250

$

12,616,346

$

9,382,334

Other comprehensive income (loss):

Unrealized gains (losses), net of taxes of $-0- for all periods presented

(820,553)

750,396

(2,491,498)

2,571,312

Other comprehensive income (loss)

(820,553)

750,396

(2,491,498)

2,571,312

Accumulated other comprehensive income balance, end of period

$

10,124,848

$

11,953,646

$

10,124,848

$

11,953,646

There was no reclassification adjustment during the periods presented above.

X

- Definition
The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 17

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Reclassification Adjustments

-URI http://asc.fasb.org/extlink&oid=6522872

+ Details

Name: us-gaap_ComprehensiveIncomeNoteTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 53 R19.htm IDEA: XBRL DOCUMENT v3.2.0.727

Fair Value of Financial Instruments
6 Months Ended

Feb. 28, 2015

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

Fair Value of Financial Instruments

The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:

Level 1 Quoted prices in active markets for identical assets or liabilities.

Level 2 Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.

Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of February 28, 2015, segregated among the appropriate levels within the fair value hierarchy:

Quoted prices in active
markets for identical

Significant other
observable inputs

Significant
unobservable

(Level 1)

(Level 2)

(Level 3)

Assets

Investments available-for-sale

$

—

$

17,885,213

$

—

The Company’s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $7,984,646, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R15.htm IDEA: XBRL DOCUMENT v3.2.0.727

Use of Estimates
6 Months Ended

Feb. 28, 2015

Use Of Estimates [Abstract]

Usage Of Estimates [Text Block]

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company’s estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowance and the provision for doubtful accounts. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.

X

- Definition
Usage of estimates.
+ References
No definition available.
+ Details

Name: dyii_UsageOfEstimatesTextBlock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: dyii_UseOfEstimatesAbstract

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R13.htm IDEA: XBRL DOCUMENT v3.2.0.727

Notes payable
6 Months Ended

Feb. 28, 2015

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

Notes Payable

In November 2011, the Company borrowed $116,339 as notes payable from a financial institution at an interest rate of 4.5%, which was to be repaid in 36 monthly installments, and was secured by specific equipment purchased at our Pasadena facility. The Company paid down the balance of $6,734 of notes payable during the three months ended November 30, 2014.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20,22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 56 R14.htm IDEA: XBRL DOCUMENT v3.2.0.727

Inventories
6 Months Ended

Feb. 28, 2015

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

Inventories

Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a, b, c

-Article 5

+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 57 R16.htm IDEA: XBRL DOCUMENT v3.2.0.727

Net Loss per Common Share
6 Months Ended

Feb. 28, 2015

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Net Loss per Common Share

The following table presents the computation of basic and diluted loss per common share attributable to the Company:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Basic and diluted loss per common share:

Numerator:

Net loss

$

(1,719,796)

$

(517,565)

$

(2,720,293)

$

(1,226,426)

Less: Net (income) loss attributable to noncontrolling interest

33

(59)

(85)

(33)

Net loss attributable to Dynacq Healthcare, Inc.

$

(1,719,763)

$

(517,624)

$

(2,720,378)

$

(1,226,459)

Denominator:

Basic and diluted average common shares outstanding

13,888,010

14,418,626

13,888,010

14,436,483

Basic and diluted loss per common share

$

(0.12)

$

(0.04)

$

(0.20)

$

(0.08)

Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the reporting period. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. For the calculation of diluted net income (loss) per share, the basic weighted average number of shares is increased by the dilutive effect of stock options determined using the treasury stock method. However, if it is anti-dilutive, the dilutive effect of the stock options is not included in the calculation of diluted net loss per share. Stock options with exercise prices exceeding current market prices that were excluded from the computation of net loss per share amounted to approximately 784,000 shares and 1,069,000 shares for the six months ended February 28, 2015 and 2014, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 58 R34.htm IDEA: XBRL DOCUMENT v3.2.0.727

Basis of Presentation (Details Textual) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Basis Of Presentation [Line Items]

Corporate Office Costs $ 1.1 $ 1.0 $ 2.0 $ 1.9

X

- Definition
Basis Of Presentation [Line Items]
+ References
No definition available.
+ Details

Name: dyii_BasisOfPresentationLineItems

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Corporate office costs.
+ References
No definition available.
+ Details

Name: dyii_CorporateOfficeCosts

Namespace Prefix: dyii_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 59 R51.htm IDEA: XBRL DOCUMENT v3.2.0.727

Industry Segments and Geographic Information (Details) - USD ($)
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Segment Reporting Information [Line Items]

Net patient service revenues $ 1,754,888 $ 2,231,387 $ 4,073,566 $ 4,490,634

Income (loss) before taxes and discontinued operations (1,719,796) (517,565) (2,720,293) (1,226,426)

US Division [Member]

Segment Reporting Information [Line Items]

Net patient service revenues 1,754,888 2,231,387 4,073,566 4,490,634

Income (loss) before taxes and discontinued operations (820,388) 25,532 (1,315,776) (352,426)

Corporate [Member]

Segment Reporting Information [Line Items]

Net patient service revenues 0 0 0 0

Income (loss) before taxes and discontinued operations $ (899,408) $ (543,097) $ (1,404,517) $ (874,000)

X

- Definition
Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 954

-SubTopic 605

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51673510&loc=SL9156442-115640

+ Details

Name: us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 940

-SubTopic 20

-Section 25

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51673353&loc=d3e41242-110953

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 5

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=dyii_UsDivisionSegmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=us-gaap_IntersegmentEliminationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 60 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727

Revenue Recognition
6 Months Ended

Feb. 28, 2015

Revenue Recognition [Abstract]

Revenue Recognition [Text Block]

Revenue Recognition

Background

The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.

Revenue Recognition Policy

The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company’s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.

The following table shows gross revenues and allowances for the three and six months ended February 28, 2015 and 2014:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Gross billed charges

$

8,059,057

$

6,618,079

$

16,317,829

$

13,658,418

Allowances

6,304,169

4,386,692

12,244,263

9,167,784

Net revenue

$

1,754,888

$

2,231,387

$

4,073,566

$

4,490,634

Allowance percentage

78

%

66

%

75

%

67

%

Contractual Allowance

The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.

For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.

Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.

A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.

Through February 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $4.2 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $4.2 million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual’s petitions and ordered the Company to refund approximately $300,000, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court’s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other 47 cases, the Court of Appeals reversed the district court’s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $300,000. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $4,476,097.

During the time that the carriers’ petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of February 28, 2015, the Company has accrued the total potential refund amount of $11.3 million, and an additional amount of $3.7 million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers’ Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.

Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $10,254,990 during fiscal year 2011 and $149,875 during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $779,583 during fiscal year 2011 and $136,542 during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.

Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of “fair and reasonable” charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company’s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 pending cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately 80 cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company’s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining “fair and reasonable” reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties’ closing arguments were filed in June 2015.

Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period’s net patient service revenues.

Provision for Doubtful Accounts

Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.

The Company computes its allowances based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.

Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.

The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.

The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.

The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.

X

- Definition
The entire disclosure pertaining to sales arrangements for goods or services that reduce the amount of revenue recognized for example sales returns, allowances, incentives, rebates, discounts and loyalty programs.
+ References
No definition available.
+ Details

Name: dyii_RevenueRecognitionTextBlock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenueRecognitionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 61 R26.htm IDEA: XBRL DOCUMENT v3.2.0.727

Industry Segments and Geographic Information
6 Months Ended

Feb. 28, 2015

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Industry Segments and Geographic Information

The Industry Segment “U.S. Division” comprises of the Company’s Pasadena facility. The Company at the present time has the U.S. Division and the Corporate Division.

Certain previously reported financial information has been reclassified to conform to the current period’s presentation.

Corporate Division

The Company formed Sino Bond to hold and manage investments in Hong Kong. Sino Bond invests in debt instruments (corporate and municipal) and equity securities in Europe and Asia, including initial public offerings and pre-initial public offerings. The Company invests in various marketable securities. As of February 28, 2015, the balance of these securities is valued at approximately $17.9 million. During the six months ended February 28, 2014, the Company also traded in initial public offerings of equity securities on the Hong Kong Stock Exchange and had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

The Corporate Division includes interest and other income related to its investments in securities, corporate personnel compensation expenses, and general and administrative expenses. Such expenses and income are not allocated to our operating division, as they relate to our general corporate activities.

We generally evaluate performance based on profit or loss from operations before income taxes and non-recurring charges and other criteria. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies. There are no transfers between segments.

Summarized financial information concerning the business segments from continuing operations is as follows:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Revenues from external customers

Net patient service revenues

U.S. Division

$

1,754,888

$

2,231,387

$

4,073,566

$

4,490,634

Corporate

—

—

—

—

Consolidated

$

1,754,888

$

2,231,387

$

4,073,566

$

4,490,634

Income (loss) before taxes

U.S. Division

$

(820,388)

$

25,532

$

(1,315,776)

$

(352,426)

Corporate

(899,408)

(543,097)

(1,404,517)

(874,000)

Consolidated

$

(1,719,796)

$

(517,565)

$

(2,720,293)

$

(1,226,426)

February 28, 2015

August 31, 2014

Total Assets

U.S. Division

$

15,118,700

$

15,967,472

Corporate

26,840,320

31,793,055

Consolidated

$

41,959,020

$

47,760,527

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 62 R49.htm IDEA: XBRL DOCUMENT v3.2.0.727

Accumulated Other Comprehensive Income (Loss) (Details Textual) - USD ($)
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Accumulated Other Comprehensive Income (Loss) [Line Items]

Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax $ 0 $ 0 $ 0 $ 0

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of tax expense (benefit) before reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (e,f)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 63 R41.htm IDEA: XBRL DOCUMENT v3.2.0.727

Stock Based Compensation (Details 1) - Feb. 28, 2015 - shares
shares in Thousands

Total

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Options Outstanding, Number of Shares 784

Options Outstanding, Weighted Average Remaining Contractual Life (Years) 6 years 6 months

Options Exercisable, Number of Shares 589

Range One [Member]

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Options Outstanding, Number of Shares 250

Options Outstanding, Weighted Average Remaining Contractual Life (Years) 6 years 10 months 24 days

Options Exercisable, Number of Shares 188

Range Two [Member]

Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]

Options Outstanding, Number of Shares 534

Options Outstanding, Weighted Average Remaining Contractual Life (Years) 6 years 4 months 24 days

Options Exercisable, Number of Shares 401

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dyii_RangeOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=dyii_RangeTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 64 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727

Consolidated Statements of Comprehensive Income (Loss) - USD ($)
3 Months Ended 6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Feb. 28, 2015

Feb. 28, 2014

Net loss $ (1,719,796) $ (517,565) $ (2,720,293) $ (1,226,426)

Other comprehensive income (loss), net of taxes:

Net change in fair value of available-for-sale securities, net of taxes of $-0- (820,553) 750,396 (2,491,498) 2,571,312

Other comprehensive income (loss) (820,553) 750,396 (2,491,498) 2,571,312

Comprehensive income (loss) (2,540,349) 232,831 (5,211,791) 1,344,886

Less comprehensive (income) loss attributable to noncontrolling interest 33 (59) (85) (33)

Comprehensive income (loss) attributable to Dynacq Healthcare, Inc. $ (2,540,316) $ 232,772 $ (5,211,876) $ 1,344,853

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 55

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 19

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-Subparagraph (a),(c)

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 55

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 65 R10.htm IDEA: XBRL DOCUMENT v3.2.0.727

Reclassification
6 Months Ended

Feb. 28, 2015

Reclassification [Abstract]

Disclosure of Reclassification Amount [Text Block]

Reclassification

Certain previously reported financial information has been reclassified to conform to the current period’s presentation. The impact of such reclassification was not significant to the prior period’s overall presentation.

X

- References
No definition available.
+ Details

Name: dyii_ReclassificationAbstract

Namespace Prefix: dyii_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for any adjustments made during the period to avoid double counting in comprehensive income items displayed as part of net income that also had been displayed as part of other comprehensive income in that period or earlier periods. These adjustments include reclassifications to net income of items in accumulated comprehensive income, such as deferred gains or losses on qualifying hedges when hedged item reported in net income, holding gains or losses on available-for-sale securities transferred into trading category, unrealized holding gains or losses on debt securities transferred from held-to-maturity category into available-for-sale category and accumulated translation adjustment attributable to foreign subsidiary or investment in foreign entity upon sale or liquidation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Reclassification Adjustments

-URI http://asc.fasb.org/extlink&oid=6522872

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 17

-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e716-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

+ Details

Name: us-gaap_DisclosureOfReclassificationAmountTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 66 R27.htm IDEA: XBRL DOCUMENT v3.2.0.727

Significant Accounting Policies (Policies)
6 Months Ended

Feb. 28, 2015

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All such adjustments are of a normal and recurring nature. The majority of the Company's expenses are "cost of revenue" items. Costs that could be classified as general and administrative by the Company would include the corporate office costs, including advertising and marketing expenses, which were approximately $1.1 million and $1.0 million for the three months ended February 28, 2015 and 2014, respectively, and approximately $2.0 million and $1.9 million for the six months ended February 28, 2015 and 2014, respectively. These financial statements should be read in conjunction with the audited financial statements as of August 31, 2014. Operating results for the three and six months ended February 28, 2015 are not necessarily indicative of the results that may be expected for the year ending August 31, 2015.

Reclassification, Policy [Policy Text Block]

Reclassification

Certain previously reported financial information has been reclassified to conform to the current period’s presentation. The impact of such reclassification was not significant to the prior period’s overall presentation.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents

The Company considers all highly liquid instruments with maturities of three months or less on the date of purchase to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value.

Marketable Securities, Policy [Policy Text Block]

Investments in Available-for-Sale and Trading Securities

The Company’s investments in debt instruments (corporate and municipal bonds) are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2). These investments are classified as available-for-sale securities. These investments are subject to default risk. Unrealized gains in the fair value are reported in accumulated other comprehensive income, net of related income tax effect. The Company regularly monitors its investment portfolio for any decline in fair value that is other than temporary and records any such impairment as an impairment loss. The determination of the gain or loss on the sale of any security is made using the specific identification method.

The Company also invested in initial public offerings of equity securities on the Hong Kong Stock Exchange. These investments are classified as trading securities, and were carried at fair value. These investments were subject to fluctuations in the market price. During the six months ended February 28, 2014, the Company had a net gain of $161,864 in these securities. During the first quarter of fiscal year 2014, the Company sold all of its trading securities and has not held any such securities since November 30, 2013.

Investment In Real Estates And Notes Payable [Policy Text Block]

Notes Payable

In November 2011, the Company borrowed $116,339 as notes payable from a financial institution at an interest rate of 4.5%, which was to be repaid in 36 monthly installments, and was secured by specific equipment purchased at our Pasadena facility. The Company paid down the balance of $6,734 of notes payable during the three months ended November 30, 2014.

Inventory, Policy [Policy Text Block]

Inventories

Inventories, consisting primarily of medical supplies, are stated at the lower of cost or market, with cost determined by use of the average cost method.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The most significant of the Company’s estimates is the determination of revenue to recognize for the services the Company provides and the determination of allowances, which includes the contractual allowance and the provision for doubtful accounts. See “Revenue Recognition” below for further discussion. Actual results could differ materially from those estimates used in the preparation of these financial statements.

Fair Value of Financial Instruments, Policy [Policy Text Block]

Fair Value of Financial Instruments

The fair value of financial instruments is estimated based on market trading information, where available. Absent published market values for an instrument or other assets, management uses observable market data to arrive at its estimates of fair value. Management believes that the carrying amount of cash and cash equivalents, accounts receivable and accrued liabilities approximate fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. A three-level fair value hierarchy prioritizes the inputs used to measure fair value. The three levels of inputs used to measure fair value are as follows:

Level 1 Quoted prices in active markets for identical assets or liabilities.

Level 2 Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted price for identical or similar assets and liabilities in markets that are not active; or other input that are observable or can be corroborated by observable market data.

Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following table summarizes our financial assets and liabilities measured and reported in the Company’s statement of financial position at fair value on a recurring basis as of February 28, 2015, segregated among the appropriate levels within the fair value hierarchy:

Quoted prices in active
markets for identical

Significant other
observable inputs

Significant
unobservable

(Level 1)

(Level 2)

(Level 3)

Assets

Investments available-for-sale

$

—

$

17,885,213

$

—

The Company’s investments in Level 2 are in perpetual debt instruments (corporate and municipal bonds) traded on the European markets, at a cost of $7,984,646, are recorded at fair value based on quoted market prices that are traded in less active markets or priced using a quoted market price for similar investments or are priced using non-binding market consensus prices that can be corroborated by observable market data (Level 2), and there has been no change in valuation techniques for these investments (Level 2).

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

Background

The Company's revenue recognition policy is significant because net patient service revenue is a primary component of its results of operations. Revenue is recognized as services are delivered. The determination of the amount of revenue to be recognized in connection with the Company's services is subject to significant judgments and estimates, which are discussed below.

Revenue Recognition Policy

The Company has established billing rates for its medical services which it bills as services are delivered. Gross billings are then reduced by the Company’s estimate of allowances, which includes the contractual allowance and the provision for doubtful accounts, to arrive at net patient service revenues. Net patient service revenues may not represent amounts ultimately collected. The Company adjusts current period revenue for differences in estimated revenue recorded in prior periods and actual cash collections.

The following table shows gross revenues and allowances for the three and six months ended February 28, 2015 and 2014:

Three months ended February 28,

Six months ended February 28,

2015

2014

2015

2014

Gross billed charges

$

8,059,057

$

6,618,079

$

16,317,829

$

13,658,418

Allowances

6,304,169

4,386,692

12,244,263

9,167,784

Net revenue

$

1,754,888

$

2,231,387

$

4,073,566

$

4,490,634

Allowance percentage

78

%

66

%

75

%

67

%

Contractual Allowance

The Company computes its contractual allowance based on the estimated collections on its gross billed charges. The Company computes its estimate by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months. A significant amount of our net revenue results from Texas workers' compensation claims, which are governed by the rules and regulations of the Texas Department of Workers’ Compensation (“TDWC”) and the workers’ compensation healthcare networks. If our hospital chooses to participate in a network, the amount of revenue that will be generated from workers’ compensation claims will be governed by the network contract.

For claims arising prior to the implementation of workers’ compensation networks and out of network claims, inpatient and outpatient surgical services are either reimbursed pursuant to the Acute Care In-Patient Hospital Fee Guideline or at a "fair and reasonable" rate for services in which the fee guideline is not applicable. Starting March 1, 2008, the Texas Workers’ Compensation 2008 Acute Care Hospital Outpatient and Inpatient Facility Fee Guidelines (the “Guidelines”) became effective. Under these Guidelines, the reimbursement amounts are determined by applying the most recently adopted and effective Medicare reimbursement formula and factors; however, if the maximum allowable reimbursement for the procedure performed cannot be calculated using these Guidelines, then reimbursement is determined on a fair and reasonable basis.

Should we disagree with the amount of reimbursement provided by a third-party payer, we are required to pursue the medical dispute resolution (“MDR”) process at the TDWC to request proper reimbursement for services. From January 2007 to November 2008, the Company had been successful in its pursuit of collections regarding the stop-loss cases pending before the State Office of Administrative Hearings (“SOAH”), receiving positive rulings in over 90% of its claims presented for administrative determination. A 2007 district court decision upholding our interpretation of the statute as applied to the stop-loss claims was appealed by certain insurance carriers, and on November 13, 2008 the Third Court of Appeals determined that in order for a hospital to be reimbursed at 75% of its usual and customary audited charges for an inpatient admission, the hospital must not only bill at least $40,000, but also show that the admission involved unusually costly and unusually extensive services. Procedurally, the decision means that each case where a carrier raised an issue regarding whether the services provided were unusually costly or unusually extensive would be remanded to either SOAH or MDR for a case-by-case determination of whether the services provided meet these standards. As a result of the Third Court of Appeals opinion, any stop-loss cases pending at SOAH have been remanded to the TDWC since these cases have not been reviewed or decided by the two-prong standard decided by the Third Court of Appeals. The SOAH Administrative Law judges determined that the most appropriate location for these cases is the TDWC.

A petition asking the Texas Supreme Court to review the Third Court of Appeals decision has been denied. Therefore, the Company is bound by the Third Court of Appeals decision. The Texas Supreme Court’s decision delayed final adjudication in these pending stop-loss cases. The uncertain outcome in these cases will depend on a very lengthy process. We anticipate further, lengthy litigation at the Travis County District Courts and the Texas Courts of Appeals. Because of this lengthy process and the uncertainty of recovery in these cases, collection of a material amount of funds in these pending stop-loss cases cannot be anticipated.

Through February 2015, insurance carriers have voluntarily paid the awards in the decisions and orders issued by SOAH, plus interest, in approximately 180 cases, involving approximately $11 million in claims. In most of these cases, when the payments were made, the carriers requested refunds of the payments made in the event that the SOAH decisions and orders were reversed on appeal (which they were). Our request that the TDWC Commissioner enforce the awards which were not voluntarily paid by the carriers was refused in approximately 130 cases. As a result of the reversal of the SOAH decisions and orders, Texas Mutual Insurance Company and other carriers filed petitions in Travis County district court seeking a refund in cases in which the awards were voluntarily paid. The district court found in favor of Texas Mutual and the Company was ordered to refund approximately $4.2 million, including prejudgment interest, pending remand for a case-by-case determination of whether the services provided were unusually costly and unusually extensive. The Company did not object to the reversal and remand of the SOAH decisions and orders, but did object to the judgments ordering refunds and those judgments were appealed to the Third Court of Appeals. As part of the appeals, the Company deposited the amounts that were ordered to be refunded as cash deposits into the registry of the court in order to stay execution of the judgments ordering refunds. On June 6, 2013, the judgments ordering refunds were reversed by the Court of Appeals. The Court of Appeals held that if Texas Mutual wants a refund, it must pursue the refund demand administratively through the TDWC rather than through the district courts. Texas Mutual filed a motion for rehearing with the Court of Appeals which ultimately was denied. The Company filed motions in all 47 cases with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in January 2014, the Company received the deposits and accrued interest totaling $4.2 million. In addition, Texas Mutual filed three additional petitions in district court for cases that were left out of the original 47. The court granted Texas Mutual’s petitions and ordered the Company to refund approximately $300,000, including prejudgment interest to Texas Mutual. These judgments were granted before the Court of Appeals reversed the district court’s original judgments. These three cases were appealed to the Court of Appeals and the funds ordered refunded were deposited with the district clerk. As with the other 47 cases, the Court of Appeals reversed the district court’s final judgments in these three cases and the Company filed motions with the district court asking that the district clerk be ordered to release the deposited funds to the Company, and in February 2014, the Company received the deposits and accrued interest totaling approximately $300,000. The total refund received by the Company in fiscal year 2014 for the 50 stop-loss cases discussed above was $4,476,097.

During the time that the carriers’ petitions seeking refunds were pending, because of the uncertainty of the results at that time, as of February 28, 2015, the Company has accrued the total potential refund amount of $11.3 million, and an additional amount of $3.7 million in interest payable, as accrued liabilities. This includes the deposit amounts refunded back to the Company in January and February 2014. We do not anticipate that any other carriers will pursue refund demands through district court but instead will pursue them administratively through TDWC. The cases in which the SOAH decisions and orders were reversed have been or are being remanded to TDWC for determinations of whether the services provided were unusually costly and unusually extensive. The carriers contend that the voluntary payments made pursuant to the Decisions and Orders were premature payments by the carriers and may be ordered to be refunded. The Company disagrees with this contention. After the reversal of the judgments it obtained from the district court ordering refunds, on December 4, 2013, Texas Mutual made a formal request to the Commissioner of Workers’ Compensation that he administratively order the Company to make refunds to Texas Mutual (in the same amount that was sought in the district court). The Company responded to this request on December 11, 2013, asking that it be denied. The matter is pending at this time. As to the matters remanded to TDWC and SOAH, once the Company is given the opportunity to present its evidence regarding whether the services provided were unusually costly and unusually extensive, the Company anticipates that it will prevail in many of the underlying stop-loss fee disputes and that payments refunded to the carriers will be recaptured. In March 2014, a settlement conference with one self-insured entity successfully resolved the stop-loss cases in which that entity was involved. Although the Company is willing to participate in settlement negotiations, we anticipate that few, if any, other carriers are interested in doing so at this time. It is anticipated that hearings at SOAH on the pending stop-loss cases will begin in November 2015.

Due to the uncertainties associated with these stop-loss fee dispute cases, the Company recognized increases in the contractual allowance at our Pasadena facility of $10,254,990 during fiscal year 2011 and $149,875 during the fiscal quarter ended August 31, 2013, (and an additional contractual allowance amount of $779,583 during fiscal year 2011 and $136,542 during the fiscal quarter ended August 31, 2013, at our Garland facility, which was classified as discontinued operations). The Company has also recognized interest expense related to these refunds starting from fiscal year 2011.

Some claims regarding payment for ambulatory surgical center and hospital outpatient services remain pending at the TDWC and/or SOAH. It is expected that these remaining claims will be adjudicated at SOAH and possibly in the Texas district and appellate courts. The basis for reimbursement for these services made the subject of these pending cases is the same as it was for the other ASC and outpatient cases that have been either tried or settled: the determination of “fair and reasonable” charges. In 2007, the Company received unfavorable rulings from SOAH in all of its appeals of unfavorable decisions related to services provided in 2001 and 2002. The 179 cases, which were appealed to the Travis County district courts, challenged the constitutionality of the relevant statutory language. The Company received an unfavorable ruling in its lead case in March 2009, which ruling was appealed to and was upheld by the Third Court of Appeals on August 26, 2010. The Texas Supreme Court denied a petition asking for review of the Third Court of Appeals decision. The unfavorable interpretation by the Texas Courts of Appeal in the Company’s lead case negatively affects the recovery of additional reimbursement, not only in the lead case, but in the remaining 178 pending cases. Consequently, the Company is bound by the Third Court of Appeals’ ruling that interprets the applicable statute and fee guideline to require that the amount that will be paid to a provider must not only be at a “fair and reasonable rate” but also must “ensure the quality of medical care” and “achieve effective cost control” and be the same or less than that charged to others with an equivalent standard of living. This ruling has impacted cases in which a fee guideline was not applicable, specifically all pending cases involving ambulatory surgical services provided from 2001 through 2004 as well as all pending cases involving hospital outpatient services provided prior to March 1, 2008, when the Guidelines took effect. Since the Third Court of Appeals’ unfavorable ruling, collection, if any, in these cases depends on the Company’s ability to establish the criteria in this ruling. The Company was given the opportunity to establish the criteria in approximately 80 cases, which were set for hearing on the merits from March through May 2012 and was unsuccessful. In 2014, hearings were held in 23 of the Company’s hospital outpatient cases at SOAH. Decisions and Orders were handed down by SOAH adopting the methodology for determining “fair and reasonable” reimbursement that was put forth by the Company and ordered additional reimbursement in each of the 23 cases plus interest be paid to the Company. The carrier has appealed these decisions to Travis County district court and the cases have been consolidated. In April 2015 a large group of outpatient cases with various carriers were tried at SOAH. The Company and the carriers have presented their evidence and the parties’ closing arguments were filed in June 2015.

Due to the uncertainties regarding the accounts receivable in the MDR process, the 2008 and 2010 Third Court of Appeals’ opinions and our legal counsel’s advice that settlements with insurance carriers in stop-loss cases have virtually stopped, the Company had fully reserved all accounts receivable related to the MDR process as of August 31, 2008. The Company has had settlement negotiations with insurance carriers for ambulatory surgical center and hospital outpatient cases. Some of these negotiations have been successful. Any monies collected for these MDR accounts receivable is recorded as current period’s net patient service revenues.

Provision for Doubtful Accounts

Although outcomes vary, our policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service while complying with all federal and state laws and regulations. In non-emergency circumstances or for elective procedures and services, it is our policy to verify insurance prior to a patient being treated; however, there are various exceptions that can occur.

The Company computes its allowances based on the estimated collections on its gross billed charges. The Company computes its estimate of allowance, which is a combination of contractual allowance and provision for doubtful accounts, by taking into account collections received, up to 30 days after the end of the period, for the services performed and also estimating amounts collectible for the services performed within the last six months.

Accounts receivable represent net receivables for services provided by the Company. At each balance sheet date management reviews the accounts receivable for collectibility and provides full allowance reserves for any accounts receivable deemed uncollectible.

The allowances stated as a percentage of gross receivables at the balance sheet dates is larger than the allowance percentage used to reduce gross billed charges due to the application of partial cash collections to the outstanding gross receivable balances, without any adjustment being made to the allowances. The allowance amounts netted against gross receivables are not adjusted until such time as the final collections on an individual receivable are recognized.

The focal point of our business is providing patient care services, including complex orthopedic and bariatric procedures. The Company pursues optimal reimbursement from third-party payers for these services. In some instances, we do not have contractual arrangements with third-party payers which provide for “prompt payment” which may result in additional time to collect the expected reimbursement.

The collection process may also be extended due to our efforts to obtain all optimal reimbursement available to the Company. Specifically, for medical services provided to injured workers, the Company may initially receive reimbursement that may not be within the fee guidelines or regulatory guidelines mandating reimbursement. The Company reviews and pursues those particular claims that are determined to warrant additional reimbursement pursuant to the fee or regulatory guidelines. The Company's pursuit of additional reimbursement amounts that it believes are due under fee or regulatory guidelines may be accomplished through established dispute resolution procedures with applicable regulatory authorities.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

No recent accounting pronouncements or other authoritative guidance has been issued that management considers likely to have a material impact on our consolidated financial statements.

X

- Definition
The entire policy disclosure of investments in real estates and notes payable.
+ References
No definition available.
+ Details

Name: dyii_InvestmentInRealEstatesAndNotesPayablePolicyTextBlock

Namespace Prefix: dyii_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 305

-SubTopic 10

-Section 05

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 203

-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 60

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.6(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4556-108314

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Financial Reporting Release (FRR)

-Number 206

-Paragraph b

-Subparagraph i, ii

-Chapter 2

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 6

-Subparagraph a

-Article 5

+ Details

Name: us-gaap_InventoryPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investments in debt and equity securities that have readily determinable fair values (marketable securities). At a minimum, the disclosure might address accounting policies for investments classified as trading, available for sale, or held to maturity and may include how the entity determines whether impairments of available for sale or held to maturity investments are other than temporary, how the fair values of the entity's securities are determined, and the entity's accounting treatment for transfers between investment categories.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section S50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6381980&loc=d3e87707-122711

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62652-112803

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 5

-Section M

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 2, 12

-Article 5

+ Details

Name: us-gaap_MarketableSecuritiesPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.2.0.727 html 47 195 1 false 14 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.dynacq.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - Consolidated Balance Sheets Sheet http://www.dynacq.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 103 - Statement - Consolidated Balance Sheets [Parenthetical] Sheet http://www.dynacq.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets [Parenthetical] Statements 3 false false R4.htm 104 - Statement - Consolidated Statements of Operations Sheet http://www.dynacq.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 105 - Statement - Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.dynacq.com/role/ConsolidatedStatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) Statements 5 false false R6.htm 106 - Statement - Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] Sheet http://www.dynacq.com/role/ConsolidatedStatementsOfComprehensiveIncomeLossParenthetical Consolidated Statements of Comprehensive Income (Loss) [Parenthetical] Statements 6 false false R7.htm 107 - Statement - Consolidated Statements of Cash Flows Sheet http://www.dynacq.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 108 - Disclosure - General Sheet http://www.dynacq.com/role/General General Notes 8 false false R9.htm 109 - Disclosure - Basis of Presentation Sheet http://www.dynacq.com/role/BasisOfPresentation Basis of Presentation Notes 9 false false R10.htm 110 - Disclosure - Reclassification Sheet http://www.dynacq.com/role/Reclassification Reclassification Notes 10 false false R11.htm 111 - Disclosure - Cash and Cash Equivalents Sheet http://www.dynacq.com/role/CashAndCashEquivalents Cash and Cash Equivalents Notes 11 false false R12.htm 112 - Disclosure - Investments in Available-for-Sale and Trading Securities Sheet http://www.dynacq.com/role/InvestmentsInAvailableforsaleAndTradingSecurities Investments in Available-for-Sale and Trading Securities Notes 12 false false R13.htm 113 - Disclosure - Notes payable Notes http://www.dynacq.com/role/NotesPayable Notes payable Notes 13 false false R14.htm 114 - Disclosure - Inventories Sheet http://www.dynacq.com/role/Inventories Inventories Notes 14 false false R15.htm 115 - Disclosure - Use of Estimates Sheet http://www.dynacq.com/role/UseOfEstimates Use of Estimates Notes 15 false false R16.htm 116 - Disclosure - Net Loss per Common Share Sheet http://www.dynacq.com/role/NetLossPerCommonShare Net Loss per Common Share Notes 16 false false R17.htm 117 - Disclosure - Treasury Stock Sheet http://www.dynacq.com/role/TreasuryStock Treasury Stock Notes 17 false false R18.htm 118 - Disclosure - Stock Based Compensation Sheet http://www.dynacq.com/role/StockBasedCompensation Stock Based Compensation Notes 18 false false R19.htm 119 - Disclosure - Fair Value of Financial Instruments Sheet http://www.dynacq.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 19 false false R20.htm 120 - Disclosure - Foreign Currency Translation Sheet http://www.dynacq.com/role/ForeignCurrencyTranslation Foreign Currency Translation Notes 20 false false R21.htm 121 - Disclosure - Revenue Recognition Sheet http://www.dynacq.com/role/RevenueRecognition Revenue Recognition Notes 21 false false R22.htm 122 - Disclosure - Noncontrolling Interest Sheet http://www.dynacq.com/role/NoncontrollingInterest Noncontrolling Interest Notes 22 false false R23.htm 123 - Disclosure - Accumulated Other Comprehensive Income (Loss) Sheet http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) Notes 23 false false R24.htm 124 - Disclosure - Contingencies Sheet http://www.dynacq.com/role/Contingencies Contingencies Notes 24 false false R25.htm 125 - Disclosure - Recent Accounting Pronouncements Sheet http://www.dynacq.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 25 false false R26.htm 126 - Disclosure - Industry Segments and Geographic Information Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformation Industry Segments and Geographic Information Notes 26 false false R27.htm 127 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.dynacq.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.dynacq.com/role/RecentAccountingPronouncements 27 false false R28.htm 128 - Disclosure - Net Loss per Common Share (Tables) Sheet http://www.dynacq.com/role/NetLossPerCommonShareTables Net Loss per Common Share (Tables) Tables http://www.dynacq.com/role/NetLossPerCommonShare 28 false false R29.htm 129 - Disclosure - Stock Based Compensation (Tables) Sheet http://www.dynacq.com/role/StockBasedCompensationTables Stock Based Compensation (Tables) Tables http://www.dynacq.com/role/StockBasedCompensation 29 false false R30.htm 130 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.dynacq.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.dynacq.com/role/FairValueOfFinancialInstruments 30 false false R31.htm 131 - Disclosure - Revenue Recognition (Tables) Sheet http://www.dynacq.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.dynacq.com/role/RevenueRecognition 31 false false R32.htm 132 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLoss 32 false false R33.htm 133 - Disclosure - Industry Segments and Geographic Information (Tables) Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationTables Industry Segments and Geographic Information (Tables) Tables http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformation 33 false false R34.htm 134 - Disclosure - Basis of Presentation (Details Textual) Sheet http://www.dynacq.com/role/BasisOfPresentationDetailsTextual Basis of Presentation (Details Textual) Details http://www.dynacq.com/role/BasisOfPresentation 34 false false R35.htm 135 - Disclosure - Investments in Available-for-Sale and Trading Securities (Details Textual) Sheet http://www.dynacq.com/role/InvestmentsInAvailableforsaleAndTradingSecuritiesDetailsTextual Investments in Available-for-Sale and Trading Securities (Details Textual) Details http://www.dynacq.com/role/InvestmentsInAvailableforsaleAndTradingSecurities 35 false false R36.htm 136 - Disclosure - Notes Payable (Details Textual) Notes http://www.dynacq.com/role/NotesPayableDetailsTextual Notes Payable (Details Textual) Details 36 false false R37.htm 137 - Disclosure - Net Loss per Common Share (Details) Sheet http://www.dynacq.com/role/NetLossPerCommonShareDetails Net Loss per Common Share (Details) Details http://www.dynacq.com/role/NetLossPerCommonShareTables 37 false false R38.htm 138 - Disclosure - Net Loss per Common Share (Details Textual) Sheet http://www.dynacq.com/role/NetLossPerCommonShareDetailsTextual Net Loss per Common Share (Details Textual) Details http://www.dynacq.com/role/NetLossPerCommonShareTables 38 false false R39.htm 139 - Disclosure - Treasury Stock (Details Textual) Sheet http://www.dynacq.com/role/TreasuryStockDetailsTextual Treasury Stock (Details Textual) Details http://www.dynacq.com/role/TreasuryStock 39 false false R40.htm 140 - Disclosure - Stock Based Compensation (Details) Sheet http://www.dynacq.com/role/StockBasedCompensationDetails Stock Based Compensation (Details) Details http://www.dynacq.com/role/StockBasedCompensationTables 40 false false R41.htm 141 - Disclosure - Stock Based Compensation (Details 1) Sheet http://www.dynacq.com/role/StockBasedCompensationDetails1 Stock Based Compensation (Details 1) Details http://www.dynacq.com/role/StockBasedCompensationTables 41 false false R42.htm 142 - Disclosure - Stock Based Compensation (Details Textual) Sheet http://www.dynacq.com/role/StockBasedCompensationDetailsTextual Stock Based Compensation (Details Textual) Details http://www.dynacq.com/role/StockBasedCompensationTables 42 false false R43.htm 143 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://www.dynacq.com/role/FairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) Details http://www.dynacq.com/role/FairValueOfFinancialInstrumentsTables 43 false false R44.htm 144 - Disclosure - Fair Value of Financial Instruments (Details Textual) Sheet http://www.dynacq.com/role/FairValueOfFinancialInstrumentsDetailsTextual Fair Value of Financial Instruments (Details Textual) Details http://www.dynacq.com/role/FairValueOfFinancialInstrumentsTables 44 false false R45.htm 145 - Disclosure - Revenue Recognition (Details) Sheet http://www.dynacq.com/role/RevenueRecognitionDetails Revenue Recognition (Details) Details http://www.dynacq.com/role/RevenueRecognitionTables 45 false false R46.htm 146 - Disclosure - Revenue Recognition (Details Textual) Sheet http://www.dynacq.com/role/RevenueRecognitionDetailsTextual Revenue Recognition (Details Textual) Details http://www.dynacq.com/role/RevenueRecognitionTables 46 false false R47.htm 147 - Disclosure - Noncontrolling Interest (Details Textual) Sheet http://www.dynacq.com/role/NoncontrollingInterestDetailsTextual Noncontrolling Interest (Details Textual) Details http://www.dynacq.com/role/NoncontrollingInterest 47 false false R48.htm 148 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) (Details) Details http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossTables 48 false false R49.htm 149 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Details Textual) Sheet http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossDetailsTextual Accumulated Other Comprehensive Income (Loss) (Details Textual) Details http://www.dynacq.com/role/AccumulatedOtherComprehensiveIncomeLossTables 49 false false R50.htm 150 - Disclosure - Contingencies (Details Textuals) Sheet http://www.dynacq.com/role/ContingenciesDetailsTextuals Contingencies (Details Textuals) Details http://www.dynacq.com/role/Contingencies 50 false false R51.htm 151 - Disclosure - Industry Segments and Geographic Information (Details) Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationDetails Industry Segments and Geographic Information (Details) Details http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationTables 51 false false R52.htm 152 - Disclosure - Industry Segments and Geographic Information (Details 1) Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationDetails1 Industry Segments and Geographic Information (Details 1) Details http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationTables 52 false false R53.htm 153 - Disclosure - Industry Segments and Geographic Information (Details Textual) Sheet http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationDetailsTextual Industry Segments and Geographic Information (Details Textual) Details http://www.dynacq.com/role/IndustrySegmentsAndGeographicInformationTables 53 false false All Reports Book All Reports In ''Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Consolidated Statements of Cash Flows'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. dyii-20150228.xml dyii-20150228_cal.xml dyii-20150228_def.xml dyii-20150228_lab.xml dyii-20150228_pre.xml dyii-20150228.xsd true true XML 68 R38.htm IDEA: XBRL DOCUMENT v3.2.0.727

Net Loss per Common Share (Details Textual) - shares
6 Months Ended

Feb. 28, 2015

Feb. 28, 2014

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Stock options with exercise prices exceeding current market prices 784,000 1,069,000

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 69 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727

Foreign Currency Translation
6 Months Ended

Feb. 28, 2015

Foreign Currency [Abstract]

Foreign Currency Disclosure [Text Block]

Foreign Currency Translation

The functional currency of the Company as a whole is the U.S. Dollar. The Company has designated the U.S. Dollar as the functional currency for Sino Bond Inc. Limited, a Hong Kong corporation and wholly owned subsidiary of the Company (“Sino Bond”). The effects of foreign currency exchange adjustments are included as a component of Rent and Other Income in the Consolidated Statements of Operations.

X

- References
No definition available.
+ Details

Name: us-gaap_ForeignCurrencyAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30690-110894

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30857-110895

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32157-110900

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6450189&loc=d3e30700-110894

+ Details

Name: us-gaap_ForeignCurrencyDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Revenue Recognition (Details Textual)		3 Months Ended	6 Months Ended	12 Months Ended
Revenue Recognition (Details Textual)	Nov. 13, 2008 USD ($)	Aug. 31, 2013 USD ($)	Feb. 28, 2015 USD ($)	Aug. 31, 2014 USD ($)	Aug. 31, 2011 USD ($)
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Accrued Liabilities			$ 300,000
Interest Payable, Current			$ 3,700,000
Loss Contingency, Pending Claims, Number			179
Number Of Cases Filed Motions			47
Loss Contingency, Receivable, Receipts			$ 4,200,000
Receivables Collection Period			30 years
Percentage Of Claims With Positive Rulings			90.00%
Reimbursement Of Usual And Customary Audited Charges Percentage	75.00%
Minimum Billing Requirement For Reimbursement	$ 40,000
Number Of Cases Awards Paid By Insurance Carriers			180
Awards Paid By Insurance Carriers Amount			$ 11,000,000
Number Of Cases In Which Awards Not Paid By Insurance Carriers			130
Loss Contingency Refund Of Voluntary Award Including Prejudgment Interest			$ 4,200,000
Accrued Income Current And Non Current			300,000
Loss Contingency Amount Of Refund In Case Of Additional Motions Granted			$ 11,300,000
Loss Contingency Pending Claims Number Negatively Affecting Recovery Of Additional Reimbursement			178
Number Of Cases With Opportunity To Establish Criteria			80
Litigation Settlement, Amount				$ 4,476,097
Garland Facility [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Additional Loss Contractual Allowance		$ 136,542			$ 779,583
Pasadena Facility [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Increase In Facility Contractual Allowance		$ 149,875			$ 10,254,990

Contingencies (Details Textuals) - USD ($)	1 Months Ended			12 Months Ended
Contingencies (Details Textuals) - USD ($)	Apr. 30, 2015	Aug. 31, 2014	Sep. 30, 2013	Aug. 31, 2014	Feb. 28, 2015
Commitment And Contingencies [Line Items]
Interest Payable					$ 11,300,000
Additional Interest Payable Current And Noncurrent					$ 3,700,000
Treasury Stock, Shares, Acquired		530,616	125,000	530,616
Litigation Settlement, Expense				$ 2,047,652
Subsequent Event [Member]
Commitment And Contingencies [Line Items]
Treasury Stock, Shares, Acquired	427,886

Stock Based Compensation (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
Stock Based Compensation (Details Textual) - USD ($)	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2015	Feb. 28, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense associated with the Company's stock options	$ 49,341	$ 49,341	$ 98,682	$ 98,682
Total unrecognized compensation expense for outstanding stock options	$ 82,000		82,000
Employee Service Share Based Compensation Nonvested Stock Options Compensation Cost Not Yet Recognized Period	6 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 0	$ 0	$ 0	$ 0
Year 2011 Stock Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	15,000,000		15,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	250,000		250,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	14,750,000		14,750,000
Year 2000 Stock Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	5,000,000		5,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	534,000		534,000

Net Loss per Common Share (Details) - USD ($)	3 Months Ended		6 Months Ended
Net Loss per Common Share (Details) - USD ($)	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2015	Feb. 28, 2014
Numerator:
Net loss	$ (1,719,796)	$ (517,565)	$ (2,720,293)	$ (1,226,426)
Less: Net (income) loss attributable to noncontrolling interest	33	(59)	(85)	(33)
Net loss attributable to Dynacq Healthcare, Inc.	$ (1,719,763)	$ (517,624)	$ (2,720,378)	$ (1,226,459)
Denominator:
Basic and diluted average common shares outstanding	13,888,010	14,418,626	13,888,010	14,436,483
Basic and diluted loss per common share	$ (0.12)	$ (0.04)	$ (0.2)	$ (0.08)

Industry Segments and Geographic Information (Details 1) - USD ($)	Feb. 28, 2015	Aug. 31, 2014
Segment Reporting Information [Line Items]
Total Assets	$ 41,959,020	$ 47,760,527
US Division [Member]
Segment Reporting Information [Line Items]
Total Assets	15,118,700	15,967,472
Corporate [Member]
Segment Reporting Information [Line Items]
Total Assets	$ 26,840,320	$ 31,793,055

Noncontrolling Interest (Details Textual)	Feb. 28, 2015
Noncontrolling Interest [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	1.00%

Fair Value of Financial Instruments (Details) - Fair Value, Measurements, Recurring [Member]	Feb. 28, 2015 USD ($)
Quoted Prices in Active Markets for Identical Level 1 [Member]
Assets
Investments available-for-sale	$ 0
Significant Other Observable Inputs Level 2 [Member]
Assets
Investments available-for-sale	17,885,213
Significant Unobservable Level 3 [Member]
Assets
Investments available-for-sale	$ 0

Fair Value of Financial Instruments (Details Textual)	Feb. 28, 2015 USD ($)
Significant Other Observable Inputs Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading Securities, Cost	$ 7,984,646

Stock Based Compensation (Details) - 6 months ended Feb. 28, 2015 - $ / shares shares in Thousands	Total
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Outstanding, Beginning balance	995
Shares, Granted	0
Shares, Exercised	0
Shares, Expired or canceled	(211)
Shares Outstanding, Ending balance	784
Weighted Average Option Exercise Price Per Share Outstanding, Beginning balance	$ 2.18
Weighted Average Option Exercise Price Per Share, Granted	0
Weighted Average Option Exercise Price Per Share, Exercised	0
Weighted Average Option Exercise Price Per Share, Expired or canceled	4.27
Weighted Average Option Exercise Price Per Share, Ending balance	$ 1.62

Consolidated Balance Sheets - USD ($)	Feb. 28, 2015	Aug. 31, 2014
Current assets:
Cash and cash equivalents	$ 14,282,560	$ 16,819,504
Accounts receivable, net of allowances of approximately $125,799,000 and $154,132,000	1,611,933	1,986,633
Accounts receivable, other	355,531	380,456
Inventories	262,603	298,662
Interest receivable	104,461	122,041
Prepaid expenses	108,025	262,944
Total current assets	16,725,113	19,870,240
Investments available-for-sale	17,885,213	20,678,130
Property and equipment, net	6,360,673	6,224,136
Income tax receivable	800,920	800,920
Other assets	187,101	187,101
Total assets	41,959,020	47,760,527
Current liabilities:
Accounts payable	1,394,843	1,015,856
Accrued liabilities	17,464,214	18,512,986
Current portion of notes payable	0	6,734
Current portion of capital lease obligations	29,689	26,513
Total current liabilities	18,888,746	19,562,089
Non-current liabilities:
Long-term portion of capital lease obligations	26,067	41,123
Total liabilities	$ 18,914,813	$ 19,603,212
Commitments and contingencies
Dynacq stockholders' equity:
Preferred stock, $.01 par value; 5,000,000 shares authorized, none issued or outstanding	$ 0	$ 0
Common stock, $.001 par value; 100,000,000 shares authorized, 14,418,626 shares issued and 13,888,010 shares outstanding at February 28, 2015 and August 31, 2014	14,419	14,419
Treasury stock, 530,616 shares at February 28, 2015 and August 31, 2014, at cost	(27,061)	(27,061)
Additional paid-in capital	10,578,427	10,479,745
Accumulated other comprehensive income	10,124,848	12,616,346
Retained earnings	2,289,683	5,010,061
Total Dynacq stockholders' equity	22,980,316	28,093,510
Non-controlling interest	63,891	63,805
Total equity	23,044,207	28,157,315
Total liabilities and equity	$ 41,959,020	$ 47,760,527

Revenue Recognition (Details) - USD ($)	3 Months Ended		6 Months Ended
Revenue Recognition (Details) - USD ($)	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2015	Feb. 28, 2014
Gross Revenues And Contractual Allowances [Line Items]
Gross billed charges	$ 8,059,057	$ 6,618,079	$ 16,317,829	$ 13,658,418
Allowances	6,304,169	4,386,692	12,244,263	9,167,784
Net revenue	$ 1,754,888	$ 2,231,387	$ 4,073,566	$ 4,490,634
Allowance percentage	78.00%	66.00%	75.00%	67.00%

Investments in Available-for-Sale and Trading Securities (Details Textual)	6 Months Ended
	Feb. 28, 2014 USD ($)
HONG KONG [Member]
Investment Securities [Line Items]
Trading Securities Realized Gain Loss	$ 161,864

Notes Payable (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
Notes Payable (Details Textual) - USD ($)	Nov. 30, 2011	Nov. 30, 2014
Debt Instrument [Line Items]
Secured Debt	$ 116,339
Notes Payable Secured By Equipment At Interest Rate	4.50%
Repayments Of Notes Payable Secured By Equipment		$ 6,734
Notes Payable Repayment Period	36 months

Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Feb. 28, 2015	Feb. 28, 2014
Cash flows from operating activities
Net loss	$ (2,720,293)	$ (1,226,426)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization	173,080	194,844
Gain on sale of investments available-for-sale and trading securities	0	(161,864)
Stock based compensation	98,682	98,682
Gain on sale of assets	(2,750)	0
Foreign currency exchange (gains) losses	301,419	(70,971)
Changes in operating assets and liabilities:
Accounts receivable	374,700	(398,685)
Accounts receivable, other	24,925	(24,931)
Interest receivable	17,581	(6,477)
Inventories	36,058	7,123
Prepaid expenses	154,919	71,577
Accounts payable	378,987	71,045
Accrued liabilities	(1,021,710)	4,148,276
Net cash from operating activities	(2,184,402)	2,702,193
Cash flows from investing activities
Sales proceeds of investments available-for-sale and trading securities	0	1,233,286
Purchase of equipment	(309,617)	(106,079)
Sales proceeds of equipment	2,750	0
Net cash from investing activities	(306,867)	1,127,207
Cash flows from financing activities
Principal payments on notes payable	(6,734)	(19,905)
Purchase of treasury stock	(27,061)	0
Payments on capital lease	(11,880)	(101,915)
Net cash from financing activities	(45,675)	(121,820)
Net change in cash and cash equivalents	(2,536,944)	3,707,580
Cash at beginning of period	16,819,504	13,585,447
Cash at end of period	14,282,560	17,293,027
Cash paid during the period for:
Interest	1,534	20,130
Income taxes	0	0
Non cash investing and financing activities:
Unrealized change in fair value of available-for-sale securities	$ (2,491,498)	$ 2,571,312

Consolidated Balance Sheets [Parenthetical] - USD ($)	Feb. 28, 2015	Aug. 31, 2014
Allowance For Doubtful Accounts Receivable Current (in dollars)	$ 125,799,000	$ 154,132,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	14,418,626	14,418,626
Common Stock, shares outstanding	13,888,010	13,888,010
Treasury Stock, Shares	530,616	530,616

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Feb. 28, 2015	Aug. 31, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Feb. 28, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q2
Entity Registrant Name	DYNACQ HEALTHCARE INC
Entity Central Index Key	0000890908
Current Fiscal Year End Date	--08-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	DYII
Entity Common Stock, Shares Outstanding		13,460,124

Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
Consolidated Statements of Operations - USD ($)	Feb. 28, 2015	Feb. 28, 2014	Feb. 28, 2015	Feb. 28, 2014
Net patient service revenue	$ 1,754,888	$ 2,231,387	$ 4,073,566	$ 4,490,634
Costs and expenses:
Compensation and benefits	1,657,603	1,592,448	3,281,313	3,044,215
Medical services and supplies	343,838	304,093	855,225	921,563
Other operating expenses	1,287,181	1,046,262	2,538,186	2,158,740
Depreciation and amortization	86,531	86,535	173,080	194,844
Total costs and expenses	3,375,153	3,029,338	6,847,804	6,319,362
Operating loss	(1,620,265)	(797,951)	(2,774,238)	(1,828,728)
Other income (expense):
Rent and other income (expense)	(189,450)	141,564	(168,149)	417,109
Interest income	193,944	224,292	429,059	426,615
Interest expense	(104,025)	(85,470)	(206,965)	(241,422)
Total other income (expense), net	(99,531)	280,386	53,945	602,302
Loss before income taxes	(1,719,796)	(517,565)	(2,720,293)	(1,226,426)
Provision (benefit) for income taxes	0	0	0	0
Net loss	(1,719,796)	(517,565)	(2,720,293)	(1,226,426)
Less: Net (income) loss attributable to noncontrolling interest	33	(59)	(85)	(33)
Net loss attributable to Dynacq Healthcare, Inc.	$ (1,719,763)	$ (517,624)	$ (2,720,378)	$ (1,226,459)
Basic and diluted loss per common share
Basic and diluted loss per common share (in dollars per share)	$ (0.12)	$ (0.04)	$ (0.2)	$ (0.08)
Basic and diluted average common shares outstanding (in shares)	13,888,010	14,418,626	13,888,010	14,436,483

Stock Based Compensation (Details 1) - Feb. 28, 2015 - shares shares in Thousands	Total
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Shares	784
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	6 years 6 months
Options Exercisable, Number of Shares	589
Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Shares	250
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	6 years 10 months 24 days
Options Exercisable, Number of Shares	188
Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Options Outstanding, Number of Shares	534
Options Outstanding, Weighted Average Remaining Contractual Life (Years)	6 years 4 months 24 days
Options Exercisable, Number of Shares	401

Net Loss per Common Share (Details Textual) - shares	6 Months Ended
Net Loss per Common Share (Details Textual) - shares	Feb. 28, 2015	Feb. 28, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options with exercise prices exceeding current market prices	784,000	1,069,000